0001075415-24-000015.txt : 20240506 0001075415-24-000015.hdr.sgml : 20240506 20240506162947 ACCESSION NUMBER: 0001075415-24-000015 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DIVERSIFIED HEALTHCARE TRUST CENTRAL INDEX KEY: 0001075415 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 043445278 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15319 FILM NUMBER: 24917974 BUSINESS ADDRESS: STREET 1: C/O THE RMR GROUP STREET 2: TWO NEWTON PL., 255 WASH. ST., STE. 300 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (617) 796-8350 MAIL ADDRESS: STREET 1: C/O THE RMR GROUP STREET 2: TWO NEWTON PL., 255 WASH. ST., STE. 300 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: SENIOR HOUSING PROPERTIES TRUST DATE OF NAME CHANGE: 19981217 10-Q 1 dhc-20240331.htm 10-Q dhc-20240331
0001075415false12/312024Q1http://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherLiabilitieshttp://fasb.org/us-gaap/2023#OtherLiabilities00010754152024-01-012024-03-310001075415dhc:SeniorNotesDue2042Member2024-01-012024-03-310001075415dhc:SeniorNotesDue2046Member2024-01-012024-03-3100010754152024-05-01xbrli:shares00010754152024-03-31iso4217:USD00010754152023-12-310001075415us-gaap:SecuredDebtMember2024-03-310001075415us-gaap:SecuredDebtMember2023-12-310001075415us-gaap:UnsecuredDebtMember2024-03-310001075415us-gaap:UnsecuredDebtMember2023-12-31iso4217:USDxbrli:shares0001075415dhc:RentalIncomeMember2024-01-012024-03-310001075415dhc:RentalIncomeMember2023-01-012023-03-310001075415dhc:ResidentFeesAndServicesMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMember2023-01-012023-03-3100010754152023-01-012023-03-310001075415srt:AffiliatedEntityMember2024-01-012024-03-310001075415srt:AffiliatedEntityMember2023-01-012023-03-310001075415us-gaap:CommonStockMember2023-12-310001075415us-gaap:AdditionalPaidInCapitalMember2023-12-310001075415us-gaap:RetainedEarningsMember2023-12-310001075415us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001075415dhc:CumulativeCommonDistributionsMember2023-12-310001075415us-gaap:RetainedEarningsMember2024-01-012024-03-310001075415us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001075415dhc:CumulativeCommonDistributionsMember2024-01-012024-03-310001075415us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001075415us-gaap:CommonStockMember2024-01-012024-03-310001075415us-gaap:CommonStockMember2024-03-310001075415us-gaap:AdditionalPaidInCapitalMember2024-03-310001075415us-gaap:RetainedEarningsMember2024-03-310001075415us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001075415dhc:CumulativeCommonDistributionsMember2024-03-310001075415us-gaap:CommonStockMember2022-12-310001075415us-gaap:AdditionalPaidInCapitalMember2022-12-310001075415us-gaap:RetainedEarningsMember2022-12-310001075415us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001075415dhc:CumulativeCommonDistributionsMember2022-12-3100010754152022-12-310001075415us-gaap:RetainedEarningsMember2023-01-012023-03-310001075415dhc:CumulativeCommonDistributionsMember2023-01-012023-03-310001075415us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001075415us-gaap:CommonStockMember2023-01-012023-03-310001075415us-gaap:CommonStockMember2023-03-310001075415us-gaap:AdditionalPaidInCapitalMember2023-03-310001075415us-gaap:RetainedEarningsMember2023-03-310001075415us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001075415dhc:CumulativeCommonDistributionsMember2023-03-3100010754152023-03-31dhc:propertydhc:state0001075415us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2024-03-310001075415dhc:SeniorLivingCommunitiesMember2024-03-310001075415dhc:JointVentureMember2024-03-31dhc:jointVenture0001075415stpr:AZus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberdhc:MedicalOfficeMember2024-03-310001075415stpr:AZus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberdhc:MedicalOfficeMember2024-01-012024-03-310001075415stpr:AZus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberdhc:MedicalOfficeMember2024-03-012024-03-310001075415us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberdhc:LifeScienceAndMedicalOfficeMember2024-03-310001075415dhc:SeniorLivingCommunitiesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2024-03-310001075415dhc:PropertiesUnderAgreementToSellMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2024-05-020001075415dhc:MedicalOfficeMember2024-01-012024-03-310001075415dhc:MedicalOfficeMember2024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMember2024-03-31xbrli:pureutr:sqft0001075415us-gaap:CorporateJointVentureMemberdhc:TheLSMDFundREITLLCMember2024-03-310001075415us-gaap:CorporateJointVentureMember2024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMemberstpr:MA2024-03-310001075415us-gaap:CorporateJointVentureMemberstpr:CAdhc:TheLSMDFundREITLLCMember2024-03-310001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2024-03-310001075415srt:MinimumMemberus-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMember2024-03-310001075415dhc:USSwapRateMemberus-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMember2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:SecuredOvernightFinancingRateSOFRMemberstpr:CAdhc:TheLSMDFundREITLLCMember2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMemberus-gaap:InterestRateCapMemberdhc:SecuredOvernightFinancingRateSOFRMemberdhc:TheLSMDFundREITLLCMemberstpr:CA2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:SecuredOvernightFinancingRateSOFRMemberstpr:CAdhc:TheLSMDFundREITLLCMember2024-03-31dhc:option0001075415us-gaap:CorporateJointVentureMemberstpr:CAdhc:TheLSMDFundREITLLCMember2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:MedicalOfficeBuildingandLifeScienceBuildingMember2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMember2024-01-012024-03-310001075415us-gaap:CorporateJointVentureMember2023-01-012023-03-310001075415dhc:AlerisLifeIncMember2024-03-310001075415dhc:AlerisLifeIncMember2024-03-310001075415us-gaap:EquityMethodInvestmentsMemberdhc:AlerisLifeIncMember2024-01-012024-03-310001075415dhc:AlerisLifeIncMember2024-01-012024-03-310001075415us-gaap:MortgagesMember2024-03-310001075415dhc:FinanceLeasedPropertiesMember2024-03-310001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2023-12-210001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2024-03-310001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2023-01-012023-01-310001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2023-01-310001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2023-02-280001075415us-gaap:LineOfCreditMemberus-gaap:UnsecuredDebtMember2023-02-012023-02-280001075415us-gaap:SecuredDebtMemberdhc:SeniorSecuredNoteDue2026Member2024-03-310001075415us-gaap:SecuredDebtMemberdhc:SeniorSecuredNotesDueJanuary2026Member2024-03-310001075415dhc:SeniorUnsecuredNotes975PercentDue2025Memberus-gaap:SeniorNotesMember2024-03-310001075415us-gaap:SeniorNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2024-03-310001075415dhc:UnsecuredDebtNotGuaranteedMember2024-03-310001075415us-gaap:SecuredDebtMemberdhc:SeniorSecuredNotesDueJanuary2026Member2024-01-012024-03-310001075415us-gaap:SecuredDebtMemberdhc:SeniorSecuredNoteDue2026Member2024-01-012024-03-310001075415us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeaportInnovationLLCMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMember2024-03-310001075415us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeaportInnovationLLCMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMember2023-12-310001075415us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:TheLSMDFundREITLLCMemberdhc:JointVentureMember2024-03-310001075415us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:TheLSMDFundREITLLCMemberdhc:JointVentureMember2023-12-310001075415us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310001075415us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001075415us-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMemberus-gaap:MeasurementInputDiscountRateMember2024-03-310001075415dhc:MeasurementInputMarketCapitalizationRateMemberus-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMember2024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:SeaportInnovationLLCMember2024-01-012024-03-310001075415srt:MinimumMemberus-gaap:CorporateJointVentureMemberdhc:TheLSMDFundREITLLCMemberus-gaap:MeasurementInputDiscountRateMember2024-03-310001075415us-gaap:CorporateJointVentureMembersrt:MaximumMemberdhc:TheLSMDFundREITLLCMemberus-gaap:MeasurementInputDiscountRateMember2024-03-310001075415dhc:MeasurementInputMarketCapitalizationRateMembersrt:MinimumMemberus-gaap:CorporateJointVentureMemberdhc:TheLSMDFundREITLLCMember2024-03-310001075415dhc:MeasurementInputMarketCapitalizationRateMemberus-gaap:CorporateJointVentureMembersrt:MaximumMemberdhc:TheLSMDFundREITLLCMember2024-03-310001075415us-gaap:CorporateJointVentureMemberdhc:TheLSMDFundREITLLCMember2024-01-012024-03-310001075415us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberdhc:MedicalOfficeMember2024-03-310001075415us-gaap:FairValueMeasurementsNonrecurringMemberdhc:MedicalOfficeMember2024-03-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes9.750PercentDue2024Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes9.750PercentDue2024Member2024-03-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes9.750PercentDue2024Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes9.750PercentDue2024Member2023-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes9.750PercentDue2024Member2023-12-310001075415dhc:SeniorSecuredNotesMemberdhc:SeniorSecuredNotesZeroCouponRateDue2026Member2024-03-310001075415dhc:SeniorSecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorSecuredNotesZeroCouponRateDue2026Member2024-03-310001075415dhc:SeniorSecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorSecuredNotesZeroCouponRateDue2026Member2024-03-310001075415dhc:SeniorSecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorSecuredNotesZeroCouponRateDue2026Member2023-12-310001075415dhc:SeniorSecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorSecuredNotesZeroCouponRateDue2026Member2023-12-310001075415dhc:SeniorUnsecuredNotes4.75PercentDue2028Memberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2023-12-310001075415dhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2023-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2024-03-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2023-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4375PercentDue2031Member2023-12-310001075415dhc:SeniorUnsecuredNotes5625PercentDue2042Memberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2024-03-310001075415dhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2023-12-310001075415dhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMember2023-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Member2024-03-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Member2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Member2023-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Member2023-12-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SecuredDebtsAndFinanceLeasesMember2024-03-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SecuredDebtsAndFinanceLeasesMember2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SecuredDebtsAndFinanceLeasesMember2023-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SecuredDebtsAndFinanceLeasesMember2023-12-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001075415us-gaap:FairValueInputsLevel1Member2024-03-31dhc:security0001075415us-gaap:FairValueInputsLevel1Member2023-12-310001075415us-gaap:FairValueInputsLevel2Member2023-12-310001075415us-gaap:FairValueInputsLevel2Member2024-03-310001075415dhc:ReitManagementAndResearchMember2024-01-012024-03-3100010754152024-02-152024-02-150001075415us-gaap:SubsequentEventMember2024-04-112024-04-11dhc:segment0001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMemberdhc:RentalIncomeMember2024-01-012024-03-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMember2024-01-012024-03-310001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2024-01-012024-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2024-01-012024-03-310001075415us-gaap:CorporateNonSegmentMember2024-01-012024-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2024-03-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2024-03-310001075415us-gaap:CorporateNonSegmentMember2024-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMemberdhc:RentalIncomeMember2023-01-012023-03-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMember2023-01-012023-03-310001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2023-01-012023-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001075415dhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2023-01-012023-03-310001075415dhc:ResidentFeesAndServicesMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2023-01-012023-03-310001075415us-gaap:CorporateNonSegmentMember2023-01-012023-03-310001075415dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2023-12-310001075415us-gaap:OperatingSegmentsMemberdhc:SeniorHousingOperatingPortfolioSegmentMember2023-12-310001075415us-gaap:CorporateNonSegmentMember2023-12-310001075415srt:AffiliatedEntityMemberdhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMember2024-01-012024-03-31dhc:community0001075415srt:AffiliatedEntityMemberdhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMember2023-01-012023-03-310001075415srt:AffiliatedEntityMemberdhc:FiveStarQualityCareIncMember2024-01-012024-03-310001075415srt:AffiliatedEntityMemberdhc:FiveStarQualityCareIncMember2023-01-012023-03-310001075415srt:AffiliatedEntityMemberus-gaap:OperatingExpenseMemberdhc:FiveStarQualityCareIncMember2024-01-012024-03-310001075415srt:AffiliatedEntityMemberus-gaap:OperatingExpenseMemberdhc:FiveStarQualityCareIncMember2023-01-012023-03-310001075415srt:AffiliatedEntityMemberdhc:FiveStarQualityCareIncMemberdhc:RehabilitationServicesMember2024-01-012024-03-310001075415srt:AffiliatedEntityMemberdhc:FiveStarQualityCareIncMemberdhc:RehabilitationServicesMember2023-01-012023-03-310001075415srt:AffiliatedEntityMemberdhc:SeniorLivingCommunityMemberdhc:ThirdPartyManagersMember2024-01-012024-03-310001075415srt:AffiliatedEntityMemberdhc:SeniorLivingCommunityMemberdhc:ThirdPartyManagersMember2023-01-012023-03-310001075415srt:AffiliatedEntityMemberdhc:SeniorLivingCommunityMemberdhc:ThirdPartyManagersMembersrt:ScenarioForecastMember2024-04-012024-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:BasicHousingAndSupportServicesMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMemberdhc:BasicHousingAndSupportServicesMember2023-01-012023-03-310001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2023-01-012023-03-310001075415dhc:ResidentFeesAndServicesMemberdhc:PrivatePayAndOtherThirdPartyPayerServicesMember2024-01-012024-03-310001075415dhc:ResidentFeesAndServicesMemberdhc:PrivatePayAndOtherThirdPartyPayerServicesMember2023-01-012023-03-31dhc:employee0001075415dhc:SeniorLivingCommunityMemberdhc:ReitManagementAndResearchMember2024-01-012024-03-31dhc:agreement0001075415dhc:ReitManagementAndResearchMember2023-01-012023-03-31dhc:jointVenture_arrangement0001075415dhc:DiversifiedHealthcareTrustMemberdhc:ABPTrustAndMr.PortnoyMember2024-03-310001075415dhc:AlerisLifeIncMemberus-gaap:RelatedPartyMember2023-03-200001075415dhc:AlerisLifeIncMemberdhc:AlerisLifeIncMember2023-03-200001075415dhc:AlerisLifeIncMember2023-02-022023-02-020001075415dhc:AlerisLifeIncMember2024-02-160001075415dhc:AlerisLifeIncMember2024-02-162024-02-160001075415dhc:ABPTrustMemberdhc:AlerisLifeIncMember2024-02-160001075415dhc:ReitManagementAndResearchLLCMemberus-gaap:RelatedPartyMember2024-01-012024-03-310001075415dhc:ReitManagementAndResearchLLCMemberus-gaap:RelatedPartyMember2024-03-310001075415dhc:ReitManagementAndResearchLLCMemberdhc:RentalIncomeMember2024-01-012024-03-310001075415dhc:ReitManagementAndResearchLLCMemberdhc:RentalIncomeMember2023-01-012023-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549 
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the quarterly period ended March 31, 2024
OR 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
Commission File Number 1-15319 
DIVERSIFIED HEALTHCARE TRUST
(Exact Name of Registrant as Specified in Its Charter) 
Maryland 04-3445278
(State or Other Jurisdiction of Incorporation or
Organization)		 (IRS Employer Identification No.)
 Two Newton Place, 255 Washington Street, Suite 300, Newton, MA 02458-1634
(Address of Principal Executive Offices) (Zip Code) 
617 - 796 - 8350
(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title Of Each ClassTrading Symbol(s)Name Of Each Exchange On Which Registered
Common Shares of Beneficial InterestDHCThe Nasdaq Stock Market LLC
5.625% Senior Notes due 2042DHCNIThe Nasdaq Stock Market LLC
6.25% Senior Notes due 2046DHCNLThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐ 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No ☐ 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large accelerated filer☐ Accelerated filer☒
Non-accelerated filer☐ Smaller reporting company☐
Emerging growth company☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒
Number of registrant's common shares outstanding as of May 1, 2024: 240,393,722

DIVERSIFIED HEALTHCARE TRUST
FORM 10-Q
 
March 31, 2024
 
INDEX
  Page
 
   
   
 
   
 
   
 
   
 
   
   
   
   
 
   
 
   
   
   
 
 
References in this Quarterly Report on Form 10-Q to the Company, we, us or our include Diversified Healthcare Trust and its consolidated subsidiaries unless otherwise expressly stated or the context indicates otherwise.


PART I.  Financial Information
 
Item 1.  Financial Statements.
 
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands, except share data)
(unaudited)
 March 31,December 31,
 20242023
Assets  
Real estate properties:  
Land$641,481 $652,977 
Buildings and improvements6,129,767 6,165,490 
Total real estate properties, gross6,771,248 6,818,467 
Accumulated depreciation(2,062,327)(2,020,843)
Total real estate properties, net4,708,921 4,797,624 
Investments in unconsolidated joint ventures130,299 129,916 
Assets of properties held for sale38,107 9,447 
Cash and cash equivalents207,123 245,939 
Restricted cash1,040 1,022 
Equity method investment15,740 — 
Acquired real estate leases and other intangible assets, net31,723 33,948 
Other assets, net215,084 228,240 
Total assets$5,348,037 $5,446,136 
Liabilities and Shareholders' Equity  
Senior secured notes, net$751,890 $731,211 
Senior unsecured notes, net2,073,757 2,072,618 
Secured debt and finance leases, net12,197 13,020 
Liabilities of properties held for sale218 32 
Accrued interest23,751 22,847 
Other liabilities237,521 269,517 
Total liabilities3,099,334 3,109,245 
Commitments and contingencies
Shareholders' equity:  
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,393,722 and 240,423,898 shares issued and outstanding, respectively
2,404 2,405 
Additional paid in capital4,618,950 4,618,470 
Cumulative net income1,692,019 1,778,278 
Cumulative other comprehensive loss(4)— 
Cumulative distributions(4,064,666)(4,062,262)
Total shareholders' equity2,248,703 2,336,891 
Total liabilities and shareholders' equity$5,348,037 $5,446,136 

 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
1
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(amounts in thousands, except per share data)
(unaudited)
 Three Months Ended March 31,
 20242023
Revenues:  
Rental income$62,650 $66,438 
Residents fees and services308,126 279,592 
Total revenues370,776 346,030 
Expenses:  
Property operating expenses307,604 286,080 
Depreciation and amortization70,133 64,800 
General and administrative7,568 5,873 
Acquisition and certain other transaction related costs86 93 
Impairment of assets12,142 5,925 
Total expenses397,533 362,771 
(Loss) gain on sale of properties(5,874)1,233 
Gains and losses on equity securities, net— 8,126 
Interest and other income2,237 4,195 
Interest expense (including net amortization of debt discounts, premiums and issuance costs of $24,863 and $2,074, respectively)
(57,576)(47,780)
Loss on modification or early extinguishment of debt— (1,075)
Loss before income tax (expense) benefit and equity in net earnings (losses) of investees(87,970)(52,042)
Income tax (expense) benefit(187)31 
Equity in net earnings (losses) of investees1,898 (647)
Net loss$(86,259)$(52,658)
Other comprehensive loss:  
Equity in unrealized losses of an investee(4)— 
Other comprehensive loss(4)— 
Comprehensive loss$(86,263)$(52,658)
Weighted average common shares outstanding (basic and diluted)239,193 238,589 
Per common share amounts (basic and diluted):  
Net loss$(0.36)$(0.22)
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(dollars in thousands)
(unaudited)
Number of
Shares		Common
Shares		Additional
Paid In
Capital		Cumulative
Net Income		Cumulative Other Comprehensive LossCumulative DistributionsTotal Shareholders' Equity
Balance at December 31, 2023:240,423,898 $2,405 $4,618,470 $1,778,278 $— $(4,062,262)$2,336,891 
Net loss— — — (86,259)— — (86,259)
Equity in unrealized losses of an investee— — — — (4)— (4)
Distributions— — — — — (2,404)(2,404)
Share grants— — 558 — — — 558 
Share repurchases(30,176)(1)(78)— — — (79)
Balance at March 31, 2024:240,393,722 $2,404 $4,618,950 $1,692,019 $(4)$(4,064,666)$2,248,703 
Balance at December 31, 2022:239,694,842 $2,397 $4,617,031 $2,071,850 $— $(4,052,667)$2,638,611 
Net loss— — — (52,658)— — (52,658)
Distributions— — — — — (2,397)(2,397)
Share grants— — 270 — — — 270 
Share repurchases(5,975)— (6)— — — (6)
Share forfeitures(6,400)— (1)— — — (1)
Balance at March 31, 2023:239,682,467 $2,397 $4,617,294 $2,019,192 $— $(4,055,064)$2,583,819 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
(unaudited)
 Three Months Ended March 31,
 20242023
Cash flows from operating activities:  
Net loss$(86,259)$(52,658)
Adjustments to reconcile net loss to cash provided by operating activities:  
Depreciation and amortization70,133 64,800 
Net amortization of debt discounts, premiums and issuance costs24,863 2,074 
Straight line rental income(291)(2,448)
Amortization of acquired real estate leases and other intangible assets, net28 (311)
Loss on modification or early extinguishment of debt— 1,075 
Impairment of assets12,142 5,925 
Loss (gain) on sale of properties5,874 (1,233)
Gains and losses on equity securities, net— (8,126)
Other non-cash adjustments, net(385)(674)
Unconsolidated joint venture distributions1,231 1,411 
Equity in net (earnings) losses of investees(1,898)647 
Change in assets and liabilities:  
Deferred leasing costs, net(669)(1,954)
Other assets10,102 15,499 
Accrued interest904 2,540 
Other liabilities(7,173)(20,525)
Net cash provided by operating activities28,602 6,042 
Cash flows from investing activities:  
Real estate improvements(46,723)(60,292)
Proceeds from sale of properties, net3,343 3,548 
Investment in AlerisLife Inc.(15,459)— 
Net cash used in investing activities(58,839)(56,744)
Cash flows from financing activities:  
Repayments of borrowings on credit facility— (250,000)
Repayment of other debt(822)(538)
Payment of debt issuance costs(5,257)(1,990)
Repurchase of common shares(78)(6)
Distributions to shareholders(2,404)(2,397)
Net cash used in financing activities(8,561)(254,931)
Decrease in cash and cash equivalents and restricted cash(38,798)(305,633)
Cash and cash equivalents and restricted cash at beginning of period246,961 688,302 
Cash and cash equivalents and restricted cash at end of period$208,163 $382,669 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(dollars in thousands)
(unaudited)
Three Months Ended March 31,
20242023
Supplemental cash flow information:  
Interest paid$31,809 $43,166 
Income taxes paid$— $— 
Non-cash investing activities:
Receivable from AlerisLife Inc. tender offer$— $14,006 
Real estate improvements accrued, not paid$17,369 $20,195 
Supplemental disclosure of cash and cash equivalents and restricted cash:
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within our condensed consolidated balance sheets to the amount shown in our condensed consolidated statements of cash flows:
As of March 31,
20242023
Cash and cash equivalents$207,123 $380,117 
Restricted cash (1)
1,040 2,552 
Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows$208,163 $382,669 
(1) Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


5
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 
Note 1.  Basis of Presentation
The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2023, or our Annual Report.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.
The preparation of these financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 450, Contingencies, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.
Note 2.  Recent Accounting Pronouncements

On November 27, 2023, the FASB issued Accounting Standards Update, or ASU, No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, or ASU No. 2023-07, which requires public entities to: (i) provide disclosures of significant segment expenses and other segment items if they are regularly provided to the Chief Operating Decision Maker, or the CODM, and included in each reported measure of segment profit or loss; (ii) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by ASC 280, Segment Reporting, or ASC 280, in interim periods; and (iii) disclose the CODM’s title and position, as well as an explanation of how the CODM uses the reported measures and other disclosures. Public entities with a single reportable segment must apply all the disclosure requirements of ASU No. 2023-07, as well as all the existing segment disclosures under ASC 280. The amendments in ASU No. 2023-07 are incremental to the requirements in ASC 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU No. 2023-07 should be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact ASU No. 2023-07 will have on our consolidated financial statements and disclosures.
On December 14, 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, or ASU No. 2023-09, which requires public entities to enhance their annual income tax disclosures by requiring: (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 should be applied prospectively but entities have the option to apply it retrospectively to all prior periods presented in the financial statements. ASU No. 2023-09 is effective for annual periods
6
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact ASU No. 2023-09 will have on our consolidated financial statements and disclosures.
Note 3.  Real Estate and Other Investments
As of March 31, 2024, we owned 371 properties located in 36 states and Washington, D.C., including four properties classified as held for sale and two closed senior living communities, and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states.
Acquisitions and Dispositions:
We did not acquire any properties during the three months ended March 31, 2024.
During the three months ended March 31, 2024, we sold one property for a sales price of $3,600, excluding closing costs, as presented in the table below. The sale of this property does not represent a significant disposition and we do not believe this sale represents a strategic shift in our business. As a result, the results of operations for this property are included in continuing operations through the date of sale of such property in our condensed consolidated statements of comprehensive income (loss).
Date of SaleLocationType of PropertyNumber of Properties
Sales Price (1)
Loss on Sale
March 2024ArizonaMedical Office1$3,600 $5,874 
(1)Sales price excludes closing costs.
As of March 31, 2024, we had four properties classified as held for sale in our condensed consolidated balance sheet as follows:
Type of PropertyNumber of PropertiesReal Estate Properties, Net
Medical Office and Life Science3$34,245 
Senior Living11,525 
4$35,770 
As of May 2, 2024, we had two properties under agreements to sell for an aggregate sales price of approximately $10,375, excluding closing costs. We may not complete the sales of any or all of the properties we currently plan to sell. Also, we may sell some or all of these properties at amounts that are less than currently expected and/or less than the carrying values of such properties and we may incur losses on any such sales as a result.
Impairment:
We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future undiscounted cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value.
During the three months ended March 31, 2024, we recorded impairment charges of $12,142 related to two medical office properties that were classified as held for sale as of March 31, 2024.
7
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
Equity Method Investments in Unconsolidated Joint Ventures:
As of March 31, 2024, we had equity investments in unconsolidated joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at March 31, 2024
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$85,922 1MA1,134,479 
The LSMD Fund REIT LLC20%44,377 10CA, MA, NY, TX, WA1,068,763 
$130,299 112,203,242 
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at March 31, 2024 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2) (3)
3.53%11/6/2028$620,000 
Mortgage Notes Payable (secured by nine properties in five states) (4)
3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (4) (5)
6.38%2/9/2025266,825 
4.22%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)We provide certain guaranties on this debt.
(3)This mortgage loan requires interest only payments until the anticipated repayment date on August 6, 2026, at which time all accrued and unpaid interest along with the principal balance of $620,000 is expected to be repaid. This mortgage loan matures on November 6, 2028 and any unpaid principal from the anticipated repayment date through the maturity date bears interest at a variable rate of the greater of 6.53% or the then effective U.S. swap rate for the swap terminating on the maturity date plus 5.00%.
(4)The debt securing these properties is non-recourse to us.
(5)This mortgage loan matures on February 9, 2025 and requires interest to be paid at an annual rate of the one month term secured overnight financing rate, or SOFR, plus a premium of 1.90%. This joint venture has also purchased an interest rate cap through February 2025 with a SOFR strike rate equal to 4.48% and an initial premium of $1,200. The maturity date of this mortgage loan is subject to two remaining one-year extension options.

We account for the unconsolidated joint venture for 10 medical office and life science properties in which we own a 20% equity interest, or the LSMD JV, and the unconsolidated joint venture for a life science property located in Boston, Massachusetts in which we own a 10% equity interest, or the Seaport JV, using the equity method of accounting under the fair value option. During the three months ended March 31, 2024 and 2023, respectively, we recognized a $1,613 and $(647) change in the fair value of our investments in our unconsolidated joint ventures. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 6 for further information regarding the valuation of our investment in these joint ventures.
Equity Method Investment in AlerisLife:
As of March 31, 2024, we owned approximately 34.0% of the outstanding common shares of AlerisLife Inc., or AlerisLife. We account for our 34.0% non-controlling interest in AlerisLife using the equity method of accounting.
As of March 31, 2024, our investment in AlerisLife had a carrying value of $15,740. The cost basis of our investment in AlerisLife exceeded our proportionate share of AlerisLife's total stockholders' equity book value on the date of acquisition of our initial interest in AlerisLife, which was February 16, 2024, by an aggregate of $29,500. As required under GAAP, we are amortizing this difference to equity in earnings of an investee over 21 years, the weighted average remaining useful life of the real estate assets owned by AlerisLife and the intangible contract asset with us as of the date of acquisition. We recorded amortization of the basis difference of $174 for the three months ended March 31, 2024. We recognized income of $111 related to our investment in AlerisLife for the three months ended March 31, 2024. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 11 for further information regarding our investment in AlerisLife.
8
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
Note 4.  Leases
We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.
Our leases provide for base rent payments and, in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.
We increased rental income to record revenue on a straight line basis by $291 and $2,448 for the three months ended March 31, 2024 and 2023, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $74,704 and $75,306 of straight line rent receivables at March 31, 2024 and December 31, 2023, respectively, and are included in other assets, net in our condensed consolidated balance sheets.
We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $11,350 and $11,986 for the three months ended March 31, 2024 and 2023, respectively, of which tenant reimbursements totaled $11,284 and $11,924, respectively.
Right of Use Asset and Lease Liability: For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $22,555 and $22,937, respectively, as of March 31, 2024, and $23,366 and $23,748, respectively, as of December 31, 2023. The right of use assets and related lease liabilities are included within other assets, net and other liabilities, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.
Note 5.  Indebtedness
Our principal debt obligations, excluding any debt obligations of our joint ventures, at March 31, 2024 were: (1) $2,100,000 outstanding principal amount of senior unsecured notes; (2) $940,534 outstanding principal amount of senior secured notes; and (3) $8,669 principal amount of mortgage debt secured by one property. The mortgaged property had a net book value of $13,466 at March 31, 2024. We also had two properties subject to finance leases that expire in 2026 with lease obligations totaling $3,528 at March 31, 2024; these two properties had an aggregate net book value of $22,365 at March 31, 2024.
Until its repayment in full on December 21, 2023, we had a $450,000 credit facility that was fully drawn. As of December 21, 2023, our former credit facility was paid off in full and the related credit agreement was terminated. The weighted average annual interest rate for borrowings under our former credit facility was 7.6% for the three months ended March 31, 2023. In January 2023, pursuant to the credit agreement, we repaid $113,627 in outstanding borrowings under our former credit facility and the commitments were reduced to $586,373. In February 2023, we and our lenders amended the credit agreement to reduce the commitments from $586,373 to $450,000 following our repayment of $136,373 in outstanding borrowings under our former credit facility, and as a result of that reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $1,075 for the three months ended March 31, 2023.
As of March 31, 2024, all $940,534 of our senior secured notes due 2026 are fully and unconditionally guaranteed, on a joint, several and senior secured basis, by certain of our subsidiaries that own 95 properties, or the Collateral Guarantors, and on a joint, several and unsecured basis, by all our subsidiaries other than the Collateral Guarantors and certain excluded subsidiaries, and all $500,000 of our 9.75% senior notes due 2025 and all $500,000 of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint, several and unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries. The notes and related guarantees (other than our senior secured notes and the guarantees provided by the
9
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
Collateral Guarantors) are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and the notes and related guarantees are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1,100,000 of senior unsecured notes do not have the benefit of any guarantees as of March 31, 2024.
Our senior secured notes due 2026 and the guarantees provided by the Collateral Guarantors are secured by a first priority lien and security interest in each of the collateral properties and 100% of the equity interests in each of the Collateral Guarantors. No cash interest will accrue on these notes prior to maturity. The accreted value of these notes will increase at a rate of 11.25% per annum compounded semiannually on January 15 and July 15 of each year, such that the accreted value will equal the principal amount at maturity. During the three months ended March 31, 2024, we recognized discount accretion of $20,659 for our senior secured notes due 2026 in interest expense in our condensed consolidated statements of comprehensive income (loss). We have a one-time option to extend the maturity date of these notes by one year, to January 15, 2027, subject to satisfaction of certain conditions and payment of an extension fee. If we exercise this option, interest payments will be due semiannually during the extension period at an initial interest rate of 11.25% with increases of 50 basis points every 90 days these notes remain outstanding.
Note 6.  Fair Value of Assets and Liabilities
The following table presents certain of our assets that are measured at fair value at March 31, 2024 and December 31, 2023, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of March 31, 2024As of December 31, 2023
DescriptionCarrying ValueCarrying Value
Recurring Fair Value Measurements Assets:  
Investment in unconsolidated joint venture (Level 3) (1)
$85,922 $85,699 
Investment in unconsolidated joint venture (Level 3) (2)
$44,377 $44,217 
Non-Recurring Fair Value Measurements Assets:
Real estate properties held for sale (Level 2) (3)
$19,744 $— 
(1)The 10% equity interest we own in the Seaport JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 8.00%, an exit capitalization rate of 6.00%, a holding period of 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(2)The 20% equity interest we own in the LSMD JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 6.50% and 8.00%, exit capitalization rates of between 4.75% and 7.00%, holding periods of 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(3)We have assets in our condensed consolidated balance sheets that are measured at fair value on a non-recurring basis. During the three months ended March 31, 2024, we recorded impairment charges of $12,142 to reduce the carrying value of two medical office properties that are classified as held for sale to their estimated sales price, less estimated costs to sell, of $19,744 under agreements to sell that we have entered into with third parties. See Note 3 for further information about impairment charges and the properties we have classified as held for sale.
In addition to the assets described in the table above, our financial instruments at March 31, 2024 and December 31, 2023 included cash and cash equivalents, restricted cash, certain other assets, senior unsecured notes, senior secured notes, secured debt and finance leases and certain other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
10
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 As of March 31, 2024As of December 31, 2023
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 9.750% coupon rate, due 2025
$497,892 $500,350 $497,454 $490,750 
Senior secured notes, zero coupon rate, due 2026
751,890 798,419 731,211 771,981 
Senior unsecured notes, 4.750% coupon rate, due 2028
495,065 405,400 494,746 384,110 
Senior unsecured notes, 4.375% coupon rate, due 2031
494,060 374,350 493,845 375,000 
Senior unsecured notes, 5.625% coupon rate, due 2042
343,041 200,480 342,946 211,400 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,699 153,600 243,627 154,000 
Secured debt and finance leases (2)
12,197 11,638 13,020 12,284 
 $2,837,844 $2,444,237 $2,816,849 $2,399,525 
(1)Includes unamortized net discounts, premiums and debt issuance costs.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
We estimated the fair values of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs as defined in the fair value hierarchy under GAAP) as of March 31, 2024 and December 31, 2023. We estimated the fair values of our three issuances of senior unsecured notes due 2025, 2028 and 2031 and our issuance of senior secured notes due 2026 using an average of the bid and ask price on Nasdaq on or about March 31, 2024 and December 31, 2023 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.
Note 7.  Shareholders' Equity
Common Share Purchases:
During the three months ended March 31, 2024, we purchased an aggregate of 30,176 of our common shares, valued at a weighted average share price of $2.58 per common share, from certain former employees of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares. We withheld and purchased these common shares at their fair market values based upon the trading prices of our common shares at the close of trading on Nasdaq on the applicable purchase dates.
Distributions:
During the three months ended March 31, 2024, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 11, 2024January 22, 2024February 15, 2024$0.01 $2,404 
On April 11, 2024, we declared a quarterly distribution to common shareholders of record on April 22, 2024 of $0.01 per share, or approximately $2,404. We expect to pay this distribution on or about May 16, 2024 using cash on hand.
Note 8.  Segment Reporting
We operate in, and report financial information for, the following two segments: Medical Office and Life Science Portfolio and senior housing operating portfolio, or SHOP. We aggregate the operating results of our properties in these two reporting segments based on their similar operating and economic characteristics. Our Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed
11
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities on our behalf.
We also report “non-segment” operations, which consists of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
For the Three Months Ended March 31, 2024
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$54,149 $— $8,501 $62,650 
Residents fees and services— 308,126 — 308,126 
Total revenues54,149 308,126 8,501 370,776 
Expenses:    
Property operating expenses23,897 283,416 291 307,604 
Depreciation and amortization20,740 46,922 2,471 70,133 
General and administrative— — 7,568 7,568 
Acquisition and certain other transaction related costs
— — 86 86 
Impairment of assets12,142 — — 12,142 
Total expenses56,779 330,338 10,416 397,533 
Loss on sale of properties(5,874)— — (5,874)
Gains on equity securities, net— — — — 
Interest and other income— — 2,237 2,237 
Interest expense(222)(68)(57,286)(57,576)
Loss before income tax expense and equity in net earnings of investees(8,726)(22,280)(56,964)(87,970)
Income tax expense— — (187)(187)
Equity in net earnings of investees1,613 — 285 1,898 
Net loss$(7,113)$(22,280)$(56,866)$(86,259)
 As of March 31, 2024
 
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,834,609 $3,103,540 $409,888 $5,348,037 
12
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 For the Three Months Ended March 31, 2023
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$57,022 $— $9,416 $66,438 
Residents fees and services— 279,592 — 279,592 
Total revenues57,022 279,592 9,416 346,030 
Expenses:    
Property operating expenses23,515 262,329 236 286,080 
Depreciation and amortization20,035 42,152 2,613 64,800 
General and administrative— — 5,873 5,873 
Acquisition and certain other transaction related costs
— — 93 93 
Impairment of assets2,308 3,617 — 5,925 
Total expenses45,858 308,098 8,815 362,771 
Gain on sale of properties— 1,233 — 1,233 
Gains on equity securities, net— — 8,126 8,126 
Interest and other income— — 4,195 4,195 
Interest expense(109)(271)(47,400)(47,780)
Loss on modification or early extinguishment of debt— — (1,075)(1,075)
Income (loss) before income tax benefit and equity in net losses of investees11,055 (27,544)(35,553)(52,042)
Income tax benefit— — 31 31 
Equity in net losses of investees(647)— — (647)
Net income (loss)$10,408 $(27,544)$(35,522)$(52,658)
 As of December 31, 2023
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,866,422 $3,134,978 $444,736 $5,446,136 
Note 9. Senior Living Community Management Agreements
Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages many of our SHOP communities. Five Star manages these communities for us pursuant to a master management agreement. AlerisLife guarantees the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.
In connection with ABP Trust’s acquisition of AlerisLife on March 20, 2023, we amended the master management agreement with AlerisLife to eliminate any change of control default or event of default provisions. See Note 11 for further information regarding ABP Trust's acquisition of AlerisLife.
Our Senior Living Communities Managed by Five Star. Five Star managed 119 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by Five Star to our taxable REIT subsidiaries, or TRSs.
We incurred management fees payable to Five Star of $10,407 and $10,014 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $9,998 and $9,137, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $409 and $877, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
13
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
We incurred fees of $10 and $879 for the three months ended March 31, 2024 and 2023, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services.
Our Senior Living Communities Managed by Other Third Party Managers. Several other third party managers managed 111 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by these third party managers to our TRSs.
In March 2024, we terminated our management agreement with one of our third party managers which manages certain of our communities located in Wisconsin and Illinois. We have transitioned these communities to another third party manager which we have an existing relationship with. The terms of the management agreement for these communities are generally consistent with the terms of the existing management agreements with our other third party managers. We paid termination and other fees of $1,106 during the second quarter of 2024, and expect to incur additional costs during 2024, related to the transition of these communities.
We incurred management fees payable to these third party managers of $5,725 and $5,238 for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended March 31,
Revenue from contracts with customers:20242023
Basic housing and support services$243,655 $222,187 
Medicare and Medicaid programs23,849 21,657 
Private pay and other third party payer SNF services 40,622 35,748 
Total residents fees and services$308,126 $279,592 
Note 10. Business and Property Management Agreements with RMR
We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of many of our properties, including our medical office and life science properties, and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.
We recognized net business management fees of $4,878 and $3,270 for the three months ended March 31, 2024 and 2023, respectively. The net business management fees we recognized for the three months ended March 31, 2024 include $849 of estimated incentive fees based on our common share total return, as defined in our business management agreement. Although we recognized estimated incentive fees in accordance with GAAP, the actual amount of annual incentive fees for 2024, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2024, and will be payable in January 2025. We did not incur any incentive fee payable for the year ended December 31, 2023. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss).
We recognized aggregate net property management and construction supervision fees of $1,904 and $1,992 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $1,538 and $1,463, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $366 and $529, respectively, were capitalized as building
14
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,728 and $3,533 for these expenses and costs for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.
Management Agreements between our Joint Ventures and RMR. We have two separate joint venture arrangements with third party institutional investors, the Seaport JV and the LSMD JV. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures.
Note 11. Related Person Transactions
We have relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the majority owned subsidiary of RMR. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and, until the acquisition of AlerisLife by ABP Trust on March 20, 2023, the chair of the board of directors and a managing director of AlerisLife, and currently the sole director of AlerisLife. Jennifer F. Francis, our other Managing Trustee, our former President and Chief Executive Officer and a former managing director of AlerisLife served as an officer of RMR until December 31, 2023 and will remain an employee of RMR until her retirement on July 1, 2024. Our current President and Chief Executive Officer and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and secretary of AlerisLife and, until March 20, 2023, a managing director of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees of other public companies to which RMR or its subsidiaries provide management services. Mr. Portnoy serves as the chair of the board and as a managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services. As of March 31, 2024, ABP Trust and Mr. Portnoy owned 9.8% of our outstanding common shares.
AlerisLife. Until March 20, 2023, we were AlerisLife's largest stockholder, owning approximately 31.9% of AlerisLife's outstanding common shares, and ABP Acquisition LLC, or ABP Acquisition, a subsidiary of ABP Trust, together with ABP Trust, owned approximately 6.1% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own. RMR provides management services to both us and AlerisLife.
On February 2, 2023, AlerisLife entered into an Agreement and Plan of Merger, or the ALR Merger Agreement, with certain subsidiaries of ABP Trust, pursuant to which ABP Trust acquired all of the publicly held outstanding AlerisLife common shares at a price of $1.31 per share by tender offer.
In connection with the ALR Merger Agreement, on February 2, 2023, we agreed to tender all the AlerisLife common shares that we and our subsidiary then owned, into the tender offer at the tender offer price, subject to the right, but not the obligation, to purchase, on or before December 31, 2023, AlerisLife common shares at the tender offer price, and otherwise pursuant to a stockholders agreement to be entered into at the time of any such purchase. On December 20, 2023, we and ABP Trust extended our right to purchase AlerisLife common shares until March 31, 2024.
15
DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
On February 16, 2024, we exercised this purchase right and acquired, together with our applicable TRS, approximately 34.0% of the then outstanding AlerisLife common shares from ABP Trust at the tender offer price, for a total purchase price of $14,890, and we, our applicable TRS, ABP Trust and AlerisLife entered into a stockholders agreement. Following this acquisition, ABP Trust owns the remaining approximately 66.0% of AlerisLife.
See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star).
Our Joint Ventures. In connection with our entering into the LSMD JV in January 2022, we paid mortgage escrow amounts and closing costs that were payable by that joint venture. The remaining costs totaled $6,080 as of March 31, 2024 and are included in other assets, net, in our condensed consolidated balance sheet. RMR provides management services to each of the Seaport JV and the LSMD JV. See Note 10 for further information regarding those management agreements with RMR.
Our Manager, RMR. We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.
Leases with RMR. We lease office space to RMR in certain of our properties for RMR’s property management offices. We recognized rental income from RMR for this leased office space of $109 and $61 for the three months ended March 31, 2024 and 2023, respectively.
For further information about these and other such relationships and certain other related person transactions, see our Annual Report.
Note 12.  Income Taxes
We have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended March 31, 2024 and 2023, we recognized income tax expense of $187 and benefit of $31, respectively.
Note 13. Weighted Average Common Shares
We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share.
16
Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion should be read in conjunction with our condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q and with our Annual Report.
OVERVIEW
We are a REIT organized under Maryland law that primarily owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of March 31, 2024, we owned 371 properties located in 36 states and Washington, D.C., including four properties classified as held for sale and two closed senior living communities. At March 31, 2024, the gross book value of our real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, was $7.2 billion.
As of March 31, 2024, we owned an equity interest in each of the Seaport JV and the LSMD JV that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet that were 98% leased with an average (by annualized rental income) remaining lease term of 5.1 years.
We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, high interest rates, prolonged high inflation, labor market challenges, supply chain disruptions, volatility in the public equity and debt markets, geopolitical risks, economic downturns or a possible recession and changes in real estate utilization. We expect to experience continued volatility in labor, insurance and food costs in our SHOP segment.
In response to significant and prolonged increases in inflation, the U.S. Federal Reserve has raised interest rates multiple times since the beginning of 2022. Although the U.S. Federal Reserve has indicated that it may lower interest rates in 2024, we cannot be sure that it will do so, and interest rates may remain at the current high levels or continue to increase. These inflationary pressures in the United States, as well as global geopolitical instability and tensions, have given rise to uncertainty regarding economic downturns or a possible recession and potential disruptions in the financial markets. An economic recession, or continued or intensified disruptions in the financial markets, could adversely affect our financial condition and that of our managers, operators and tenants, could adversely impact the ability or willingness of our managers, operators, tenants or residents to pay amounts owed to us, could impair our ability to effectively deploy our capital or realize our target returns on our investments, may restrict our access to, and would likely increase our cost of, capital, and may cause the values of our properties and of our securities to decline.
We are encouraged by positive trends, including increases in rates and occupancy, in our SHOP segment. Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to generate better returns at our communities than we experienced in the years following the COVID-19 pandemic. While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase rates in excess of increases in costs, resulting in improving returns to us.
For further information and risks relating to these economic uncertainties, including changes related to the COVID-19 pandemic, and their impact on our business and financial condition, see Part I, Item 1, "Business" and Part I, Item 1A, "Risk Factors" in our Annual Report.
PORTFOLIO OVERVIEW
The following tables present an overview of our portfolio (dollars in thousands, except investment per square foot or unit data):
As of March 31, 2024Number
of Properties		Square Feet or Number of Units 
Gross Book Value of Real Estate Assets(1)
% of Total Gross Book Value of Real Estate Assets
Investment per Square Foot or Unit(2)
Q1 2024 Revenues% of
Q1 2024 Revenues
Q1 2024 NOI (3)
% of Q1 2024 NOI
Medical Office and Life Science Portfolio (4)
102 8,486,969 sq. ft.$2,263,388 31.4 %$267 $54,149 14.6 %$30,252 47.9 %
SHOP232 25,220 units4,540,601 63.1 %$180,040 308,126 83.1 %24,710 39.1 %
Triple net leased senior living communities27 2,062 units202,907 2.8 %$98,403 5,377 1.5 %5,335 8.4 %
Wellness centers10 812,000 sq. ft.194,416 2.7 %$239 3,124 0.8 %2,875 4.6 %
Total371  $7,201,312 100.0 %$370,776 100.0 %$63,172 100.0 %
17
 Occupancy
As of and For the Three Months Ended March 31,
 20242023
Medical Office and Life Science Portfolio (5)
82.9 %85.1 %
SHOP78.9 %76.9 %
Triple net leased senior living communities100.0 %100.0 %
Wellness centers100.0 %100.0 %
(1)Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.
(2)Represents gross book value of real estate assets divided by number of rentable square feet or living units, as applicable.
(3)We calculate our NOI on a consolidated basis and by reportable segment. Our definition of NOI and our reconciliation of net income (loss) to NOI are included below under the heading “Non-GAAP Financial Measures”.
(4)Our medical office and life science property leases include some triple net leases where, in addition to paying fixed rents, the tenants assume the obligation to operate and maintain the properties at their expense, and some net and modified gross leases where we are responsible for the operation and maintenance of the properties and we charge tenants for some or all of the property operating costs. A portion of our medical office and life science property leases are full-service leases where we receive fixed rent from our tenants and no reimbursement for our property operating costs.
(5)Medical office and life science property occupancy data is as of March 31, 2024 and 2023 and includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy.
During the three months ended March 31, 2024, we entered into new and renewal leases in our Medical Office and Life Science Portfolio segment as summarized in the following table (dollars and square feet in thousands, except per square foot amounts):
Three Months Ended March 31, 2024
 New LeasesRenewalsTotal
Square feet leased during the quarter25 76 101 
Weighted average rental rate change (by rentable square feet)35.3 %7.0 %11.5 %
Weighted average lease term (years)6.3 2.9 3.6 
Total leasing costs and concession commitments (1)
$1,418 $696 $2,114 
Total leasing costs and concession commitments per square foot (1)
$56.49 $9.18 $20.95 
Total leasing costs and concession commitments per square foot per year (1)
$8.97 $3.16 $5.88 
(1)Includes commitments made for leasing expenditures and concessions, such as tenant improvements, leasing commissions, tenant reimbursements and free rent.
18
During the three months ended March 31, 2024, we entered into renewal leases at three of our wellness centers totaling 129,600 square feet at rates that were 7.5% higher than prior rents for the same space at a weighted average lease term of five years. We did not incur any leasing costs or concessions commitments for these renewals.
Lease Expiration Schedules
As of March 31, 2024, lease expirations in our Medical Office and Life Science Portfolio segment were as follows (dollars in thousands):
YearNumber of TenantsSquare Feet LeasedPercent of TotalCumulative Percent of Total
Annualized  Rental Income(1)
Percent of TotalCumulative Percent of Total
202457484,323 6.9 %6.9 %$12,366 5.6 %5.6 %
202576617,857 8.8 %15.7 %17,462 8.0 %13.6 %
202657739,881 10.5 %26.2 %23,389 10.7 %24.3 %
202766981,909 14.0 %40.2 %24,605 11.2 %35.5 %
2028541,161,376 16.5 %56.7 %35,975 16.4 %51.9 %
202953597,467 8.5 %65.2 %17,385 7.9 %59.8 %
203025300,877 4.3 %69.5 %7,750 3.5 %63.3 %
203122917,785 13.0 %82.5 %26,771 12.2 %75.5 %
203216268,698 3.8 %86.3 %11,869 5.4 %80.9 %
2033 and thereafter44966,376 13.7 %100.0 %41,721 19.1 %100.0 %
Total4707,036,549 100.0 %$219,293 100.0 %
Weighted average remaining lease term (in years)5.0 5.5 
(1)Annualized rental income is based on rents pursuant to existing leases as of March 31, 2024, including straight line rent adjustments and estimated recurring expense reimbursements for certain net and modified gross leases and excluding lease value amortization at certain of our medical office and life science properties.
As of March 31, 2024, lease expirations at our triple net leased senior living communities leased to third party operators and wellness centers were as follows (dollars in thousands):
YearNumber of PropertiesNumber of Units or Square Feet
Annualized  Rental Income(1)
Percent of TotalCumulative Percent of Total
2024— — $— — %— %
2025— — — — %— %
2026— — — — %— %
20274 533 units4,612 11.8 %11.8 %
2028— — — — %11.8 %
20291 155 units547 1.4 %13.2 %
20305 283 units and 129,500 sq. ft.5,046 12.9 %26.1 %
2031— — — — %26.1 %
203218 876 units9,836 25.1 %51.2 %
2033 and thereafter9 215 units and 682,500 sq. ft.19,148 48.8 %100.0 %
Total37 $39,189 100.0 %
(1)Annualized rental income is based on rents pursuant to existing leases as of March 31, 2024. Annualized rental income includes estimated percentage rents and straight line rent adjustments and excludes lease value amortization.



19

RESULTS OF OPERATIONS (dollars and square feet in thousands, unless otherwise noted)
We operate in, and report financial information for, the following two segments: Medical Office and Life Science Portfolio and SHOP. We aggregate the operating results of our properties in these two reporting segments based on their similar operating and economic characteristics. Our Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities on our behalf.
We also report “non-segment” operations, which consists of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
The following table summarizes the results of operations of each of our segments for the three months ended March 31, 2024 and 2023:
Three Months Ended March 31,
20242023
Revenues:
Medical Office and Life Science Portfolio$54,149 $57,022 
SHOP308,126 279,592 
Non-Segment8,501 9,416 
Total revenues$370,776 $346,030 
Net income (loss):
Medical Office and Life Science Portfolio$(7,113)$10,408 
SHOP(22,280)(27,544)
Non-Segment(56,866)(35,522)
Net loss$(86,259)$(52,658)
The following section analyzes and discusses the results of operations of each of our segments for the periods presented.
20

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023 (dollars and square feet in thousands, except average monthly rate):
Unless otherwise indicated, references in this section to changes or comparisons of results, income or expenses refer to comparisons of the results for the three months ended March 31, 2024 to the three months ended March 31, 2023. Our definition of net operating income, or NOI, and our reconciliation of net income (loss) to NOI and a description of why we believe NOI is an appropriate supplemental measure are included below under the heading “Non-GAAP Financial Measures.”
Three Months Ended March 31,
20242023$ Change% Change
NOI by segment:
Medical Office and Life Science Portfolio$30,252 $33,507 $(3,255)(9.7)%
SHOP24,710 17,263 7,447 43.1 %
Non-Segment8,210 9,180 (970)(10.6)%
Total NOI63,172 59,950 3,222 5.4 %
Depreciation and amortization70,133 64,800 5,333 8.2 %
General and administrative7,568 5,873 1,695 28.9 %
Acquisition and certain other transaction related costs86 93 (7)(7.5)%
Impairment of assets12,142 5,925 6,217 104.9 %
(Loss) gain on sale of properties(5,874)1,233 (7,107)nm
Gains and losses on equity securities, net— 8,126 (8,126)(100.0)%
Interest and other income2,237 4,195 (1,958)(46.7)%
Interest expense
(57,576)(47,780)(9,796)20.5 %
Loss on modification or early extinguishment of debt— (1,075)1,075 (100.0)%
Loss before income tax (expense) benefit and equity in net earnings (losses) of investees(87,970)(52,042)(35,928)69.0 %
Income tax (expense) benefit(187)31 (218)nm
Equity in net earnings (losses) of investees1,898 (647)2,545 nm
Net loss$(86,259)$(52,658)$(33,601)63.8 %
    nm - not meaningful
Medical Office and Life Science Portfolio:
 
Comparable Properties (1)
All Properties
 As of March 31,As of March 31,
 2024202320242023
Total properties93 93 102 105 
Total square feet7,651 7,657 8,487 8,809 
Occupancy89.8 %92.9 %82.9 %85.1 %
Three Months Ended March 31,
Comparable (1)
Non-Comparable
 Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20242023ChangeChange2024202320242023ChangeChange
Rental income$52,344 $53,560 $(1,216)(2.3)%$1,805 $3,462 $54,149 $57,022 $(2,873)(5.0)%
Property operating expenses(21,771)(20,671)1,100 5.3 %(2,126)(2,844)(23,897)(23,515)382 1.6 %
NOI$30,573 $32,889 $(2,316)(7.0)%$(321)$618 $30,252 $33,507 $(3,255)(9.7)%
(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since January 1, 2023; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and properties owned by unconsolidated joint ventures in each of which we own an equity interest.
Rental income. Rental income decreased at our comparable properties primarily due to vacancies at certain of our properties, partially offset by increased parking revenue at one of our properties. Rental income also decreased at our non-comparable
21

properties primarily due to a tenant default at one of our properties, partially offset by an increase in rental income at one of our recently redeveloped properties.
Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, management fees, salaries and benefit costs of property level personnel, repairs and maintenance expense, cleaning expense and other direct costs of operating these properties. The increase in property operating expenses at our comparable properties is primarily due to an increase in repairs and maintenance expense, real estate taxes and other direct costs. Property operating expenses decreased at our non-comparable properties primarily due to dispositions since January 1, 2023.
Net operating income. The change in NOI reflects the net changes in rental income and property operating expenses described above.
SHOP:
 
Comparable Properties (1)
All Properties
 As of and For the Three MonthsAs of and For the Three Months
 Ended March 31,Ended March 31,
 2024202320242023
Total properties229 229 232 234 
Number of units25,160 25,160 25,220 25,327 
Occupancy79.0 %77.1 %78.9 %76.9 %
Average monthly rate (2)
$5,165 $4,837 $5,165 $4,837 
Three Months Ended March 31,
Comparable (1)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20242023ChangeChange2024202320242023ChangeChange
Residents fees and services$308,111 $279,416 $28,695 10.3 %$15 $176 $308,126 $279,592 $28,534 10.2 %
Property operating expenses(282,820)(261,805)21,015 8.0 %(596)(524)(283,416)(262,329)21,087 8.0 %
NOI$25,291 $17,611 $7,680 43.6 %$(581)$(348)$24,710 $17,263 $7,447 43.1 %
(1)Consists of senior living communities that we have owned and which have been in service, reported in the same segment and operated by the same operator continuously since January 1, 2023; excludes communities classified as held for sale, closed or out of service, if any.
(2)Average monthly rate reflects the average monthly residents fees and services per occupied unit for the period presented. The average monthly rate is calculated based on the actual number of days during the period.
Residents fees and services. Residents fees and services are the revenues earned at our managed senior living communities. We recognize these revenues as services are provided and related fees are accrued. Residents fees and services increased at our comparable properties primarily due to increases in occupancy and average monthly rate at our communities.
Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, wages and benefit costs of community level personnel, repairs and maintenance expense, management fees, cleaning expense and other direct costs of operating these communities. Property operating expenses increased at our comparable properties primarily due to increases in labor costs, dietary expenses, insurance costs and other direct costs, partially offset by reduced contract labor.
Net operating income. The change in NOI reflects the net changes in residents fees and services and property operating expenses described above.
22

Non-Segment(1):
 
Comparable Properties (2)
All Properties
 As of and For the Three Months Ended March 31,As of and For the Three Months Ended March 31,
 2024202320242023
Total properties:
Triple net leased senior living communities26 26 27 27 
Wellness centers10 10 10 10 
Rent coverage:
Triple net leased senior living communities (3)
1.49 x1.47 x1.49 x1.47 x
Wellness centers (3)
1.67 x1.72 x1.67 x1.72 x
Three Months Ended March 31,
Comparable (2)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20242023ChangeChange2024202320242023ChangeChange
Rental income$8,360 $9,416 $(1,056)(11.2)%$141 $— $8,501 $9,416 $(915)(9.7)%
Property operating expenses(250)(236)14 5.9 %(41)— (291)(236)55 23.3 %
NOI$8,110 $9,180 $(1,070)(11.7)%$100 $— $8,210 $9,180 $(970)(10.6)%
(1)Non-segment operations consists of all of our other operations, including certain senior living communities and wellness centers that are leased to third party operators, which segment we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
(2)Consists of properties that we have owned and which have been reported in the same segment and leased to the same operator continuously since January 1, 2023; excludes properties classified as held for sale, if any.
(3)All tenant operating data presented are based upon the operating results provided by our tenants for the most recent prior period for which tenant operating results are available to us. Rent coverage is calculated using the annualized operating cash flows from our triple net lease tenants' operations of our properties, before subordinated charges, if any, divided by annualized rental income. We have not independently verified tenant operating data. Excludes data for historical periods prior to our ownership of certain properties, as well as data for properties sold or classified as held for sale, if any, or for which there was a transfer of operations during the periods presented. Excludes rent coverage for one of our closed senior living communities, the tenant of which was in default under the applicable lease with us as of March 31, 2024.
Rental income. Rental income decreased at our comparable properties primarily due to a cash settlement and higher cash rents received during the three months ended March 31, 2023 from a tenant previously in default under leases for six of our wellness centers. In January 2023, we agreed to amend the lease for three of these wellness centers and repossess the remaining three wellness centers. The three wellness centers we repossessed were subsequently re-leased to other tenants.
Property operating expenses. Property operating expenses consist of real estate taxes, insurance and other expenses that are not paid directly by our tenants. There was not a significant change in property operating expenses.
Net operating income. The change in NOI reflects the net changes in rental income and property operating expenses described above.
Consolidated:
Depreciation and amortization expense. Depreciation and amortization expense increased primarily due to the purchase of capital improvements at certain of our properties, partially offset by certain depreciable assets becoming fully depreciated and dispositions since January 1, 2023.
General and administrative expense. General and administrative expense consists of fees paid to RMR under our business management agreement, legal and accounting fees, fees and expenses of our Trustees, equity compensation expense and other costs relating to our status as a publicly traded company. General and administrative expense increased primarily due to $849 of estimated business management incentive fees that we recognized for the three months ended March 31, 2024 as a result of our total shareholder return exceeding the returns for the MSCI U.S. REIT/Health Care REIT Index over the applicable measurement period and an increase in our business management fees of $759.
Acquisition and certain other transaction related costs. Acquisition and certain other transaction related costs primarily represent costs incurred with acquisitions and non-recurring transactions that we expensed under GAAP.
23

Impairment of assets. For information about our asset impairment charges, see Note 3 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q and Note 3 to our consolidated financial statements included in Part IV, Item 15 of our Annual Report.
(Loss) gain on sale of properties. For information regarding (loss) gain on sale of properties, see Note 3 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q and Note 3 to our consolidated financial statements included in Part IV, Item 15 of our Annual Report.
Gains and losses on equity securities, net. Gains and losses on equity securities, net, represent the net unrealized losses to adjust our investment in AlerisLife to its fair value. For further information regarding our investment in AlerisLife, see Note 11 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Interest and other income. The decrease in interest and other income is primarily due to lower average invested cash balances, partially offset by increased interest rates on invested cash balances during the three months ended March 31, 2024 compared to the three months ended March 31, 2023.
Interest expense. Interest expense increased primarily due to the issuance of $940,534 of our senior secured notes due 2026 in December 2023, resulting in discount accretion of $20,659 in the 2024 period. This increase was partially offset by the repayment and termination of our former credit facility and the redemption of $250,000 of our senior notes that were scheduled to mature in May 2024. The net proceeds from our $940,534 senior secured notes due 2026 were used to make these repayments aggregating $700,000.
Income tax (expense) benefit. Income tax (expense) benefit is the result of operating income we earned in certain jurisdictions where we are subject to state income taxes.
Equity in net earnings (losses) of investees. Equity in net earnings (losses) of investees is the change in the fair value of our investments in our joint ventures and also represents our proportionate share of the earnings of our equity method investment in AlerisLife. For further information regarding our investment in AlerisLife, see Notes 3 and 11 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
24

Non-GAAP Financial Measures (dollars in thousands, except per share amounts)
We present certain "non-GAAP financial measures" within the meaning of applicable rules of the Securities and Exchange Commission, or the SEC, including funds from operations, or FFO, normalized funds from operations, or Normalized FFO, and NOI for the three months ended March 31, 2024 and 2023. These measures do not represent cash generated by operating activities in accordance with GAAP and should not be considered alternatives to net income (loss) as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) as presented in our condensed consolidated statements of comprehensive income (loss). We consider these non-GAAP measures to be appropriate supplemental measures of operating performance for a REIT, along with net income (loss). We believe these measures provide useful information to investors because by excluding the effects of certain historical amounts, such as depreciation and amortization, they may facilitate a comparison of our operating performance between periods and with other REITs and, in the case of NOI, reflecting only those income and expense items that are generated and incurred at the property level may help both investors and management to understand the operations of our properties.
Funds From Operations and Normalized Funds From Operations
We calculate FFO and Normalized FFO as shown below. FFO is calculated on the basis defined by the National Association of Real Estate Investment Trusts, which is net income (loss), calculated in accordance with GAAP, excluding any gain or loss on sale of properties, equity in net earnings or losses of investees, loss on impairment of real estate assets, gains or losses on equity securities, net, if any, and including adjustments to reflect our proportionate share of FFO of our equity method investees, plus real estate depreciation and amortization of consolidated properties, as well as certain other adjustments currently not applicable to us. In calculating Normalized FFO, we adjust for the items shown below including similar adjustments for our unconsolidated joint ventures, if any, and include business management incentive fees, if any, only in the fourth quarter versus the quarter when they are recognized as an expense in accordance with GAAP due to their quarterly volatility not necessarily being indicative of our core operating performance and the uncertainty as to whether any such business management incentive fees will be payable when all contingencies for determining such fees are known at the end of the calendar year. FFO and Normalized FFO are among the factors considered by our Board of Trustees when determining the amount of distributions to our shareholders. Other factors include, but are not limited to, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance, and our expected needs for and availability of cash to pay our obligations. Other real estate companies and REITs may calculate FFO and Normalized FFO differently than we do.
Our calculations of FFO and Normalized FFO for the three months ended March 31, 2024 and 2023 and reconciliations of net income (loss), the most directly comparable financial measure under GAAP reported in our condensed consolidated financial statements, to FFO and Normalized FFO appear in the following table. This table also provides a comparison of distributions to shareholders, FFO and Normalized FFO and net income (loss) per share for these periods.
25

 Three Months Ended March 31,
 20242023
Net loss$(86,259)$(52,658)
Depreciation and amortization70,133 64,800 
Loss (gain) on sale of properties5,874 (1,233)
Impairment of assets12,142 5,925 
Gains on equity securities, net— (8,126)
Equity in net (earnings) losses of investees(1,898)647 
Share of FFO from unconsolidated joint ventures2,014 1,999 
Adjustments to reflect our share of FFO attributable to an equity method investment582 (1,586)
FFO2,588 9,768 
Business management incentive fees (1)
849 — 
Acquisition and certain other transaction related costs86 93 
Loss on modification or early extinguishment of debt— 1,075 
Adjustments to reflect our share of Normalized FFO attributable to an equity method investment— 1,576 
Normalized FFO$3,523 $12,512 
Weighted average common shares outstanding (basic and diluted)239,193 238,589 
Per common share data (basic and diluted):
Net loss$(0.36)$(0.22)
FFO$0.01 $0.04 
Normalized FFO$0.01 $0.05 
Distributions declared $0.01 $0.01 
(1)Incentive fees under our business management agreement are payable after the end of each calendar year, are calculated based on common share total return, as defined, and are included in general and administrative expense in our condensed consolidated statements of comprehensive income (loss). In calculating net income (loss) in accordance with GAAP, we recognize estimated business management incentive fee expense, if any, in the first, second and third quarters. Although we recognize this expense, if any, in the first, second and third quarters for purposes of calculating net income (loss), we do not include these amounts in the calculation of Normalized FFO until the fourth quarter, when the amount of the business management incentive fee expense for the calendar year, if any, is determined.
Property Net Operating Income (NOI)
We calculate NOI as shown below. The calculation of NOI excludes certain components of net income (loss) in order to provide results that are more closely related to our property level results of operations. We define NOI as income from our real estate less our property operating expenses. NOI excludes amortization of capitalized tenant improvement costs and leasing commissions that we record as depreciation and amortization. We use NOI to evaluate individual and company-wide property level performance. Other real estate companies and REITs may calculate NOI differently than we do.
26

The calculation of NOI by reportable segment is included above in this Item 2. The following table includes the reconciliation of net loss to NOI for the three months ended March 31, 2024 and 2023.
Three Months Ended March 31,
20242023
Reconciliation of Net Loss to NOI:  
Net loss$(86,259)$(52,658)
Equity in net (earnings) losses of investees(1,898)647 
Income tax expense (benefit)187 (31)
Loss before income tax (expense) benefit and equity in net earnings (losses) of investees(87,970)(52,042)
Loss on modification or early extinguishment of debt— 1,075 
Interest expense57,576 47,780 
Interest and other income(2,237)(4,195)
Gains on equity securities, net— (8,126)
Loss (gain) on sale of properties5,874 (1,233)
Impairment of assets12,142 5,925 
Acquisition and certain other transaction related costs86 93 
General and administrative7,568 5,873 
Depreciation and amortization70,133 64,800 
Total NOI$63,172 $59,950 
Medical Office and Life Science Portfolio NOI$30,252 $33,507 
SHOP NOI24,710 17,263 
Non-Segment NOI8,210 9,180 
Total NOI$63,172 $59,950 
LIQUIDITY AND CAPITAL RESOURCES
Our principal sources of cash to meet operating and capital expenses, pay our debt service obligations and make distributions to our shareholders are the operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities and proceeds from the disposition of certain properties. We believe that these sources of funds will be sufficient to meet our operating and capital expenses, pay our debt service obligations and make distributions to our shareholders for at least the next 12 months. Our future cash flows from operating activities will depend primarily upon:
•our ability to receive rents from our tenants;
•our ability to maintain or increase the occupancy of, and the rates at, our properties;
•our and our managers' abilities to control operating expenses and capital expenses at our properties, including increased operating expenses that we may incur in response to wage and commodity price inflation, limited labor availability and increased insurance costs; and
•our managers' abilities to maintain or increase our returns from our managed senior living communities.
Although the senior living industry has been adversely affected by a slow recovery from the COVID-19 pandemic, as well as economic and market conditions, there have been signs of recovery. While we are encouraged by positive trends, including increases in rates and occupancy in our SHOP segment and favorable supply and demand dynamics in the senior living industry, generally, we cannot be sure that these trends will continue to benefit us and any benefits we do realize may be uneven. While we continue to experience volatility in labor, insurance and food costs in our SHOP segment, we expect increases in these costs to moderate and we continue to work with our senior living operators to manage these costs and to increase rates and occupancy at our communities, which we believe will enable our managers to generate better returns to us.
27
We also continue to invest capital in our SHOP segment in order to capitalize on these positive trends and increase the probability of higher cash flows to us.
On December 21, 2023, we completed a private offering of $940.5 million in aggregate principal amount at maturity of senior secured notes due January 2026, with a one-year extension option. The net proceeds from the offering were approximately $730.4 million after deducting initial purchaser discounts and estimated offering costs. We used a portion of the net proceeds to repay in full the $450.0 million outstanding under our then secured credit facility and to redeem $250.0 million of our senior notes that were scheduled to mature in May 2024. As a result of these transactions, we have no significant debt maturities until June 2025 when $500.0 million of our senior notes will become due, and as of March 31, 2024, we had $207.1 million of cash and cash equivalents. Additionally, as of March 31, 2024, our ratio of consolidated income available for debt service to debt service is above the 1.5x incurrence requirement under our senior notes, on a pro forma basis. We are able to refinance existing or maturing debt and issue new debt as long as this ratio is at or above 1.5x on a pro forma basis at the time of such refinancing or issuance.
Until its repayment in full and termination on December 21, 2023, we had a $450.0 million credit facility that was fully drawn.
During the three months ended March 31, 2024, we sold one property for a sales price of $3.6 million, excluding closing costs. As of May 2, 2024, we had two properties under agreements to sell for an aggregate sales price of approximately $10.4 million, excluding closing costs. We may not complete the sales of any or all of the properties we currently plan to sell. Also, we may sell some or all of these properties at amounts that are less than currently expected and/or less than the carrying values of such properties and we may incur losses on any such sales as a result.
The following is a summary of our sources and uses of cash flows for the periods presented, as reflected in our condensed consolidated statements of cash flows (dollars in thousands):
 Three Months Ended March 31,
 20242023
Cash and cash equivalents and restricted cash at beginning of period$246,961 $688,302 
Net cash provided by (used in):
Operating activities28,602 6,042 
Investing activities(58,839)(56,744)
Financing activities(8,561)(254,931)
Cash and cash equivalents and restricted cash at end of period$208,163 $382,669 
Our Operating Liquidity and Resources
We generally receive minimum rents from tenants at our medical office and life science properties, triple net leased senior living communities and wellness centers monthly, we receive residents fees and services revenues, net of expenses, from our managed senior living communities monthly and we receive percentage rents from tenants at certain of our senior living communities monthly, quarterly or annually.
The change in cash provided by operating activities for the three months ended March 31, 2024 compared to the prior period was primarily due to increased NOI as a result of increased rates and occupancy at the senior living communities in our SHOP segment. Additionally, cash interest payments decreased in the 2024 period compared to the 2023 period primarily due to the repayment and termination of our former credit facility and the redemption of $250.0 million of senior notes that were scheduled to mature in May 2024.
Our Investing Liquidity and Resources
The change in cash used in investing activities for the three months ended March 31, 2024 compared to the prior period was primarily due to our purchase on February 16, 2024 of approximately 34.0% of the then outstanding AlerisLife common shares from ABP Trust at the tender offer price of $1.31 per share for a total purchase price, including transaction related costs, of $15.5 million, partially offset by a decrease in real estate improvements in the 2024 period compared to the 2023 period.
28
The following is a summary of capital expenditures, development, redevelopment and other activities for the periods presented (dollars in thousands):
 Three Months Ended March 31,
 20242023
Medical Office and Life Science Portfolio capital expenditures:
   Lease related costs (1)
$6,029 $6,748 
   Building improvements (2)
919 856 
Recurring capital expenditures - Medical Office and Life Science Portfolio6,948 7,604 
Wellness centers lease related costs (1)
6,923 — 
SHOP segment fixed assets and capital improvements10,091 23,644 
Total recurring capital expenditures$23,962 $31,248 
Development, redevelopment and other activities - Medical Office and Life Science Portfolio (3)
$713 $1,922 
Development, redevelopment and other activities - SHOP segment (3)
1,189 16,223 
Total development, redevelopment and other activities$1,902 $18,145 
(1)Lease related costs generally include capital expenditures to improve tenants' space or amounts paid directly to tenants to improve their space and other leasing related costs, such as brokerage commissions and tenant inducements.
(2)Building improvements generally include capital expenditures to replace obsolete building components that extend the useful life of existing assets or other improvements to increase the marketability of the property.
(3)Development, redevelopment and other activities generally include capital expenditures that reposition a property or result in new sources of revenue.
We generally plan to continue investing capital in our properties, including redevelopment projects, to better position these properties in their respective markets in order to increase our returns in future years. However, we have deferred, and may continue to defer, our capital expenditures to preserve liquidity.
As of March 31, 2024, we had estimated unspent leasing related obligations at our triple net leased wellness centers and our medical office and life science properties of approximately $43.2 million, of which we expect to spend approximately $33.1 million during the next 12 months. We expect to fund these obligations using operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities, cash on hand, proceeds from the disposition of certain properties and future financing activities with unencumbered properties.
We are currently in the process of redeveloping certain properties in our Medical Office and Life Science Portfolio and a number of our managed senior living communities, which projects are expected to be completed at various times between 2024 and 2025. We continue to assess opportunities to redevelop other properties in our Medical Office and Life Science Portfolio and SHOP segment. These redevelopment projects may require significant capital expenditures and time to complete, and we have deferred, and may in the future defer, certain redevelopment projects to preserve liquidity.
Due to labor availability constraints and wage and commodity price inflation, the capital investments we plan to make may be delayed or cost more than we expect. For further information regarding our dispositions, see Note 3 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Our Financing Liquidity and Resources
The change in cash used in financing activities for the three months ended March 31, 2024 compared to the prior period was primarily due to higher repayments of borrowings under our former credit facility during the 2023 period.
As of March 31, 2024, we had $207.1 million of cash and cash equivalents. We typically use cash balances, net proceeds from offerings of securities, debt issuances or dispositions of assets and cash flows from our operations to fund our operations, debt repayments, distributions, acquisitions, investments, capital expenditures and other general business purposes.
Until its repayment in full and termination on December 21, 2023, we had a $450.0 million credit facility that was fully drawn. At December 21, 2023, our former credit facility required interest to be paid on borrowings at an annual rate of 8.4%, plus a facility fee of $0.3 million per quarter.
29
During the three months ended March 31, 2024, we paid quarterly cash distributions to our shareholders totaling approximately $2.4 million using existing cash balances. On April 11, 2024, we declared a quarterly distribution payable to common shareholders of record on April 22, 2024 in the amount of $0.01 per share, or approximately $2.4 million. We expect to pay this distribution on or about May 16, 2024 using cash on hand. For further information regarding the distribution we paid during 2023, see Note 7 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
We believe we may have access to certain types of financings, including debt or equity offerings, to fund our operations and repay our debts and other obligations as they become due. Our ability to complete, and the costs associated with, future debt or equity transactions depends primarily upon credit market conditions and our then creditworthiness and our ability to be in compliance with our debt covenants as discussed below. We have no control over market conditions. Our credit and debt ratings depend upon evaluations by credit rating agencies of our business practices and plans, including our ability to maintain our earnings, to stagger our debt maturities and to balance our use of debt and equity capital so that our financial performance and leverage ratios afford us flexibility to withstand any reasonably anticipated adverse changes. Similarly, our ability to raise equity capital in the future will depend primarily upon equity capital market conditions and our ability to conduct our business to maintain and grow our operating cash flows. We intend to conduct our business activities in a manner which will afford us reasonable access to capital for investment and financing activities, but we cannot be sure that we will be able to successfully carry out that intention. A protracted negative impact on the economy or the industries in which our properties and businesses operate, wage and commodity price inflation, high interest rates, increased insurance costs, geopolitical risks or other economic, market or industry conditions, including the delayed recovery of the senior housing industry, economic downturns and a possible recession, may have various negative consequences including a decline in financing availability and increased costs for financing. Further, those conditions could also disrupt capital markets and limit our access to financing from public sources, particularly if the global financial markets experience significant disruptions.
In January 2023, pursuant to the then existing credit agreement, we repaid $113.6 million in outstanding borrowings under our former credit facility and the commitments were reduced to $586.4 million. In February 2023, we and our lenders amended the credit agreement to reduce the commitments from $586.4 million to $450.0 million following our repayment of $136.4 million in outstanding borrowings under our former credit facility.
In December 2023, we issued $940.5 million in aggregate principal amount at maturity of our senior secured notes due 2026 in a private offering, raising net proceeds of $730.4 million, after deducting initial purchaser discounts and estimated offering costs. These notes are fully and unconditionally guaranteed, on a joint, several and senior secured basis, by the Collateral Guarantors, and on a joint, several and unsecured basis, by all our subsidiaries other than the Collateral Guarantors and certain excluded subsidiaries. These notes and the guarantees provided by the Collateral Guarantors are secured by a first priority lien and security interest in each of the collateral properties and 100% of the equity interests in each of the Collateral Guarantors. No cash interest will accrue on these notes prior to maturity. The accreted value of these notes will increase at a rate of 11.25% per annum compounded semiannually on January 15 and July 15 of each year. We used the net proceeds from this offering to repay in full and terminate our then $450.0 million secured credit facility and to redeem $250.0 million of our senior notes which were scheduled to mature in May 2024.
In January 2024, Moody's Investors Service, or Moody's, upgraded our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031 ratings from Ca to Caa3 and our senior unsecured debt rating from C to Ca, and Moody's also assigned a Caa2 rating to our senior secured notes due 2026.
In January 2024, Standard & Poor's Rating Services, or Standard & Poor's, upgraded our 9.75% senior notes due 2025 rating from CCC+ to B, our 4.375% senior notes due 2031 rating from CCC+ to B and our senior unsecured debt rating from CCC- to CCC, and Standard & Poor's also assigned a B rating to our senior secured notes due 2026.
For further information regarding our outstanding debt, see Note 5 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Debt Covenants
Our principal debt obligations at March 31, 2024 were: (1) $2.1 billion outstanding principal amount of senior unsecured notes; (2) $940.5 million outstanding principal amount of senior secured notes; and (3) $8.7 million aggregate principal amount of mortgage notes (excluding discounts, premiums and net debt issuance costs) secured by one property. For further information regarding our indebtedness, see Note 5 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
30
Our senior notes are governed by our senior notes indentures and their supplements. Our senior notes indentures and their supplements provide for acceleration of payment of all amounts outstanding upon the occurrence and continuation of certain events of default. Our senior notes indentures and their supplements also contain covenants that restrict our ability to incur debts, including debts secured by mortgages on our properties, in excess of calculated amounts and require us to maintain various financial ratios. As of March 31, 2024, we believe we were in compliance with all of the covenants under our senior notes indentures and their supplements and our other debt obligations. Although we continue to take steps to enhance our ability to maintain sufficient liquidity, as noted elsewhere in this Quarterly Report on Form 10-Q, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from wage or commodity price inflation, high interest rates, geopolitical risks or other economic, market or industry conditions, including the delayed recovery of the senior housing industry, economic downturns or a possible recession, may cause increased pressure on our ability to satisfy financial and other covenants. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy our debt covenants and conditions.
Our senior notes indentures and their supplements do not contain provisions for acceleration which could be triggered by our debt ratings. See "—Our Financing Liquidity and Resources" above for information regarding recent changes to our issuer credit rating and senior debt ratings.
Our senior unsecured notes indentures and their supplements contain cross default provisions to any other debts of more than $20.0 million ($50.0 million or more in the case of our senior notes indentures and supplements entered in February 2016, February 2018, June 2020, February 2021 and December 2023).
The loan agreements governing the aggregate $620.0 million secured debt financing related to the Seaport JV contain customary covenants and provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default. We no longer include this $620.0 million of secured debt financing in our condensed consolidated balance sheet following the deconsolidation of the net assets of this joint venture; however, we continue to provide certain guaranties on this debt. The debt secured by the properties included in the LSMD JV in which we own a 20% equity interest is guaranteed by this joint venture and is non-recourse to us.
Supplemental Guarantor Information
On May 28, 2020, we issued $1.0 billion of our 9.75% senior notes due 2025. We subsequently redeemed $500.0 million of this debt in June 2022, with $500.0 million remaining outstanding. On February 3, 2021, we issued $500.0 million of our 4.375% senior notes due 2031. As of March 31, 2024, all $500.0 million of our 9.75% senior notes due 2025 and all $500.0 million of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint, several and unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries. The notes and related guarantees are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1.1 billion of senior unsecured notes do not have the benefit of any guarantees.
A subsidiary guarantor's guarantee of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, and all other obligations of such subsidiary guarantor under the indenture governing the notes will automatically terminate and such subsidiary guarantor will automatically be released from all of its obligations under such subsidiary guarantee and the indenture under certain circumstances, including on or after the date (a) the notes have an investment grade rating from two rating agencies and one of such investment grade ratings is a mid-BBB investment grade rating and (b) no default or event of default has occurred and is continuing under the indenture. Our non-guarantor subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due on our 9.75% senior notes due 2025 or our 4.375% senior notes due 2031 or the respective guarantees, or to make any funds available therefor, whether by dividend, distribution, loan or other payments. The rights of holders of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, to benefit from any of the assets of our non-guarantor subsidiaries are subject to the prior satisfaction of claims of those subsidiaries' creditors and any preferred equity holders. As a result, our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031 and the respective guarantees are structurally subordinated to all indebtedness, guarantees and other liabilities of our subsidiaries that do not guarantee our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, including guarantees of other indebtedness of ours, payment obligations under lease agreements, trade payables and preferred equity.
31
The following tables present summarized financial information for guarantor entities and issuer, on a combined basis after eliminating (i) intercompany transactions and balances among the guarantor entities and (ii) equity in earnings from, and any investments in, any subsidiary that is a non-guarantor (dollars in thousands):
March 31, 2024December 31, 2023
Real estate properties, net$3,633,182 $3,685,280 
Other assets, net465,650 502,590 
Total assets$4,098,832 $4,187,870 
Indebtedness, net$2,825,647 $2,803,829 
Other liabilities214,307 241,742 
Total liabilities$3,039,954 $3,045,571 
Three Months Ended March 31, 2024
Revenues$324,711 
Expenses365,317 
Loss from continuing operations(95,658)
Net loss(93,947)
Related Person Transactions
We have relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star) and others related to them. For further information about these and other such relationships and related person transactions, see Notes 9, 10 and 11 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, our Annual Report, our definitive Proxy Statement for our 2024 Annual Meeting of Shareholders and our other filings with the SEC. In addition, see the section captioned “Risk Factors” of our Annual Report for a description of risks that may arise as a result of these and other related person transactions and relationships. We may engage in additional transactions with related persons, including businesses to which RMR or its subsidiaries provide management services.
Critical Accounting Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
A discussion of our critical accounting estimates is included in our Annual Report. There have been no significant changes in our critical accounting estimates since the year ended December 31, 2023.
Impact of Government Reimbursement
For the three months ended March 31, 2024, substantially all of our NOI was generated from properties where a majority of the revenues are derived from our tenants' and residents' private resources, and a small amount of our NOI was generated from properties where a majority of the revenues are derived from Medicare and Medicaid payments. Nonetheless, we own, and our tenants, managers and operators operate, facilities in many states that participate in federal and state healthcare payment programs, including the federal Medicare and state Medicaid programs and other federal and state healthcare payment programs. Also, some of our medical office and life science property tenants participate in federal Medicare and state Medicaid programs and other government healthcare payment programs.
32
For more information regarding the government healthcare funding and regulation of our business, please see the section captioned “Business—Government Regulation and Reimbursement” in our Annual Report and the section captioned “Management's Discussion and Analysis of Financial Condition and Results of Operations—Impact of Government Reimbursement” in our Annual Report.
Item 3.  Quantitative and Qualitative Disclosures About Market Risk.
We are exposed to risks associated with market changes in interest rates. We manage our exposure to this market risk by monitoring available financing alternatives. Other than as described below, we do not currently foresee any significant changes in our exposure to fluctuations in interest rates or in how we manage this exposure in the near future.
We may in the future enter into hedge arrangements or derivative contracts from time to time to mitigate our exposure to changes in interest rates.
Fixed Rate Debt
There have been no material changes to market interest rate risks associated with our fixed rate debt during the three months ended March 31, 2024. For a discussion of market interest rate risks associated with our fixed rate debt, see "Quantitative and Qualitative Disclosures About Market Risk" included in Part II, Item 7A of our 2023 Annual Report.
Floating Rate Debt
At March 31, 2024, we did not have any floating rate debt obligations.
Item 4.  Controls and Procedures.
As of the end of the period covered by this Quarterly Report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of our President and Chief Executive Officer and our Chief Financial Officer and Treasurer, of the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, our President and Chief Executive Officer and our Chief Financial Officer and Treasurer concluded that our disclosure controls and procedures are effective.
There have been no changes in our internal control over financial reporting during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
33
Warning Concerning Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions. These forward-looking statements include, among others, statements about: our efforts to manage costs and increase occupancy at our SHOP communities; demand for medical office and life science leased space; our future leasing activity; market demand and supply for healthcare services for older adults and senior living communities; expected costs related to the transition of certain senior living communities; our leverage; the sufficiency of our liquidity; our liquidity needs and sources; our capital expenditure plans and commitments; the transition of operations at certain of our senior living communities to new managers; our acquisitions and our pending or potential property dispositions; our redevelopment, repositioning and construction activities and plans; and the amount and timing of future distributions.
Forward-looking statements reflect our current expectations, are based on judgments and assumptions, are inherently uncertain and are subject to risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from expected future results, performance or achievements expressed or implied in those forward-looking statements. Some of the risks, uncertainties and other factors that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include, but are not limited to, the following:
•The impact of unfavorable market and commercial real estate industry conditions due to possible reduced demand for healthcare related space and senior living communities, high interest rates, wage and commodity price inflation, limited labor availability, increased insurance costs, supply chain disruptions, volatility in the public equity and debt markets, pandemics, geopolitical instability and tensions, economic downturns or a possible recession or changes in real estate utilization, among other things, on us and our managers and other operators and tenants,
•Our senior living operators' abilities to successfully and profitably operate the communities they manage for us,
•The continuing impact of changing market practices, including those that arose or intensified during the COVID-19 pandemic, or delayed returns to prior market practices on us and our managers and other operators and tenants, such as reduced demand for leased medical office, life science and other space of ours and residencies at senior living communities, increased operating costs and labor availability constraints,
•The financial strength of our managers and other operators and tenants,
•Whether the aging U.S. population and increasing life spans of seniors will increase the demand for senior living communities and other medical and healthcare related properties and healthcare services,
•Whether our tenants will renew or extend their leases or whether we will obtain replacement tenants on terms as favorable to us as our prior leases,
•The likelihood that our tenants and residents will pay rent or be negatively impacted by continuing unfavorable market and commercial real estate industry conditions,
•Our managers' abilities to increase or maintain rates charged to residents of our senior living communities and manage operating costs for those communities,
•Our ability to increase or maintain occupancy at our properties on terms desirable to us,
•Our ability to increase rents when our leases expire or renew,
•Costs we incur and concessions we grant to lease our properties,
•Risk and uncertainties regarding the costs and timing of development, redevelopment and repositioning activities, including as a result of prolonged high inflation, cost overruns, supply chain challenges, labor shortages, construction delays or inability to obtain necessary permits or volatility in the commercial real estate markets,
•Our ability to manage our capital expenditures and other operating costs effectively and to maintain and enhance our properties and their appeal to tenants and residents,
34
•Our ability to effectively raise and balance our use of debt and equity capital,
•Our ability to comply with the financial covenants under our debt agreements,
•Our ability to make required payments on our debt,
•Our ability to maintain sufficient liquidity and otherwise manage leverage,
•Our credit ratings,
•Our ability to sell properties at prices or returns we target,
•Our ability to sell additional equity interests in, or contribute additional properties to, our existing joint ventures, or enter into additional, real estate joint ventures or to attract co-venturers and benefit from our existing joint ventures or any real estate joint ventures we may enter into,
•Our ability to acquire, develop, redevelop or reposition properties that realize our targeted returns,
•Our ability to pay distributions to our shareholders and to maintain or increase the amount of such distributions,
•The ability of RMR to successfully manage us,
•Competition in the real estate industry, particularly in those markets in which our properties are located,
•Government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements,
•Compliance with, and changes to, federal, state and local laws and regulations, accounting rules, tax laws and similar matters,
•Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses,
•Actual and potential conflicts of interest with our related parties, including our Managing Trustees, RMR, ABP Trust, AlerisLife and others affiliated with them,
•Limitations imposed by and our ability to satisfy complex rules to maintain our qualification for taxation as a REIT for U.S. federal income tax purposes,
•Acts of terrorism, outbreaks of pandemics or other public health safety events or conditions, war or other hostilities, global climate change or other manmade or natural disasters beyond our control, and
•Other matters.
These risks, uncertainties and other factors are not exhaustive and should be read in conjunction with other cautionary statements that are included in our periodic filings. The information contained elsewhere in this Quarterly Report on Form 10-Q or in our other filings with the SEC, including under the caption “Risk Factors”, or incorporated herein or therein, identifies other important factors that could cause differences from our forward-looking statements. Our other filings with the SEC are available on the SEC's website at www.sec.gov.
You should not place undue reliance upon our forward-looking statements.
Except as required by law, we do not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.
35
Statement Concerning Limited Liability
The Amended and Restated Declaration of Trust establishing Diversified Healthcare Trust, dated September 20, 1999, as amended and supplemented, as filed with the State Department of Assessments and Taxation of Maryland, provides that no trustee, officer, shareholder, employee or agent of Diversified Healthcare Trust shall be held to any personal liability, jointly or severally, for any obligation of, or claim against, Diversified Healthcare Trust. All persons dealing with Diversified Healthcare Trust in any way shall look only to the assets of Diversified Healthcare Trust for the payment of any sum or the performance of any obligation.
36
PART II.   Other Information
 
Item 1A. Risk Factors.
There have been no material changes to risk factors from those we previously disclosed in our Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer purchases of equity securities. The following table provides information about our purchases of our equity securities during the quarter ended March 31, 2024:
Calendar Month
Number of Shares Purchased(1)
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 - January 31, 20245,535 $3.59 — $— 
March 1 - March 31, 202424,641 2.35 — — 
Total30,176 $2.58 — $— 

(1) These common share withholdings and purchases were made to satisfy tax withholding and payment obligations of certain former employees of RMR in connection with the vesting of prior awards of our common shares. We withheld and purchased these common shares at their fair market values based upon the trading prices of our common shares at the close of trading on Nasdaq on the purchase dates.
Item 6. Exhibits.
Exhibit
Number		Description
3.1
3.2
3.3
3.4
3.5
4.1
4.2
4.3
4.4
4.5
37
4.6
4.7
4.8
4.9
4.10
4.11
4.12
4.13
4.14
4.15
4.16
4.17
4.18
10.1
10.2
10.3
22.1
31.1
31.2
38
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document. (Filed herewith.)
101.CALXBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)
101.DEFXBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)
101.LABXBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)
101.PREXBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)
104Cover Page Interactive Data File. (Formatted as Inline XBRL and contained in Exhibit 101.)
39
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 DIVERSIFIED HEALTHCARE TRUST
  
  
 By:/s/ Christopher J. Bilotto
  Christopher J. Bilotto
  President and Chief Executive Officer
  
Dated: May 6, 2024 
  
  
 By:/s/ Matthew C. Brown
  Matthew C. Brown
  Chief Financial Officer and Treasurer
  (principal financial and accounting officer)
  
Dated: May 6, 2024 

40
 EX-4.11 2 dhc_033124xexhibitx411.htm EX-4.11 Document

Exhibit 4.11
SUPPLEMENTAL INDENTURE
THIS SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March 1, 2024, among SNH Durham LLC and SNH Maryland Heights LLC, each a Delaware limited liability company, SNH Granite Gate Inc., a Maryland corporation, SNH Granite Gate Tenant LLC, a Maryland limited liability company, and SNH Medical Office Properties Trust, a Maryland real estate investment trust (together, the “Additional Subsidiary Guarantors”), each a subsidiary of Diversified Healthcare Trust, a real estate investment trust organized and existing under the laws of the State of Maryland (the “Company”), the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking organization organized and existing under the laws of the United States (the “Trustee”).
W I T N E S S E T H
WHEREAS, the Company (then known as Senior Housing Properties Trust) and the Trustee are parties to an Indenture (the “Base Indenture”), dated as of February 18, 2016 (as supplemented by that certain Third Supplemental Indenture (the “Third Supplemental Indenture”), dated as of June 2, 2020, among the Company, the Initial Subsidiary Guarantors party thereto and the Trustee, providing for the issuance of the Company’s 9.750% Senior Notes due 2025 (the “Notes”), as supplemented by that certain Supplemental Indenture, dated as of March 5, 2021, among the Company, the Subsidiary Guarantors party thereto and the Trustee that certain Supplemental Indenture, dated as of September 9, 2022, among the Company, the Subsidiary Guarantors party thereto and the Trustee and that certain Supplemental Indenture, dated as of November 22, 2022, among the Company, the Subsidiary Guarantors party thereto and the Trustee, and as from time to time hereafter further amended, supplemented or otherwise modified so far as it applies to the Notes, the “Indenture”);
WHEREAS, the Indenture provides that under certain circumstances the Additional Subsidiary Guarantors shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Additional Subsidiary Guarantors will fully and unconditionally guarantee the Notes, jointly and severally with all of the other Subsidiary Guarantors, on the terms and conditions set forth herein;
WHEREAS, all acts and requirements necessary to make this Supplemental Indenture the legal, valid and binding obligation of the Company, each Additional Subsidiary Guarantor and the Trustee have been done; and
WHEREAS, pursuant to Section 901 of the Base Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Additional Subsidiary Guarantors and the Trustee mutually covenant and agree as follows:
1.    CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE. Each Additional Subsidiary Guarantor hereby agrees that its obligations to the Holders and the Trustee pursuant to the Subsidiary Guarantee shall be as expressly set forth in Article 6 of the Third Supplemental Indenture and in such other provisions of the Indenture as are applicable to the Subsidiary Guarantors (including, without limitation, Article 3 of the Third Supplemental Indenture), and reference is made to the Indenture for the precise terms of this Supplemental Indenture. The terms of Article 6 of the Third Supplemental Indenture and such other provisions of the Indenture (including, without limitation, Article 3 of the Third Supplemental Indenture) as are applicable to the Subsidiary Guarantors are incorporated herein by reference.
3.    THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
4.    COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
5.    EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.


6.    THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Additional Subsidiary Guarantors and the Company.
[Remainder of page intentionally left blank.]


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.

COMPANY:

DIVERSIFIED HEALTHCARE TRUST

By: /s/ Matthew C. Brown
Name: Matthew C. Brown
Title: Chief Financial Officer and Treasurer


ADDITIONAL SUBSIDIARY GUARANTORS:

SNH DURHAM LLC
SNH GRANITE GATE INC.
SNH GRANITE GATE TENANT LLC
SNH MARYLAND HEIGHTS LLC
SNH MEDICAL OFFICE PROPERTIES TRUST


By: /s/ Matthew C. Brown
Name: Matthew C. Brown
Title: Chief Financial Officer and Treasurer


[Signature Page to Supplemental Indenture for 9.750% Senior Notes due 2025 (March 2024)]

TRUSTEE:

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee

By: /s/ David W. Doucette    
Name: David W. Doucette
Title: Vice President

[Signature Page to Supplemental Indenture for 9.750% Senior Notes due 2025 (March 2024)]
 EX-4.16 3 dhc_033124xexhibitx416.htm EX-4.16 Document

Exhibit 4.16
SUPPLEMENTAL INDENTURE
THIS SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March 1, 2024, among SNH Durham LLC and SNH Maryland Heights LLC, each a Delaware limited liability company, SNH Granite Gate Inc., a Maryland corporation, SNH Granite Gate Tenant LLC, a Maryland limited liability company, and SNH Medical Office Properties Trust, a Maryland real estate investment trust (together, the “Additional Subsidiary Guarantors”), each a subsidiary of Diversified Healthcare Trust, a real estate investment trust organized and existing under the laws of the State of Maryland (the “Company”), the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), a national banking organization organized and existing under the laws of the United States (the “Trustee”).
W I T N E S S E T H
WHEREAS, the Company (then known as Senior Housing Properties Trust) and the Trustee are parties to an Indenture (the “Base Indenture”), dated as of February 18, 2016 (as supplemented by that certain Fourth Supplemental Indenture (the “Fourth Supplemental Indenture”), dated as of February 8, 2021, among the Company, the Initial Subsidiary Guarantors party thereto and the Trustee, providing for the issuance of the Company’s 4.375% Senior Notes due 2031 (the “Notes”), as supplemented by that certain Supplemental Indenture, dated as of March 5, 2021, among the Company, the Subsidiary Guarantors party thereto and the Trustee that certain Supplemental Indenture, dated as of September 9, 2022, among the Company, the Subsidiary Guarantors party thereto and the Trustee and that certain Supplemental Indenture, dated as of November 22, 2022, among the Company, the Subsidiary Guarantors party thereto and the Trustee, and as from time to time hereafter further amended, supplemented or otherwise modified so far as it applies to the Notes, the “Indenture”);
WHEREAS, the Indenture provides that under certain circumstances the Additional Subsidiary Guarantors shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Additional Subsidiary Guarantors will fully and unconditionally guarantee the Notes, jointly and severally with all of the other Subsidiary Guarantors, on the terms and conditions set forth herein;
WHEREAS, all acts and requirements necessary to make this Supplemental Indenture the legal, valid and binding obligation of the Company, each Additional Subsidiary Guarantor and the Trustee have been done; and
WHEREAS, pursuant to Section 901 of the Base Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Additional Subsidiary Guarantors and the Trustee mutually covenant and agree as follows:
1.    CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE. Each Additional Subsidiary Guarantor hereby agrees that its obligations to the Holders and the Trustee pursuant to the Subsidiary Guarantee shall be as expressly set forth in Article 6 of the Fourth Supplemental Indenture and in such other provisions of the Indenture as are applicable to the Subsidiary Guarantors (including, without limitation, Article 3 of the Fourth Supplemental Indenture), and reference is made to the Indenture for the precise terms of this Supplemental Indenture. The terms of Article 6 of the Fourth Supplemental Indenture and such other provisions of the Indenture (including, without limitation, Article 3 of the Fourth Supplemental Indenture) as are applicable to the Subsidiary Guarantors are incorporated herein by reference.
3.    THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
4.    COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
5.    EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.


6.    THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Additional Subsidiary Guarantors and the Company.
[Remainder of page intentionally left blank.]


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.

COMPANY:

DIVERSIFIED HEALTHCARE TRUST

By: /s/ Matthew C. Brown
Name: Matthew C. Brown
Title: Chief Financial Officer and Treasurer


ADDITIONAL SUBSIDIARY GUARANTORS:

SNH DURHAM LLC
SNH GRANITE GATE INC.
SNH GRANITE GATE TENANT LLC
SNH MARYLAND HEIGHTS LLC
SNH MEDICAL OFFICE PROPERTIES TRUST


By: /s/ Matthew C. Brown
Name: Matthew C. Brown
Title: Chief Financial Officer and Treasurer


[Signature Page to Supplemental Indenture for 4.375% Senior Notes due 2031 (March 2024)]

TRUSTEE:

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee

By: /s/ David W. Doucette    
Name: David W. Doucette
Title: Vice President

[Signature Page to Supplemental Indenture for 4.375% Senior Notes due 2031 (March 2024)]
 EX-10.1 4 dhc_033124xexhibitx101.htm EX-10.1 Document

Exhibit 10.1
RELEASE OF CERTAIN GUARANTORS
Reference is made to that certain Third Supplemental Indenture, dated as of June 2, 2020, as supplemented by that certain Supplemental Indenture, dated as of March 5, 2021, that certain Supplemental Indenture, dated as of September 9, 2022, and that certain Supplemental Indenture, dated as of November 22, 2022 (the “Third Supplemental Indenture”), among Diversified Healthcare Trust (formerly known as Senior Housing Properties Trust), a Maryland real estate investment trust, U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as Trustee (the “Trustee”), SNH GP Valencia LLC, a Delaware limited liability company (the “Released Guarantor”) and certain other Subsidiaries of the Company, as Guarantors, to the Indenture, dated as of February 18, 2016 (the “Indenture”), between the Company and the Trustee, relating to the Company’s 9.750% Senior Notes due 2025 (the “Notes”). The terms defined in the Third Supplemental Indenture are used herein as therein defined, unless otherwise defined herein.
Pursuant to Section 6 of the Third Supplemental Indenture, the undersigned, as Trustee, hereby confirms the release and discharge of the Released Guarantor from any and all obligations and liabilities under the Subsidiary Guarantee, and further hereby confirms the termination and release of the Released Guarantor of all other obligations under the Third Supplemental Indenture, the Indenture or the Notes, each as of December 21, 2023.


Dated as of March 1, 2024.
U.S. Bank Trust Company, National Association, as Trustee
By:    /s/ David W. Doucette             
Name: David W. Doucette
Title: Vice President

 EX-10.2 5 dhc_033124xexhibitx102.htm EX-10.2 Document

Exhibit 10.2
RELEASE OF CERTAIN GUARANTORS
Reference is made to that certain Fourth Supplemental Indenture, dated as of February 8, 2021, as supplemented by that certain Supplemental Indenture, dated as of March 5, 2021, that certain Supplemental Indenture, dated as of September 9, 2022, and that certain Supplemental Indenture, dated as of November 22, 2022 (the “Fourth Supplemental Indenture”), among Diversified Healthcare Trust (formerly known as Senior Housing Properties Trust), a Maryland real estate investment trust, U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as Trustee (the “Trustee”), SNH GP Valencia LLC, a Delaware limited liability company (the “Released Guarantor”) and certain other Subsidiaries of the Company, as Guarantors, to the Indenture, dated as of February 18, 2016 (the “Indenture”), between the Company and the Trustee, relating to the Company’s 4.375% Senior Notes due 2031 (the “Notes”). The terms defined in the Fourth Supplemental Indenture are used herein as therein defined, unless otherwise defined herein.
Pursuant to Section 6 of the Fourth Supplemental Indenture, the undersigned, as Trustee, hereby confirms the release and discharge of the Released Guarantor from any and all obligations and liabilities under the Subsidiary Guarantee, and further hereby confirms the termination and release of the Released Guarantor of all other obligations under the Fourth Supplemental Indenture, the Indenture or the Notes, each as of December 21, 2023.


Dated as of March 1, 2024.
U.S. Bank Trust Company, National Association, as Trustee
By:    /s/ David W. Doucette             
Name: David W. Doucette
Title: Vice President

 EX-10.3 6 dhc_033124xexhibitx103.htm EX-10.3 Document

Exhibit 10.3
        




STOCKHOLDERS AGREEMENT
by and among
ALERISLIFE INC.
a Maryland corporation,
DIVERSIFIED HEALTHCARE TRUST
a Maryland real estate investment trust,
DHC HOLDINGS LLC
a Maryland limited liability company,
and
ABP TRUST
a Maryland statutory trust
dated as of
February 16, 2024











TABLE OF CONTENTS

Page
ARTICLE I DEFINITIONS1
ARTICLE II MANAGEMENT AND OPERATION OF THE COMPANY8
Section 2.01Voting Arrangements8
Section 2.02Related Party Redemptions8
ARTICLE III TRANSFER OF INTERESTS8
Section 3.01General Restrictions on Transfer8
Section 3.02Right of First Offer9
Section 3.03Drag-along Rights11
Section 3.04Tag-along Rights13
Section 3.05Multiple Classes of Shares14
Section 3.06Repurchase Rights15
Section 3.07Put Rights17
ARTICLE IV OTHER ACTIVITIES; RELATED PARTY TRANSACTIONS; CONFIDENTIALITY; PRE-EMPTIVE RIGHTS; REIT COMPLIANCE18
Section 4.01Other Business Activities18
Section 4.02Confidentiality18
Section 4.03Certain Pre-emptive Rights for Additional Equity19
Section 4.04REIT Compliance21
ARTICLE V FINANCIAL INFORMATION; ACCESS RIGHTS21
Section 5.01Financial Information21
Section 5.02Access Rights21
ARTICLE VI REPRESENTATIONS AND WARRANTIES22
Section 6.01Representations and Warranties22
ARTICLE VII TERM AND TERMINATION23
Section 7.01Termination23
Section 7.02Effect of Termination23
ARTICLE VIII MISCELLANEOUS23
Section 8.01Expenses23
Section 8.02Release of Liability; Waiver of Fiduciary Duties23
Section 8.03Notices24
Section 8.04Interpretation24
Section 8.05Headings24
Section 8.06Severability24
Section 8.07Entire Agreement24
Section 8.08Assignment; Successors24
Section 8.09No Third Party Beneficiaries24
Section 8.10Amendment and Modification; Waiver25
Section 8.11Governing Law25


Section 8.12Venue25
Section 8.13Dispute Resolution25
Section 8.14Further Assurances27
Section 8.15Counterparts27
Section 8.16No Liability27
EXHIBITS
Exhibit A–    Notice Addresses
Exhibit B–    Form of Joinder Agreement




STOCKHOLDERS AGREEMENT
This Stockholders Agreement (this “Agreement”), dated as of February 16, 2024, is entered into by and among AlerisLife Inc., a Maryland corporation (the “Company”), Diversified Healthcare Trust, a Maryland real estate investment trust (“DHC”), DHC Holdings LLC, a Maryland limited liability company and a subsidiary of DHC (“DHC TRS”), ABP Trust, a Maryland statutory trust (“ABP” or the “Initial Stockholder”) and the Permitted Transferees of the Initial Stockholder, DHC and DHC TRS who after the date hereof acquire Company Shares (such Persons, collectively with the Initial Stockholder, DHC and DHC TRS, the “Stockholders”).
RECITALS
WHEREAS, pursuant to that certain Stock Purchase Agreement by and among the Initial Stockholder, DHC and DHC TRS, dated as of February 16, 2024, DHC and DHC TRS acquired 2,674,484 and 8,691,790 shares of common stock, par value $0.01 per share, of the Company (“Company Common Stock”), respectively, from ABP;
WHEREAS, prior to DHC’s and DHC TRS’s acquisition of Company Common Stock, all of the outstanding shares of the Company Common Stock were owned by the Initial Stockholder; and
WHEREAS, the Stockholders and the Company deem it in their best interests to set forth in this Agreement their respective rights and obligations in connection with certain matters related to the ownership, governance and operation of the Company;
NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

ARTICLE I
DEFINITIONS
Capitalized terms used in this Agreement and not otherwise defined shall have the meanings set forth in this Article I.
“AAA” has the meaning set forth in Section 8.13(a).
“ABP Put Valuation Firm” has the meaning set forth in Section 3.07(d)(i).
“Additional Company Shares” has the meaning set forth in Section 4.03(a).
“Adverse Regulatory Event” has the meeting set forth in Section 4.04(a).
“Affiliate” means with respect to any Person, any other Person who, directly or indirectly (including through one or more intermediaries), controls, is controlled by, or is under common control with, such Person. For purposes of this definition, “control,” when used with respect to any specified Person, shall mean the power, direct or indirect, to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities or partnership or other ownership interests, by contract or otherwise; and the terms “controlling” and “controlled” shall have correlative meanings.
“Agreement” has the meaning set forth in the preamble.
“Appellate Rules” has the meaning set forth in Section 8.13(g).
“Applicable Law” means all applicable provisions of (a) constitutions, treaties, statutes, laws (including the common law), rules, regulations, decrees, ordinances, codes, proclamations, declarations or orders of any Governmental


Authority, (b) any consents or approvals of any Governmental Authority and (c) any orders, decisions, advisory or interpretative opinions, injunctions, judgments, awards, decrees of, or agreements with, any Governmental Authority.
“Award” has the meaning set forth in Section 8.13(e).
“Base Price” means $1.31 per Company Share; provided that such amount shall be proportionately adjusted as a result of any reclassification, stock split (including reverse stock split), stock dividend or stock distribution, recapitalization, merger, combination, exchange of shares, subdivision or other similar transaction in the Company Shares.
“Business Day” means any day other than Saturday, Sunday, or any other day on which banking institutions in The Commonwealth of Massachusetts are authorized by Applicable Law or executive action to close.
“Bylaws” means the bylaws of the Company as amended, modified, supplemented or restated from time to time in accordance with Applicable Law or the Charter.
“Charter” means the articles of incorporation of the Company as amended, modified, supplemented or restated from time to time in accordance with Applicable Law.
“Chosen Courts” has the meaning set forth in Section 8.12.
“Code” means the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.
“Company” has the meaning set forth in the preamble.
“Company Change of Control” means any transaction or series of related transactions (as a result of a tender offer, merger, consolidation or otherwise) that results in, or that is in connection with, (a) any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers acquiring beneficial ownership, directly or indirectly, of a majority of the then issued and outstanding voting Company Shares or (b) the sale, lease, exchange, conveyance, transfer or other disposition (for cash, equity, securities or other consideration) of all or substantially all of the property and assets of the Company and its Subsidiaries (if any) on a consolidated basis (including any liquidation, dissolution or winding up of the affairs of the Company, or any other distribution made in connection therewith), to any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers.
“Company Common Stock” has the meaning set forth in the recitals.
“Company Shares” means the Company Common Stock, preferred stock and all other capital stock of the Company, whether voting or nonvoting, and any securities issued in respect thereof, or in substitution therefor, in connection with any stock split, dividend or combination, or any reclassification, recapitalization, merger, consolidation, exchange or similar reorganization.
“Determined Repurchase Price” has the meaning set forth in Section 3.06(d)(iii).
“Determined Put Price” has the meaning set forth in Section 3.07(d)(iii).
“Determined ROFO Price” has the meaning set forth in Section 3.02(f)(iii).
“DHC” has the meaning set forth in the preamble.
“DHC Change of Control” means any transaction or series of related transactions (as a result of a tender offer, merger, consolidation or otherwise) that results in, or that is in connection with, (a) any Person or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Persons acquiring beneficial ownership, directly or indirectly, of a majority of the then issued and outstanding voting shares of beneficial interest of DHC, (b) the sale, lease, exchange,
2


conveyance, transfer or other disposition (for cash, equity, securities or other consideration) of all or substantially all of the property and assets of DHC and its Subsidiaries (if any) on a consolidated basis (including any liquidation, dissolution or winding up of the affairs of DHC, or any other distribution made in connection therewith), to any Person or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Persons or (c) the following individuals cease for any reason to constitute a majority of the number of DHC trustees then serving on the DHC board of trustees: individuals who, on the date of this Agreement, constitute all of the members of the DHC board of trustees and any new DHC trustee (other than a DHC trustee whose initial election or appointment to office is in connection with an actual or threatened election contest, including, but not limited to, a consent solicitation, relating to the election of DHC trustees) whose appointment or election by the DHC board of trustees or nomination for election by DHC’s shareholders was approved or recommended by a vote of at least two-thirds (2/3) of the DHC trustees then in office who either were DHC trustees on the date of this Agreement or whose appointment, election or nomination for election was previously so approved or recommended.
“DHC Offer Notice” has the meaning set forth in Section 3.02(b).
“DHC Parties” means DHC, DHC TRS and their Permitted Transferees who acquire Company Shares.
“DHC ROFO Price” has the meaning set forth in Section 3.02(c) .
“DHC Valuation Firm” has the meaning set forth in Section 3.06(d)(i).
“Director” means each director of the Company.
“Disputes” has the meaning set forth in Section 8.13(a).
“Drag-along Notice” has the meaning set forth in Section 3.03(b).
“Drag-along Participating Stockholders” has the meaning set forth in Section 3.03(a).
“Drag-along Sale” has the meaning set forth in Section 3.03(a).
“Drag-along Stockholder” has the meaning set forth in Section 3.03(a).
“Dragging Stockholders” has the meaning set forth in Section 3.03(a).
“Electing Put Party” has the meaning set forth in Section 3.07(a).
“Electing DHC Parties” has the meaning set forth in Section 3.02(a).
“Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor federal statute, and the rules and regulations thereunder, which shall be in effect at the time.
“Excluded Shares” means any: (a) Company Shares issued or sold in connection with (i) a grant to any existing or prospective consultants, employees, officers or Directors pursuant to any stock option, employee stock purchase or similar equity-based plans or other compensation agreement maintained by the Company and approved by the Directors or (ii) the exercise or conversion of options to purchase Company Shares, or Company Shares issued to any existing or prospective consultants, employees, officers or Directors pursuant to any stock option, employee stock purchase or similar equity-based plans or any other compensation agreement; provided, however, that after giving effect to any grant pursuant to this clause (a), the aggregate amount of Company Shares issued, on a fully diluted basis, pursuant to this clause (a) shall not be more than fifteen percent (15%) of the outstanding Company Shares (by vote or value) on a fully diluted basis at the time of the issuance of such Company Shares; and (b) Company Shares or any equity of a Subsidiary of the Company issued or sold in connection with (i) any bona fide acquisition from a Third Party Purchaser on arms’ length terms of such Third Party Purchaser’s stock, assets, properties or business (whether by merger, acquisition of equity securities, acquisition of assets or otherwise) approved by the Directors; (ii) a Public Offering; (iii) a bona fide leasing or debt financing arrangements with a
3


Third Party Purchaser; or (iv) a bona fide strategic alliance or transaction with any Third Party Purchaser on arms’ length terms at the time the Company Shares were issued or the right or option to acquire such Company Shares were granted.
“Exercising Pre-emptive Stockholder” has the meaning set forth in Section 4.03(d).
“Final Price” has the meaning set forth in Section 3.07(e).
“Fiscal Year” means for financial accounting purposes, the fiscal year employed from time to time by the Company.
“GAAP” means United States generally accepted accounting principles in effect from time to time.
“Governmental Authority” means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Applicable Law), or any arbitrator, court or tribunal of competent jurisdiction.
“Immediate Family Member” means Adam Portnoy, Diane Portnoy or any lineal descendant of Adam Portnoy or Diane Portnoy (including descendants by adoption), the spouse of any lineal descendant of Adam Portnoy or Diane Portnoy, the estate of any such Person, or a trust for the principal benefit of one or more such Persons (including a trust the principal beneficiary of which is another trust for the principal benefit of one or more such Persons).
“Information” has the meaning set forth in Section 4.02(a).
“Initial ROFO Exercise Period” has the meaning set forth in Section 3.02(d).
“Initial Stockholder” has the meaning set forth in the preamble.
“Initial Stockholder Parties” means the Initial Stockholder and its Permitted Transferees who acquire Company Shares.
“Issuance Notice” has the meaning set forth in Section 4.03(b).
“Joinder Agreement” means the joinder agreement in the form and substance of Exhibit B attached hereto.
“Joint Valuation Firm” means a mutually acceptable Third Party Valuation Firm.
“Management Agreement” means that certain Amended and Restated Master Management Agreement, dated as of June 9, 2021, among the Company and certain of its subsidiaries, and DHC and certain of its subsidiaries, as amended from time to time.
“Non-Exercising Pre-emptive Stockholder” has the meaning set forth in Section 4.03(d).
“Offered Shares” has the meaning set forth in Section 3.02(c).
“Organizational Documents” means the Charter, Bylaws and any written agreement between or among any Stockholders.
“Over-allotment Exercise Period” has the meaning set forth in Section 4.03(d).
“Over-allotment Notice” has the meaning set forth in Section 4.03(d).
“Permitted Transfer” means any of the following:
4


(a)the Transfer of any Company Shares by a Stockholder to one or more of its Permitted Transferees; or
(b)a pledge of any Company Shares by any DHC Party that creates a security interest in the pledged Company Shares pursuant to a bona fide loan or indebtedness transaction, in each case, with a third party lender that makes the loan in the ordinary course of its business, so long as a DHC Party continues to exercise exclusive voting control over the pledged Company Shares; provided, however, that a foreclosure on the pledged Company Shares or other action that would result in a Transfer of the pledged Company Shares to the pledgee shall not be a “Permitted Transfer” within the meaning of this paragraph (b) of this definition unless the pledgee is a Permitted Transferee.
“Permitted Transferee” means any of the following:
(a)with respect to the DHC Parties:
(i)any Affiliate of DHC, which is controlled, directly or indirectly, by DHC; provided, however, that such Affiliate shall only remain a Permitted Transferee for as long as such entity is controlled, directly or indirectly, by DHC;
(ii)any other Stockholder; or
(iii)any entity to which The RMR Group LLC or its Subsidiaries provide management services at the time of the Permitted Transfer; and
(b)with respect to the Initial Stockholder, any Immediate Family Member.
“Person” means an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association or other entity.
“Pre-emptive Acceptance Notice” has the meaning set forth in Section 4.03(c).
“Pre-emptive Exercise Period” has the meaning set forth in Section 4.03(c).
“Pre-emptive Purchaser” has the meaning set forth in Section 4.03(b).
“Pre-emptive Stockholder” has the meaning set forth in Section 4.03(a).
“Proceeding” means any suit, action, proceeding, arbitration, mediation, audit, hearing, inquiry or, to the knowledge of the Person in question, investigation (in each case, whether civil, criminal, administrative, investigative, formal or informal) commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Authority.
“Proposed Transferee” has the meaning set forth in Section 3.04(a).
“Public Offering” means the sale of Company Common Stock by the Company to the public pursuant to a registration statement (other than a pursuant to a registration statement on Form S-4 or Form S-8 or any successor form) declared effective under the Securities Act.
“Put Alternative Value” has the meaning set forth in Section 3.07(c).
“Put Alternative Value Notice” has the meaning set forth in Section 3.07(c).
“Put Event” means a breach by the Company or any Initial Stockholder Party of Section 4.04(b) has occurred.
“Put Exercise Period” has the meaning set forth in Section 3.07(c).
“Put Notice” has the meaning set forth in Section 3.07(a).
5


“Put Price” has the meaning set forth in Section 3.07(a).
“Put Right” has the meaning set forth in Section 3.07(a).
“Put Shares” has the meaning set forth in Section 3.07(a).
“REIT” means a Person that is an entity intending in good faith to qualify as a real estate investment trust under the Code.
“REIT Party” means each of (i) DHC together with its Subsidiaries and (ii) any Permitted Transferee of a DHC Party that is, or is a Subsidiary of, a REIT, together with all Subsidiaries of the applicable REIT.
“Related Party Agreement” means any agreement, arrangement or understanding between the Company and its Subsidiaries, on the one hand, and any Stockholder or any Affiliate of a Stockholder (other than DHC or its Subsidiaries) or any Director, officer or employee of the Company, on the other hand, as such agreement may be amended, modified, supplemented or restated in accordance with the terms of this Agreement.
“Related Party Transaction” means any transaction between the Company and any Stockholder or any Affiliate of a Stockholder (other than DHC or its Subsidiaries) or any Director, officer or employee of the Company.
“Repurchase Acceptance Notice” has the meaning set forth in Section 3.06(b).
“Repurchase Alternative Value” has the meaning set forth in Section 3.06(b).
“Repurchase Alternative Value Notice” has the meaning set forth in Section 3.06(b).
“Repurchase Exercise Period” has the meaning set forth in Section 3.06(b).
“Repurchase Notice” has the meaning set forth in Section 3.06(a).
“Repurchase Shares” has the meaning set forth in Section 3.06(a).
“Repurchase Price” has the meaning set forth in Section 3.06(a).
“Repurchase Right” has the meaning set forth in Section 3.06(a).
“Repurchase Withdrawal Period” has the meaning set forth in Section 3.06(d)(iv).
“ROFO Acceptance Notice” has the meaning set forth in Section 3.02(d).
“ROFO Alternative Value” has the meaning set forth in Section 3.02(d).
“ROFO Alternative Value Notice” has the meaning set forth in Section 3.02(d).
“ROFO Process” has the meaning set forth in Section 3.06(g).
“Rules” has the meaning set forth in Section 8.13(a).
“Sale Notice” has the meaning set forth in Section 3.04(b).
“Second ROFO Exercise Period” has the meaning set forth in Section 3.02(f)(iv).
“Securities Act” means the Securities Act of 1933, as amended, or any successor federal statute, and the rules and regulations thereunder, which shall be in effect at the time.
6


“Selling Stockholder” has the meaning set forth in Section 3.04(a).
“Subsidiary” means with respect to any Person, any other Person of which a majority of the outstanding equity interests having the power to vote for directors or managers, or comparable Persons charged with governance authority, are owned, directly or indirectly, by the first Person.
“Stockholders” has the meaning set forth in the preamble.
“Tag-along Notice” has the meaning set forth in Section 3.04(c).
“Tag-along Participating Stockholders” has the meaning set forth in Section 3.04(a).
“Tag-along Period” has the meaning set forth in Section 3.04(c).
“Tag-along Sale” has the meaning set forth in Section 3.04(a).
“Tag-along Stockholder” has the meaning set forth in Section 3.04(a).
“Termination Event” means either of the following:
(a)the termination by DHC, at once, or from time to time, of the Management Agreement with respect to Communities (as defined in the Management Agreement) representing, in the aggregate, sixty percent (60%) or more of the Portfolio Gross Revenues (as defined in the Management Agreement) for the last full calendar year preceding DHC’s first exercise of any termination rights under the Management Agreement; or
(b)the occurrence of a DHC Change of Control.
“Third Party Purchaser” means any Person who, immediately prior to the contemplated transaction with respect to the Company, (a) does not directly or indirectly own or have the right to acquire any outstanding Company Shares or (b) is not a Person who is or would qualify as a Permitted Transferee of any Person who directly or indirectly owns or has the right to acquire any Company Shares.
“Third Party Valuation Firm” means any independent investment bank or valuation firm with a national, established reputation for the valuation of securities.
“Transfer” means to, directly or indirectly, sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition of, any Company Shares owned by a Person or any interest (including a beneficial interest) in any Company Shares owned by a Person; provided, however, that a transfer that occurs by operation of law pursuant to a merger, acquisition, consolidation or other business combination transaction that results in a DHC Change of Control shall not be deemed to be a Transfer for purposes of Section 3.02 or Section 3.04.
“Waived ROFO Transfer Period” has the meaning set forth in Section 3.02(h).
“Waived Repurchase Transfer Period” has the meaning set forth in Section 3.06(f).
“Withdrawal Period” has the meaning set forth in Section 3.02(f)(iv).
7



ARTICLE II
MANAGEMENT AND OPERATION OF THE COMPANY
Section 2.01Voting Arrangements. In addition to any vote or consent of the Directors or Stockholders required by Applicable Law, without the approval of DHC, the Company shall not, and shall not enter into any commitment to, and shall not permit any of its Subsidiaries to, or enter into any commitment to:
(a)amend, modify or waive any provision of the Charter or Bylaws or the governing documents of such Subsidiary or enter into, amend, modify or waive any provision of any written agreement among the Company and any of its stockholders or such Subsidiary and any of its equityholders (other than this Agreement which can only be amended pursuant to Section 8.10), in each case, in a manner (i) disproportionately adverse to the DHC Parties as compared to all other stockholders of the Company holding the same class of Company Shares as the DHC Parties or (ii) materially adverse to the DHC Parties (it being understood the amendment, modification, or waiver of any provision of the Charter or Bylaws or any such governing documents or the entering into, or amendment, modification or waiver of any provision of, any such agreements to permit the authorization and effect the issuance of Company Shares with preferences or priorities over the Company Common Stock shall not be deemed adverse to the DHC Parties in their capacity as holders of Company Common Stock; provided, that any amendment, modification, or waiver of any provision of the Charter or Bylaws or the governing documents of a Subsidiary or the entering into, or amendment, modification or waiver of any provision of, any agreements among the Company and any of its stockholders or a Subsidiary and any of its equityholders that would cause the Company to be in breach of, or be otherwise unable to comply with its obligations under, this Agreement shall be deemed materially adverse to the DHC Parties); or
(b)subject to Section 2.02, enter into, amend in any material respect, waive or terminate any Related Party Agreement or Related Party Transaction other than on terms that are on an arm’s length basis and no less favorable to the Company or the relevant Subsidiary than could be obtained from an unaffiliated third party.
Section 2.02Related Party Redemptions. The Company shall give DHC prior notice of any redemption of any Company Shares or any equity interests of any Subsidiary from the Initial Stockholder or any Immediate Family Member, which notice shall specify the proposed redemption price and any other material terms related to such proposed redemption, as well as evidence reasonably satisfactory to DHC of the current valuation of the Company Shares or equity interests proposed to be redeemed.

ARTICLE III
TRANSFER OF INTERESTS
Section 3.01General Restrictions on Transfer.
(a)Except for Permitted Transfers or in accordance with the procedures described in Section 3.02, Section 3.03, Section 3.04, Section 3.06 or Section 3.07, each Stockholder agrees that it will not, directly or indirectly, voluntarily or involuntarily Transfer any of its Company Shares. Any Company Shares transferred to a Third Party Purchaser pursuant to Section 3.02, Section 3.03, Section 3.04, Section 3.06 or Section 3.07 shall cease to be subject to this Agreement.
(b)In addition to any legends required by Applicable Law and any legends set forth in the Organizational Documents, any certificate representing the Company Shares held by a Stockholder shall bear a legend substantially in the following form:
“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A STOCKHOLDERS AGREEMENT (A COPY OF WHICH IS ON FILE WITH THE COMPANY). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE MADE EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF SUCH AGREEMENT AND (A) PURSUANT TO A REGISTRATION STATEMENT EFFECTIVE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION THEREUNDER. THE HOLDER OF THIS CERTIFICATE,
8


BY ACCEPTANCE OF THIS CERTIFICATE, AGREES TO BE BOUND BY ALL OF THE PROVISIONS OF SUCH STOCKHOLDERS AGREEMENT.”
(c)Each Stockholder shall give notice to the Company and the other Stockholders prior to any proposed Transfer (whether or not a Permitted Transfer) of any of its Company Shares. In connection with the consummation of any Transfer by a Stockholder of any of its Company Shares (including by operation of law) to a Permitted Transferee, such Permitted Transferee shall be required to execute and deliver to the Company and each other Stockholder, a Joinder Agreement; it being understood that such Permitted Transferee shall automatically be deemed to be a party to, and shall be bound by, all of the terms and conditions of this Agreement, whether or not such Permitted Transferee has executed and delivered a Joinder Agreement.
(d)Notwithstanding any other provision of this Agreement, but subject to Section 4.04(b), each Stockholder agrees that it will not, directly or indirectly, Transfer any of its Company Shares (i) if it would cause a violation of the Securities Act or other applicable federal or state securities laws (it being understood that, upon request by the Company, there must be delivered to the Company an opinion of counsel in form and substance satisfactory to the Company to the effect that such Transfer may be effected without registration under the Securities Act), (ii) if it would cause the Company or any of its Subsidiaries to be required to register as an investment company under the Investment Company Act of 1940, as amended or (iii) if it would cause the assets of the Company or any of its Subsidiaries to be deemed plan assets as defined under the Employee Retirement Income Security Act of 1974 or its accompanying regulations or result in any “prohibited transaction” thereunder involving the Company.
(e)Any Transfer or attempted Transfer of any Company Shares in violation of this Agreement shall be null and void, no such Transfer shall be recorded on the Company’s books and the purported transferee in any such Transfer shall not be treated (and the purported transferor shall continue be treated) as the owner of the Company Shares for all purposes of this Agreement.
Section 3.02Right of First Offer.
(a)Subject to Section 3.06(g), one or more DHC Parties (the “Electing DHC Parties”) may Transfer all or any portion of their Company Shares to a Third Party Purchaser; provided, however, that any such Transfer must be in compliance with this Section 3.02; and, provided further, that the DHC Parties may only initiate a Transfer pursuant to this Section 3.02 once in any calendar year.
(b)Prior to Transferring any Company Shares to any Third Party Purchaser, the Electing DHC Parties shall provide ABP with notice (a “DHC Offer Notice”) of their desire to Transfer some or all of their Company Shares to a Third Party.
(c)The DHC Offer Notice shall specify the number of Company Shares that the Electing DHC Parties desire to Transfer (such Company Shares, the “Offered Shares”) and shall include a valuation (without any reduction for minority interests) of the Offered Shares from a Third Party Valuation Firm (the “DHC ROFO Price”), together with reasonable supporting information. Upon request of the Electing DHC Parties, the Company and ABP shall provide the Third Party Valuation Firm appointed by the Electing DHC Parties to determine the DHC ROFO Price with such information related to the Offered Shares, the Company and ABP as such Third Party Valuation Firm may reasonably request in connection with its determination. Except as provided in Section 3.06(g), the Electing DHC Parties shall bear the costs of such Third Party Valuation Firm.
(d)Upon receipt of the DHC Offer Notice, ABP shall have ten (10) Business Days (the “Initial ROFO Exercise Period”) to elect, by delivering notice to the Electing DHC Parties, that ABP will (i) purchase all, but not less than all, of the Offered Shares at the DHC ROFO Price (a “ROFO Acceptance Notice”) or (ii) provide the Electing DHC Parties with a valuation of the Offered Shares (without any reduction for minority interests) from an alternative Third Party Valuation Firm (a “ROFO Alternative Value”), together with reasonable supporting information, within forty-five (45) days after the end of the Initial ROFO Exercise Period (such notice, a “ROFO Alternative Value Notice”). Any ROFO Acceptance Notice shall be binding upon delivery and irrevocable by ABP.
9


(e)If ABP delivers a ROFO Acceptance Notice during the Initial ROFO Exercise Period, the Electing DHC Parties shall sell, and ABP shall purchase, all, but not less than all, of the Offered Shares at the DHC ROFO Price. If ABP does not deliver a ROFO Acceptance Notice or a ROFO Alternative Value Notice during the Initial ROFO Exercise Period, or if it delivers a ROFO Alternative Value Notice but does not thereafter provide the ROFO Alternative Value when and as required by Section 3.02(f)(i), then ABP shall be deemed to have waived its rights to purchase the Offered Shares under this Section 3.02 with respect to such DHC Offer Notice.
(f)If ABP provides a ROFO Alternative Value Notice during the Initial ROFO Exercise Period, the following provisions shall apply:
(i)the ROFO Alternative Value Notice shall specify the Third Party Valuation Firm selected by ABP to provide the ROFO Alternative Value, which Third Party Valuation Firm shall be required to deliver to the Electing DHC Parties and ABP within forty-five (45) days after the end of the Initial ROFO Exercise Period its determination of the ROFO Alternative Value, together with reasonable supporting information. ABP shall bear the costs of the Third Party Valuation Firm appointed by it.
(ii)If the ROFO Alternative Value is at least ninety percent (90%) and not more than one hundred and ten percent (110%) of the DHC ROFO Price, then ABP shall have the right, to be exercised within three (3) Business Days of the date of the delivery of the ROFO Alternative Value, to again send a ROFO Acceptance Notice and if ABP sends a ROFO Acceptance Notice, ABP shall purchase, and the Electing DHC Parties shall sell, all, but not less than all, of the Offered Shares to ABP at the average of the DHC ROFO Price and the ROFO Alternative Value.
(iii)If the ROFO Alternative Value is greater than one hundred and ten percent (110%) of the DHC ROFO Price or less than ninety percent (90%) of the DHC ROFO Price, then ABP and the Electing DHC Parties shall jointly appoint a Joint Valuation Firm to determine the value of the Offered Shares, which shall be instructed to provide the Electing DHC Parties and ABP with its determination of the value of the Offered Shares (without any reduction for minority interests) (the “Determined ROFO Price”), together with reasonable supporting information, within thirty (30) days of its appointment. The Joint Valuation Firm shall be provided with the prior valuations of the Offered Shares obtained by the Electing DHC Parties and ABP, but shall not be obligated to base its determination on such valuations. ABP shall also provide the Joint Valuation Firm such additional information related to the Offered Shares and ABP as the Joint Valuation Firm may reasonably request in connection with its determination. Except as provided in Section 3.06(g), the cost of the Joint Valuation Firm will be borne fifty percent (50%) by the Electing DHC Parties and fifty percent (50%) by ABP or as they may otherwise agree. The Joint Valuation Firm shall act as an expert and not an arbitrator and the decision of the Joint Valuation Firm as to the Determined ROFO Price, absent manifest error, shall be final and non-appealable.
(iv)If the Determined ROFO Price is greater than one hundred and ten percent (110%) of the DHC ROFO Price or less than ninety percent (90%) of the DHC ROFO Price, the Electing DHC Parties shall have ten (10) days following delivery of the Determined ROFO Price (the “Withdrawal Period”) to provide ABP with notice of their withdrawal of the DHC Offer Notice, in which event, the Electing DHC Parties shall not be permitted to sell the Offered Shares to a Third Party Purchaser without sending a new DHC Offer Notice in accordance with, and otherwise complying with, this Section 3.02. If the DHC Parties do not send notice of their withdrawal of the DHC Offer Notice during the Withdrawal Period, then ABP shall have ten (10) days following the end of the Withdrawal Period (the “Second ROFO Exercise Period”) to again deliver a ROFO Acceptance Notice to the Electing DHC Parties and in such event the Electing DHC Parties shall sell, and ABP shall purchase all, but not less than all, of the Offered Shares at the Determined ROFO Price. If ABP does not deliver a ROFO Acceptance Notice during the Second ROFO Exercise Period, it shall be deemed to have waived its rights to purchase the Offered Shares under this Section 3.02 with respect to such DHC Offer Notice.
(g)The closing of the purchase and sale of the Offered Shares to ABP pursuant to this Section 3.02 shall occur on a date that is not later than seventy-five (75) days after the date on which ABP delivers a ROFO Acceptance Notice pursuant to this Section 3.02, or as otherwise agreed in writing by the Electing DHC Parties and ABP. At the closing of the purchase and sale of the Offered Shares to ABP pursuant to this Section 3.02, ABP shall deliver to the Electing DHC Parties the purchase price for the Offered Shares as determined pursuant to this Section 3.02 by wire transfer of immediately available funds and the Electing DHC Parties shall deliver to ABP the certificate(s) representing the Offered Shares, if any,
10


(or an affidavit of loss with respect to such certificate(s)) accompanied by stock powers and all necessary stock transfer taxes paid and stamps affixed, if necessary.
(h)If ABP does not deliver a ROFO Acceptance Notice or a ROFO Alternative Value Notice during the Initial ROFO Exercise Period or a ROFO Acceptance Notice during the Second ROFO Exercise Period, or has otherwise waived or been deemed to have waived its rights to purchase the Offered Shares, the Electing DHC Parties may, during the one hundred and twenty (120) day period immediately following the later of the expiration of the Initial ROFO Exercise Period or the Second ROFO Exercise Period, as applicable (the “Waived ROFO Transfer Period”), Transfer all of the Offered Shares to a Third Party Purchaser at a price not less than ninety-eight percent (98%) of the lesser of the DHC ROFO Price, the average of the DHC ROFO Price and the ROFO Alternative Value or the Determined ROFO Price. If the Electing DHC Parties do not Transfer the Offered Shares within the Waived ROFO Transfer Period, the Electing DHC Parties may not Transfer the Offered Shares unless the Electing DHC Parties send a new DHC Offer Notice in accordance with, and otherwise comply with, this Section 3.02.
(i)Each Stockholder shall take all actions as may be reasonably necessary to consummate the Transfer contemplated by this Section 3.02, including entering into agreements and delivering certificates and instruments and consents as may be deemed necessary or appropriate.
(j)During the Waived ROFO Transfer Period, neither the Company nor any Initial Stockholder Party shall engage in any marketing for sale or sale of the Company or any of its Subsidiaries (whether by merger, consolidation or sale of all or substantially all of the assets of the Company or its Subsidiaries) or any Company Shares (including by way of issuance of Company Shares, but other than the Offered Shares on behalf of the Electing DHC Parties) and the Company and ABP shall provide the Electing DHC Parties with reasonable assistance and cooperation at the Electing DHC Parties’ expense in connection with their marketing and sale of their Offered Shares.
(k)ABP’s rights under this Section 3.02 to acquire the Offered Shares may be assigned in whole or in part to the Company or any other Stockholder.
Section 3.03Drag-along Rights.
(a)Drag-along Rights. For so long as the Initial Stockholder Parties own, or hold voting control over, in aggregate at least a majority of the issued and outstanding Company Shares on a fully diluted basis, if such Stockholders (the “Dragging Stockholders”) receive a bona fide offer from a Third Party Purchaser to consummate, in one transaction or a series of related transactions, a Company Change of Control (a “Drag-along Sale”), and if the Dragging Stockholders have delivered a copy of such bona fide offer from such Third Party Purchaser to the Company and each DHC Party and each other Stockholder, then the Dragging Stockholders shall have the right to require that each DHC Party and other Stockholder (each, a “Drag-along Stockholder” and the Drag-along Stockholders, the Dragging Stockholders, and any other stockholders of the Company participating in the Drag-along Sale, the “Drag-along Participating Stockholders”) participate in such Transfer in the manner set forth in this Section 3.03. Notwithstanding anything to the contrary in this Agreement, but subject to Section 4.04(b), each Dragging Stockholder and each Drag-along Stockholder shall vote in favor of the Transfer and take all actions to approve such transaction and to waive any dissenters, appraisal or other similar rights.
(b)Exercise. The Dragging Stockholders shall exercise their rights pursuant to this Section 3.03 by delivering a notice (the “Drag-along Notice”) to each Drag-along Stockholder no later than thirty (30) days prior to the closing date of such Drag-along Sale. The Drag-along Notice shall set forth:
(i)the total number of Company Shares to be sold in the Drag-along Sale to the Third Party Purchaser if the Drag-along Sale is structured as a Transfer of Company Shares and the percentage of the outstanding Company Shares represented by such Company Shares;
(ii)the identity of the Third Party Purchaser;
(iii)the proposed date and time of the closing, if known, of the Drag-along Sale;
11


(iv)the per Company Share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(v)a copy of any form of agreement proposed to be executed in connection therewith.
(c)Amount of Company Shares Transferred. If the Drag-along Sale is structured as a Transfer of Company Shares, then, subject to Section 3.03(d) and Section 3.05, each Drag-along Participating Stockholder shall Transfer the amount of Company Shares equal to the product of (i) the total amount of Company Shares to be sold to the Third Party Purchaser as stated in the Drag-along Notice, and (ii) a fraction (1) the numerator of which is equal to the amount of Company Shares then held by such Drag-along Participating Stockholder, and (2) the denominator of which is equal to the amount of Company Shares then held in aggregate by the Drag-along Participating Stockholders.
(d)Consideration; Representations. Subject to the provisions of this Section 3.03(d) and Section 3.05, the consideration to be received by each Drag-along Participating Stockholder in the Drag-along Sale shall be the same form and amount of consideration per Company Share (or, if Third Party Purchaser gives any Drag-along Participating Stockholder an option as to the form and amount of consideration to be received, the same option shall be given to each Drag-along Participating Stockholder) and the terms and conditions of such Transfer shall be the same for all Drag-along Participating Stockholders; provided, however, and notwithstanding anything in this Agreement to the contrary, in no event shall any DHC Party be required to accept any consideration having a minimum value less than the Base Price. Additionally, and notwithstanding anything in this Agreement to the contrary, in no event shall any Drag-along Stockholder be required to: (i) accept any consideration in a Drag-along Sale other than cash or freely marketable publicly traded securities; (ii) enter into any non-compete, non-solicitation or similar agreements in connection with such Drag-along Sale; or (iii) make any representations, warranties or indemnities other than with respect to such Drag-along Stockholder’s ownership of its Company Shares and its power and right to enter into and consummate such Drag-along Sale; provided, however, that each Drag-along Stockholder may be required to participate in any indemnities with respect to representations related to the Company made to the Third Party Purchaser on a pro rata basis with the other Drag-along Participating Stockholders based on the aggregate consideration received by such Drag-along Participating Stockholder (except with respect to representations and warranties or covenants or indemnities as to any specific Drag-along Participating Stockholder for which only such Drag-along Participating Stockholder shall be responsible), so long as the aggregate indemnification obligations and liability for fraud or intentional misrepresentation on the part of the Company of any Drag-along Stockholder in connection with such Drag-along Sale do not exceed the actual amount of proceeds received by such Drag-along Stockholder in such Drag-along Sale and in no event shall any Drag-along Participating Stockholder be liable to a Third Party Purchaser for any fraud or intentional misrepresentation on the part of any other Drag-along Participating Stockholder.
(e)Expenses. The fees and expenses of each Dragging Stockholder incurred in connection with a Drag-along Sale and for the benefit of all Drag-along Participating Stockholders (it being understood that costs incurred by or on behalf of a Dragging Stockholder for its sole benefit will not be considered to be for the benefit of all Drag-along Participating Stockholders), to the extent not paid or reimbursed by the Company or the Third Party Purchaser, shall be shared on a pro rata basis by each Drag-along Participating Stockholder based on the aggregate consideration received by such Drag-along Participating Stockholder in the Drag-along Sale; provided, that no Drag-along Stockholder shall be obligated to make or reimburse any out-of-pocket expenditure prior to the consummation of the Drag-along Sale.
(f)Cooperation. Each Stockholder shall take all actions as may be reasonably necessary to consummate the Drag-along Sale, including entering into agreements and delivering certificates, assignments and instruments, in each case, consistent with the agreements being entered into and the certificates, as applicable, being delivered by each Dragging Stockholder and the terms of this Section 3.03.
(g)Timing of Closing. The Dragging Stockholders shall have one hundred and eighty (180) days following the date of the Drag-along Notice in which to consummate the Drag-along Sale, on the terms set forth in the Drag-along Notice and the terms of this Section 3.03 (which one hundred and eighty (180) day period may be extended for a reasonable time not to exceed an additional ninety (90) days to the extent reasonably necessary to obtain any required approvals or consents). If at the end of such period the Dragging Stockholders have not completed the Drag-along Sale, then the Dragging Stockholders may not thereafter effect a Transfer of Company Shares pursuant to this Section 3.03 without again sending a new Drag-along Notice and complying with the provisions of this Section 3.03.
12


Section 3.04Tag-along Rights.
(a)Tag-along Rights. If at any time one or more Initial Stockholder Parties (the “Selling Stockholders”) propose to Transfer any of their Company Shares to a Third Party Purchaser (the “Proposed Transferee”), and if such Selling Stockholders cannot or have not elected to exercise the rights of Dragging Stockholders set forth in Section 3.03 in connection with such Transfer (a “Tag-along Sale”), then each DHC Party and each other Stockholder (each, a “Tag-along Stockholder” and the Selling Stockholders, the Tag-along Stockholders and any other stockholders of the Company participating in such Tag-along Sale, collectively, the “Tag-along Participating Stockholders”) shall be permitted to participate in such Tag-along Sale with respect to the Company Shares owned by such Tag-along Stockholder on the terms and conditions set forth in this Section 3.04.
(b)Notice. The Selling Stockholders shall deliver to the Company and each Tag-along Stockholder a notice (a “Sale Notice”) of the proposed Tag-along Sale no later than twenty (20) Business Days prior to the closing date of such Tag-along Sale. The Sale Notice shall set forth:
(i)the total number of Company Shares the Proposed Transferee has offered to acquire and the percentage of the outstanding Company Shares represented by such Company Shares;
(ii)the number of Company Shares that the Selling Stockholders propose to Transfer in the Tag-along Sale and the percentage of the outstanding Company Shares owned by the Selling Stockholders represented by such Company Shares;
(iii)the identity of the Proposed Transferee;
(iv)the proposed date and time of the closing, if known, of the Tag-along Sale;
(v)the per Company Share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(vi)a copy of any form of agreement proposed to be executed in connection therewith.
(c)Exercise. Each Tag-along Stockholder shall exercise its right to participate in a Tag-along Sale by delivering to the Selling Stockholders a notice (a “Tag-along Notice”) stating its election to do so and specifying the number of its Company Shares it desires to Transfer in such Tag-along Sale (up to the maximum number it is permitted to Transfer pursuant to this Section 3.04) no later than twenty (20) days after receipt of the Sale Notice (the “Tag-along Period”). The election by a Tag-along Stockholder set forth in its Tag-along Notice shall be irrevocable except as provided in this Section 3.04(c), and such Tag-along Stockholder shall be bound and obligated, and entitled, to Transfer such Company Shares in the proposed Tag-along Sale on and subject to the terms and conditions set forth in this Section 3.04. Each Tag-along Stockholder shall have the right to Transfer in a Tag-along Sale up to the same percentage of its Company Shares as the percentage of the Company Shares held by the Selling Stockholders being Transferred in such Tag-along Sale. For the avoidance of doubt, if the aggregate number of Company Shares that the Tag-along Participating Stockholders have elected to Transfer in the Tag-along Sale exceeds the number of Company Shares that the Proposed Transferee is willing to acquire, then the number of Company Shares that each Tag-along Participating Stockholder will Transfer in the Tag-along Sale shall be proportionately reduced until the aggregate number of Company Shares that the Tag-along Participating Stockholders will Transfer in such Tag-along Sale equals the number of Company Shares that the Proposed Transferee is willing to acquire; provided, that in no event will the number of Company Shares that the Tag-along Stockholder is permitted to sell in the Tag-along Sale be reduced to less than the same percentage of such Tag-along Stockholder’s Company Shares as the percentage of the Company Shares held by the Selling Stockholders being Transferred in such Tag-along Sale. Notwithstanding the foregoing, if the terms of, or agreements for, a Tag-along Sale materially change from those provided in the Sale Notice or if the percentage of the Company Shares owned by the Selling Stockholders to be Transferred in the Tag-along Sale shall change from the percentage set forth in the Sale Notice, the Selling Stockholders shall deliver to each Tag-along Stockholder (whether or not such Tag-along Stockholder has previously sent a timely Tag-along Notice) an updated Sale Notice reflecting such changes and each Tag-along Stockholder shall have the right, exercisable within ten (10) Business Days, to elect to participate in, change its participation in or withdraw its participation in such Tag-along Sale.
13


(d)Transfer. A Tag-along Stockholder who does not deliver a timely Tag-along Notice in compliance with Section 3.04(c) shall be deemed to have waived its rights to participate in such Transfer and the Selling Stockholders shall (subject to the rights of any other Tag-along Stockholders who have provided a timely Tag-along Notice) thereafter be free to Transfer to the Proposed Transferee its Company Shares at a per Company Share price that is not greater than one hundred and two percent (102%) of the per Company Share price set forth in the Sale Notice and on other terms and conditions which are not materially more favorable in the aggregate to the Selling Stockholders than those set forth in the Sale Notice without any further obligation to the non-accepting Tag-along Stockholders.
(e)Consideration; Representations. Subject to the provisions of this Section 3.04(e) and Section 3.05, the consideration to be received by a Tag-along Stockholder in the Tag-along Sale shall be the same form and amount of consideration per Company Share to be received by the Selling Stockholders (or, if the Selling Stockholders are given an option as to the form and amount of consideration to be received, the same option shall be given to each Tag-along Stockholder) and the terms and conditions of such Transfer shall be the same as those upon which each Selling Stockholder Transfers its Company Shares. Each Tag-along Stockholder shall make or provide the same representations, warranties, covenants, indemnities and agreements as each Selling Stockholder makes or provides in connection with the Tag-along Sale (except that in the case of representations, warranties, covenants, indemnities and agreements pertaining specifically to the Selling Stockholders or any other Tag-along Participating Stockholder, a Tag-along Stockholder shall only make the comparable representations, warranties, covenants, indemnities and agreements pertaining specifically to itself); provided, that (i) the Selling Stockholders shall use commercially reasonable efforts to cause all representations, warranties, covenants and indemnities to be made by each Tag-along Participating Stockholder to be several and not joint obligations of the Tag-along Participating Stockholders and (ii) unless otherwise agreed by each Tag-along Stockholder, any indemnification obligation in respect of breaches of representations, warranties and covenants (other than those that pertain to an individual Tag-along Participating Stockholder, which shall be the sole obligation of such Tag-along Participating Stockholder) shall be borne on a pro rata basis by each Tag-along Participating Stockholder based on the aggregate consideration received by such Tag-along Participating Stockholder in such Tag-along Sale; provided, that in no event shall (x) the amount of the indemnification obligation and liability for fraud or intentional misrepresentation on the part of the Company of a Tag-along Stockholder exceed the aggregate proceeds received by such Tag-along Stockholder in such Tag-along Sale; (y) any Tag-along Stockholder be required to enter into any non-compete, non-solicitation or similar agreements in connection with such Tag-along Sale and (z) in no event shall any Tag-along Stockholder be liable for any fraud or intentional misrepresentation by any other stockholder of the Company.
(f)Expenses. The fees and expenses of the Selling Stockholders incurred in connection with a Tag-along Sale and for the benefit of all Tag-along Participating Stockholders (it being understood that costs incurred by or on behalf of the Selling Stockholders for their sole benefit will not be considered to be for the benefit of all Tag-along Participating Stockholders), to the extent not paid or reimbursed by the Company or the Proposed Transferee, shall be shared by each Tag-along Participating Stockholder on a pro rata basis, based on the aggregate consideration received by such Tag-along Participating Stockholder; provided, that no Tag-along Stockholder shall be obligated to make or reimburse any out-of-pocket expenditure prior to the consummation of the Tag-along Sale.
(g)Cooperation. Each Tag-along Stockholder shall take all actions as may be reasonably necessary to consummate the Tag-along Sale, including entering into agreements and delivering certificates, assignments, and instruments, in each case consistent with the agreements being entered into and the certificates, as applicable, being delivered by the Selling Stockholders and the terms of this Section 3.04.
(h)Timing of Closing. The Selling Stockholders shall have ninety (90) days following the expiration of the Tag-along Period in which to consummate such Tag-along Sale to the Proposed Transferee, on and subject to the terms and conditions set forth in the Sale Notice and this Section 3.04 (which ninety (90) day period may be extended for a reasonable time not to exceed an additional ninety (90) days to the extent reasonably necessary to obtain any required approvals and consents). If at the end of such period the Selling Stockholders have not completed such Transfer, then the Selling Stockholders may not thereafter effect a Transfer of Company Shares subject to this Section 3.04 without again fully complying with the provisions of this Section 3.04.
Section 3.05Multiple Classes of Shares. If at any time the Company has more than one class of Company Shares which may impact the application of the provisions of Section 3.03 or Section 3.04 in connection with a Drag-along
14


Sale or a Tag-along Sale, respectively, including in connection with the consideration to be paid by the Third Party Purchaser for any class of Company Shares, the Directors and the Drag-along Participating Stockholders and Tag-along Participating Stockholders shall use reasonable best efforts to cooperate to apply Section 3.03 or Section 3.04, as applicable, in good faith in a reasonable and equitable manner in consideration of the capital structure of the Company, in order to carry out the intent of such provisions; provided, that there shall be no minority or other similar discount for less than a controlling interest or for nonvoting Company Shares, and no premium for voting Company Shares or a controlling interest, in the Company.
Section 3.06Repurchase Rights.
(a)Subject to Section 3.06(g), following a Termination Event, ABP shall have the right (a “Repurchase Right”), exercised by notice (the “Repurchase Notice”) given to the DHC Parties any time prior to the one year anniversary of such Termination Event, to purchase all, but not less than all, of the Company Shares then owned by the DHC Parties (the “Repurchase Shares”). The Repurchase Notice shall include a valuation (without any reduction for minority interests) of the Repurchase Shares as of the date of the Termination Event from a Third Party Valuation Firm (the “Repurchase Price”), together with reasonable supporting information.
(b)Upon receipt of the Repurchase Notice, the DHC Parties shall have ten (10) Business Days (the “Repurchase Exercise Period”), to elect, by delivering notice to ABP, that the DHC Parties will (i) sell the Repurchase Shares at the Repurchase Price (the “Repurchase Acceptance Notice”) or (ii) provide ABP with a valuation of the Repurchase Shares (without any reduction for minority interests) as of the date of the Termination Event from an alternate Third Party Valuation Firm (a “Repurchase Alternative Value”), together with reasonable supporting information, within thirty (30) days after the end of the Repurchase Exercise Period (such notice, a “Repurchase Alternative Value Notice”).
(c)If the DHC Parties provide a Repurchase Acceptance Notice during the Repurchase Exercise Period, the DHC Parties shall sell, and ABP shall purchase, all, but not less than all, of the Repurchase Shares at the Repurchase Price. If the DHC Parties fail to provide a Repurchase Acceptance Notice or a Repurchase Alternative Value Notice during the Repurchase Exercise Period, or if they deliver a Repurchase Alternative Value Notice but do not thereafter provide the Repurchase Alternative Value when and as required by Section 3.06(d)(i), then they will be deemed to have delivered a Repurchase Acceptance Notice.
(d)If the DHC Parties provide a Repurchase Alternative Value Notice during the Repurchase Exercise Period, the following provisions will apply:
(i)The Repurchase Alternative Value Notice shall specify the Third Party Valuation Firm (the “DHC Valuation Firm”) selected by the DHC Parties to provide the Repurchase Alternative Value, which Third Party Valuation Firm shall be required to deliver to the DHC Parties and ABP within thirty (30) days after the end of the Repurchase Exercise Period its determination of the Repurchase Alternative Value, together with reasonable supporting information. ABP shall provide the DHC Valuation Firm such additional information related to the Repurchase Shares and ABP as the DHC Valuation Firm may reasonably request in connection with its determination. The DHC Parties shall bear the costs of the DHC Valuation Firm.
(ii)If the Repurchase Alternative Value is at least ninety percent (90%) and not more than one hundred and ten percent (110%) of the Repurchase Price, then, subject to Section 3.06(a), the DHC Parties shall be deemed to have delivered a Repurchase Acceptance Notice and the DHC Parties shall sell, and ABP shall purchase, all, but not less than all, of the Repurchase Shares at the average of the Repurchase Price and the Repurchase Alternative Value.
(iii)If the Repurchase Alternative Value is less than ninety percent (90%) or greater than one hundred and ten percent (110%) of the Repurchase Price, then ABP and the DHC Parties shall jointly appoint a Joint Valuation Firm to determine the value of the Repurchase Shares, which shall be instructed to provide the DHC Parties and ABP with its determination of the value of the Repurchase Shares (without any reduction for minority interests) as of the date of the Termination Event (the “Determined Repurchase Price”), together with reasonable supporting information, within thirty (30) days of its appointment. The Joint Valuation Firm shall be provided with the prior valuations of the Repurchase Shares obtained by the DHC Parties and ABP, but shall not be obligated to base its determination on such valuations. ABP shall also provide the Joint Valuation Firm such additional information related to the Repurchase Shares and ABP as the Joint
15


Valuation Firm may reasonably request in connection with its determination. The cost of the Joint Valuation Firm will be borne fifty percent (50%) by the DHC Parties and fifty percent (50%) by ABP or as they may otherwise agree. The Joint Valuation Firm shall act as an expert and not an arbitrator and the decision of the Joint Valuation Firm as to the Determined Repurchase Price, absent manifest error, shall be final and non-appealable. Upon delivery of the Determined Repurchase Price, ABP shall purchase, and the DHC Parties shall sell, all, but not less than all, of the Repurchase Shares at the Determined Repurchase Price, subject to Section 3.06(d)(iv).
(iv)If the Determined Repurchase Price is more than one hundred and ten percent (110%) of the Repurchase Price, ABP shall have ten (10) days following delivery of the Determined Repurchase Price (the “Repurchase Withdrawal Period”) to withdraw the Repurchase Notice by notice given to the DHC Parties; provided, that ABP shall reimburse the Electing DHC Parties for the costs of the DHC Valuation Firm and Joint Valuation Firm incurred by them in connection with any ROFO Process that was terminated as provided in Section 3.06(g)(iii). If ABP does not withdraw the Repurchase Notice in such ten (10) day period, then ABP shall purchase, and the DHC Parties shall sell, all, but not less than all, of the Repurchase Shares at the Determined Repurchase Price.
(v)Notwithstanding the foregoing, in no event shall any DHC Party be required to accept a Repurchase Price having a minimum value less than the Base Price.
(e)The closing of the purchase and sale of the Repurchase Shares pursuant to this Section 3.06 shall occur on a date that is not later than ninety (90) days after the purchase price for the Repurchase Shares has been finally determined pursuant to this Section 3.06 or as otherwise agreed in writing by the DHC Parties and ABP. At the closing of the purchase and sale of the Repurchase Shares to ABP pursuant to this Section 3.06, ABP shall deliver to the DHC Parties the purchase price for the Repurchase Shares as determined pursuant to this Section 3.06 by wire transfer of immediately available funds and the DHC Parties shall deliver to ABP the certificate(s) representing the Repurchase Shares, if any, (or an affidavit of loss with respect to such certificates) accompanied by stock powers and all necessary stock transfer taxes paid and stamps affixed, if necessary.
(f)If ABP withdraws the Repurchase Notice in accordance with Section 3.06(d)(iv), the DHC Parties may during the one hundred and twenty (120) day period immediately following the date that they receive the notice from ABP that it is withdrawing the Repurchase Notice (the “Waived Repurchase Transfer Period”), Transfer all of the Repurchase Shares to any Third Party Purchaser at a price not less than ninety eight percent (98%) of the lesser of the Repurchase Price, the average of the Repurchase Price and the Repurchase Alternative Value or the Determined Repurchase Price and the provisions of Section 3.02(i) and Section 3.02(j) shall apply mutatis mutandis during the Waived Repurchase Transfer Period.
(g)Notwithstanding anything in this Agreement to the contrary, but subject to Section 4.04(b), (i) ABP may not exercise the Repurchase Right at any time during the pendency of a Drag-along Sale, a Tag-along Sale or a transaction which is reasonably likely to result in a Company Change of Control; (ii) if a Termination Event has occurred, the DHC Parties may not thereafter send an DHC Offer Notice until a date that is not less than ninety (90) days following the date of the Termination Event or after such ninety (90) day period if ABP has then delivered a Repurchase Notice pursuant to this Section 3.06 unless and until such Repurchase Notice is withdrawn pursuant to Section 3.06(d)(iv); (iii) if as of the date a Termination Event occurs, the process with respect to an outstanding DHC Offer Notice is then pending pursuant to Section 3.02 (a “ROFO Process”), then (A) the ROFO Process shall be suspended for ninety (90) days following the Termination Event, and terminated if ABP sends a Repurchase Notice within such ninety (90) day period; (B) if ABP fails to send a Repurchase Notice in such ninety (90) day period, then as of the ninety-first (91st) day following the Termination Event, at the Electing DHC Parties’ option, the ROFO Process shall resume with any applicable time periods extended to reflect such suspension; and (C) if ABP sends a Repurchase Notice within such ninety (90) period following the Termination Event and thereafter withdraws the Repurchase Notice in accordance with Section 3.06(d)(iv), the DHC Parties shall have the right following such withdrawal to send another DHC Offer Notice to ABP even if the DHC Parties have previously sent an DHC Offer Notice in that calendar year; and (iv) if a ROFO Process is reinstated pursuant to clause (iii) of this Section 3.06(g) or the DHC Parties send an DHC Offer Notice permitted by clause (ii) of this Section 3.06(g), ABP shall not thereafter have the right to send a Repurchase Notice unless and until the applicable ROFO Process has been completed in accordance with Section 3.02 and the Repurchase Right will only be exercisable with respect to the remaining Company Shares owned by the DHC Parties after the ROFO Process has been completed. For the avoidance of doubt, nothing in this Section 3.06 limits the
16


right of the DHC Parties to Transfer any or all of their Repurchase Shares at any time pursuant to Section 3.03 or Section 3.04 or otherwise in compliance with this Agreement.
(h)ABP may assign the Repurchase Right in whole or in part to the Company or any other Stockholder.
Section 3.07Put Rights.
(a)At any time that a Put Event then exists, each REIT Party shall have the right (a “Put Right”) exercised by notice to ABP (the “Put Notice”) to require ABP to purchase from such REIT Party (the “Electing Put Party”), such number of the Company Shares owned by such REIT Party as is necessary to cause the Company Shares owned by such REIT Party to not exceed the Company Shares that such REIT Party may own pursuant to the limit in Section 4.04(b) (such number of Company Shares to be purchased, the “Put Shares”). The purchase price per Put Share shall initially be the Base Price (the “Put Price”).
(b)Upon receipt of the Put Notice, ABP shall within three (3) Business Days purchase all of the Put Shares at the Put Price, subject to the remaining provisions of this Section 3.07.
(c)Without limiting the obligation of ABP to purchase the Put Shares pursuant to Section 3.07(b), the Electing Put Party shall have ten (10) Business Days following the delivery of the Put Notice (the “Put Exercise Period”), to elect, by delivering notice to ABP, that ABP provide the Electing Put Party with a valuation of the Put Shares (without any reduction for minority interests) as of the date of the Put Notice from a Third Party Valuation Firm (a “Put Alternative Value”), together with reasonable supporting information, within thirty (30) days after the end of the Put Exercise Period (such notice, a “Put Alternative Value Notice”).
(d)If ABP provides a Put Alternative Value Notice during the Put Exercise Period, the following provisions will apply:
(i)The Put Alternative Value Notice shall specify the Third Party Valuation Firm (the “Alternative Put Valuation Firm”) selected by ABP to provide the Put Alternative Value, which Alternative Put Valuation Firm shall be required to deliver to the Electing Put Party and ABP within thirty (30) days after the end of the Put Exercise Period its determination of the Put Alternative Value, together with reasonable supporting information. The Company and ABP shall provide the Alternative ABP Valuation Firm such additional information related to the Put Shares, the Company and ABP as the Alternative Put Valuation Firm may reasonably request in connection with its determination. ABP shall bear the costs of the Alternative Put Valuation Firm.
(ii)If the Put Alternative Value is less than the Base Price or not more than one hundred and ten percent (110%) of the Put Price, then the purchase price for the Put Shares shall the Put Price.
(iii)If the Put Alternative Value is greater than one hundred and ten percent (110%) of the Put Price, then ABP and the Electing Put Party shall jointly appoint a Joint Valuation Firm to determine the value of the Put Shares, which shall be instructed to provide the Electing Put Party and ABP with its determination of the value of the Put Shares (without any reduction for minority interests) as of the date of the Put Notice (the “Determined Put Price”), together with reasonable supporting information, within thirty (30) days of its appointment. The Joint Valuation Firm shall be provided with the prior valuation of the Put Shares obtained by ABP, but shall not be obligated to base its determination on such valuation. The Company and ABP shall also provide the Joint Valuation Firm such additional information related to the Put Shares, the Company and ABP as the Joint Valuation Firm may reasonably request in connection with its determination. The cost of the Joint Valuation Firm will be borne fifty percent (50%) by the Electing Put Party and fifty percent (50%) by ABP or as they may otherwise agree. The Joint Valuation Firm shall act as an expert and not an arbitrator and the decision of the Joint Valuation Firm as to the Determined Put Price, absent manifest error, shall be final and non-appealable. Upon delivery of the Determined Put Price, the purchase price for the Put Shares shall be adjusted to the Determined Put Price, but shall in no event be lower than the Put Price.
17


(e)If the final purchase price determined for the Put Shares pursuant to this Section 3.07 (the “Final Price”) is greater than the Put Price, ABP shall promptly, and in any event within ten (10) Business Days, pay to the Electing Put Party the difference between the Put Price and the Final Price by wire transfer of immediately available funds.
(f)At the closing of the purchase and sale of the Put Shares pursuant to this Section 3.07, ABP shall deliver to the Electing Put Party the purchase price for the Put Shares as determined pursuant to this Section 3.07 by wire transfer of immediately available funds and the Electing Put Party shall deliver to ABP the certificate(s) representing the Put Shares, if any, (or an affidavit of loss with respect to such certificates) accompanied by stock powers and all necessary stock transfer taxes paid and stamps affixed, if necessary.
(g)For the avoidance of doubt, the rights of the REIT Parties under this Section 3.07 are in addition to any other rights or remedies of the REIT Parties at equity or under Applicable Law as a result of the occurrence of a Put Event.
(h)ABP may assign its right (but not its obligation) to purchase the Put Shares, in whole or in part, to the Company or any other Stockholder.

ARTICLE IV
OTHER ACTIVITIES; RELATED PARTY TRANSACTIONS; CONFIDENTIALITY; PRE-EMPTIVE RIGHTS; REIT COMPLIANCE
Section 4.01Other Business Activities. Each Stockholder may engage independently or with others in other business ventures of every nature and description including the ownership, operation, management, syndication and development of a business which is competitive with the Company or any of its Subsidiaries or their respective businesses, and neither the Stockholders nor the Company or its Subsidiaries shall have any rights in and to such independent ventures or the income or profits derived therefrom.
Section 4.02Confidentiality.
(a)Confidentiality. Each DHC Party shall use commercially reasonable efforts to keep confidential any information (including any budgets, business plans and analyses) concerning the Company or its Subsidiaries, including their assets, business, operations, financial condition or prospects (“Information”) received by it solely in its capacity as a Stockholder; provided, that nothing herein shall prevent such DHC Party from disclosing such Information: (i) upon the order of any court or administrative agency or the request or demand of any regulatory agency or authority having jurisdiction over such Stockholder; (ii) to the extent compelled by legal process or required or requested pursuant to subpoena, interrogatories or other discovery requests; (iii) as may be appropriate or required under Applicable Law, including the rules and regulations of the U.S. Securities and Exchange Commission, The Nasdaq Stock Market LLC or the Financial Industry Regulatory Authority Inc.; (iv) subject to the provisions of this Section 4.02, to those Persons who have a need to know such Information in connection with the conduct of such DHC Party’s business, including its officers, trustees, directors, attorneys, accountants, and other representatives and agents; (v) in connection with any Proceeding based upon or in connection with the subject matter of this Agreement or the transactions contemplated hereby; (vi) to any other Stockholder; or (vii) to any potential Third Party Purchaser in connection with a proposed Transfer of Company Shares by such DHC Party as long as such Third Party Purchaser agrees to be bound by the provisions of this Section 4.02 as if an DHC Party; provided, that in the case of clauses (i) or (ii) of this Section 4.02 such DHC Party provides prior notice to the Company of the proposed disclosure as far in advance of such disclosure as practicable and uses reasonable efforts to insure that any Information so disclosed is accorded confidential treatment to the extent requested by the Company at the Company’s expense.
(b)Exceptions. The restrictions of Section 4.02(a) shall not apply to Information that: (i) is or becomes generally available to the public other than as a result of a disclosure by an DHC Party in violation of this Agreement; (ii) is or becomes available to an DHC Party on a nonconfidential basis prior to its disclosure to the receiving Person; (iii) is or has been independently developed or conceived by an DHC Party without use of any Information; or (iv) becomes available to the receiving Person on a nonconfidential basis from a source other than an DHC Party; provided, that such source is not known by the receiving Person to be bound by a confidentiality agreement with the Company or such Subsidiary.
18


Section 4.03Certain Pre-emptive Rights for Additional Equity.
(a)Issuance of Additional Company Shares. The Company hereby grants to each Stockholder (each, a “Pre-emptive Stockholder”) the right to purchase a pro rata portion of any Company Shares (other than Excluded Shares) proposed to be issued or sold after the date hereof by the Company to any Person (“Additional Company Shares”). The Company shall not permit any Subsidiary to not be a wholly-owned Subsidiary of the Company, except as a result of the issuance or sale by such Subsidiary of Excluded Shares.
(b)Additional Issuance Notices. If the Company desires to issue Additional Company Shares, the Company shall give notice (an “Issuance Notice”) of the proposed issuance or sale to each Pre-emptive Stockholder within seven (7) days following any meeting of the Directors at which any such issuance or sale is approved. The Issuance Notice shall be accompanied by a written offer to purchase such Additional Company Shares from each prospective purchaser of such Additional Company Shares (each, a “Pre-emptive Purchaser”) and shall set forth the material terms and conditions of the proposed issuance or sale, including:
(i)The identity of each Pre-emptive Purchaser, if known, and the aggregate amount and a description of the Additional Company Shares proposed to be issued and the percentage of the Company Shares that such issuance would represent;
(ii)the proposed issuance date, which subject to Section 4.03(g), shall be at least thirty (30) days from the date of the Issuance Notice;
(iii)the proposed purchase price per Company Share of the Additional Company Shares and the form of such purchase price if other than cash; and
(iv)if the consideration to be paid by any Pre-emptive Purchaser includes non-cash consideration, the Directors’ good faith determination of the fair market value thereof.
The Issuance Notice shall also be accompanied by a statement of the Company Shares ownership of each stockholder of the Company and a calculation in reasonable detail as to each Pre-emptive Stockholder’s pro rata share of the Additional Company Shares.
(c)Exercise of Pre-emptive Rights. Each Pre-emptive Stockholder shall for a period of twenty (20) days following the receipt of an Issuance Notice (the “Pre-emptive Exercise Period”) have the right to elect irrevocably to purchase all or any portion of its pro rata share of the Additional Company Shares, at the purchase price set forth in the Issuance Notice, by delivering notice to the Company (a “Pre-emptive Acceptance Notice”) specifying the number of Additional Company Shares it desires to purchase. The delivery of a Pre-emptive Acceptance Notice by a Pre-emptive Stockholder shall be a binding and irrevocable subscription by such Pre-emptive Stockholder for the number of Additional Company Shares described in its Pre-emptive Acceptance Notice in accordance with the terms of this Section 4.03. The failure of a Pre-emptive Stockholder to deliver an Acceptance Notice by the end of the Pre-emptive Exercise Period shall constitute a waiver of its rights under this Section 4.03 with respect to the purchase of such Additional Company Shares, but shall not affect its rights with respect to any future issuances or sales of Additional Company Shares.
(d)Over-allotment. No later than seven (7) days following the expiration of the Pre-emptive Exercise Period, the Company shall notify each Pre-emptive Stockholder in writing of the number of Additional Company Shares that each Pre-emptive Stockholder has agreed to purchase (including, for the avoidance of doubt, where such number is zero) (the “Over-allotment Notice”). Each Pre-emptive Stockholder exercising its rights to purchase its pro rata share of the Additional Company Shares in full (an “Exercising Pre-emptive Stockholder”) shall have a right of over-allotment such that if any other Pre-emptive Stockholder has failed to exercise its right under this Section 4.03, or any other stockholder of the Company having pre-emptive rights to purchase Company Shares in such transaction has failed, to purchase its pro rata share of the Additional Company Shares in full (each, a “Non-Exercising Pre-emptive Stockholder”), such Exercising Pre-emptive Stockholder may purchase its pro rata share (computed on the basis of the Exercising Pre-emptive Stockholders and other stockholders of the Company who choose to purchase in the over-allotment in proportion to their pro rata share of the Additional Company Shares, and otherwise so that one hundred percent (100%) of the over-allotment may be subscribed for
19


and purchased by the Exercising Pre-emptive Stockholders and such other stockholders) of such Non-Exercising Pre-emptive Stockholders’ unsubscribed for allotment, by giving notice to the Company within ten (10) Business Days of receipt of the Over-allotment Notice (the “Over-allotment Exercise Period”).
(e)Sale of Additional Shares. Any Additional Company Shares not subscribed for by a Pre-emptive Stockholder pursuant to Section 4.03(c) and Section 4.03(d) may be sold by the Company following the expiration of the Pre-emptive Exercise Period and, if applicable, the Over-allotment Exercise Period, to the Pre-emptive Purchasers on terms no less favorable to the Company than those set forth in the Issuance Notice and, for the avoidance of doubt, at a price at least equal to or higher than the purchase price described in the Issuance Notice; provided, such sale is completed no later than sixty (60) days following the expiration of the Pre-emptive Exercise Period and, if applicable, the Over-allotment Exercise Period (subject to the extension of such sixty (60) day period for a reasonable time not to exceed an additional sixty (60) days to the extent reasonably necessary to obtain any third party approvals). If the Company has not sold all of the remaining Additional Company Shares to the Pre-emptive Purchasers by such date, the Company shall not thereafter issue or sell any such Additional Company Shares without first again offering such Additional Company Shares to the Pre-emptive Stockholders in accordance with the procedures set forth in this Section 4.03 and no Pre-emptive Stockholder shall be obligated to complete the purchase of the Additional Company Shares that it subscribed for pursuant to Section 4.03(c) and Section 4.03(d).
(f)Additional Company Shares Sale Closing. Except as provided in Section 4.03(g), the closing of any purchase by any Pre-emptive Stockholder shall be consummated substantially contemporaneously with the consummation of the sale to the Pre-emptive Purchasers. The Company shall deliver the Additional Company Shares to be purchased by a Pre-emptive Stockholder in accordance with this Section 4.03 free and clear of any liens (other than those arising hereunder and those attributable to the actions of the purchasers thereof), and the Company shall represent and warrant to such Pre-emptive Stockholder that such Additional Company Shares shall be, upon issuance thereof to such Pre-emptive Stockholder and after payment therefor, duly authorized, validly issued, fully paid and non-assessable. The Company, in the discretion of its Directors, may deliver to each purchasing Pre-emptive Stockholder certificates evidencing the Additional Company Shares. Each purchasing Pre-emptive Stockholder shall deliver to the Company the purchase price for the Additional Company Shares purchased by it by wire transfer of immediately available funds. Each party to the purchase and sale of Additional Company Shares pursuant to this Section 4.03 shall take all such other actions as may be reasonably necessary to consummate the purchase and sale including, without limitation, entering into such additional agreements as may be necessary or appropriate. Notwithstanding anything to the contrary contained in this Agreement, the Directors in their discretion may at any time prior to the closing of the issuance and sale of any Additional Company Shares, upon five (5) Business Days’ notice to the Pre-emptive Stockholders, cancel the issuance and sale of such Additional Company Shares in their entirety, in which event the Company shall not thereafter issue any Additional Company Shares without first again offering such Additional Company Shares to the Pre-emptive Stockholders in accordance with the procedures set forth in this Section 4.03.
(g)Delay. Notwithstanding anything to the contrary set forth in this Section 4.03, if approved by the Directors, the Company may, in lieu of concurrently offering any Additional Company Shares to all Stockholders, initially offer, sell and issue Additional Company Shares to only certain Stockholders so long as promptly, but in any event, within five (5) Business Days thereafter, the Company provides an Issue Notice (which Issue Notice shall include the material details of the prior issuance of Additional Company Shares pursuant to this Section 4.03) to each Pre-emptive Stockholder and complies with the provisions of this Section 4.03(g) with respect to all Pre-emptive Stockholders by offering to such Pre-emptive Stockholders their share of such Additional Company Shares (as otherwise determined pursuant to Section 4.03(a) prior to any sales and issuances permitted by this Section 4.03(g)); provided, that (i) prior to the Company complying with the provisions of this Section 4.03(g), no Additional Company Shares issued pursuant to this Section 4.03(g) shall be entitled to vote on any matter presented to the stockholders of the Company and the Company shall not declare or pay any dividends or other distributions with respect to the Additional Company Shares issued to the Stockholders pursuant to this Section 4.03(g) and (ii) in no event shall any Pre-emptive Stockholder be required to acquire any Additional Company Shares from any other Stockholder in connection with its exercise of its rights under this Section 4.03.
20


Section 4.04REIT Compliance.
(a)Adverse Regulatory Event. In the event of an Adverse Regulatory Event arising from or in connection with this Agreement or a REIT Party’s ownership of Company Shares, the Company and the Stockholders shall work together in good faith to eliminate the impact of such Adverse Regulatory Event, including entering into such amendments to this Agreement as may be necessary or appropriate or to permit such REIT Party to effect the Transfer of its Company Shares. For purposes of this Agreement, the term “Adverse Regulatory Event” means any time that an Applicable Law imposes upon a REIT Party (or could impose upon a REIT Party in its reasonable opinion) any material threat to such REIT Party’s or any of its Affiliates’ status as a “real estate investment trust” under the Code.
(b)Ownership of Company Shares. Notwithstanding anything in this Agreement to the contrary, neither the Company nor any Stockholder shall have any authority to take, and none shall take, any action which shall cause any REIT Party to own (directly, indirectly, or constructively) at any time more than thirty-four percent (34%) in aggregate of the vote or value of the then outstanding Company Shares (as determined under each of Sections 856(d)(3) (inclusive of Section 856(d)(5)), 856(d)(9)(F), and 856(l)(2) of the Code).

ARTICLE V
FINANCIAL INFORMATION; ACCESS RIGHTS
Section 5.01Financial Information. In addition to, and without limiting any rights that the DHC Parties may have with respect to the inspection of the books and records of the Company under Applicable Law, the Company shall furnish to each DHC Party, the following information:
(a)as soon as available, and in any event within forty-five (45) days following the end of each Fiscal Year, the audited consolidated balance sheet of the Company and its Subsidiaries as at the end of each such Fiscal Year and the audited consolidated statements of income, cash flows and changes in stockholders’ equity of the Company and its Subsidiaries for such Fiscal Year, accompanied by the certification of independent certified public accountants of recognized national standing selected by the Directors, to the effect that, except as set forth therein, such financial statements have been prepared in accordance with GAAP, applied on a basis consistent with prior years and fairly present in all material respects the consolidated financial condition of the Company and its Subsidiaries as of the dates thereof and the results of its operations and changes in its cash flows and stockholders’ equity for the periods covered thereby;
(b)as soon as available, and in any event within thirty (30) days following the end of each fiscal quarter, the unaudited consolidated balance sheet of the Company and its Subsidiaries at the end of such quarter and the unaudited consolidated statements of income, cash flows and changes in stockholders’ equity of the Company and its Subsidiaries for such quarter, all in reasonable detail and all prepared in accordance with GAAP, consistently applied and certified by the Company’s Chief Financial Officer;
(c)draft financial statements related to the Fiscal Year and each fiscal quarter shall be provided within thirty (30) days and twenty (20) days, respectively, following the end of the period in question; and
(d)to the extent the Company or any of its Subsidiaries is required by Applicable Law or pursuant to the terms of any outstanding indebtedness of the Company to prepare such reports, any annual reports, quarterly reports and other periodic reports actually prepared by the Company or Subsidiary promptly following filing or submission thereof.
Section 5.02Access Rights.
(a)The Company shall: (i) afford to the DHC Parties and their officers, trustees, directors, employees, attorneys, accountants and other representatives and agents, during normal business hours and upon reasonable notice, reasonable access to its officers, employees, auditors, and books and records; and (ii) afford such DHC Parties and other Persons the opportunity to consult with its officers and senior management from time to time regarding the Company’s affairs, finances and accounts as the DHC Parties, or such other Persons on behalf of the DHC Parties, may reasonably
21


request upon reasonable notice, including presenting to such DHC Parties and such other Persons customary management presentations regarding the Company’s affairs, finances, accounts and related matters at the request of DHC.
(b)The rights set forth in Section 5.02(a) above shall not and are not intended to limit any rights which the DHC Parties may have to inspect or audit the books and records of the Company, or to inspect its properties or discuss its affairs, finances and accounts, under Applicable Law or any other agreement to which DHC or any of its Affiliates on the one hand, and the Company or any of its Affiliates on the other hand, are a party.
(c)Notwithstanding anything to the contrary herein, the information and access rights provided to the DHC Parties shall be expressly subject to the confidentiality and use restrictions set forth in Section 4.02.

ARTICLE VI
REPRESENTATIONS AND WARRANTIES
Section 6.01Representations and Warranties. Each Stockholder and the Company, severally and not jointly, represent and warrant to each other party that:
(a)It has full power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the other agreements and documents contemplated hereby, the performance of its obligations hereunder and thereunder and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all requisite action of such Stockholder or the Company, as applicable. It has duly executed and delivered this Agreement.
(b)This Agreement constitutes the legal, valid and binding obligation of such party enforceable against such party in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law). The execution, delivery and performance of this Agreement, and the consummation of the transactions contemplated hereby, require no action by or in respect of, or filing with, any Governmental Authority.
(c)The Company and the Initial Stockholder represent and warrant that the execution, delivery and performance by each of them of this Agreement and the consummation of the transactions contemplated hereby do not (i) conflict with or result in any violation or breach of any provision of the Organizational Documents or the governing documents of any of the Company’s Subsidiaries or of the Initial Stockholder, (ii) conflict with or result in any violation or breach of any provision of any Applicable Law applicable to them, or (iii) require any consent or other action by any Person under any provision of any material agreement or other instrument to which any of them is a party or is otherwise bound other than those which have been obtained, except, with respect to the foregoing clauses (ii) and (iii), where such conflict, violation, default or failure to obtain consent would not reasonably be expected to have a material adverse effect on the Company or its Subsidiaries, taken as a whole.
(d)DHC, on behalf of itself and DHC TRS, represents and warrants that the execution, delivery and performance by it and DHC TRS of this Agreement and the consummation of the transactions contemplated hereby do not (i) conflict with or result in any violation or breach of any provision of their governing documents, (ii) conflict with or result in any violation or breach of any provision of any Applicable Law applicable to them, or (iii) require any consent or other action by any Person under any provision of any material agreement or other instrument to which such party is a party or is otherwise bound other than those which have been obtained, except, with respect to the foregoing clauses (ii) and (iii), where such conflict, violation, default or failure to obtain consent would not reasonably be expected to have a material adverse effect on DHC or its Subsidiaries, taken as a whole.
(e)Except for this Agreement and the Organizational Documents, such party has not entered into or agreed to be bound by any other agreements or arrangements of any kind with any party with respect to the Company Shares, including agreements or arrangements with respect to the acquisition or disposition of the Company Shares or any interest therein or the
22


voting of the Company Shares (whether or not such agreements and arrangements are with the Company or any other stockholder of the Company).
ARTICLE VII
TERM AND TERMINATION
Section 7.01Termination. This Agreement shall terminate upon the earliest of:
(a)the consummation of a Public Offering resulting in a market value of the Company Common Stock held by public stockholders who are otherwise Third Party Purchasers of at least twenty million ($20,000,000) dollars;
(b)the consummation of a Company Change of Control;
(c)the date on which the DHC Parties no longer hold any Company Shares;
(d)the dissolution, liquidation, or winding up of the Company; or
(e)upon the unanimous written consent of all DHC Parties and the Company.
Section 7.02Effect of Termination.
(a)The termination of this Agreement shall terminate all further rights and obligations of the Stockholders under this Agreement, except that such termination shall not affect:
(i)the existence of the Company;
(ii)the obligation of any party to pay any amounts arising on or prior to the date of termination, or as a result of or in connection with such termination;
(iii)the rights which any Stockholder may have by operation of Applicable Law as a stockholder of the Company; or
(iv)provisions of this Agreement which by their terms are intended or are stated to survive termination of this Agreement.
(b)The following provisions shall survive the termination of this Agreement:
(i) Section 4.02, Section 7.02 and Article VIII; and
(ii)Section 3.07 and Section 4.04, but only so long as a REIT Party owns Company Shares; provided, that the obligations of an Initial Stockholder Party under such Sections shall terminate at such time as such Initial Stockholder Party neither owns or controls any Company Shares.
ARTICLE VIII
MISCELLANEOUS
Section 8.01Expenses. Except as otherwise expressly provided herein, all costs and expenses, including fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement or the transactions and matters contemplated by this Agreement shall be paid by the party incurring such costs and expenses.
Section 8.02Release of Liability; Waiver of Fiduciary Duties. Subject to Section 7.02, if any Stockholder shall Transfer all of the Company Shares held by such Stockholder in compliance with the provisions of this Agreement without retaining any interest therein, then such Stockholder shall cease to be a party to this Agreement in its capacity as a Stockholder and shall be relieved and have no further liability arising hereunder in its capacity as a Stockholder for events
23


occurring from and after the date of such Transfer. To the maximum extent permitted by Applicable Law, each Stockholder and its successors and assigns and, as applicable, its shareholders, stockholders, beneficial interest owners, members, partners, trustees, directors, officers, employees and agents, waives any and all fiduciary duties any Stockholder may now or in the future have to any other Stockholder, in each case in its capacity as a stockholder of the Company, in connection with this Agreement or the transactions and matters contemplated by this Agreement.
Section 8.03Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt), (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested), (c) on the date sent by email of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient or (d) when received if mailed by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses set forth on Exhibit A hereto (or at such other address in the United States for a party as shall be specified in a notice given in accordance with this Section 8.03).
Section 8.04Interpretation. For purposes of this Agreement, (a) the words “include,” “includes” and “including” shall be deemed to be followed by the words “without limitation”; (b) the word “or” is not exclusive; and (c) the words “herein,” “hereof,” “hereby,” “hereto” and “hereunder” refer to this Agreement as a whole. The definitions given for any defined terms in this Agreement shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. Unless the context otherwise requires, references herein: (i) to Articles, Sections and Exhibits mean the Articles and Sections of, and the Exhibits attached to, this Agreement; (ii) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (iii) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.
Section 8.05Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.
Section 8.06Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.
Section 8.07Entire Agreement. This Agreement and the Organizational Documents constitute the sole and entire agreement of the parties with respect to the subject matter contained herein and therein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency or conflict between this Agreement and the Organizational Documents, the Stockholders and the Company shall, to the extent permitted by Applicable Law, amend, consent to or waive provisions of each such Organizational Document to comply with the terms of this Agreement.
Section 8.08Assignment; Successors. Except as expressly set forth in this Agreement, this Agreement and the rights, interests and obligations of the parties hereunder may not be assigned, transferred or delegated. This Agreement and the rights, interests and obligations of a party hereunder may be assigned, transferred or delegated by a party to a Person who succeeds to all or substantially all the assets of such party, which successor or Person agrees in a writing delivered to the other parties hereto to be subject to and bound by all interests and obligations set forth in this Agreement. This Agreement shall bind and inure to the benefit of and be enforceable by the parties and their respective successors and permitted assigns, including Permitted Transferees who acquire Company Shares in accordance with the terms of this Agreement.
Section 8.09No Third Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns and, except as expressly set forth in this Agreement, nothing herein is
24


intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.
Section 8.10Amendment and Modification; Waiver. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.
Section 8.11Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Maryland without giving effect to any choice or conflict of law provision or rule (whether of the State of Maryland or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than those of the State of Maryland.
Section 8.12Venue. Each party hereto agrees that it shall bring any Proceeding in respect of any claim arising out of or related to this Agreement or the transactions contemplated hereby exclusively in the courts of the State of Maryland and the Federal courts of the United States, in each case, located in the City of Baltimore (the “Chosen Courts”). Solely in connection with claims arising under this Agreement or the transactions contemplated hereby, each party hereto irrevocably and unconditionally (i) submits to the exclusive jurisdiction of the Chosen Courts, (ii) agrees not to commence any such Proceeding except in such courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Proceeding in the Chosen Courts, (iv) waives, to the fullest extent permitted by Applicable Law, the defense of an inconvenient forum to the maintenance of such Proceeding and (v) agrees that service of process upon such party in any such Proceeding shall be effective if notice is given in accordance with Section 8.03. Nothing in this Agreement will affect the right of any party to serve process in any other manner permitted by Applicable Law. A final judgment in any such Proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Applicable Law. EACH PARTY HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. Notwithstanding anything herein to the contrary, if a demand for arbitration of a Dispute is made pursuant to Section 8.13, this Section 8.12 shall not pre-empt resolution of the Dispute pursuant to Section 8.13.
Section 8.13Dispute Resolution.
(a)Disputes. Any disputes, claims or controversies arising out of or relating to this Agreement, the Organizational Documents or the transactions contemplated hereby, including any disputes, claims or controversies brought by or on behalf of a party hereto, a direct or indirect parent of a party, or any holder of equity interests (which, for purposes of this Section 8.13, shall mean any holder of record or any beneficial owner of equity interests, or any former holder of record or beneficial owner of equity interests) of a party, either on its own behalf, on behalf of a party or on behalf of any series or class of equity interests of a party or holders of any equity interests of a party against a party or any of their respective trustees, directors, members, officers, managers (including The RMR Group LLC or its parent and their respective successor), agents or employees, including any disputes, claims or controversies relating to the meaning, interpretation, effect, validity, performance, application or enforcement of this Agreement, including the agreements set forth in this Section 8.13, or the governing documents of a party (all of which are referred to as “Disputes”), or relating in any way to such a Dispute or Disputes shall, on the demand of any party to such Dispute or Disputes, be resolved through binding and final arbitration in accordance with the Commercial Arbitration Rules (the “Rules”) of the American Arbitration Association (the “AAA”) then in effect, except as those Rules may be modified in this Section 8.13. For the avoidance of doubt, and not as a limitation, Disputes are intended to include derivative actions against the trustees, directors, officers or managers of a party and class actions by a holder of equity interests against those Persons and a party. For the avoidance of doubt, a Dispute shall include a Dispute made derivatively on behalf of one party against another party.
25


(b)Selection of Arbitrators. There shall be three (3) arbitrators. If there are only two (2) parties to the Dispute, each party shall select one (1) arbitrator within fifteen (15) days after receipt by respondent of a copy of a demand for arbitration. Such arbitrators may be affiliated or interested persons of such parties. If there are more than two (2) parties to the Dispute, all claimants, on the one hand, and all respondents, on the other hand, shall each select, by the vote of a majority of the claimants or the respondents, as the case may be, one (1) arbitrator within fifteen (15) days after receipt of a demand for arbitration. Such arbitrators may be affiliated or interested persons of the claimants or the respondents, as the case may be. If either a claimant (or all claimants) or a respondent (or all respondents) fail(s) to timely select an arbitrator, then the party (or parties) who has selected an arbitrator may request the AAA to provide a list of three (3) proposed arbitrators in accordance with the Rules (each of whom shall be neutral, impartial and unaffiliated with any party) and the party (or parties) that failed to timely appoint an arbitrator shall have ten (10) days from the date the AAA provides such list to select one (1) of the three (3) arbitrators proposed by the AAA. If the party (or parties) fail(s) to select the second (2nd) arbitrator by that time, the party (or parties) who have appointed the first (1st) arbitrator shall then have ten (10) days to select one (1) of the three (3) arbitrators proposed by the AAA to be the second (2nd) arbitrator; and, if they should fail to select the second (2nd) arbitrator by such time, the AAA shall select, within fifteen (15) days thereafter, one (1) of the three (3) arbitrators it had proposed as the second (2nd) arbitrator. The two (2) arbitrators so appointed shall jointly appoint the third (3rd) and presiding arbitrator (who shall be neutral, impartial and unaffiliated with any party) within fifteen (15) days of the appointment of the second (2nd) arbitrator. If the third (3rd) arbitrator has not been appointed within the time limit specified herein, then the AAA shall provide a list of proposed arbitrators in accordance with the Rules, and the arbitrator shall be appointed by the AAA in accordance with a listing, striking and ranking procedure, with each party having a limited number of strikes, excluding strikes for cause.
(c)Location of Arbitration. Any arbitration hearings shall be held in Boston, Massachusetts, unless otherwise agreed by the parties, but the seat of arbitration shall be Maryland.
(d)Scope of Discovery. There shall be only limited documentary discovery of documents directly related to the issues in dispute, as may be ordered by the arbitrators. For the avoidance of doubt, it is intended that there shall be no depositions and no other discovery other than limited documentary discovery as described in the preceding sentence.
(e)Arbitration Award. In rendering an award or decision (an “Award”), the arbitrators shall be required to follow the laws of the State of Maryland, without regard to principles of conflicts of law. Any arbitration proceedings or Award rendered hereunder, and the validity, effect and interpretation of the agreements set forth in this Section 8.13 shall be governed by the Federal Arbitration Act, 9 U.S.C. § 1 et seq. An Award shall be in writing and may, but shall not be required to, briefly state the findings of fact and conclusions of law on which it is based. Any monetary Award shall be made and payable in U.S. dollars free of any tax, deduction or offset. Subject to Section 8.13(f), each party against which an Award assesses a monetary obligation shall pay that obligation on or before the thirtieth (30th) day following the date of such Award or such other date as such Award may provide.
(f)Costs. Except to the extent expressly provided by this Agreement or as otherwise agreed by the parties thereto, to the maximum extent permitted by Applicable Law of the State of Maryland, each party involved in a Dispute shall bear its own costs and expenses (including attorneys’ fees), and the arbitrators shall not render an Award that would include shifting of any such costs or expenses (including attorneys’ fees) or, in a derivative case or class action, award any portion of a party’s Award to the claimant or the claimant’s attorneys. Each party (or, if there are more than two (2) parties to the Dispute, all claimants, on the one hand, and all respondents, on the other hand, respectively) shall bear the costs and expenses of its (or their) selected arbitrator and the parties (or, if there are more than two (2) parties to the Dispute, all claimants, on the one hand, and all respondents, on the other hand) shall equally bear the costs and expenses of the third (3rd) appointed arbitrator.
(g)Appeals. Notwithstanding any language to the contrary in this Agreement, any Award, including, but not limited to, any interim Award, may be appealed pursuant to the AAA’s Optional Appellate Arbitration Rules (“Appellate Rules”). An Award shall not be considered final until after the time for filing the notice of appeal pursuant to the Appellate Rules has expired. Appeals must be initiated within thirty (30) days of receipt of an Award by filing a notice of appeal with any AAA office. Following the appeal process, the decision rendered by the appeal tribunal may be entered in any court having jurisdiction thereof. For the avoidance of doubt, and despite any contrary provision of the Appellate Rules, Section
26


8.13(g) shall apply to any appeal pursuant to this Section 8.13 and the appeal tribunal shall not render an Award that would include shifting of any costs or expenses (including attorneys’ fees) of any party.
(h)Final Judgment. Following the expiration of the time for filing the notice of appeal, or the conclusion of the appeal process set forth in Section 8.13(g), an Award shall be final and binding upon the parties thereto and shall be the sole and exclusive remedy between those parties relating to the Dispute, including any claims, counterclaims, issues or accounting presented to the arbitrators. Judgment upon an Award may be entered in any court having jurisdiction. To the fullest extent permitted by law, no application or appeal to any court of competent jurisdiction may be made in connection with any question of law arising in the course of arbitration or with respect to any Award made, except for actions relating to enforcement of the agreements set forth in this Section 8.13 or any arbitral award issued hereunder and except for actions seeking interim or other provisional relief in aid of arbitration proceedings in any court of competent jurisdiction.
(i)Intended Beneficiaries. This Section 8.13 is intended to benefit and be enforceable by the parties hereto and their respective shareholders, stockholders, members, beneficial interest owners, direct and indirect parents, trustees, directors, officers, managers (including The RMR Group LLC or its parent and their respective successor), members, agents or employees and their respective successors and assigns and shall be binding on the parties, and such Persons and be in addition to, and not in substitution for, any other rights to indemnification or contribution that such Persons may have by contract or otherwise.
Section 8.14Further Assurances. In connection with this Agreement and the transactions contemplated hereby, each Stockholder, the Company and each transferee of Company Shares agrees, at the request of the Company or any Stockholder, to execute and deliver such additional documents, instruments, conveyances and assurances and to take such further actions as may be required to carry out the provisions hereof and give effect to the transactions contemplated hereby.
Section 8.15Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.
Section 8.16No Liability. NO TRUSTEE, OFFICER, DIRECTOR, SHAREHOLDER, MEMBER, EMPLOYEE OR AGENT OF ANY PARTY SHALL BE HELD TO ANY PERSONAL LIABILITY, JOINTLY OR SEVERALLY, FOR ANY OBLIGATION OF, OR CLAIM AGAINST, SUCH PARTY. ALL PERSONS DEALING WITH SUCH PARTY IN ANY WAY, SHALL LOOK ONLY TO THE ASSETS OF SUCH PARTY FOR THE PAYMENT OF ANY SUM OR THE PERFORMANCE OF ANY OBLIGATION.
[Signature page follows]
27


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by, as applicable, their respective officers thereunto duly authorized.
THE COMPANY:
AlerisLife Inc.

By:    /s/ Jeffrey C. Leer            
        Jeffrey C. Leer
        President and Chief Executive Officer
DHC:
Diversified Healthcare Trust

By:    /s/ Matthew C. Brown            
        Matthew C. Brown
        Chief Financial Officer and Treasurer
DHC TRS:
DHC Holdings LLC

By:    /s/ Matthew C. Brown            
        Matthew C. Brown
        Chief Financial Officer and Treasurer
THE INITIAL STOCKHOLDER:
ABP Trust
By:    /s/ Matthew P. Jordan            
        Matthew P. Jordan
        Treasurer
[Signature Page to AlerisLife Inc. Stockholders Agreement]

Exhibit A

NOTICE ADDRESSES
If to the Company:
Two Newton Place
255 Washington Street, Suite 230
Newton, Massachusetts 02458
Attention:    President and Chief Executive Officer and
Secretary
Email:    jleer@5ssl.com
jclark@rmrgroup.com

If to any DHC Party:
Two Newton Place
255 Washington Street, Suite 300
Newton, Massachusetts 02458-1632
Attention:    Chief Financial Officer and Treasurer and Secretary
Email:    mbrown@rmrgroup.com
jclark@rmrgroup.com

If to any ABP Party:
Two Newton Place
255 Washington Street, Suite 300
Newton, Massachusetts 02458-1632
Attention:    Treasurer and Secretary
Email:    mjordan@rmrgroup.com
jclark@rmrgroup.com


A-1



Exhibit B
FORM OF JOINDER AGREEMENT
This JOINDER AGREEMENT (the “Joinder Agreement”), dated as of __________, is entered into by _________________, [a ___________ organized under the laws of _____________ ] / [an individual residing at [___________] (the “New Stockholder”). All capitalized terms not defined in this Joinder Agreement shall have the meaning ascribed to such terms in that certain Stockholders Agreement dated as of February 16, 2024 by and among the individuals and entities named and listed therein as “Stockholders” and AlerisLife Inc., a Maryland corporation (the “Company”), as it may be amended from time to time (the “Stockholders Agreement”).
WHEREAS, the New Stockholder desires to acquire Company Shares [in a Transfer from [___________]] and in connection therewith become a party to the Stockholders Agreement; and
WHEREAS, the New Stockholder shall become a party to the Stockholders Agreement, and in furtherance of the foregoing, the New Stockholder shall execute and deliver this Joinder Agreement to the Company and each Stockholder.
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the New Stockholder hereby agrees as follows:
1.Agreement to be Bound. The New Stockholder hereby agrees that, upon execution of this Joinder Agreement, the New Stockholder shall become a party to the Stockholders Agreement as [an DHC Party / Initial Stockholder Party], and shall be fully bound by, subject to, and have all of the benefits and burdens of all of the covenants, terms and conditions of the Stockholders Agreement as [an DHC Party / Initial Stockholder Party] thereunder.
2.Successors and Assigns. This Joinder Agreement shall bind and inure to the benefit of and be enforceable by the Company and each Stockholder, and their respective permitted successors, heirs and assigns.
3.Counterparts. This Joinder Agreement may be executed in separate counterparts each of which shall be an original and all of which taken together shall constitute one and the same agreement.
4.Notices. All notices, demands or other communications to the New Stockholder shall be directed to the respective United States address set forth next to the New Stockholder’s name on the signature page hereto.
5.Governing Law. This Joinder Agreement shall be governed by and construed in accordance with the law (other than the law governing conflict of law questions) of the State of Maryland.
6.Descriptive Headings. The descriptive headings of this Joinder Agreement are for convenience of reference only and do not constitute a part of this Joinder Agreement.
B-1



IN WITNESS WHEREOF, the New Stockholder has executed this Joinder Agreement as of the date first above written.
[____________________]
[By:                        ]
     [Name]
    [Title]

Address:
_____________________________
_____________________________
_____________________________

Accepted and agreed to:
THE COMPANY:
AlerisLife Inc.

By:                     
Name:
Title:
B-2
 EX-31.1 7 dhc_033124xexhibitx311.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
 
I, Christopher J. Bilotto, certify that:
 
1.I have reviewed this Quarterly Report on Form 10-Q of Diversified Healthcare Trust;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 
  
Date: May 6, 2024/s/ Christopher J. Bilotto
 Christopher J. Bilotto
 President and Chief Executive Officer


 EX-31.2 8 dhc_033124xexhibitx312.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
 
I, Matthew C. Brown, certify that:
 
1.I have reviewed this Quarterly Report on Form 10-Q of Diversified Healthcare Trust;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 
  
Date: May 6, 2024/s/ Matthew C. Brown
 Matthew C. Brown
 Chief Financial Officer and Treasurer


 EX-32.1 9 dhc_033124xexhibitx321.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SEC. 1350
 

 
    In connection with the filing by Diversified Healthcare Trust (the “Company”) of the Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), each of the undersigned hereby certifies, to the best of his knowledge:
 
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
      
 /s/ Christopher J. Bilotto
 Christopher J. Bilotto
 President and Chief Executive Officer
   
   
 /s/ Matthew C. Brown
 Matthew C. Brown
 Chief Financial Officer and Treasurer
 
Date: May 6, 2024


 EX-101.SCH 10 dhc-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Real Estate and Other Investments link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Fair Value of Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Senior Living Community Management Agreements link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Business and Property Management Agreements with RMR link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Related Person Transactions link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Weighted Average Common Shares link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Real Estate and Other Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Fair Value of Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Senior Living Community Management Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Real Estate and Other Investments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Real Estate and Other Investments - Schedule of Disposal Groups (Details) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Real Estate and Other Investments - Impairment Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Real Estate and Other Investments - Mortgage Debt Joint Venture (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Indebtedness (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Shareholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Segment Reporting - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Segment Reporting - Income Statements (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Segment Reporting - Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Senior Living Community Management Agreements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Business and Property Management Agreements with RMR (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Related Person Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 dhc-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 dhc-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 dhc-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Repayment of other debt Repayments of Other Debt Variable Rate [Domain] Variable Rate [Domain] Statistical Measurement [Domain] Statistical Measurement [Domain] Unsecured revolving credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Change in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Related person transactions Related Party Transaction [Line Items] Investment, Name [Domain] Investment, Name [Domain] Revolving credit facility, interest rate payable (as a percent) Line of Credit Facility, Interest Rate at Period End Indebtedness Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Number of management agreements Related Party, Management Agreements Related Party, Management Agreements Segment Reporting [Abstract] Segment Reporting [Abstract] Investment, Name [Axis] Investment, Name [Axis] Commitments and contingencies Commitments and Contingencies Disaggregation of Revenue Disaggregation of Revenue [Line Items] Property management and construction supervision fees Property Management and Construction Supervision Fees Represents the property management and construction supervision fees incurred pursuant to business and property management agreements with related parties. Shareholders' Equity Equity [Text Block] Geographical [Axis] Geographical [Axis] Total real estate properties, gross Real Estate Investment Property, at Cost Income Taxes Income Tax Disclosure [Text Block] Ownership [Axis] Ownership [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Distributions to shareholders Distributions to shareholders Total Distributions Payments of Ordinary Dividends, Common Stock Net loss - diluted (in dollars per share) Earnings Per Share, Diluted Aggregate principal amount of mortgage debt Secured Debt Land Land Level 3 Fair Value, Inputs, Level 3 [Member] Unsecured Revolving Credit Facility Line of Credit [Member] Leases Lessor, Operating Leases [Text Block] Trading Symbol(s) Trading Symbol Investment in AlerisLife Inc. Payments to Acquire Equity Method Investments Net loss Net loss Net loss Net Income (Loss) Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Number of communities managed Number of Communities Managed by Related Party Represents the number of communities managed by a related party. Properties Under Agreement To Sell Properties Under Agreement To Sell [Member] Properties Under Agreement To Sell SHOP Senior Housing Operating Portfolio Segment [Member] Senior Housing Operating Portfolio [Member] Medical Office and Life Science Portfolio Medical Office and Life Science Portfolio Segment [Member] Medical Office and Life Science Portfolio Segment Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Amortization of debt discount Amortization of Debt Discount (Premium) Share repurchases Stock Repurchased During Period, Value Loss on modification or early extinguishment of debt Gain (Loss) On Early Extinguishment Of Debt Gain (Loss) On Early Extinguishment Of Debt Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Carrying Value Reported Value Measurement [Member] Equity Components [Axis] Equity Components [Axis] Senior secured note due 2026 Senior Secured Note Due 2026 [Member] Senior Secured Note Due 2026 Buildings and improvements Buildings and Improvements, Gross Senior Unsecured Notes Senior Unsecured Notes [Member] Senior Unsecured Notes [Member] Amortization of acquired real estate leases and other intangible assets, net Amortization of Acquired Real Estate Leases and Other Intangible Assets Represents the amortization of acquired real estate leases and other intangible assets during the period. Measurement Basis [Axis] Measurement Basis [Axis] RMR Reit Management And Research [Member] Represents details pertaining to Reit Management and Research LLC, or RMR. Entity Smaller Reporting Company Entity Small Business Local Phone Number Local Phone Number Fair Value Measurement [Domain] Fair Value Measurement [Domain] Forecast Forecast [Member] Per common share amounts (basic and diluted): Per Common Share Amounts, Basic and Diluted [Abstract] Per Common Share Amounts, Basic and Diluted Reimbursement revenue lease Reimbursement Revenue Lease Reimbursement Revenue Lease Distributions to common shareholders declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Measurement Frequency [Axis] Measurement Frequency [Axis] Number of real estate properties collateralized Number of Real Estate Properties Collateralized Represents the number of real estate properties serving as a collateral for debt, as of the balance sheet date. Depreciation and amortization Depreciation Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Portion at Fair Value Measurement Estimated Fair Value Portion at Fair Value Measurement [Member] Income Statement Location [Axis] Income Statement Location [Axis] Period of actual amount of incentive fees Period Of Actual Amount Of Incentive Fees Period Of Actual Amount Of Incentive Fees Schedule of Joint Ventures Equity Method Investments [Table Text Block] Business and Property Management Agreements with RMR Business And Property Management Agreements [Text Block] Business And Property Management Agreements Mortgages Mortgages [Member] Number of properties closed Number Of Real Estate Properties Closed Number Of Real Estate Properties Closed Product and Service [Domain] Product and Service [Domain] Number joint venture arrangements Number Joint Venture Arrangements Number Joint Venture Arrangements Real estate properties: Real Estate Investment Property, Net [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Acquisition and certain other transaction related costs Business Combination, Acquisition Related Costs Document Quarterly Report Document Quarterly Report Senior Secured Notes Due January 2026 Senior Secured Notes Due January 2026 [Member] Senior Secured Notes Due January 2026 Non-cash investing activities: Noncash Investing Activities [Abstract] Represents the information pertaining to the Non cash investing activities. Interest expense (including net amortization of debt discounts, premiums and issuance costs of $24,863 and $2,074, respectively) Interest expense Interest Expense Distributions Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Loss on modification or early extinguishment of debt Loss on modification or early extinguishment of debt Loss on modification or early extinguishment of debt Gain (Loss) on Extinguishment of Debt Schedule of Dividends Declared and Paid Dividends Declared [Table Text Block] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Related Person Transactions Related Party Transactions Disclosure [Text Block] Aggregate sales price Properties Held For Sale, Sales Price Properties Held For Sale, Sales Price Fair value measurement, number of debt securities Fair Value Measurement, Number Of Debt Securities Fair Value Measurement, Number Of Debt Securities Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Discount Rate Measurement Input, Discount Rate [Member] Real Estate [Abstract] Real Estate [Abstract] Real Estate [Domain] Real Estate [Domain] Entity Shell Company Entity Shell Company Real estate properties held for sale Long-Lived Asset, Held-for-Sale, Fair Value Disclosure Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Acquired real estate leases and other intangible assets, net Finite-Lived Intangible Assets, Net 6.25% Senior Notes due 2046 Senior Notes Due 2046 [Member] Senior Notes Due 2046 [Member] Counterparty Name [Domain] Counterparty Name [Domain] Sales price Sale Price Real Estate Aggregate Sales Price This element represents the aggregate sales price excluding closing costs, of real estate properties sold by the entity. Number of properties acquired Number Of Properties Acquired Number Of Properties Acquired Other liabilities Increase (Decrease) in Other Operating Liabilities Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Fair value disclosure Debt Instrument, Fair Value Disclosure Common shares of beneficial interest, shares issued (in shares) Common Stock, Shares, Issued Property management agreement expense Related Party Transaction, Expenses from Property Management Agreement Transactions with Related Party Expenses recognized during the period resulting from property management transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period. Purchase price Business Combination, Consideration Transferred Name Of Each Exchange On Which Registered Security Exchange Name Weighted average share price (in dollars per share) Stock Repurchased During Period, Weighted Average Price Stock Repurchased During Period, Weighted Average Price Cumulative other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Investment owned, percentage of total shares outstanding Investment Owned, Percentage of Total Shares Outstanding Represents the number of shares held as a percentage of the total shares outstanding at the end of the period. Total expenses Costs and Expenses Maximum Maximum [Member] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Medical Office Medical Office [Member] Medical Office Entity Address, Address Line One Entity Address, Address Line One Termination and other fees Payments For Termination And Other Fees Payments For Termination And Other Fees Holding period Equity Securities, FV-NI, Holding Period Equity Securities, FV-NI, Holding Period Number of extension options Number Of Extension Options Number Of Extension Options Ownership interest by parent Subsidiary, Ownership Percentage, Parent Other non-cash adjustments, net Other Noncash Income (Expense) Business Acquisition [Axis] Business Acquisition [Axis] Secured debt and finance leases, net Secured Debt And Finance Lease Obligations, Net Secured Debt And Finance Lease Obligations, Net Subsequent Event Subsequent Event [Member] Real Estate [Table] Real Estate [Table] Variable Rate [Axis] Variable Rate [Axis] Loss on Sale Gains (Losses) on Sales of Investment Real Estate Income Statement [Abstract] Income Statement [Abstract] Expenses: Expenses: Costs and Expenses [Abstract] Share forfeitures (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title Of Each Class Title of 12(b) Security Related Party [Domain] Related Party, Type [Domain] Noncontrolling interest, ownership percentage by parent Subsidiary, Ownership Percentage, Noncontrolling Owner Finance Leased Properties Finance Leased Properties [Member] Finance Leased Properties Operating Segments Operating Segments [Member] Real Estate Real Estate [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Business management fees incurred Business Management Fees Represents the business management fees incurred pursuant to business management agreement with related parties. Accumulated depreciation Real Estate Investment Property, Accumulated Depreciation Estimated incentive fees Incentive Fee Expense Entity Tax Identification Number Entity Tax Identification Number Equity method investment Equity Method Investments Senior Living Communities Senior Living Community [Member] Represents the information pertaining to senior living properties. Senior apartments are marketed to residents who are generally capable of caring for themselves. Residence is usually restricted on the basis of age. Purpose built properties may have special function rooms, concierge services, high levels of security and assistance call systems for emergency use. AlerisLife Inc AlerisLife Inc [Member] AlerisLife Inc Statistical Measurement [Axis] Statistical Measurement [Axis] Real Estate and Other Investments Real Estate Disclosure [Text Block] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Investments in affiliates, fair value Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure 5.625% Senior Notes due 2042 Senior Notes Due 2042 [Member] Senior Notes Due 2042 [Member] Repurchase of common shares Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Segments [Domain] Segments [Domain] Share-based Compensation Arrangement by Share-based Payment Award Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Senior unsecured notes, 5.625% coupon rate, due 2042 Senior Unsecured Notes 5.625 Percent Due 2042 [Member] Senior Unsecured Notes 5.625 Percent Due 2042 Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Seaport Innovation LLC Seaport Innovation LLC [Member] Seaport Innovation LLC Consolidation Items [Domain] Consolidation Items [Domain] Cumulative net income Retained Earnings (Accumulated Deficit) Principal balance Debt face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code The LSMD Fund REIT LLC The LSMD Fund REIT LLC [Member] The LSMD Fund REIT LLC Leases [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] Diversified Healthcare Trust Diversified Healthcare Trust [Member] Diversified Healthcare Trust Schedule of Carrying Value and Fair Value of the Financial Instruments Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Variable lease, payment Variable Lease, Payment Accrued interest Increase (Decrease) in Interest Payable, Net Reit Management And Research L L C Reit Management And Research L L C [Member] Represents details pertaining to Reit Management and Research LLC, or RMR. Common shares of beneficial interest, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Related party transaction, closing cost Related Party Transaction, Closing Cost Related Party Transaction, Closing Cost Joint Venture Joint Venture [Member] Joint Venture [Member] Measurement input Equity Securities, FV-NI, Measurement Input Equity in unrealized losses of an investee OCI, Equity Method Investment, after Tax California CALIFORNIA Accreted value increase rate Debt Instrument, Interest Rate, Accreted Value, Increase Rate, Percentage Debt Instrument, Interest Rate, Accreted Value, Increase Rate, Percentage Asset Class [Domain] Asset Class [Domain] Common shares of beneficial interest, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Five Star Five Star Quality Care Inc [Member] Represents the information pertaining to Five Star Quality Care, Inc. Debt Instrument [Axis] Debt Instrument [Axis] Liabilities of properties held for sale Disposal Group, Including Discontinued Operation, Liabilities Operating lease, liability Operating Lease, Liability US Swap Rate US Swap Rate [Member] US Swap Rate Measurement Input Type [Domain] Measurement Input Type [Domain] Senior unsecured notes, 6.250% coupon rate, due 2046 Senior Unsecured Notes 6.25 Percent Due 2046 [Member] Senior Unsecured Notes 6.25 Percent Due 2046 Total liabilities Liabilities Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Arizona ARIZONA Cumulative Other Comprehensive Loss AOCI Attributable to Parent [Member] Measurement Frequency [Domain] Measurement Frequency [Domain] Rental income Rental Income [Member] Rental Income [Member] Debt extension term Debt Instrument, Extension Term Debt Instrument, Extension Term Debt Disclosure [Abstract] Debt Disclosure [Abstract] Related Party Transaction [Domain] Related Party Transaction [Domain] Disposed of by sale Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Affiliated Entity Affiliated Entity [Member] Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,393,722 and 240,423,898 shares issued and outstanding, respectively Common Stock, Value, Issued General and administrative General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Equity Method Investments Equity Method Investments [Member] Real estate improvements Payments for Capital Improvements Senior Notes Senior Notes [Member] Accrued interest Interest Payable Impairment of assets Impairment of assets Asset Impairment Charges Restricted cash Restricted cash Restricted Cash Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Amortization Amortization Cumulative Distributions Cumulative Common Distributions [Member] Represents cumulative distributions to common shareholders. Entity Filer Category Entity Filer Category Interest Rate Cap Interest Rate Cap [Member] Other liabilities Other Liabilities Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Held for sale Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Recent Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Proceeds from sale of properties, net Proceeds from Sale, Real Estate, Held-for-Investment Share repurchases (in shares) Number of shares (in shares) Stock Repurchased During Period, Shares Basic housing and support services Basic Housing And Support Services [Member] Basic Housing And Support Services [Member] Initial extension period interest rate Debt Instrument, Initial Interest Rate During Extension Period Debt Instrument, Initial Interest Rate During Extension Period Residents fees and services Resident Fees And Services [Member] Resident Fees And Services [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Secured debt and finance leases Secured Debts and Finance Leases [Member] Secured Debts and Finance Leases Entities [Table] Entities [Table] Related party transaction capitalized amount Related Party Transaction Capitalized Amount Related Party Transaction Capitalized Amount Non-Recurring Fair Value Measurements Assets Fair Value, Nonrecurring [Member] Rehabilitation Services Rehabilitation Services [Member] Rehabilitation Services [Member] Non-Segment Corporate, Non-Segment [Member] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Cumulative distributions Cumulative Common Stock Dividends The amount as of the balance sheet date representing cumulative distributions to common shareholders. Interest rate (as a percent) Interest rate (as a percent) Coupon rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Information Entity Information [Line Items] Beginning balance Ending balance Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Share forfeitures Shares Issued, Value, Share-Based Payment Arrangement, Forfeited Number of employees Entity Number of Employees Number of unconsolidated joint ventures Number Of Unconsolidated Joint Ventures Number Of Unconsolidated Joint Ventures Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Level 2 Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Operating Expense Operating Expense [Member] Equity method investment, difference between carrying amount and underlying equity Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Entity Emerging Growth Company Entity Emerging Growth Company Unsecured Debt, Not Guaranteed Unsecured Debt, Not Guaranteed [Member] Unsecured Debt, Not Guaranteed Assets of properties held for sale Asset, Held-for-Sale, Not Part of Disposal Group Disposal Group Classification [Domain] Disposal Group Classification [Domain] Number of consecutive renewal terms of agreement Related Party Transaction, Property Management Agreement, Number of Consecutive Renewal Terms Represents the number of consecutive renewal terms of agreement that the entity has the option to renew. Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Common Shares Common Stock [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Weighted Average Common Shares Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Corporate Joint Venture Corporate Joint Venture [Member] Senior Secured Notes Senior Secured Notes [Member] Senior Secured Notes Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Equity method investment ownership percentage Equity method investment ownership percentage Equity Method Investment, Ownership Percentage Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total shareholders' equity Equity, Including Portion Attributable to Noncontrolling Interest Medical Office and Life Science Life Science and Medical Office [Member] Life Science and Medical Office Minimum Minimum [Member] Party transaction property management and construction supervision fees capitalized Property Management And Construction Supervision Fees, Capitalized Property Management And Construction Supervision Fees, Capitalized Unconsolidated joint venture distributions Proceeds from Equity Method Investment, Distribution Distribution per share (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Area of real estate properties (in square feet) Area of Real Estate Property Number of properties owned (property) Number of Properties Number of Real Estate Properties Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Senior unsecured notes, 4.375% coupon rate, due 2031 Senior Unsecured Notes 4.375 Percent Due 2031 [Member] Senior Unsecured Notes 4.375 Percent Due 2031 Medical Office Building and Life Science Building Medical Office Building and Life Science Building [Member] Medical Office Building and Life Science Building [Member] Operating Lease, Right-of-Use Asset, Statement of Financial Position Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities ABP Trust And Adam D. Portnoy ABP Trust And Mr. Portnoy [Member] ABP Trust And Mr. Portnoy Cumulative Net Income Retained Earnings [Member] Straight line rental income, excluding properties held-for-sale Straight Line Rent, Excluding Properties Held-for-Sale Straight Line Rent, Excluding Properties Held-for-Sale Number of properties included in joint venture agreement Number Of Properties Included In Joint Venture Agreement Number Of Properties Included In Joint Venture Agreement Total liabilities and shareholders' equity Liabilities and Equity Real estate improvements accrued, not paid Construction in Progress Expenditures Incurred but Not yet Paid Third Party Managers Third Party Managers [Member] Third Party Managers Ownership [Domain] Ownership [Domain] Operating lease, right-of-use asset Operating Lease, Right-of-Use Asset Net loss - basic (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Contract Type [Axis] Contract Type [Axis] Contract Type Entity Address, City or Town Entity Address, City or Town Related Party Related Party [Member] Schedule of Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Straight line rental income Increase (decrease) in straight line rental income Straight Line Rent Receivable from AlerisLife Inc. tender offer Receivable From Tender Offer Receivable From Tender Offer Income taxes paid Income Taxes Paid Document Transition Report Document Transition Report Total real estate properties, net Total real estate properties, net Real Estate Investment Property, Net Unsecured Debt Unsecured Debt [Member] Increase in interest rate Debt Instrument, Increase In Initial Interest Rate During Extension Period Debt Instrument, Increase In Initial Interest Rate During Extension Period Common shares of beneficial interest, shares authorized (in shares) Common Stock, Shares Authorized Repayments of borrowings on credit facility Repayments of lines of credit Repayments of Lines of Credit Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gains and losses on equity securities, net Equity Securities, FV-NI, Gain (Loss) Contract Type [Domain] Contract Type [Domain] Contract Type Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net loss to cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Interest and other income Interest and other income Interest and Other Income Subsequent Event Type [Axis] Subsequent Event Type [Axis] Investments in unconsolidated joint ventures DHC carrying value Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures Finance lease obligations Finance Lease, Liability Deferred leasing costs, net Increase (Decrease) in Deferred Leasing Fees Operating Lease, Liability, Statement of Financial Position Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] (Loss) gain on sale of properties Loss (gain) on sale of properties Gain (Loss) on Sale of Properties Related Party [Axis] Related Party, Type [Axis] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other assets, net Other Assets Entity Registrant Name Entity Registrant Name Other assets Increase (Decrease) in Other Operating Assets Senior unsecured notes, 4.750% coupon rate, due 2028 Senior Unsecured Notes 4.75 Percent Due 2028 [Member] Senior Unsecured Notes 4.75 Percent Due 2028 [Member] Property management and construction supervision fees paid Property Management And Construction Supervision Fees Paid Represents the property management and construction supervision fees paid to related parties. Number of states Number Of States Number Of States Massachusetts MASSACHUSETTS Document Period End Date Document Period End Date Senior unsecured notes, 9.750% coupon rate, due 2025 Senior Unsecured Notes 9.750 Percent Due 2024 [Member] Senior Unsecured Notes 9.750 Percent Due 2024 Entity Central Index Key Entity Central Index Key Interest expense (including net amortization of debt premiums, discounts and issuance costs) Net amortization of debt discounts, premiums and issuance costs Amortization of Debt Issuance Costs and Discounts Segment reporting Segment Reporting Information [Line Items] Senior Living Community Management Agreements Concentration Risk Disclosure [Text Block] Income tax (expense) benefit Income tax expense (benefit) Income Tax Expense (Benefit) Senior Living Senior Living Communities [Member] Senior Living Communities Finance leased asset, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Fair Value of Assets and Liabilities Fair Value Disclosures [Text Block] Payment of debt issuance costs Payments of Financing Costs Number of operating segments Number of Operating Segments Encumbered properties (property) Encumbered Properties Encumbered Properties Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Property operating expenses Property operating expenses Operating Costs and Expenses Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Real Estate Properties, Net Real Estate, Held-for-Sale SOFR Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR) Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Senior notes Senior Notes Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Senior unsecured notes, 9.75% due 2025 Senior Unsecured Notes 9.75 Percent Due 2025 [Member] Senior Unsecured Notes 9.75 Percent Due 2025 Basis points per annum (as a percent) Debt Instrument, Basis Spread on Variable Rate Equity interest in each collateral guarantee Debt Instrument, Percentage Of Equity Interest As Collateral Guarantee Debt Instrument, Percentage Of Equity Interest As Collateral Guarantee Senior secured notes, zero coupon rate, due 2026 Senior Secured Notes, Zero Coupon Rate, Due 2026 [Member] Senior Secured Notes, Zero Coupon Rate, Due 2026 Weighted average common shares outstanding (diluted) (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of Disposal Groups Disposal Groups, Including Discontinued Operations [Table Text Block] Share grants Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture Step acquisition, ownership percentage including subsequent acquisition Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage Additional paid in capital Additional Paid in Capital, Common Stock Additional Paid In Capital Additional Paid-in Capital [Member] Gains and losses on equity securities, net Gains on equity securities, net Equity Securities, FV-NI, Realized Gain (Loss) Total assets Total assets Assets Equity in net earnings (losses) of investees Equity in net (earnings) losses of investees Income (Loss) from Equity Method Investments Cover [Abstract] Cover [Abstract] Initial premium Debt Instrument, Unamortized Premium Number of states in which properties are located Number of States in which Entity Operates Investment owned balance per shares Investment, Sale Of Stock, Price Per Share Investment Owned Balance Per Shares Recurring Fair Value Measurements Assets Fair Value, Recurring [Member] ABP Trust ABP Trust [Member] ABP Trust Private pay and other third party payer SNF services Private Pay And Other Third Party Payer Services [Member] Private Pay And Other Third Party Payer Services [Member] Segment Reporting Segment Reporting Disclosure [Text Block] Decrease in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Loss before income tax (expense) benefit and equity in net earnings (losses) of investees Income (loss) before income tax benefit and equity in net losses of investees Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Secured Debts Secured Debt [Member] Equity Component [Domain] Equity Component [Domain] Scenario [Axis] Scenario [Axis] Indebtedness Debt Instrument [Line Items] Weighted average common shares outstanding (basic) (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Medicare and Medicaid programs Medicare And Medicaid Programs [Member] Medicare And Medicaid Programs [Member] Extension term Debt Instrument, Extension Option Term Debt Instrument, Extension Option Term Revenues: Revenues: Revenues [Abstract] Other comprehensive loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Related Party Transaction [Axis] Related Party Transaction [Axis] Segments [Axis] Segments [Axis] Statement Summarized financial information of significant tenant Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Estimated Fair Value Estimate of Fair Value Measurement [Member] Scenario [Domain] Scenario [Domain] Market Capitalization Rate Measurement Input, Market Capitalization Rate [Member] Measurement Input, Market Capitalization Rate Shareholders' equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Real Estate, Type of Property [Axis] Real Estate, Type of Property [Axis] EX-101.PRE 14 dhc-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - shares
 3 Months Ended
Mar. 31, 2024
May 01, 2024
Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 1-15319  
Entity Registrant Name DIVERSIFIED HEALTHCARE TRUST  
Entity Incorporation, State or Country Code MD  
Entity Tax Identification Number 04-3445278  
Entity Address, Address Line One Two Newton Place, 255 Washington Street, Suite 300,  
Entity Address, City or Town Newton  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02458-1634  
City Area Code 617  
Local Phone Number 796 - 8350  
Title Of Each Class Common Shares of Beneficial Interest  
Trading Symbol(s) DHC  
Name Of Each Exchange On Which Registered NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Smaller Reporting Company false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   240,393,722
Entity Central Index Key 0001075415  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
5.625% Senior Notes due 2042    
Entity Information    
Title Of Each Class 5.625% Senior Notes due 2042  
Trading Symbol(s) DHCNI  
Name Of Each Exchange On Which Registered NASDAQ  
6.25% Senior Notes due 2046    
Entity Information    
Title Of Each Class 6.25% Senior Notes due 2046  
Trading Symbol(s) DHCNL  
Name Of Each Exchange On Which Registered NASDAQ  
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Real estate properties:    
Land $ 641,481 $ 652,977
Buildings and improvements 6,129,767 6,165,490
Total real estate properties, gross 6,771,248 6,818,467
Accumulated depreciation (2,062,327) (2,020,843)
Total real estate properties, net 4,708,921 4,797,624
Investments in unconsolidated joint ventures 130,299 129,916
Assets of properties held for sale 38,107 9,447
Cash and cash equivalents 207,123 245,939
Restricted cash 1,040 [1] 1,022
Equity method investment 15,740 0
Acquired real estate leases and other intangible assets, net 31,723 33,948
Other assets, net 215,084 228,240
Total assets 5,348,037 5,446,136
Liabilities and Shareholders' Equity    
Secured debt and finance leases, net 12,197 13,020
Liabilities of properties held for sale 218 32
Accrued interest 23,751 22,847
Other liabilities 237,521 269,517
Total liabilities 3,099,334 3,109,245
Commitments and contingencies
Shareholders' equity:    
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,393,722 and 240,423,898 shares issued and outstanding, respectively 2,404 2,405
Additional paid in capital 4,618,950 4,618,470
Cumulative net income 1,692,019 1,778,278
Cumulative other comprehensive loss (4) 0
Cumulative distributions (4,064,666) (4,062,262)
Total shareholders' equity 2,248,703 2,336,891
Total liabilities and shareholders' equity 5,348,037 5,446,136
Secured Debts    
Liabilities and Shareholders' Equity    
Senior notes 751,890 731,211
Unsecured Debt    
Liabilities and Shareholders' Equity    
Senior notes $ 2,073,757 $ 2,072,618
[1] Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 300,000,000 300,000,000
Common shares of beneficial interest, shares issued (in shares) 240,393,722 240,423,898
Common shares of beneficial interest, shares outstanding (in shares) 240,393,722 240,423,898
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Revenues $ 370,776 $ 346,030
Expenses:    
Property operating expenses 307,604 286,080
Depreciation and amortization 70,133 64,800
General and administrative 7,568 5,873
Acquisition and certain other transaction related costs 86 93
Impairment of assets 12,142 5,925
Total expenses 397,533 362,771
(Loss) gain on sale of properties (5,874) 1,233
Gains and losses on equity securities, net 0 8,126
Interest and other income 2,237 4,195
Interest expense (including net amortization of debt discounts, premiums and issuance costs of $24,863 and $2,074, respectively) (57,576) (47,780)
Loss on modification or early extinguishment of debt 0 (1,075)
Loss before income tax (expense) benefit and equity in net earnings (losses) of investees (87,970) (52,042)
Income tax (expense) benefit (187) 31
Equity in net earnings (losses) of investees 1,898 (647)
Net loss (86,259) (52,658)
Other comprehensive loss:    
Equity in unrealized losses of an investee (4) 0
Other comprehensive loss (4) 0
Comprehensive loss $ (86,263) $ (52,658)
Weighted average common shares outstanding (basic) (in shares) 239,193 238,589
Weighted average common shares outstanding (diluted) (in shares) 239,193 238,589
Per common share amounts (basic and diluted):    
Net loss - basic (in dollars per share) $ (0.36) $ (0.22)
Net loss - diluted (in dollars per share) $ (0.36) $ (0.22)
Affiliated Entity    
Expenses:    
Equity in net earnings (losses) of investees $ 1,898 $ (647)
Rental income    
Revenues:    
Revenues 62,650 66,438
Residents fees and services    
Revenues:    
Revenues $ 308,126 $ 279,592
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Interest expense (including net amortization of debt premiums, discounts and issuance costs) $ 24,863 $ 2,074
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Other Comprehensive Loss
Cumulative Distributions
Beginning balance (in shares) at Dec. 31, 2022   239,694,842        
Beginning balance at Dec. 31, 2022 $ 2,638,611 $ 2,397 $ 4,617,031 $ 2,071,850 $ 0 $ (4,052,667)
Increase (Decrease) in Stockholders' Equity            
Net loss (52,658)     (52,658)    
Equity in unrealized losses of an investee 0          
Distributions (2,397)         (2,397)
Share grants 270   270      
Share repurchases (in shares)   (5,975)        
Share repurchases (6)   (6)      
Share forfeitures (in shares)   (6,400)        
Share forfeitures (1)   (1)      
Ending balance (in shares) at Mar. 31, 2023   239,682,467        
Ending balance at Mar. 31, 2023 $ 2,583,819 $ 2,397 4,617,294 2,019,192 0 (4,055,064)
Beginning balance (in shares) at Dec. 31, 2023 240,423,898 240,423,898        
Beginning balance at Dec. 31, 2023 $ 2,336,891 $ 2,405 4,618,470 1,778,278 0 (4,062,262)
Increase (Decrease) in Stockholders' Equity            
Net loss (86,259)     (86,259)    
Equity in unrealized losses of an investee (4)       (4)  
Distributions (2,404)         (2,404)
Share grants 558   558      
Share repurchases (in shares)   (30,176)        
Share repurchases $ (79) $ (1) (78)      
Ending balance (in shares) at Mar. 31, 2024 240,393,722 240,393,722        
Ending balance at Mar. 31, 2024 $ 2,248,703 $ 2,404 $ 4,618,950 $ 1,692,019 $ (4) $ (4,064,666)
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (86,259) $ (52,658)
Adjustments to reconcile net loss to cash provided by operating activities:    
Depreciation and amortization 70,133 64,800
Net amortization of debt discounts, premiums and issuance costs 24,863 2,074
Straight line rental income (291) (2,448)
Amortization of acquired real estate leases and other intangible assets, net 28 (311)
Loss on modification or early extinguishment of debt 0 1,075
Impairment of assets 12,142 5,925
Loss (gain) on sale of properties 5,874 (1,233)
Gains and losses on equity securities, net 0 (8,126)
Other non-cash adjustments, net (385) (674)
Unconsolidated joint venture distributions 1,231 1,411
Equity in net (earnings) losses of investees (1,898) 647
Change in assets and liabilities:    
Deferred leasing costs, net (669) (1,954)
Other assets 10,102 15,499
Accrued interest 904 2,540
Other liabilities (7,173) (20,525)
Net cash provided by operating activities 28,602 6,042
Cash flows from investing activities:    
Real estate improvements (46,723) (60,292)
Proceeds from sale of properties, net 3,343 3,548
Investment in AlerisLife Inc. (15,459) 0
Net cash used in investing activities (58,839) (56,744)
Cash flows from financing activities:    
Repayments of borrowings on credit facility 0 (250,000)
Repayment of other debt (822) (538)
Payment of debt issuance costs (5,257) (1,990)
Repurchase of common shares (78) (6)
Distributions to shareholders (2,404) (2,397)
Net cash used in financing activities (8,561) (254,931)
Decrease in cash and cash equivalents and restricted cash (38,798) (305,633)
Cash and cash equivalents and restricted cash at beginning of period 246,961 688,302
Cash and cash equivalents and restricted cash at end of period $ 208,163 $ 382,669
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Supplemental cash flow information:    
Interest paid $ 31,809 $ 43,166
Income taxes paid 0 0
Non-cash investing activities:    
Receivable from AlerisLife Inc. tender offer 0 14,006
Real estate improvements accrued, not paid $ 17,369 $ 20,195
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Statement of Cash Flows [Abstract]        
Cash and cash equivalents $ 207,123 $ 245,939 $ 380,117  
Restricted cash 1,040 [1] 1,022 2,552 [1]  
Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows $ 208,163 $ 246,961 $ 382,669 $ 688,302
[1] Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2023, or our Annual Report.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.
The preparation of these financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 450, Contingencies, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Recent Accounting Pronouncements
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Recent Accounting Pronouncements Recent Accounting Pronouncements
On November 27, 2023, the FASB issued Accounting Standards Update, or ASU, No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, or ASU No. 2023-07, which requires public entities to: (i) provide disclosures of significant segment expenses and other segment items if they are regularly provided to the Chief Operating Decision Maker, or the CODM, and included in each reported measure of segment profit or loss; (ii) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by ASC 280, Segment Reporting, or ASC 280, in interim periods; and (iii) disclose the CODM’s title and position, as well as an explanation of how the CODM uses the reported measures and other disclosures. Public entities with a single reportable segment must apply all the disclosure requirements of ASU No. 2023-07, as well as all the existing segment disclosures under ASC 280. The amendments in ASU No. 2023-07 are incremental to the requirements in ASC 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU No. 2023-07 should be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact ASU No. 2023-07 will have on our consolidated financial statements and disclosures.
On December 14, 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, or ASU No. 2023-09, which requires public entities to enhance their annual income tax disclosures by requiring: (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 should be applied prospectively but entities have the option to apply it retrospectively to all prior periods presented in the financial statements. ASU No. 2023-09 is effective for annual periods
beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact ASU No. 2023-09 will have on our consolidated financial statements and disclosures.
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments
 3 Months Ended
Mar. 31, 2024
Real Estate [Abstract]  
Real Estate and Other Investments Real Estate and Other Investments
As of March 31, 2024, we owned 371 properties located in 36 states and Washington, D.C., including four properties classified as held for sale and two closed senior living communities, and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states.
Acquisitions and Dispositions:
We did not acquire any properties during the three months ended March 31, 2024.
During the three months ended March 31, 2024, we sold one property for a sales price of $3,600, excluding closing costs, as presented in the table below. The sale of this property does not represent a significant disposition and we do not believe this sale represents a strategic shift in our business. As a result, the results of operations for this property are included in continuing operations through the date of sale of such property in our condensed consolidated statements of comprehensive income (loss).
Date of SaleLocationType of PropertyNumber of Properties
Sales Price (1)
Loss on Sale
March 2024ArizonaMedical Office1$3,600 $5,874 
(1)Sales price excludes closing costs.
As of March 31, 2024, we had four properties classified as held for sale in our condensed consolidated balance sheet as follows:
Type of PropertyNumber of PropertiesReal Estate Properties, Net
Medical Office and Life Science3$34,245 
Senior Living11,525 
4$35,770 
As of May 2, 2024, we had two properties under agreements to sell for an aggregate sales price of approximately $10,375, excluding closing costs. We may not complete the sales of any or all of the properties we currently plan to sell. Also, we may sell some or all of these properties at amounts that are less than currently expected and/or less than the carrying values of such properties and we may incur losses on any such sales as a result.
Impairment:
We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future undiscounted cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value.
During the three months ended March 31, 2024, we recorded impairment charges of $12,142 related to two medical office properties that were classified as held for sale as of March 31, 2024.
Equity Method Investments in Unconsolidated Joint Ventures:
As of March 31, 2024, we had equity investments in unconsolidated joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at March 31, 2024
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$85,922 1MA1,134,479 
The LSMD Fund REIT LLC20%44,377 10CA, MA, NY, TX, WA1,068,763 
$130,299 112,203,242 
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at March 31, 2024 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2) (3)
3.53%11/6/2028$620,000 
Mortgage Notes Payable (secured by nine properties in five states) (4)
3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (4) (5)
6.38%2/9/2025266,825 
4.22%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)We provide certain guaranties on this debt.
(3)This mortgage loan requires interest only payments until the anticipated repayment date on August 6, 2026, at which time all accrued and unpaid interest along with the principal balance of $620,000 is expected to be repaid. This mortgage loan matures on November 6, 2028 and any unpaid principal from the anticipated repayment date through the maturity date bears interest at a variable rate of the greater of 6.53% or the then effective U.S. swap rate for the swap terminating on the maturity date plus 5.00%.
(4)The debt securing these properties is non-recourse to us.
(5)This mortgage loan matures on February 9, 2025 and requires interest to be paid at an annual rate of the one month term secured overnight financing rate, or SOFR, plus a premium of 1.90%. This joint venture has also purchased an interest rate cap through February 2025 with a SOFR strike rate equal to 4.48% and an initial premium of $1,200. The maturity date of this mortgage loan is subject to two remaining one-year extension options.

We account for the unconsolidated joint venture for 10 medical office and life science properties in which we own a 20% equity interest, or the LSMD JV, and the unconsolidated joint venture for a life science property located in Boston, Massachusetts in which we own a 10% equity interest, or the Seaport JV, using the equity method of accounting under the fair value option. During the three months ended March 31, 2024 and 2023, respectively, we recognized a $1,613 and $(647) change in the fair value of our investments in our unconsolidated joint ventures. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 6 for further information regarding the valuation of our investment in these joint ventures.
Equity Method Investment in AlerisLife:
As of March 31, 2024, we owned approximately 34.0% of the outstanding common shares of AlerisLife Inc., or AlerisLife. We account for our 34.0% non-controlling interest in AlerisLife using the equity method of accounting.
As of March 31, 2024, our investment in AlerisLife had a carrying value of $15,740. The cost basis of our investment in AlerisLife exceeded our proportionate share of AlerisLife's total stockholders' equity book value on the date of acquisition of our initial interest in AlerisLife, which was February 16, 2024, by an aggregate of $29,500. As required under GAAP, we are amortizing this difference to equity in earnings of an investee over 21 years, the weighted average remaining useful life of the real estate assets owned by AlerisLife and the intangible contract asset with us as of the date of acquisition. We recorded amortization of the basis difference of $174 for the three months ended March 31, 2024. We recognized income of $111 related to our investment in AlerisLife for the three months ended March 31, 2024. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 11 for further information regarding our investment in AlerisLife.
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases
 3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases Leases
We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.
Our leases provide for base rent payments and, in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.
We increased rental income to record revenue on a straight line basis by $291 and $2,448 for the three months ended March 31, 2024 and 2023, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $74,704 and $75,306 of straight line rent receivables at March 31, 2024 and December 31, 2023, respectively, and are included in other assets, net in our condensed consolidated balance sheets.
We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $11,350 and $11,986 for the three months ended March 31, 2024 and 2023, respectively, of which tenant reimbursements totaled $11,284 and $11,924, respectively.
Right of Use Asset and Lease Liability: For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $22,555 and $22,937, respectively, as of March 31, 2024, and $23,366 and $23,748, respectively, as of December 31, 2023. The right of use assets and related lease liabilities are included within other assets, net and other liabilities, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Indebtedness
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Indebtedness Indebtedness
Our principal debt obligations, excluding any debt obligations of our joint ventures, at March 31, 2024 were: (1) $2,100,000 outstanding principal amount of senior unsecured notes; (2) $940,534 outstanding principal amount of senior secured notes; and (3) $8,669 principal amount of mortgage debt secured by one property. The mortgaged property had a net book value of $13,466 at March 31, 2024. We also had two properties subject to finance leases that expire in 2026 with lease obligations totaling $3,528 at March 31, 2024; these two properties had an aggregate net book value of $22,365 at March 31, 2024.
Until its repayment in full on December 21, 2023, we had a $450,000 credit facility that was fully drawn. As of December 21, 2023, our former credit facility was paid off in full and the related credit agreement was terminated. The weighted average annual interest rate for borrowings under our former credit facility was 7.6% for the three months ended March 31, 2023. In January 2023, pursuant to the credit agreement, we repaid $113,627 in outstanding borrowings under our former credit facility and the commitments were reduced to $586,373. In February 2023, we and our lenders amended the credit agreement to reduce the commitments from $586,373 to $450,000 following our repayment of $136,373 in outstanding borrowings under our former credit facility, and as a result of that reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $1,075 for the three months ended March 31, 2023.
As of March 31, 2024, all $940,534 of our senior secured notes due 2026 are fully and unconditionally guaranteed, on a joint, several and senior secured basis, by certain of our subsidiaries that own 95 properties, or the Collateral Guarantors, and on a joint, several and unsecured basis, by all our subsidiaries other than the Collateral Guarantors and certain excluded subsidiaries, and all $500,000 of our 9.75% senior notes due 2025 and all $500,000 of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint, several and unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries. The notes and related guarantees (other than our senior secured notes and the guarantees provided by the
Collateral Guarantors) are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and the notes and related guarantees are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1,100,000 of senior unsecured notes do not have the benefit of any guarantees as of March 31, 2024.
Our senior secured notes due 2026 and the guarantees provided by the Collateral Guarantors are secured by a first priority lien and security interest in each of the collateral properties and 100% of the equity interests in each of the Collateral Guarantors. No cash interest will accrue on these notes prior to maturity. The accreted value of these notes will increase at a rate of 11.25% per annum compounded semiannually on January 15 and July 15 of each year, such that the accreted value will equal the principal amount at maturity. During the three months ended March 31, 2024, we recognized discount accretion of $20,659 for our senior secured notes due 2026 in interest expense in our condensed consolidated statements of comprehensive income (loss). We have a one-time option to extend the maturity date of these notes by one year, to January 15, 2027, subject to satisfaction of certain conditions and payment of an extension fee. If we exercise this option, interest payments will be due semiannually during the extension period at an initial interest rate of 11.25% with increases of 50 basis points every 90 days these notes remain outstanding.
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Assets and Liabilities
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities
The following table presents certain of our assets that are measured at fair value at March 31, 2024 and December 31, 2023, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of March 31, 2024As of December 31, 2023
DescriptionCarrying ValueCarrying Value
Recurring Fair Value Measurements Assets:  
Investment in unconsolidated joint venture (Level 3) (1)
$85,922 $85,699 
Investment in unconsolidated joint venture (Level 3) (2)
$44,377 $44,217 
Non-Recurring Fair Value Measurements Assets:
Real estate properties held for sale (Level 2) (3)
$19,744 $— 
(1)The 10% equity interest we own in the Seaport JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 8.00%, an exit capitalization rate of 6.00%, a holding period of 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(2)The 20% equity interest we own in the LSMD JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 6.50% and 8.00%, exit capitalization rates of between 4.75% and 7.00%, holding periods of 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(3)We have assets in our condensed consolidated balance sheets that are measured at fair value on a non-recurring basis. During the three months ended March 31, 2024, we recorded impairment charges of $12,142 to reduce the carrying value of two medical office properties that are classified as held for sale to their estimated sales price, less estimated costs to sell, of $19,744 under agreements to sell that we have entered into with third parties. See Note 3 for further information about impairment charges and the properties we have classified as held for sale.
In addition to the assets described in the table above, our financial instruments at March 31, 2024 and December 31, 2023 included cash and cash equivalents, restricted cash, certain other assets, senior unsecured notes, senior secured notes, secured debt and finance leases and certain other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
 As of March 31, 2024As of December 31, 2023
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 9.750% coupon rate, due 2025
$497,892 $500,350 $497,454 $490,750 
Senior secured notes, zero coupon rate, due 2026
751,890 798,419 731,211 771,981 
Senior unsecured notes, 4.750% coupon rate, due 2028
495,065 405,400 494,746 384,110 
Senior unsecured notes, 4.375% coupon rate, due 2031
494,060 374,350 493,845 375,000 
Senior unsecured notes, 5.625% coupon rate, due 2042
343,041 200,480 342,946 211,400 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,699 153,600 243,627 154,000 
Secured debt and finance leases (2)
12,197 11,638 13,020 12,284 
 $2,837,844 $2,444,237 $2,816,849 $2,399,525 
(1)Includes unamortized net discounts, premiums and debt issuance costs.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
We estimated the fair values of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs as defined in the fair value hierarchy under GAAP) as of March 31, 2024 and December 31, 2023. We estimated the fair values of our three issuances of senior unsecured notes due 2025, 2028 and 2031 and our issuance of senior secured notes due 2026 using an average of the bid and ask price on Nasdaq on or about March 31, 2024 and December 31, 2023 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
Common Share Purchases:
During the three months ended March 31, 2024, we purchased an aggregate of 30,176 of our common shares, valued at a weighted average share price of $2.58 per common share, from certain former employees of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares. We withheld and purchased these common shares at their fair market values based upon the trading prices of our common shares at the close of trading on Nasdaq on the applicable purchase dates.
Distributions:
During the three months ended March 31, 2024, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 11, 2024January 22, 2024February 15, 2024$0.01 $2,404 
On April 11, 2024, we declared a quarterly distribution to common shareholders of record on April 22, 2024 of $0.01 per share, or approximately $2,404. We expect to pay this distribution on or about May 16, 2024 using cash on hand.
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
We operate in, and report financial information for, the following two segments: Medical Office and Life Science Portfolio and senior housing operating portfolio, or SHOP. We aggregate the operating results of our properties in these two reporting segments based on their similar operating and economic characteristics. Our Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed
senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities on our behalf.
We also report “non-segment” operations, which consists of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
For the Three Months Ended March 31, 2024
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$54,149 $— $8,501 $62,650 
Residents fees and services— 308,126 — 308,126 
Total revenues54,149 308,126 8,501 370,776 
Expenses:    
Property operating expenses23,897 283,416 291 307,604 
Depreciation and amortization20,740 46,922 2,471 70,133 
General and administrative— — 7,568 7,568 
Acquisition and certain other transaction related costs
— — 86 86 
Impairment of assets12,142 — — 12,142 
Total expenses56,779 330,338 10,416 397,533 
Loss on sale of properties(5,874)— — (5,874)
Gains on equity securities, net— — — — 
Interest and other income— — 2,237 2,237 
Interest expense(222)(68)(57,286)(57,576)
Loss before income tax expense and equity in net earnings of investees(8,726)(22,280)(56,964)(87,970)
Income tax expense— — (187)(187)
Equity in net earnings of investees1,613 — 285 1,898 
Net loss$(7,113)$(22,280)$(56,866)$(86,259)
 As of March 31, 2024
 
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,834,609 $3,103,540 $409,888 $5,348,037 
 For the Three Months Ended March 31, 2023
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$57,022 $— $9,416 $66,438 
Residents fees and services— 279,592 — 279,592 
Total revenues57,022 279,592 9,416 346,030 
Expenses:    
Property operating expenses23,515 262,329 236 286,080 
Depreciation and amortization20,035 42,152 2,613 64,800 
General and administrative— — 5,873 5,873 
Acquisition and certain other transaction related costs
— — 93 93 
Impairment of assets2,308 3,617 — 5,925 
Total expenses45,858 308,098 8,815 362,771 
Gain on sale of properties— 1,233 — 1,233 
Gains on equity securities, net— — 8,126 8,126 
Interest and other income— — 4,195 4,195 
Interest expense(109)(271)(47,400)(47,780)
Loss on modification or early extinguishment of debt— — (1,075)(1,075)
Income (loss) before income tax benefit and equity in net losses of investees11,055 (27,544)(35,553)(52,042)
Income tax benefit— — 31 31 
Equity in net losses of investees(647)— — (647)
Net income (loss)$10,408 $(27,544)$(35,522)$(52,658)
 As of December 31, 2023
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,866,422 $3,134,978 $444,736 $5,446,136 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Senior Living Community Management Agreements
 3 Months Ended
Mar. 31, 2024
Risks and Uncertainties [Abstract]  
Senior Living Community Management Agreements Senior Living Community Management Agreements
Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages many of our SHOP communities. Five Star manages these communities for us pursuant to a master management agreement. AlerisLife guarantees the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.
In connection with ABP Trust’s acquisition of AlerisLife on March 20, 2023, we amended the master management agreement with AlerisLife to eliminate any change of control default or event of default provisions. See Note 11 for further information regarding ABP Trust's acquisition of AlerisLife.
Our Senior Living Communities Managed by Five Star. Five Star managed 119 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by Five Star to our taxable REIT subsidiaries, or TRSs.
We incurred management fees payable to Five Star of $10,407 and $10,014 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $9,998 and $9,137, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $409 and $877, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We incurred fees of $10 and $879 for the three months ended March 31, 2024 and 2023, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services.
Our Senior Living Communities Managed by Other Third Party Managers. Several other third party managers managed 111 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by these third party managers to our TRSs.
In March 2024, we terminated our management agreement with one of our third party managers which manages certain of our communities located in Wisconsin and Illinois. We have transitioned these communities to another third party manager which we have an existing relationship with. The terms of the management agreement for these communities are generally consistent with the terms of the existing management agreements with our other third party managers. We paid termination and other fees of $1,106 during the second quarter of 2024, and expect to incur additional costs during 2024, related to the transition of these communities.
We incurred management fees payable to these third party managers of $5,725 and $5,238 for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended March 31,
Revenue from contracts with customers:20242023
Basic housing and support services$243,655 $222,187 
Medicare and Medicaid programs23,849 21,657 
Private pay and other third party payer SNF services 40,622 35,748 
Total residents fees and services$308,126 $279,592 
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business and Property Management Agreements with RMR
 3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Business and Property Management Agreements with RMR Business and Property Management Agreements with RMR
We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of many of our properties, including our medical office and life science properties, and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.
We recognized net business management fees of $4,878 and $3,270 for the three months ended March 31, 2024 and 2023, respectively. The net business management fees we recognized for the three months ended March 31, 2024 include $849 of estimated incentive fees based on our common share total return, as defined in our business management agreement. Although we recognized estimated incentive fees in accordance with GAAP, the actual amount of annual incentive fees for 2024, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2024, and will be payable in January 2025. We did not incur any incentive fee payable for the year ended December 31, 2023. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss).
We recognized aggregate net property management and construction supervision fees of $1,904 and $1,992 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $1,538 and $1,463, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $366 and $529, respectively, were capitalized as building
improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,728 and $3,533 for these expenses and costs for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.
Management Agreements between our Joint Ventures and RMR. We have two separate joint venture arrangements with third party institutional investors, the Seaport JV and the LSMD JV. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures.
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Person Transactions
 3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Person Transactions Related Person Transactions
We have relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the majority owned subsidiary of RMR. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and, until the acquisition of AlerisLife by ABP Trust on March 20, 2023, the chair of the board of directors and a managing director of AlerisLife, and currently the sole director of AlerisLife. Jennifer F. Francis, our other Managing Trustee, our former President and Chief Executive Officer and a former managing director of AlerisLife served as an officer of RMR until December 31, 2023 and will remain an employee of RMR until her retirement on July 1, 2024. Our current President and Chief Executive Officer and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and secretary of AlerisLife and, until March 20, 2023, a managing director of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees of other public companies to which RMR or its subsidiaries provide management services. Mr. Portnoy serves as the chair of the board and as a managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services. As of March 31, 2024, ABP Trust and Mr. Portnoy owned 9.8% of our outstanding common shares.
AlerisLife. Until March 20, 2023, we were AlerisLife's largest stockholder, owning approximately 31.9% of AlerisLife's outstanding common shares, and ABP Acquisition LLC, or ABP Acquisition, a subsidiary of ABP Trust, together with ABP Trust, owned approximately 6.1% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own. RMR provides management services to both us and AlerisLife.
On February 2, 2023, AlerisLife entered into an Agreement and Plan of Merger, or the ALR Merger Agreement, with certain subsidiaries of ABP Trust, pursuant to which ABP Trust acquired all of the publicly held outstanding AlerisLife common shares at a price of $1.31 per share by tender offer.
In connection with the ALR Merger Agreement, on February 2, 2023, we agreed to tender all the AlerisLife common shares that we and our subsidiary then owned, into the tender offer at the tender offer price, subject to the right, but not the obligation, to purchase, on or before December 31, 2023, AlerisLife common shares at the tender offer price, and otherwise pursuant to a stockholders agreement to be entered into at the time of any such purchase. On December 20, 2023, we and ABP Trust extended our right to purchase AlerisLife common shares until March 31, 2024.
On February 16, 2024, we exercised this purchase right and acquired, together with our applicable TRS, approximately 34.0% of the then outstanding AlerisLife common shares from ABP Trust at the tender offer price, for a total purchase price of $14,890, and we, our applicable TRS, ABP Trust and AlerisLife entered into a stockholders agreement. Following this acquisition, ABP Trust owns the remaining approximately 66.0% of AlerisLife.
See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star).
Our Joint Ventures. In connection with our entering into the LSMD JV in January 2022, we paid mortgage escrow amounts and closing costs that were payable by that joint venture. The remaining costs totaled $6,080 as of March 31, 2024 and are included in other assets, net, in our condensed consolidated balance sheet. RMR provides management services to each of the Seaport JV and the LSMD JV. See Note 10 for further information regarding those management agreements with RMR.
Our Manager, RMR. We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.
Leases with RMR. We lease office space to RMR in certain of our properties for RMR’s property management offices. We recognized rental income from RMR for this leased office space of $109 and $61 for the three months ended March 31, 2024 and 2023, respectively.
For further information about these and other such relationships and certain other related person transactions, see our Annual Report.
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
 3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended March 31, 2024 and 2023, we recognized income tax expense of $187 and benefit of $31, respectively.
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Weighted Average Common Shares
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Weighted Average Common Shares Weighted Average Common Shares
We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share.
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Recent Accounting Pronouncements (Policies)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Recent Accounting Pronouncements
On November 27, 2023, the FASB issued Accounting Standards Update, or ASU, No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, or ASU No. 2023-07, which requires public entities to: (i) provide disclosures of significant segment expenses and other segment items if they are regularly provided to the Chief Operating Decision Maker, or the CODM, and included in each reported measure of segment profit or loss; (ii) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by ASC 280, Segment Reporting, or ASC 280, in interim periods; and (iii) disclose the CODM’s title and position, as well as an explanation of how the CODM uses the reported measures and other disclosures. Public entities with a single reportable segment must apply all the disclosure requirements of ASU No. 2023-07, as well as all the existing segment disclosures under ASC 280. The amendments in ASU No. 2023-07 are incremental to the requirements in ASC 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU No. 2023-07 should be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact ASU No. 2023-07 will have on our consolidated financial statements and disclosures.
On December 14, 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, or ASU No. 2023-09, which requires public entities to enhance their annual income tax disclosures by requiring: (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 should be applied prospectively but entities have the option to apply it retrospectively to all prior periods presented in the financial statements. ASU No. 2023-09 is effective for annual periods
beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact ASU No. 2023-09 will have on our consolidated financial statements and disclosures.
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments (Tables)
 3 Months Ended
Mar. 31, 2024
Real Estate [Abstract]  
Schedule of Disposal Groups
Date of SaleLocationType of PropertyNumber of Properties
Sales Price (1)
Loss on Sale
March 2024ArizonaMedical Office1$3,600 $5,874 
(1)Sales price excludes closing costs.
As of March 31, 2024, we had four properties classified as held for sale in our condensed consolidated balance sheet as follows:
Type of PropertyNumber of PropertiesReal Estate Properties, Net
Medical Office and Life Science3$34,245 
Senior Living11,525 
4$35,770 
Schedule of Joint Ventures
As of March 31, 2024, we had equity investments in unconsolidated joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at March 31, 2024
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$85,922 1MA1,134,479 
The LSMD Fund REIT LLC20%44,377 10CA, MA, NY, TX, WA1,068,763 
$130,299 112,203,242 
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at March 31, 2024 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2) (3)
3.53%11/6/2028$620,000 
Mortgage Notes Payable (secured by nine properties in five states) (4)
3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (4) (5)
6.38%2/9/2025266,825 
4.22%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)We provide certain guaranties on this debt.
(3)This mortgage loan requires interest only payments until the anticipated repayment date on August 6, 2026, at which time all accrued and unpaid interest along with the principal balance of $620,000 is expected to be repaid. This mortgage loan matures on November 6, 2028 and any unpaid principal from the anticipated repayment date through the maturity date bears interest at a variable rate of the greater of 6.53% or the then effective U.S. swap rate for the swap terminating on the maturity date plus 5.00%.
(4)The debt securing these properties is non-recourse to us.
(5)This mortgage loan matures on February 9, 2025 and requires interest to be paid at an annual rate of the one month term secured overnight financing rate, or SOFR, plus a premium of 1.90%. This joint venture has also purchased an interest rate cap through February 2025 with a SOFR strike rate equal to 4.48% and an initial premium of $1,200. The maturity date of this mortgage loan is subject to two remaining one-year extension options.
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Assets and Liabilities (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value
The following table presents certain of our assets that are measured at fair value at March 31, 2024 and December 31, 2023, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of March 31, 2024As of December 31, 2023
DescriptionCarrying ValueCarrying Value
Recurring Fair Value Measurements Assets:  
Investment in unconsolidated joint venture (Level 3) (1)
$85,922 $85,699 
Investment in unconsolidated joint venture (Level 3) (2)
$44,377 $44,217 
Non-Recurring Fair Value Measurements Assets:
Real estate properties held for sale (Level 2) (3)
$19,744 $— 
(1)The 10% equity interest we own in the Seaport JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 8.00%, an exit capitalization rate of 6.00%, a holding period of 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(2)The 20% equity interest we own in the LSMD JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 6.50% and 8.00%, exit capitalization rates of between 4.75% and 7.00%, holding periods of 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.
(3)We have assets in our condensed consolidated balance sheets that are measured at fair value on a non-recurring basis. During the three months ended March 31, 2024, we recorded impairment charges of $12,142 to reduce the carrying value of two medical office properties that are classified as held for sale to their estimated sales price, less estimated costs to sell, of $19,744 under agreements to sell that we have entered into with third parties. See Note 3 for further information about impairment charges and the properties we have classified as held for sale.
Schedule of Carrying Value and Fair Value of the Financial Instruments The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
 As of March 31, 2024As of December 31, 2023
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 9.750% coupon rate, due 2025
$497,892 $500,350 $497,454 $490,750 
Senior secured notes, zero coupon rate, due 2026
751,890 798,419 731,211 771,981 
Senior unsecured notes, 4.750% coupon rate, due 2028
495,065 405,400 494,746 384,110 
Senior unsecured notes, 4.375% coupon rate, due 2031
494,060 374,350 493,845 375,000 
Senior unsecured notes, 5.625% coupon rate, due 2042
343,041 200,480 342,946 211,400 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,699 153,600 243,627 154,000 
Secured debt and finance leases (2)
12,197 11,638 13,020 12,284 
 $2,837,844 $2,444,237 $2,816,849 $2,399,525 
(1)Includes unamortized net discounts, premiums and debt issuance costs.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Dividends Declared and Paid
During the three months ended March 31, 2024, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 11, 2024January 22, 2024February 15, 2024$0.01 $2,404 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
For the Three Months Ended March 31, 2024
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$54,149 $— $8,501 $62,650 
Residents fees and services— 308,126 — 308,126 
Total revenues54,149 308,126 8,501 370,776 
Expenses:    
Property operating expenses23,897 283,416 291 307,604 
Depreciation and amortization20,740 46,922 2,471 70,133 
General and administrative— — 7,568 7,568 
Acquisition and certain other transaction related costs
— — 86 86 
Impairment of assets12,142 — — 12,142 
Total expenses56,779 330,338 10,416 397,533 
Loss on sale of properties(5,874)— — (5,874)
Gains on equity securities, net— — — — 
Interest and other income— — 2,237 2,237 
Interest expense(222)(68)(57,286)(57,576)
Loss before income tax expense and equity in net earnings of investees(8,726)(22,280)(56,964)(87,970)
Income tax expense— — (187)(187)
Equity in net earnings of investees1,613 — 285 1,898 
Net loss$(7,113)$(22,280)$(56,866)$(86,259)
 As of March 31, 2024
 
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,834,609 $3,103,540 $409,888 $5,348,037 
 For the Three Months Ended March 31, 2023
 
Medical Office and Life Science Portfolio
SHOPNon-SegmentConsolidated
Revenues:    
Rental income$57,022 $— $9,416 $66,438 
Residents fees and services— 279,592 — 279,592 
Total revenues57,022 279,592 9,416 346,030 
Expenses:    
Property operating expenses23,515 262,329 236 286,080 
Depreciation and amortization20,035 42,152 2,613 64,800 
General and administrative— — 5,873 5,873 
Acquisition and certain other transaction related costs
— — 93 93 
Impairment of assets2,308 3,617 — 5,925 
Total expenses45,858 308,098 8,815 362,771 
Gain on sale of properties— 1,233 — 1,233 
Gains on equity securities, net— — 8,126 8,126 
Interest and other income— — 4,195 4,195 
Interest expense(109)(271)(47,400)(47,780)
Loss on modification or early extinguishment of debt— — (1,075)(1,075)
Income (loss) before income tax benefit and equity in net losses of investees11,055 (27,544)(35,553)(52,042)
Income tax benefit— — 31 31 
Equity in net losses of investees(647)— — (647)
Net income (loss)$10,408 $(27,544)$(35,522)$(52,658)
 As of December 31, 2023
Medical Office and Life Science Portfolio
SHOP Non-SegmentConsolidated
Total assets$1,866,422 $3,134,978 $444,736 $5,446,136 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Senior Living Community Management Agreements (Tables)
 3 Months Ended
Mar. 31, 2024
Risks and Uncertainties [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended March 31,
Revenue from contracts with customers:20242023
Basic housing and support services$243,655 $222,187 
Medicare and Medicaid programs23,849 21,657 
Private pay and other third party payer SNF services 40,622 35,748 
Total residents fees and services$308,126 $279,592 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Additional Information (Details)
 3 Months Ended
Mar. 31, 2024
state
property
jointVenture
Real Estate  
Number of properties owned (property) 371
Number of states in which properties are located | state 36
Number of states | state 5
Joint Venture  
Real Estate  
Number of unconsolidated joint ventures | jointVenture 2
Senior Living  
Real Estate  
Number of properties closed 2
Held for sale  
Real Estate  
Number of properties owned (property) 4
Held for sale | Senior Living  
Real Estate  
Number of properties owned (property) 1
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details)
$ in Thousands
 1 Months Ended 3 Months Ended
Mar. 31, 2024
USD ($)
property
Mar. 31, 2024
USD ($)
property
May 02, 2024
USD ($)
property
Real Estate      
Number of properties acquired   0  
Number of properties owned (property) 371 371  
Held for sale      
Real Estate      
Number of properties owned (property) 4 4  
Medical Office      
Real Estate      
Number of properties owned (property) 2 2  
Medical Office | Arizona | Disposed of by sale      
Real Estate      
Number of properties owned (property) 1 1  
Sales price | $ $ 3,600 $ 3,600  
Properties Under Agreement To Sell | Held for sale | Subsequent Event      
Real Estate      
Number of properties owned (property)     2
Aggregate sales price | $     $ 10,375
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Schedule of Disposal Groups (Details)
$ in Thousands
 1 Months Ended 3 Months Ended
Mar. 31, 2024
USD ($)
property
Mar. 31, 2024
USD ($)
property
Real Estate    
Number of Properties 371 371
Held for sale    
Real Estate    
Number of Properties 4 4
Real Estate Properties, Net | $ $ 35,770 $ 35,770
Medical Office    
Real Estate    
Number of Properties 2 2
Medical Office and Life Science | Held for sale    
Real Estate    
Number of Properties 3 3
Real Estate Properties, Net | $ $ 34,245 $ 34,245
Senior Living | Held for sale    
Real Estate    
Number of Properties 1 1
Real Estate Properties, Net | $ $ 1,525 $ 1,525
Arizona | Medical Office | Disposed of by sale    
Real Estate    
Number of Properties 1 1
Sale Price | $ $ 3,600 $ 3,600
Loss on Sale | $ $ 5,874  
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Impairment Narrative (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
property
Mar. 31, 2023
USD ($)
Real Estate    
Impairment of assets | $ $ 12,142 $ 5,925
Number of properties owned (property) | property 371  
Medical Office    
Real Estate    
Impairment of assets | $ $ 12,142  
Number of properties owned (property) | property 2  
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
ft²
property
Dec. 31, 2023
USD ($)
Real Estate    
DHC carrying value | $ $ 130,299 $ 129,916
Number of properties owned (property) | property 371  
Corporate Joint Venture    
Real Estate    
DHC carrying value | $ $ 130,299  
Number of properties owned (property) | property 11  
Area of real estate properties (in square feet) | ft² 2,203,242  
Seaport Innovation LLC | Corporate Joint Venture    
Real Estate    
Equity method investment ownership percentage 10.00%  
DHC carrying value | $ $ 85,922  
Number of properties owned (property) | property 1  
Area of real estate properties (in square feet) | ft² 1,134,479  
The LSMD Fund REIT LLC | Corporate Joint Venture    
Real Estate    
Equity method investment ownership percentage 20.00%  
DHC carrying value | $ $ 44,377  
Number of properties owned (property) | property 10  
Area of real estate properties (in square feet) | ft² 1,068,763  
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Mortgage Debt Joint Venture (Details)
 3 Months Ended
Mar. 31, 2024
USD ($)
property
state
option
Real Estate  
Number of states in which properties are located | state 36
Corporate Joint Venture  
Real Estate  
Interest rate (as a percent) 4.22%
Principal balance $ 1,076,625,000
Corporate Joint Venture | Seaport Innovation LLC  
Real Estate  
Aggregate principal amount of mortgage debt $ 620,000,000
Seaport Innovation LLC | Corporate Joint Venture | Minimum  
Real Estate  
Interest rate (as a percent) 6.53%
Seaport Innovation LLC | Corporate Joint Venture | US Swap Rate  
Real Estate  
Basis points per annum (as a percent) 5.00%
Seaport Innovation LLC | Corporate Joint Venture | Massachusetts  
Real Estate  
Encumbered properties (property) | property 1
Interest rate (as a percent) 3.53%
Principal balance $ 620,000,000
The LSMD Fund REIT LLC | Corporate Joint Venture  
Real Estate  
Encumbered properties (property) | property 9
Number of states in which properties are located | state 5
Interest rate (as a percent) 3.46%
Principal balance $ 189,800,000
The LSMD Fund REIT LLC | Corporate Joint Venture | California  
Real Estate  
Encumbered properties (property) | property 1
Interest rate (as a percent) 6.38%
Principal balance $ 266,825,000
Number of extension options | option 2
Extension term 1 year
The LSMD Fund REIT LLC | Corporate Joint Venture | California | SOFR  
Real Estate  
Basis points per annum (as a percent) 1.90%
Initial premium $ 1,200,000
The LSMD Fund REIT LLC | Corporate Joint Venture | California | SOFR | Interest Rate Cap  
Real Estate  
Basis points per annum (as a percent) 4.48%
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
property
Mar. 31, 2023
USD ($)
Real Estate    
Equity in net earnings (losses) of investees $ 1,898 $ (647)
Corporate Joint Venture    
Real Estate    
Equity in net earnings (losses) of investees $ 1,613 $ (647)
Corporate Joint Venture | Seaport Innovation LLC    
Real Estate    
Equity method investment ownership percentage 10.00%  
Corporate Joint Venture | The LSMD Fund REIT LLC    
Real Estate    
Equity method investment ownership percentage 20.00%  
Corporate Joint Venture | Medical Office Building and Life Science Building    
Real Estate    
Number of properties included in joint venture agreement | property 10  
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Real Estate      
Equity method investment $ 15,740   $ 0
Equity in net earnings (losses) of investees 1,898 $ (647)  
AlerisLife Inc      
Real Estate      
Equity method investment, difference between carrying amount and underlying equity $ 29,500    
AlerisLife Inc      
Real Estate      
Equity method investment ownership percentage 34.00%    
Equity method investment $ 15,740    
Equity in net earnings (losses) of investees 111    
AlerisLife Inc | Equity Method Investments      
Real Estate      
Amortization $ 174    
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Leases [Abstract]      
Increase (decrease) in straight line rental income $ 291 $ 2,448  
Straight line rental income, excluding properties held-for-sale 74,704   $ 75,306
Variable lease, payment 11,350 11,986  
Reimbursement revenue lease 11,284 $ 11,924  
Operating lease, right-of-use asset 22,555   23,366
Operating lease, liability $ 22,937   $ 23,748
Operating Lease, Right-of-Use Asset, Statement of Financial Position Other assets, net   Other assets, net
Operating Lease, Liability, Statement of Financial Position Other liabilities   Other liabilities
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Indebtedness (Details)
 1 Months Ended 3 Months Ended
Feb. 28, 2023
USD ($)
Jan. 31, 2023
USD ($)
Mar. 31, 2024
USD ($)
property
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 21, 2023
USD ($)
Indebtedness            
Number of properties owned (property) | property     371      
Total real estate properties, net     $ 4,708,921,000   $ 4,797,624,000  
Repayments of lines of credit     0 $ 250,000,000    
Loss on modification or early extinguishment of debt     $ 0 $ 1,075,000    
Finance Leased Properties            
Indebtedness            
Number of properties owned (property) | property     2      
Finance lease obligations     $ 3,528,000      
Finance leased asset, net     22,365,000      
Mortgages            
Indebtedness            
Aggregate principal amount of mortgage debt     $ 8,669,000      
Number of properties owned (property) | property     1      
Total real estate properties, net     $ 13,466,000      
Unsecured Debt            
Indebtedness            
Debt face amount     $ 2,100,000,000      
Unsecured Debt | Unsecured Revolving Credit Facility            
Indebtedness            
Unsecured revolving credit facility, maximum borrowing capacity $ 450,000,000 $ 586,373,000       $ 450,000,000
Revolving credit facility, interest rate payable (as a percent)     7.60%      
Repayments of lines of credit 136,373,000 $ 113,627,000        
Loss on modification or early extinguishment of debt $ 1,075,000          
Secured Debts            
Indebtedness            
Debt face amount     $ 940,534,000      
Secured Debts | Senior secured note due 2026            
Indebtedness            
Debt face amount     940,534,000      
Amortization of debt discount     $ 20,659,000      
Secured Debts | Senior Secured Notes Due January 2026            
Indebtedness            
Number of real estate properties collateralized | property     95      
Equity interest in each collateral guarantee     100.00%      
Accreted value increase rate     11.25%      
Debt extension term     1 year      
Initial extension period interest rate     11.25%      
Increase in interest rate     0.50%      
Senior Notes | Senior unsecured notes, 9.75% due 2025            
Indebtedness            
Debt face amount     $ 500,000,000      
Interest rate (as a percent)     9.75%      
Senior Notes | Senior unsecured notes, 4.375% coupon rate, due 2031            
Indebtedness            
Debt face amount     $ 500,000,000      
Interest rate (as a percent)     4.375%      
Unsecured Debt, Not Guaranteed            
Indebtedness            
Debt face amount     $ 1,100,000,000      
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Assets and Liabilities - Assets and Liabilities (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
property
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Impairment of assets | $ $ 12,142 $ 5,925  
Number of Properties 371    
Held for sale      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Number of Properties 4    
Medical Office      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Impairment of assets | $ $ 12,142    
Number of Properties 2    
Corporate Joint Venture      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Number of Properties 11    
Corporate Joint Venture | Seaport Innovation LLC      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Equity method investment ownership percentage 10.00%    
Holding period 10 years    
Number of Properties 1    
Corporate Joint Venture | Seaport Innovation LLC | Discount Rate      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0800    
Corporate Joint Venture | Seaport Innovation LLC | Market Capitalization Rate      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0600    
Corporate Joint Venture | The LSMD Fund REIT LLC      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Equity method investment ownership percentage 20.00%    
Holding period 10 years    
Number of Properties 10    
Corporate Joint Venture | The LSMD Fund REIT LLC | Discount Rate | Minimum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0650    
Corporate Joint Venture | The LSMD Fund REIT LLC | Discount Rate | Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0800    
Corporate Joint Venture | The LSMD Fund REIT LLC | Market Capitalization Rate | Minimum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0475    
Corporate Joint Venture | The LSMD Fund REIT LLC | Market Capitalization Rate | Maximum      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Measurement input 0.0700    
Recurring Fair Value Measurements Assets | Level 3 | Joint Venture | Carrying Value | Seaport Innovation LLC      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Investments in affiliates, fair value | $ $ 85,922   $ 85,699
Recurring Fair Value Measurements Assets | Level 3 | Joint Venture | Carrying Value | The LSMD Fund REIT LLC      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Investments in affiliates, fair value | $ 44,377   44,217
Non-Recurring Fair Value Measurements Assets | Medical Office      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Aggregate sales price | $ $ 19,744    
Non-Recurring Fair Value Measurements Assets | Medical Office | Held for sale      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Number of Properties 2    
Non-Recurring Fair Value Measurements Assets | Level 2 | Carrying Value      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis      
Real estate properties held for sale | $ $ 19,744   $ 0
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Assets and Liabilities - Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Senior Unsecured Notes | Senior unsecured notes, 9.750% coupon rate, due 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 9.75%  
Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2028    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 4.75%  
Senior Unsecured Notes | Senior unsecured notes, 4.375% coupon rate, due 2031    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 4.375%  
Senior Unsecured Notes | Senior unsecured notes, 5.625% coupon rate, due 2042    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 5.625%  
Senior Unsecured Notes | Senior unsecured notes, 6.250% coupon rate, due 2046    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 6.25%  
Senior Secured Notes | Senior secured notes, zero coupon rate, due 2026    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate 0.00%  
Carrying Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure $ 2,837,844 $ 2,816,849
Carrying Value | Senior Unsecured Notes | Senior unsecured notes, 9.750% coupon rate, due 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 497,892 497,454
Carrying Value | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2028    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 495,065 494,746
Carrying Value | Senior Unsecured Notes | Senior unsecured notes, 4.375% coupon rate, due 2031    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 494,060 493,845
Carrying Value | Senior Unsecured Notes | Senior unsecured notes, 5.625% coupon rate, due 2042    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 343,041 342,946
Carrying Value | Senior Unsecured Notes | Senior unsecured notes, 6.250% coupon rate, due 2046    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 243,699 243,627
Carrying Value | Senior Secured Notes | Senior secured notes, zero coupon rate, due 2026    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 751,890 731,211
Carrying Value | Secured debt and finance leases    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 12,197 13,020
Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 2,444,237 2,399,525
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 9.750% coupon rate, due 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 500,350 490,750
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2028    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 405,400 384,110
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 4.375% coupon rate, due 2031    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 374,350 375,000
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 5.625% coupon rate, due 2042    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 200,480 211,400
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 6.250% coupon rate, due 2046    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 153,600 154,000
Estimated Fair Value | Senior Secured Notes | Senior secured notes, zero coupon rate, due 2026    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 798,419 771,981
Estimated Fair Value | Secured debt and finance leases    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure $ 11,638 $ 12,284
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Assets and Liabilities - Narrative (Details) - security
Mar. 31, 2024
Dec. 31, 2023
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value measurement, number of debt securities 2 2
Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value measurement, number of debt securities 3 3
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Apr. 11, 2024
Feb. 15, 2024
Mar. 31, 2024
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award        
Distributions to shareholders   $ 2,404 $ 2,404 $ 2,397
Subsequent Event        
Share-based Compensation Arrangement by Share-based Payment Award        
Distributions to common shareholders declared (in dollars per share) $ 0.01      
Distributions to shareholders $ 2,404      
RMR        
Share-based Compensation Arrangement by Share-based Payment Award        
Number of shares (in shares)     30,176  
Weighted average share price (in dollars per share)     $ 2.58  
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Feb. 15, 2024
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity Note [Abstract]      
Distribution per share (in dollars per share) $ 0.01    
Total Distributions $ 2,404 $ 2,404 $ 2,397
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Narrative (Details)
 3 Months Ended
Mar. 31, 2024
segment
Segment Reporting [Abstract]  
Number of operating segments 2
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Income Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 370,776 $ 346,030
Expenses:    
Property operating expenses 307,604 286,080
Depreciation and amortization 70,133 64,800
General and administrative 7,568 5,873
Acquisition and certain other transaction related costs 86 93
Impairment of assets 12,142 5,925
Total expenses 397,533 362,771
(Loss) gain on sale of properties (5,874) 1,233
Gains on equity securities, net 0 8,126
Interest and other income 2,237 4,195
Interest expense (57,576) (47,780)
Loss on modification or early extinguishment of debt 0 (1,075)
Income (loss) before income tax benefit and equity in net losses of investees (87,970) (52,042)
Income tax (expense) benefit (187) 31
Equity in net earnings (losses) of investees 1,898 (647)
Net loss (86,259) (52,658)
Rental income    
Revenues:    
Total revenues 62,650 66,438
Residents fees and services    
Revenues:    
Total revenues 308,126 279,592
Operating Segments | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 54,149 57,022
Expenses:    
Property operating expenses 23,897 23,515
Depreciation and amortization 20,740 20,035
General and administrative 0 0
Acquisition and certain other transaction related costs 0 0
Impairment of assets 12,142 2,308
Total expenses 56,779 45,858
(Loss) gain on sale of properties (5,874) 0
Gains on equity securities, net 0 0
Interest and other income 0 0
Interest expense (222) (109)
Loss on modification or early extinguishment of debt   0
Income (loss) before income tax benefit and equity in net losses of investees (8,726) 11,055
Income tax (expense) benefit 0 0
Equity in net earnings (losses) of investees 1,613 (647)
Net loss (7,113) 10,408
Operating Segments | SHOP    
Revenues:    
Total revenues 308,126 279,592
Expenses:    
Property operating expenses 283,416 262,329
Depreciation and amortization 46,922 42,152
General and administrative 0 0
Acquisition and certain other transaction related costs 0 0
Impairment of assets 0 3,617
Total expenses 330,338 308,098
(Loss) gain on sale of properties 0 1,233
Gains on equity securities, net 0 0
Interest and other income 0 0
Interest expense (68) (271)
Loss on modification or early extinguishment of debt   0
Income (loss) before income tax benefit and equity in net losses of investees (22,280) (27,544)
Income tax (expense) benefit 0 0
Equity in net earnings (losses) of investees 0 0
Net loss (22,280) (27,544)
Operating Segments | Rental income | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 54,149 57,022
Operating Segments | Rental income | SHOP    
Revenues:    
Total revenues 0 0
Operating Segments | Residents fees and services | Medical Office and Life Science Portfolio    
Revenues:    
Total revenues 0 0
Operating Segments | Residents fees and services | SHOP    
Revenues:    
Total revenues 308,126 279,592
Non-Segment    
Revenues:    
Total revenues 8,501 9,416
Expenses:    
Property operating expenses 291 236
Depreciation and amortization 2,471 2,613
General and administrative 7,568 5,873
Acquisition and certain other transaction related costs 86 93
Impairment of assets 0 0
Total expenses 10,416 8,815
(Loss) gain on sale of properties 0 0
Gains on equity securities, net 0 8,126
Interest and other income 2,237 4,195
Interest expense (57,286) (47,400)
Loss on modification or early extinguishment of debt   (1,075)
Income (loss) before income tax benefit and equity in net losses of investees (56,964) (35,553)
Income tax (expense) benefit (187) 31
Equity in net earnings (losses) of investees 285 0
Net loss (56,866) (35,522)
Non-Segment | Rental income    
Revenues:    
Total revenues 8,501 9,416
Non-Segment | Residents fees and services    
Revenues:    
Total revenues $ 0 $ 0
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Segment reporting    
Total assets $ 5,348,037 $ 5,446,136
Operating Segments | Medical Office and Life Science Portfolio    
Segment reporting    
Total assets 1,834,609 1,866,422
Operating Segments | SHOP    
Segment reporting    
Total assets 3,103,540 3,134,978
Non-Segment    
Segment reporting    
Total assets $ 409,888 $ 444,736
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Senior Living Community Management Agreements - Narrative (Details)
$ in Thousands
 3 Months Ended
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
community
Mar. 31, 2023
USD ($)
community
Property operating expenses   $ 307,604 $ 286,080
Affiliated Entity | Five Star      
Property management agreement expense   10,407 10,014
Related party transaction capitalized amount   409 877
Affiliated Entity | Five Star | Rehabilitation Services      
Property operating expenses   10 879
Affiliated Entity | Five Star | Operating Expense      
Property management agreement expense   $ 9,998 $ 9,137
Senior Living Communities | Affiliated Entity | Five Star      
Number of communities managed | community   119 119
Senior Living Communities | Affiliated Entity | Third Party Managers      
Number of communities managed | community   111 111
Property management agreement expense   $ 5,725 $ 5,238
Senior Living Communities | Affiliated Entity | Third Party Managers | Forecast      
Termination and other fees $ 1,106    
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue    
Revenues $ 370,776 $ 346,030
Residents fees and services    
Disaggregation of Revenue    
Revenues 308,126 279,592
Residents fees and services | Basic housing and support services    
Disaggregation of Revenue    
Revenues 243,655 222,187
Residents fees and services | Medicare and Medicaid programs    
Disaggregation of Revenue    
Revenues 23,849 21,657
Residents fees and services | Private pay and other third party payer SNF services    
Disaggregation of Revenue    
Revenues $ 40,622 $ 35,748
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business and Property Management Agreements with RMR (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
employee
jointVenture_arrangement
agreement
Mar. 31, 2023
USD ($)
Related person transactions    
Number of employees | employee 0  
Property management and construction supervision fees $ 1,904 $ 1,992
Property management and construction supervision fees paid 3,728 3,533
RMR    
Related person transactions    
Business management fees incurred 4,878 3,270
Estimated incentive fees $ 849  
Period of actual amount of incentive fees 3 years  
Property management and construction supervision fees $ 1,538 1,463
Party transaction property management and construction supervision fees capitalized $ 366 $ 529
Number joint venture arrangements | jointVenture_arrangement 2  
Senior Living Communities | RMR    
Related person transactions    
Number of consecutive renewal terms of agreement | agreement 2  
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Person Transactions (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Feb. 16, 2024
USD ($)
Feb. 02, 2023
$ / shares
Mar. 31, 2024
USD ($)
agreement
Mar. 31, 2023
USD ($)
Mar. 20, 2023
Related person transactions          
Revenues     $ 370,776 $ 346,030  
AlerisLife Inc          
Related person transactions          
Step acquisition, ownership percentage including subsequent acquisition 34.00%        
Purchase price $ 14,890        
Rental income          
Related person transactions          
Revenues     62,650 66,438  
Reit Management And Research L L C | Rental income          
Related person transactions          
Revenues     $ 109 $ 61  
Diversified Healthcare Trust | ABP Trust And Adam D. Portnoy          
Related person transactions          
Noncontrolling interest, ownership percentage by parent     9.80%    
AlerisLife Inc | AlerisLife Inc          
Related person transactions          
Noncontrolling interest, ownership percentage by parent         6.10%
AlerisLife Inc | ABP Trust          
Related person transactions          
Ownership interest by parent 66.00%        
AlerisLife Inc          
Related person transactions          
Investment owned balance per shares | $ / shares   $ 1.31      
Related Party | Reit Management And Research L L C          
Related person transactions          
Related party transaction, closing cost     $ 6,080    
Number of management agreements | agreement     2    
Related Party | AlerisLife Inc          
Related person transactions          
Investment owned, percentage of total shares outstanding         31.90%
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Income tax expense (benefit) $ 187 $ (31)
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +2#IE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "T@Z98#@0W!.X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)\WJ@J&;B^))07!!\1:2V=U@DX9DI-VW-ZV[740?P&-F_GSS M#4QKHC1]PN?41TSD,%^-O@M9FKAA!Z(H ;(YH->Y+HE0FKL^>4WEF?80M?G0 M>P3!^1H\DK::-$S *BY$IEIKI$FHJ4\GO#4+/GZF;H99 ]BAQT 9FKH!IJ:) M\3AV+5P $XPP^?Q=0+L0Y^J?V+D#[)0'MZ?)G7K5S( MI(/!\BL[2<>(&W:>_+JZN]\^,"6XN*[X3<776\&EN)6"OT^N/_PNPKZW;N?^ ML?%94+7PZR[4%U!+ P04 " "T@Z98F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M +2#IEC7RM\'O 8 ((H 8 >&PO=V]R:W-H965T&UL MM9KAW6N[;JUNSM[WU*(RBP0+\1:__M+ M$$FW%UXH6[ZT@KP_>4@(3X"S+>/?TQ6E CW'49*>=U9"K#_T>JF_HC%)C]F: M)O*;!>,Q$7*1+WOIFE,29$5QU,.6->C%)$PZH[-LW8R/SMA&1&%"9QREFS@F M?'=!([8][]B=PXK[<+D2:D5O=+8F2SJGXO-ZQN52KT@)PI@F:<@2Q.GBO#.V M/W@N5@79%E]"NDU??$8*Y9&Q[VIA&IQW++5'-**^4!%$_GNB'HTBE23WX]\\ MM%/\IBI\^?F0?I7!2YA'DE*/15_#0*S..R<=%- %V43BGFVO:0[45WD^B]+L M+]KNM^WC#O(WJ6!Q7BSW( Z3_7_RG!^(.@4X+\"O"FRGI,#)"YP,=+]G&=8E M$61TQMD6<;6U3%,?LF.354N:,%'-.!=$T/>L)F:F^ MZ?EY_<6^'I?4.^B6)6*5HDD2T.#'^I[$OX,7+L(X0M[!KV MQZLJWR'+6/W#WCC%X7&R.*'"4X!O30?' JH9X@P)O4 ]O1GG( M G4:(CD0&!L/3BI.O-(S#ZQOR#DL.(R8G\AJ270+*VQ'.6I H-38D6-80 M\*0 / %W*A]IKL*(HKM-_$BY"0S.L+MVW[%/36A@84.TTP+MM [:/5V&J9#- M)] =B8T]%,ZYG'Z9W,^G5]/));J>C&\>KKWQ_00]W'^>/YB8P;2&S+:E+ZQ6 M'>IIXC,N^VEV\3A"4;30)ZLX2+T,VZ@1U=$6F[7<=T^'IX8><'BIKQ8\^(ZO.,@D.GIT>$#NI'; MH8^)N5WAR(:'AVM3C:H*O\[.IY:DCW_@6V-%E41MS\J1LXVE,G6SF3#UO.:LSC% M9YP]A8EO[@9PYNW8"-J&2-G:I&S8?UZ#SE@J2(3^"=?EHQB<*$6C?]*U!X[1 M-^#BIKC:K&Q8B++^.I9SXW(Z.&!@#XU8;7B4K47*ANWGAOFRT68KED"B41$R M/!W(2>.)T[>,A&V(E*U-RH8UZ"$44J(^+M"$^"OD120U3VSA%(_%L1IOLXDQ M8@MT01,J+VBA/'K31,XD:&IR3P^.;0JO778 M.'>%"YM":Z7"M93*VW"N9C_[*4_6OO(JLS'VZXK$;\;;/!YFL>0 ;N2$$\LXVY BK*4(UY(B-"8B@ !\W0OINDEU=?P^3_):Y\?H*_\I;[PCG:?TL33V7>1IAUW).G2'&9[TG M$[!V)5SKMI,GQUB>B4U G]'?U-RF<)1E6;8U[+MVWPC1AA9AK4485IIQ3),@ MNX%X%9&ED0X.*.^Q;5B1HZW(@[DG+[' MH/5.'I0CMV%5KK8J%]:@FH-61?DN1KQXD[U_X*M86+]B-L]?* M>GKS_=MYMT3=IDA11!>RU#H>RJLEW[_PME\0;)V],_;(A&!Q]G%%24"YVD!^ MOV"R-^<+Z@>*UPY'_P%02P,$% @ M(.F6#@+V]AE!P Q!\ !@ !X M;"]W;W)K3G=;[\]E,93M>,'4F][R$7^YD53 -M]5VIO859QNK M5.0S$@31K&"BG"PN[+,/U>)"UCH7)?]0(547!:O^ON:Y?+BSHY6-*'BIA"Q1Q>\N)U?X?$43HV E_BWX@^I<(^/* MK91_FILWF\M)8!#QG&?:F&#PYYXO>9X;2X#CKX/1R?&=1K%[_6C]9^L\.'/+ M%%_*_#]BHW>7DV2"-OR.U;G^*!]^X0>'YL9>)G-E_T?X.;ZZNW5 MN^4-6O]R<_-IC5ZCS^L5^NG5/]$K)$KT:2=KQ9?QR NM/\>J>3Q;_^ %'P;]<7KZ0L1.?Z=%G MZK.^> M?SN5@HQ59+5,N[A=1B,,$7\SNN] =8G.2QO%1[ 14> 05>D%=UR+? MB'*K$*!#HH"/<<^AOFAGCC6VYET,&#!$<0^K2RZ:AVG@!CL_@IU[P7Z2&M*F M*2:Q?J> FC(,D)?T4=LE! M]IB"Y,*<'#$G7LQORGO :I/65,FZS&2I9"XV-N1_2%%J= ^_UK"F7?"3 2Q, M Y*F/?0.,1#"D1M\>@2?^K-#*0ZXY5TGT&C'\PV"Y@(IEG,7Y'2 A28XZ"?) M4"H-PY%LQD'+7($7\9*IG:T6F;G@?]7B'E".5(R#K2X&$L#BHSVH+KEPGM)T M!&V'9[$7[4=(C4ID)A,,7B=&//RR01B<(EP^\9[?\.].6G79)F3$JY8^L9>I M%C<0=?TW*KC>22C;QP7@=(\,(8_C83(YQ&C:J?>G[K1IGUN,_A2UDZ#T#(M M]E/MFF=U97N"6VVC<"=*5F:/"V0\P88TB@E.!U_/(0:T-I9>+=EB/]MVO]TS M60L/*93@?A?F$*)C];(E6?P$RV9957-3*36';^F.ZY N"8WG_2;&)4:2,5HE M+:T2/ZTVQ25OH^L QE2Z?$3W--<7D*Y9#T:)"FE/9K MH$L0!RDP_PC.SGSI)\BE+ IQZ EMKR)+#6,.+[,QS-\P&B+GB/G]ADY];MF6 M4&]5/:VBW%91]TCM9>UGS]0O9.W4ZY:4B9^4S9>6)5+&>5N1;GG)[P0,6?EQ MN4_1J[, HSVK$/2J-3]'- BF0?/O4975T$Q5XK]\,T5 PU.:TFE,B$T?P/B M[PVN-AMA9D^(S9X)4P^A*]X+6--.J,,& .@_2>?]WG%$$*; $WD.%$C*.4!+@_QKD$XS@A\4A[2%I")WY"[V!M&EO "BF_ M,[NU\"P?V9X@0Z)^/4B'H$[.+I,(F#_K3@$J0T2E+L!DQ;2J=^2A^0 MI:T67^L '7*XNT]W"?KZ=-JR/?6S_6.+NH(6U9D7?OWG,LE+63OUMNT9J']3 M^ENG$OJB6]0O9>TT")U-:O_(ON:E@!:^E-K=)]'A; T]_3U>R-JINRUCT_G_)RF]C<"S@_!"UDZ#T'8!U-\% M/)F4T>!PA 0Q#$:#4ND4)!$>(7]JR/_T2YN/9@I10+6V366% MK,UTPE4&IGDS.7?WR33[8G8!1*GJRNX+-'NNMEM#_,N>0\-I][01TRB#&9Q! M-P>&95VA0E9ZR[9@M9W/SUR?8M8YPBQXM;5'P0J K;F:.OXM#ENOL;G2WLJ MVWM^1>/S%83+]4OR>$(]:U_1G&__RJHM.(AR?@>O"\YBR+.J.3)N;K3!^\3]02P,$% @ M(.F6/+2\U"[ M @ U < !@ !X;"]W;W)KYT!&/*0K[.LD@I[HE"Q XLY0JIP:[:N7K0@%- MG2CG?A@$/3^G3'CQP(W-5#R0:\.9@)DB>IWG5/TY RZW0Z_M/0[A^[MB194$UC"7_P5*3#;UC MCZ2PI&MN;N7V BJ>KO5+)-?NGVS+V#YF3-;:R+P28S]GHGS2AZH..X)VYQE! M6 G"MPJB2A YT')E#FM"#8T'2FZ)LM'H9ANN-DZ--$S8MS@W"F<9ZDP\OKF> M3*_GTPG!UOSFZG(RNL/.V>AJ=#V>DOG%='HW)P^ ;78=W\I,IY5N8,G\GYE:H6B=I') S"3H-\_+)\ DDMC_;E/M+7)0CK M$H3.+WK&;VZH =R8AL@E.6>"BH113F92,[?3?HX6VBC<;[^:4$OO3K.W_09/ M=4$3&'KXD6E0&_#B3Q_:O>!+$_@[F>V5(:K+$+WD'H]EGB-M^5)M*18@8,E< M+9@P@*/FB!14D0WE:R '3)!4HFC1)P.EE*NCD,+N,B36<4RSUW,6I<^G WOP=N.>/RVENC&:GJSH M$YLS^6UUE\'5J/(2\I@E@J<)RMCB='!F'U\07PW(+;YS]BRVOB-%Y3%-?ZJ+ MJ_!T8"E$+&*!5"XH?&S8!8LBY0EP_%TZ'52_J09N?W_S_BDG#V0>J6 7:?2# MAW)Y.O '*&0+NH[D??K\A96$'.4O2".1_T7/I:TU0,%:R#0N!P."F"?%)WTI M [$U /SH!^!R &X/&/<,(.4 DA,MD.6T+JFDTY,L?4:9L@9OZDL>FWPTL.&) MFL:YS. IAW%R>G%[YNCV$SRZOKN? M?0&[J^\S='4#US.T__5V/C] 0_1M?HGV]PZ06-*,"<03]+!,UX(FH3A$>XWK MDY$$S.J71T&)[[S AWOP$72=)G(IT"P)6=@T^P($?L0 M80N/-7@NWC^<&."0*OXD]T=Z_-VS#4O63!SK0E,,'>N'J@5^+%8T8*<#6,&" M91LVF/[YA^U:?^EX[:]8ZD@6(]U\I"HZFRGQ+,]S3T:;;?@: ML[%K$:LR:P!S*F".,?RS%ZB'HB?\SB[#OR-G#99NQ=(UAO\N@[*?R5>D/JCD MR1-B)7$=[\*9LQUJRW.M<6M&NF;8=RV_9T:\"JMGQ'K)( !IT613T)$XS23 M_%=^0X?6Z\#P+)N0%MBNE3OVK1ZL?H75-V+]S!*(9U3 #*$ZHWUZR79-)#Q/;JN7*,G*YBE>49]!'2)0N$!6"Z>&5 M;K9_W,;V&+<@:LR<"79Z4&Z)JFU$^9!*2 O3&BL=-!;9Q',Z>:NS<['GV3T0 M<0T1&R'N?TV%.$!/>0XD2-"(J8BNBE+!>U#C#IHAY&>[,FC,;$SZYKZ62MNH M4=//@%7DBRT"[-!J &X&J0V%3;!@G7$%^Q E3&JQDPXHJXV[:^+;V.W!78N? M;5:_JT0R*.HRAUZL-YX$::RM$J6O1EG%Q&LC[5J-[4E?WM9J:!MEJ$9:IB[: M!Z#1.E2* 6%MU&*5+2%[E"CD(DC7B8300^F.^3HN)HD+L:9)P%!>0Y3Y'AX? M^B[)G^[A0\L;'T*U$2N6]_+1ZX$V((XFYSRGTR#H[,:>UZ='=BV>MED]U4)1 MJ1:G(5_PH"2?(4:SZ!4BI?04ZNORK2BIH&B)= 6SDX!=DZ%M>7WS6FNJ;1;5 MG,(C@[<^5J8>DO0%[9?3? #/$K;@18:62PKJ@IIR8)D 08'VBT5WH"CR9 -9 MPGJ*1%=KA[XW\3ID-78.MK9J=)-MK[CM\#KI9@;!L[^]N\SD(B0$U:JFV'#YU3ZR1C-.*_6*V8T#,E54II0Z&1^+:^:VQZJBRNQ1V;Q;UOOK08NSK=Q6B2 M^R;&6LBQ6<@OWH>N^ZJJ4M]MMW8Z.U/JURJ.S2K^(]^[@DFG&W@]>5("',>J MQRLV:-*U%!(*O1+U_4'"@=+Y\K-5@W-563";VI$-)9^<[_J2'4JW!V*S! M'Z$4\F@-IO].2O,"JR6ELS.0JE49>\82=5JCRIG)1?C-S+ZLF54 M_0^7K1UY:T:C5FUL5NTW-4%#5-!7TQ>F440S@>"=I(B1?B8+S][V2K*.2+M# MU)OAGGX#UR*.S2*^A;R 15^_[:)9(T WM M/J31QX)W5G0<:_<0Q@[$H^S'1'WII, MZ^:$F)L3TU$ Z;8/T#6MRKWL18NY%S FXTSYC5]Z:3.L^@YC[#&,"^MU3)JNQ!5A2 MZ-IA;^),VG(\VCJ8C5GVE)]7"Y1OEQ5'EM7=ZDS\+#\);MT_MX\OBI/MVDUQ MT'Y-LR>U+1JQ!;BTCCQ8%EEQ=EU2_6D-X@&GK-4Z(ZW M,69[X_LZWF#&]*7'4K"%.,C65@-.QP@&EJB4C& MSY+3JXZTP./Y@?VK\TY>EDSC0*;?>&(V'>_:@P17+$_-O=S?8NGGL^6+9:K= M+^S+W+H'<:Z-S$HP*[&P]Z"@FA! MPV0T740P^TI;D_G]Z);RQH\C&$\I'D'M;A9%YU";,X7";-#PF*7G\ D>HB'4 MSL[A#+B Q4;FFHE$MWU#DA3"11*QA)!),7N)]LEEY#0Y> M^\&[A!.F+B%L7$!0#YHG] S^'1Z^(R>LKCYT?.$;?&,1RPPA,LP@U86![[VE M-HH>]H]3EU60-4^3V6*_T5L68\>C:M:H=NAU/WYHM.I?3CG]3V0O?#9_H"$JYC MF0NC@9X5<*US)F*$6&JCST]=7*&FY=38IK;K!LWK%GW!W?&-G,BJ7S6KI,*I M?U1H&:JUZS\:G)[B'5:K58OKNNG)?24'-PTPVU;U0V@?974II#8 ^H_A"Z?P!02P,$% @ MM(.F6%#$IN''!@ XC$ !@ !X;"]W;W)KX2 XGU:( VR>)TPSXJ-FT+U<.5Y*3=KQ\INY9% MT;2$W7VQ)>O>>RGJD+Y\S8LOY9K2"GU+DZR\&JVK:O-^/"[G:YI&Y;M\ M0S-V99D7:52QTV(U+C<%C1:U4YJ,B:99XS2*L]'DLO[MH9AWBZN1QEM$$SJO.$3$OE[HE"8) M1V+M^+H''1UBHY).\^2O>%&MKT;.""WH,MHFU6/^^H'N M;ZANX#Q/ROH3O>YMM1&:;\LJ3_?.K 5IG.V^HV_[CCARP/H)![)W(**#<<)! MWSOH@@.Q3S@8>P=#=" G',R]@RDXZ-8)!VOO8(D1S!,.]M[!KLG:]6Y-C1=5 MT>2RR%]1P:T9&C^H^:V]&2-QQE-Q5A7L:LS\JLGT_L[S[V:^A]C1[/[CK7?] MQ$YF3^SKDW_W-$/W 9I]N'[T/]Q_]/S'V2_(_^/S[=/?Z )]GGGHUS=OT1L4 M9^AIG6_+*%N4E^.*M8NCC^?[-MSLVD!.M.$IKZ)$XC95NTWS-&7)/%M'!95% M]=3NUXM%S*LA2M!#%"_0;8:FT2:6-\4_TY1MNDTB7E3HCE8__X0M[??;;)ZG M5((5],:ZK]:T0.P^V2BSYN7_0G?8'_-2=L=A;V0O+JLB?M[R#A"0QBR##FE$ M#FE$:FCC!/0-7<59%F6$V5-S5L45;:$ZO1JPO2EJ\T-%DUQ>RQ-F!F348'XQ?)D1W+==P#!;[Y3A'(,/Z MD& !)%@(!-;*#?V0&_K W.B3#SM,ZYA"2W-# O;FBZ M^1(PS<:.J;7M@JZ=8!%V+2X,S226U32MU9G&H3.-VE,_T9EL5&$SCI+5%^O! M^N@M'WUG53[_LLZ3!2U*-D)_W<;5=UFO&I!5!@GF08+YD& !)%@(!-;*'?.0 M.Z:R$-FC"27R)\>-V1DQ+UBVFHY0;WA %LJHP^E&E(,!\2 M+( $"X' 6OE@'_+!5N:#8D:WH]SN%DCW23E5!AE*.R28#PD60(*%YWJVQ:=S MX--1\EF_UJ!5$665E$ZG.\6UQ1I61AA*9H^ /F3 !(L! )K4>D>J'1[4%G0 MS;:8KR,^0!^]',FX5<(-G:6YD@>C:YO"#!DRI \)%D""A4!@K33 6J.U:,,2 M0:J5:%W"+*&PU7&&5G:/B#YHQ 4+81":[-ZI*#A'JPN\V))XVI;G"]O-=[0 M^MZCM=DS-&%H]D"#^J!H 2A:"(763H=&"<-J*:R3#M(4Z"I4%Z*RH8XSN,C/ M1_1!(P:@:"$46IO51L/":A'+SQ8*=?-35!S4+%W*MQ)]<,GK4GW3(88E*E^@ M@7U0M 4+81":R=(H\MAI70C)DBOI#"ZZ<"QB=IYIH.(4*)K?\QX" MT*@A%%J;U$:DPFJ5ZK\M*&")S&2(E$-*.1XHF@^*%O3HC1 J8GN_1J-%$;46 M=7:]@$A4(3XE$DA5AQE**BB:#XH6@**%9[NWS6NC1I$^:M3I=0/2E8O,SC*O M.L9@4GN$]$%#!J!H(11:F]*CO55]%*4!ZP=JO,&;J23*D:YA6Y"(/="H/BA: M (H60J&U\Z'1HHA:B^JUC$ D.Y!L<1(F,\(BK5VQZ4)\I_'5+1[,%J@P!(76 M9JL1AL@@84BA'!I2'B5BC:'IKFX3(K+9V]13MWEPK8+NMP)%"Z'0VNPW(A91 MBUAJ65#.N-G5)8CAV)HN\BTQ[$S0/(D5%S!<<5.C+S'$ELN50>&U1V+8F=U* M;33+L"Q+F.&,CS:O\W\_L/Y9Q5F)$KIDKMH[FR$5NS\4[$ZJ?%/O9W_.JRI/ MZ\,UC1:TX ;L^C+/JQ\G?(O\X6\=DW\!4$L#!!0 ( +2#IE@??P2%:@< M )D> 8 >&PO=V]R:W-H965T&ULK5E=;]NX$OTKA._B MH@76M43J,YL82.-T-T#;!'6[^TS+M,U=2?22=-+<7W^'DF/9(L4D0%X221Z. MS@QGYLQ0YP]"_J,VC>LRIK=3'::+T]FTQ4L6$551_$EM7PRTK(BFJXE>N) MVDI&E\VBJIS@($@F%>7U:'K>/+N3TW.QTR6OV9U$:E=55#Y^9*5XN!B%HZ<' MW_AZH\V#R?1\2]=LSO2/[9V$N\E!RY)7K%9AQ+\#[!;B_(!I80/8+2&-HBZPQ:T8UG9Y+\8"D MD09MYJ+Q3;,:K.&UV<:YEO KAW5Z>G7[=7;]=7X]0W UO_U\,[O\#C?S[_#O MR_77[W-T^PE=7<[_0)\^W_XU1V/T8SY#[WYYCWY!O$;?-V*G:+U4YQ,-:(S. M2;%_\\?VS7C@S01]$;7>*'1=+]GR=/T$K#B8@I],^8B]"K]0^0&1\%>$ QPY M\%R]?#GQP"$'SY)&'QGR+%4;M((T46@E184@\R35O%ZWH16 M:]+Z3&UIP2Y&D+>*R7LVFO[W/V$2_.:R^8V4G7@@.G@@\FF??H4J5 KEC(UV M9=*L-*7F?CK.$ASGYY/[8_@.L1@G<780.P$6'X#%WJVY7/X-F07%2"ND!52C M0M0%+QFJ]XC-T\+LWU:*>P[AB1:/+]_ ^"TW\(V4G?@I.?@I\6[@C('2@M.V MX-9+1"LA-?]?\\!E>:LN/MJN- @)Z6VJ+95$61"X]S0]8$V?#;9C>$BLH)PO M-%IR58@=;/6OL)NLXKM*-;9PI7:T+A@JA-+.&$TMG#C*DKXU#JD@C=S&9 =C M,J\Q<$T-_R#S \1GK6D)Y;80%7,!S2P(8YR'/9PNH2@:R*3\ #3W KWL>9P6 M_^ZXA'R!EJ)$3&FJ&2H9\&SK=*$W3((EFM9KOH",HTHQLS60>2[+Y0 MXN?]_&X-_>9[XVY%(28 +M1=J+:FPCHA8QM+=I1S>\2VU#C$1]7H%'+'ZZ&7 M-*>_ ]@VF@U5L"9,&(2]?D2*%3O9$,-@1.^5>P/"%AEG(4X&@'=T'/KY^+9) MOEK4XX;;:,>"PV@C1W9E<1^P0RH9JH%AQ]*AE]RF/Z#@U4J4? E59(G^%E W MT#W@W4EFRKJ6?+$SB>D.DM@1UZ1?%5U2T6#YZ(@S]#/G=1L/T"&;EN(=5(T: M"H9Z?PB9%?QV#_61#42XS9'C,,O[M<\AED3I /B.2 M!GOE=""V*3 /^O7<(83C:*!MQ!U/8C]/MNX["F\G0)O]QFF8]GM!EQ@.XB&: MQ!U-8C]-FN[V10.)$[Q-A#A+K !PB"7!41]P"KVC2_RZ.;BM>R\8H_";#L)O MI>W4"QWW8C_W?COJAWEE=I$US.LTW$&G49)B*]IYV,^Y-TU@-0TO4-=ER217G_F*H9NZ M^.!$ZR+9.+(.(1QR0U6GXUC\_+C:)/1.-;71F19.T/:\.8ZSC%B@77+0E W0 M#>ZX$6>ORN<5KV&,?DD^>SGWU?G\1MI.O="1+O:3[C>VI8_M"1*DQD)(T& Z M/#,,%- Y<(U6M#",\NCTA4VV_2G (3+&<1 ,'920CI&)GY$/V WT=B(?&E^) MS;GC#/>9PR45DX&$)ATS$S\SWW4HFY.;"'!G< [76^P'+],:2%V;2-;\[K;&) M$Z;QU!H+G7)!G R=?9".8XF?8Z]>8P*B&BW8FM=F]FTZ"*!DL71:9E,LCI+< MWBC'P OD%PRT/*3C8^+GXU<;QLQIIM>DU/IV@8,LM,Z/'7(DP\?C8VO2Y.@C M7\7DNOGVJ5!SMMU^)#L\/7Q?O6R^*O:>?PS/KMJOI)V:]J/M%RK7YFRK9"M0 M&7Q(P<^R_0[:WFBQ;3XE+H36HFHN-XQ"T3 "\/M*"/UT8UYP^!H]_3]02P,$ M% @ M(.F6,^YEFLA P UP@ !@ !X;"]W;W)K6./\:KVKKN[0/KW M'=O$!6)('_*"]S)S]IR9G1U&*ZE^Z0S1P'.1"SVV,F/*$]O6<88%T\>R1$$[ MJ50%,S15,"RLE$43/TYQ5RN MQI9KO2S<\WEFJ@4[')5LCA&:Q_).TH-!<"E"8CJV)>S(=5O:UP0^. M*[TQADK)DY2_JLEE,K:8UKMD97CYO@%_;S6 M3EJ>F,:IS'_RQ&1C:VA!@BE;Y.9>KBYPK:=?X<4RU_4OK-:VC@7Q0AM9K)V) M0<%%\V7/ZSAL.!!.MX.W=O!V'7I['/RU@U\+;9C5LF;,L'"DY I494UHU:". M3>U-:KBHLA@91;N<_$PXO;V9G=U$9S.@471[=3F;/- D>J#/]=G-0P2WYS"= M1!=P?G7[,X*O$"W*,D=*I&$Y?+ICBD89&AZS_#-M/T8S^'3T&8Z "WC(Y$(S MD>B1;8AL=:0=KXF=-L2\/<1\N)8$K.%,))AL^]LDLE7JO2@]]0X"7C-U#+[[ M!3S'ZW7PF?Z_NW^ CM\&WJ_Q_#UX6V&,F"H.$:J!D/.E2VK@' MM7OU%BU#WQTZWT;V[P9!:[7%K=]RZ[_!+98%@F'/J/?R:R#Z&R<[ M.]P.66SQ"EI>P<$[2>P+>F#5OK@ M8$KN,4:^9$\Y0JID 9,<%==7/$6@;!V#07HF%,@T1=45B,&;V7IMX?:H%79G M;-C2'KY!FZJ;4L4, B]*)9=UR6O*6ZP6F'P!(?>7P/#5Y78'?K!; J^M/,?] MUM\A;F_TB +5O&Z=&F*Y$*9Y1-O5MCM/ZJ:TLWY*7;MILO]@FI9/3^2<"PTY MI@3I' \HF*IIH\W$R++N1$_24%^KAQG]\T!5&=!^*J5YF50'M/]EPK]02P,$ M% @ M(.F6.W]'B^Y P R L !@ !X;"]W;W)K+'(T9V9XSHB>X8[Q'R(%D.2AR$LQ,E(I-P/3%'$*!147 M; ,EOEDQ7E")6[XVQ88#332HR$W'L@*SH%EIA$-MN^7AD%4RSTJXY41414'Y MKRO(V6YDV,:CX2Y;IU(9S'"XH6N(0'[9W'+G(Z!LD@16MVX&KP%XYP+\!N"?6U+0 M ()S,_0:@%;?K-G5TDRII.&0LQWARANCJ8765Z-1D:Q4G1A)CF\SQ,EP-TO,1-M,3'Y]GU,B(W547Z3Q3Y&?*+XAKOR>.Y7@=\.EI^!3B%NYVP&?G9^^"+\[/[AS"312K59>)&D$O ND(2M:N+G>)T(\GU\CWK@I_U?%\%U3*\[IKKN!F)#8Q@9 M>)\)X%LPPK__L@/KWRZZ7S/8[#6#+5XIV($P;BN,>RIZV'X8L5K SRK;TAQU MZFSX.E2@0ZE_BVWH6#U;]==VG^D.-\^_="\/W69/W=R^9=N]0[?%R?I?R([7 MLN.=9&?OME#\='%2!_#W3F%;GG5XALGI+-_MKNZ?=D56'^,!B4^='-\_U$9^J T1*=N5ZLYF%2(]DBXK3,H9&I4VF9(,'G#B33%:H$*&2Q, E5;JLM#0%XW*-\V)"-AQG M4RXS$!==/6/N#0@%\+6>_006BK75GW!KK __!U!+ P04 " "T@Z98/RK2L:\& &$ &0 'AL M+W=O++46J)!7'_>OW[BC)=IMDO[ OMB@=C^_NWCV2IQL? M/L:***G;VKIX-JI2:IY,I[&HJ-9QXAMR^++RH=8)P[">QB:0+F52;:?SV>SQ MM-;&CLJ\8OI^6FCUW1- MZ5US%3":#EY*4Y.+QCL5:'4V6AP]N3AA>S'XS= F[CTKCF3I_4<>O"S/1C,& M1):*Q!XT_F[HDJQE1X#QJ?,Y&I;DB?O/O??G$CMB6>I(E]Z^-V6JSD8_C51) M*]W:],9O7E 7SR/V5W@;Y5=M.MO92!5M3+[N)@-!;5S^U[=='O[.A'DW82ZX M\T*"\IE.^OPT^(T*; UO_""ARFR ,XZ+7A_"D@#;CF/:Z+^8,.7^DP4<=' M8S6?S4\>\'<\Q'DL_H[O\?$KK M=%L:K#51EQ02-$<9EY6I+V1I8F%];!$ 1.-3:P)676[5N\GU1*W)4=#6;CD> M:A@T!]:ZQ&$UP0!^8SL ORP65V,%[XI#MY3H[@@K?4-J2>3V\L*@:Y,$Z7O^ M:@W!*B&3^P!K79($AO]/+3RJY/'R8[;<#ZW)!8%KYQ.$(%HH,$!/U N_@6LD M*/V7,L7*MQ:)(L72CJ5YSH?69>W44"V<:V'\ MAAH?DH);UE5U-/OA5\DR^]^2#HI80]0S*JA>4NA5X+BGPJ&?B7KI9*IOC.N: MM]8.&PKC 6VL178_@&H9WW<<@HE2<)@ZSK!%T$4; K]#!@.\Q^\E5E,2\\>5:\^PVW!8B/W>V5L*I,..H86$KP%$2]#[2 ]11J$B M\ZN/UZ!3C"M-H7GOY#@YMMY#JC2HJ+?,&KIML,\R*;H$K%J$Q^6@20AW1()33I2..%DU.GV#3JQ5 8283 MA7N]YE:/2'V16JEZ#J00[I<&YD&M@J\QW<<]]Q-U;=8."E9HE'NW:D?L?])H M7?U5TX:BPG&"5:<@IJDO)#V198^0/F617J)0@4YWG)7+[Q]B;W<6&U MJ0'1ZDULH=MY>K@(:NTA2XY! IWH-JSAB].WUCN6-\$71"QF M3$ 3F:0=#!_PFML.%0I1",CY7K8P D''*OI:WFXJ4U3"Q0ZLX@(%SOVNZ#;Z MK)(XM7&Y.N@H6'O(R_\Y2(;9L;DC,TB!L.(^QU .0)3"=5M4WHH$FKBTIE]" M83^)F8YL&TI6C9UH[\XRB]UFAV.-*W5 TU]X_(FX/E]<7XSO-KKTI4#+!P)H M;:%.'LWD),66!/\ (%X6UY?\;:+>H2N&X5A RJ:0[;>EMX@ ]#-W+Y=%[$8S?<5%! _84)4LORMB39><>]GWT7 MG#"HIJG;6IR)?,4#J0ELF."^Q,9K<3_B\AK6/:\^.K_AS,EF+,SKG4)I\B+L M=3P00 R;QO:YA76_\4C$']IRW>UD+'&2IY7LJAI02A .L[0]."PLDI#Q(7!?^ MN.O-HC]??*: -C1QJ/?3WB4+4[P_D/%7M>DS#&=M(YHK'I#.X%$1O$#PPPS_ M)6&ZV=T.AAZ$CG:'MY+Z@? (*6&IS?N%M)F">(/&O6X*W,E=!_GIWMVLIK"6 M&ZAL.2[E:]KP=KCD+O+=;F>>;\BX$ZT-FL72"E-GDQ\?C53(M\X\2+Z1F][2 M)]P;Y;'":8X"&^#[RN-@U@UX@>'J?_XG4$L#!!0 ( +2#IEARWGO)> 4 M #P. 9 >&PO=V]R:W-H965T(7(EH2( !0,O^^YX%+Z9LV6F;O$B\ M8,^>/7L!>+2V[JO/F /=%KGQQX,LA/)P-/))QH7R0UNRP9NE=84*N'6KD2\= MJS0:%?EH,AZ_'15*F\'\*#Z[=/,C6X5<&[YTY*NB4.[NE'.[/A[L#MH'5WJ5 M!7DPFA^5:L77'#Z7EPYWHPXEU04;KZTAQ\OCPE,UL<%?VA>^]XU220+ M:[_*S8?T># 60IQS$@1!X>^&SSC/!0@TOC68@\ZE&/:O6_1?8^R(9:$\G]G\ MBTY#=CS8'U#*2U7EX"E]CW MC0X]@_WQ$P:3QF 2>=>.(LMS%=3\R-DU.5D--+F(H49KD--&DG(='-YJV(7Y M%2=L ITDB:U,T&9%E\X:7"<,Z8,_&@5XD;6CI$$\K1$G3R!.Z<*:D'EZ;U). M-^U'8-=1G+043R?/ EXH-Z3I[@Y-QI/9,WC3+N1IQ)L^@=>/U>8ZT>SISY.% M#PXE\M>V@&N\V78\:9M#7ZJ$CP?H"\_NA@?SER]VWX[?/<-VUK&=/8?^OQ+T M8XCTT=#O]H:+!3N:[$7=ISL4,J9?3ZY/27M?<=JWOP[*I,JEGCZ7J0J\0];1 MR?7G'> ,H_DO8^!<\TH]TH$+3WHIVMR1<@S'JRI7+K]K/:02 MB4AWEFE>TL>2G8JAGW.BXV2[4%_9Q6#BLH_G%SO1E39)7@F -L0J!B5ZX$'! M2AA'P@T3>%OJ(""(QK]#C+T@59X#T50JWXA7+3"D236X4><&[N6+_5JS1"C\)%NY,BI.?.B3H=E:%*HDBW+W4,E^ M;GL*#>GR0?FL=5!K)(O]ZHF7RQJ-<%K"2I]@V1TK MY^%WI8V1>-42W*7]ZP&[^Z8=L'73;W1%+#@X_D]0LR&]CR-(I;:,C0!JI>@5 M$,>0OG L@_L.YAN55W4R)$)=8#,+CP1<:XB3*00GK54Y2JSQV#]EX*=/R[+1 M3]A9[MG.GMQ9-CP?[- 'D]B"Z9.Z16DT>\;>;-N><;_R>WO%P;_8*W"-JD_B M(-*NG:&Z]A'@H]^+BW840L=ZDQ&!T+S2M DT65FGFU E"A'C9M9S0#2YOZ MH!W35E<<^D0Z%&B)SK5JIEX]+5_WV$@(2J=]T'HJ_UTY[5,=C\$/&^-@2V.4 M&VVQP";1:1+S+Z2:RI*>B=,.N\3/ZZ?')!\U5Y.+%O:[/;%3SV[>;(P?[8J# MG]$5VPZ)H]Z)OF"WBM\MV'7EQ%4?[KNGW:?12?U%<+^\_J["\1G:>,IY"=/Q M<._-@%S]K5+?!%O&[X.%#?C:B)<9/N_8R0*\7UH;VAMQT'TPSO\!4$L#!!0 M ( +2#IEA"B&2!.@P (4@ 9 >&PO=V]R:W-H965T>*)>TT^D'B(0D7$A" M!X!VE%_?9Q;M2KQ9F%L(3T>[;+GUE;)C!<5>2_I]R>]0NKRZ/P%CUW;\Q>F M\KDNU;45KBH*:3>O5&YN7QX-CIJ!CWJY\C30.W^QEDLU4_[7];7%4Z^5DNE" ME4Z;4EBU>'DT'3Q_-:+Y/.&S5K>N\UN0)7-COM+#V^SE49\44KE*/4F0^.=& M7:@\)T%0X_=:YE&[)2WL_FZDOV';87^H[G] M6=7VC$E>:G+'?XO;,'O[#F5EB:#6GT@TWEU5!.E^24F;=XJ['.GW]4,A>OG9=>"5EFXH-? M*2O>EC?*>6#OW8N>QS8TN9?6(E\%DU&MU3!H= M7R4'!5Y)&XOA(!))/QD=D#=L;1ZRO.$C;/[W=.Z\!3?^L\_0(&>T7P[%RW.W MEJEZ>82 <,K>J*/SO_YE,.G__8"6HU;+T2'I?\PS?U*DF#IA%@* IZL6\4C< M*F%N2Y6)XJU'B5ZQL2E)JB MJ$I-0B*>V:HI2Z%^K[3?8%NOX!I/*BH)HV =":S*U)3.Y#IC WXSF"AN $&% MV<*OI"=1HE"93H&962QT&M3)]4()EVI58F _%@ODF1J-6$Q3:.(TI:" S:5V M:U,//!=?E,AT)DKCD: PT](NFZ[@K+)D+5R%/U8I483H4A1==UP5B\L?F,V. M!0B9,&5KRX;1EXR_PR#9#=".A]&DWX^$^M;XD7P2W. \.8 F(PC*&@360,[A MQ#EE_EA\P@ [E5RPTFZ[86:P$R%@52V"]M?+$JQ()9ZR+62-HS/#*R!;JQL5 M!++T5H8C(0AMKY8Z%>#C@EE [)M7T%PY\@[-PGSD\(A5#K\Y"D@[&?Q&D.SJ M+.&HP.E@+NCD=5D1()UU<(&IEBN63$PCL0T&KH(K6GFU9A"3H>)!Y@X_F4PA M0K$2Q(>-*ZJ,-ZR%*91X"G>X9R! O^*N:(_>T0 M46W&/K]FGS\=/,-RAPW+("MPAW@CIE9_-Z445W5X? CA,1#'@FF"?\?1Z,PC'.92PK;T.Y(\FL.;B(,'X=/-W]NAR/Q M'M+N8$$T?4>I8E:GBB&!,XJ2T5C,0AI[%]+80 RB<3(6(YHPCDY.^BT<&Y'< MP8)R5P>*"F8B6)<(], .;Y D\SS$,()EB5=+4O=..,LUI'S3Z&I4OA''@WXT M/!D_&-TQI:D"ZE#($?MRY163.H@E@4A:M&>>A_C>R8U0/JVLA8;8; T?-'K" M\[DS;!V)9]4=L7E'E-L1AM0L"U.QM92G*1*A!#^5G7W4MS4Z/ZX&68^J1CN' MM$NEM1LR\$;F53"A&Y"Z+F2U8H@QL(HB3'% D+4\/=@OMUDD%F^+M=26W,'9 M'?A7N;2D$&W%T0E9H+#R(;'HDICCC64M=+N\*ZH[J5:( @G]9XHBSQE?E90J M(0^*Z(S6F#2MUB#\A@"67^G==CX,76@D:)U3G5Q84W2]AB68BB[?=62GJ.IB M00$CN JC7&6:II)!F*ZY4X=K0[X.1"N#JJL(@4/=[IXJ&(O7H9.] M4B! MM.LPZ&_[O:QOW ?^[GN8Y\?KJMMB[PC\7!GW*V9.YN)RY\OQ =TWQ:= MUIJ?+AIW?6[LOBN6OLK;MO S'ZOB,EOJ'#/E%P;$/EM69J;\/K=NPLQ MZ#]!"3T=1V=)@JIZ-45A':#DCD[..%S>S:XNQ1O$G/CX^NTG7I)@R6B$VG>" MU>)B&F$5ROF_(O'IGY'X0A+ZD]/H9$+5>S#L1\G9F1@,4):3_A"U/ EQR(@P MP[CAA>-O-'4YLKGK:+A:0.VE7%+>GH=>+L3)+LIWH;TPU1HV?J0<="4Q1&Z[ M#$T("H%>@W.OZM;F/J[4@UTU^[XW=$2[EAM6]*E3J&O4&&UVCP#@P15XB@,3 MTK+W[IEXFN#/\)D8QN/A$T#0F_0@_12P3))^U$?/]X@]4'AVPF+WK(0-1K3! M:/)$)#UL 8SAR-.SZ/1QXN^:<($ JM0RBGXZ?B4D\/"7Q9Z3^6"23271* MS5><),0>^/MD$DTP0K!-ZSZ#F,7E@HB MA4X2*BW!8I12'=H(/E(0%6+&]A,]MA3)C:1K+SX3NNU!UI340\E-"%BHI_.0 M!O&+J$#JX0P4)M2'CE),JR4T%Q/F!/ZF=+32H G2I>)62Z:IK4*W!*G(>MEV M3YD;D/M6^U7=(S2L:QIJRHD-#V!#F_9#(2-U=!;OLZ^0(:] Q??F1G$&"$J> MANJ%1JO69KMKVZP.3&.^_TG,5.4 MT@D10C"MZZ*UV_]J.BN7/U&)JBQ> >,*Y9?(?1C@-VIN*TI&9PSPF &^3[#@ M,X:A<:BC2NH6RA:&(0'D2T+5<>88V.,27]:5E$T,T^O/D8!8,E M]5>%#IW"(#XCZUGWG3R((H6I.!^(=86,QCT,U&D598520KGV=6L@6\=TE;PM MW0/HK[5W83"L@96C>(14$%@&J=IKC'<4.QX@R_=#J[7KM>8&8Q=JNH$(O5?3 M$$"6#-TV /MI ^(A-'Q]HVU"_\5G*P0?99J6/(>*,$]"M?J!NRDDGA#MX88, MJ%#ANY.SHH;?7"=_^1RZ\$=I(_?NO.G>B;W".9)N W?*RA[%!@<4:^H^Z5:Y MIJ.K9Q>A/Z(N/X!)[\/YF&9MV\$:^!_K"AD+_!A&=+Q:A]#/-VVSN"SU=Z(G MD68R&/+TXZ>3TAQSPS. M$0%=N!^B(DN''=Y2J7;#/W_M-%.A,HL),V)16;Y;UF7X;A0^X30'C>90%L;O MX5!C=:\O>K@7IA73'"<71W^GYXY_9C.(I!NB:S51Y6EUESP0S]'!K_ MT/=OM\#>:Q(IGY? M[CE '0_&TWV^Z0C3WU+E2+"-7=SB$OXDF^:"*Y=M/Y&1UJ< M&$$HDWZE8R:."7]KC*1/=HU&YG6\U"GEZ/X)1DTY0.=IJ,)@T$*%' MW+D4(P"2LVA,67[JFEJ8U6GC']/I-9.&[)&4Z_7WX!_JVC0: ,OI#LE^&W-M MO(7KAB;2N#2*9""H"+APU7S+7PR)CGA'561;+CJ7(0TQ+=T]JOK;3;AE"&2& M41W'-#D;^"#M:.IIF'@R]?5)F>MBY>K3Y@-PQ^'JJCX%U\:WX4J+ D\Z,#"; M3D9M#7O$QXHO.\FSSB@L!V>LSN'Z(!5_8+__Z\0)D_]WYCR$1+SOHV.O\VFX M4';)'\"=X&02OA*WH^TW]FGXM+R='C[0 \VE+NG:9H&E_?AD?"1L^.@='KQ9 M\X?FN?'>%/QSI21"B2;@_<+ SOJ!-FC_Y\'Y?P%02P,$% @ M(.F6"C' MM>'$!0 3PX !D !X;"]W;W)K&ULI5=M;]LV M$/XKA!?LD^ 7V7EIF@1(VA4;T&)%NZX?AGV@I;-%E!)=DK+C_OH]1U*RW+C9 M@'U(3!WOCG?W/'>4;G;&?G$5D1>/M6[<[:CR?G,]F;BBHEJZL=E0@YV5L;7T M>+3KB=M8DF4PJO4DGTXO)K54S>CN)LC>V[L;TWJM&GIOA6OK6MK] VFSNQW- M1IW@@UI7G@63NYN-7--'\I\V[RV>)KV74M74.&4:86EU.[J?73\L6#\H_*EH MYP9KP9DLC?G"#[^5MZ,I!T2:"L\>)'ZV](JT9D<(XVOR.>J/9,/ANO/^)N2. M7);2T2NC/ZO25[>CJY$H:25;[3^8W:^4\CEG?X71+OP7NZ@[@W+1.F_J9(P( M:M7$7_F8ZC PN)K^P"!/!GF(.QX4HGPMO;R[L68G+&O#&R]"JL$:P:F&0?GH M+785[/S=6T)*[F;BX8LEDR+9/42[_ =V<_'.-+YRXI>FI/+8?H(8^D#R+I"' M_%F'[Z0=B_DL$_DT7SSC;]XG-@_^YL\F)OZZ7SIO@?W?IW*,+A:G77 _7+N- M+.AV!,([LEL:W?W\T^QB^O*9 !=]@(OGO#]3^?]B)SZ3D!9_0I-SQ@JS$C65 MJI :RY4JL-640JL5"5PC\% O%4E"0.1IT8VWH''OA+P ^=-0*!%:):; M1'@C6A<#).R:FL/6>[&DAE;*BY4UM8"$DV(/J'ZM^)PR_):B!>ELV(H!O.0U MVME8RL2.1"6W!&5/%BT#?1Q(6ZE;Y!!B3&%+%U>HI)7-FC!L_.G$X#DT/PK1 M>+&1^Z#*&61"8;:4I>(ADZ$U]Q 4NH715EHEEYIZ_;'X@!^4 1JFII@G%U1Z M1B&>F25[ELAF?S@,*6. E6+))Y3T*! 3!ND73&X.K60I<&<'#G$69MVH;Q#S M[!/RA7*AOBFT M:-MY33P$'RI55*%9P#4'-"WR"7EV^7&IC^LPYOX"#I9"9>T1;(B-RVM9OJ6F MI1^7&%B=Y2]F@>IG>;987 4J\6&^LD2BCE.4>(H*S$!$V@W!8(3%/,,Y;D/A M_M+[2** ,*DMYY^A&!UC#E+7-RWBY8(<>E<46CJG5@J;Z(&*=!G"#@P.9'.:VC42] N2;_++0M*#%4Z MG$F=IA$B)H:S =]9B(R 9XGW V@QLD:K,N2[E%KRO NWH@M0ED8TQO9AHQ85SP_'CAG;9_M3R)5/C0<'U).V9V#6GQDY MC'!4O6RMHW[JI)HD0K9H/AWLN93 M1!,3*C&ML747:<3GV21VJXH6HN^0&.V MP*S?] :\1^AGLUDV/Y]&#F#]XNKB?Q,YXZ1CGC9^,J5BB?RW*$3KA96HXRACFD^,L2@9VIUXO M)X.7_)KL.GS*8#P9=']\W^^E_=?2??Q(.*C'3RW49JT:?OE9P70ZOCP?Q=RZ M!V\VX9-A:3P^0,(2+X. D!6POS+&=P]\0/\->?&PO=V]R:W-H965TJU.YF5'B_>S.9N+2@2KJQV9'&D]S8 M2GIF]J72]-$*5U>5M(_OJ33[ MF]%LU-[X3FT+SSE0,E61=LIH82F_&;V;O7F_Y/?# M"S\JVKO!;\&>;(SYE2\^9#>C*1.BDE+/"!+_[NE+*DL& HW?&LQ1MR0;#G^W MZ%\%W^'+1CKZTI0_J>,>% LL[Z>7MM35[8?EMH/&/X&JP M!CFE.2C?>XNG"G;^]H/.:.,IT^3<]<0#D>]/TL;Z?;2>G[!>B&^,]H43_P1, M]M1^ B8=G7E+Y_W\1HG-O$? 6)_#NX)RX4RXMC:LM MB9_?;9RW2(7_'7,V8BV/8W%YO'$[F=+-"/GOR-[3Z/;O?YNMIV]?8+KLF"Y? M0O]D(#[?6ORGMF)GE4[53I:"'PBS*=56/!W%MQ/@?,U7*:K!;+SP5Y!@$#<;X S&6R7E\=-:R, M]5LTF^AU:[]Y%$83#-#KK'\S1;) M"J=^;%DN10Q_<_(+>)+P1N=)2IR1*0H-QPA= HH>=0L8J MS4AKM 5?Q.=/@N6-ER7+=+9(5O/+0PIO@89D?;YX< 5-<;NU!"PZYM5\GBS6 MJV->_:"]*H7R#GUY)Q_1I#T3S>NRA)+BCE*J-F3%/%HL$N1*H][9*+\;B@Q9?2ZQM'QO_=[5U MM=0A?1CCN3]!R [YX"!*]0LHO6H2RCK\?H,UQ$/E@UMZ;JE@K+MBF5F[(, M_H1E^M2,)1K?__,2),$!Q$X"VF'79]R0M8%H&#* /J#:Q" UEMV4 IN0X_JH M3*9RE882%L@!DA893P\>/&KEBI9T;,U,/IE>K/Y(NL2R>5JVX(\ZZ'ML;//' M6JG(T %"UY$(<*Q']KW6J8%L3%ORO2WBBQ0DRA)V2\8](P$8ETNLN6?XF* 4 M=$''3=&))$>CX5%OG,J4M*IM@&:OQ=5JT+02T0B $8R+F)?X5Z1@K(OA.46C MWV]Z!BS'P=(&"_ J:(XGEPJ(+?^XFP)X"-/D"NN]:C?&Z.?5^&+UJE7EB=JK MDS;+\>*$T6(6B_"OQ>BD.(>A"=,#[7Q(QA-+V851Q4[U\U6VFL8EU- ,@]Q]7HT*/P[><7I20?<1$B_93VQ#O M8TX.<6.5!-U+)3?7_$1+^Y/Y%*7N)T:)J#/GDL?M;IR9Q;[W=5V&WT )3CYB M4TQB>80\\X>\ A&H! 'XZ<&\#ZO>K[M8;Y^S?RZ[?7NKU?_Q-,,'9$0,!,*N MS?/Q-%FOKD(G_/1.JG0?$8SVA+R/LPC:*!HV7V?\RYE29:%X,:-XBB,/5F,E M+15\''+/EK@F<OPE1$J1O)WS!=>X9'9!9Z(;>A(,>=;.436!&P8U^8K M* H/NSY 096+9/C%XC"\N%RFK1CM5M!M/C&?!Q.8U)%).,[)B3 DYJPS/9!- M%7^A%,HUM)->JP:A2;L-!46?Y%+61[9? "FH3!:RDX4'I8.QO<_7\&W59G10 M>S6-6Z'8\6Z)+,%F^2BNIA#NT3U1+?:WX4PY/G8:,!D)X;,&\N>('N!/#V=U!+ P04 " "T@Z98KN_#V[,( "L&0 &0 M 'AL+W=OJFDBBUQTY:V M767'W3.9'-7.F26PSU8F!J+7CN M-I7%( [#T:#DLNI=G+FY#_KB3#6VD)7XH)EIRI+KS94HU/J\%_6ZB8]RL;0T M,;@XJ_E"W K[S_J#QFBP1\^,+)DI M=4>#=_EY+R2%1"$R2P@RQIC5=ENA@:EK/Q? M?M_Z86_#)#RQ(6XWQ$YO+\AI>, M:\%*P570,PVP!6L M$"M1D#Q9U0VI:R@*85B.&;=B3]!2"DV"-JP!$S7[V^7EAX U9K>8UG&7( I M.'1R-O3A#9IYH*:?_$91S)A,R]KAO.5:;\A5WK$/AA]%UFA-XSWGO_=N*IU+ M_3&\8>^JE3"6YDC7ILI4950A<[@D9W\HB?D57F(?>W7CG)*\9J^BU^Q[-AD& MTSCV#Z/I](50,4&E:9",Q_XACL;L-U7]]'P;/@I>,(B&(' &I40[2BU%D8-3 M* Z\V(J$N%<)B8RFP3A-\?#C=Y,XBG]V1A$+H_ ')KXTTFY@AA7@H&5K4'== M=:=Y*WBMM&7_^,2DP616-+D_:[EU@7G*!VX!L1E+M2L;K6G,)UT+[6R' =MB?.*K.&PV)&OK[5LAW)0NNG3_L$OH? ML*CO HA<$#])VYO;]]?_Y^QQ0APPUJ7?F;!K(2J0<@C/DBDMB4\Q^&!7VA\/ M_:ZQWW5(:?,G.8V#_._2VM6@_VU>(TM_1FWE*]$5_#]!OJ>[ VK6684ZH[=U M!NZ34/VZT5XI@7\:=I2^S1349CZHU0$=#1"4=M%4UA#@*F"VY'KA.?%]% =1 M&C.KL#)O,N&@LZYBK[K.R*X5E,U!9.H\0.B#:K:U)RO@#O"=+'I8Y" "V+ 1 M$2U+YQ::-P "7("VQIB]=YDRY"G%<($I J^K+XN^D>$+F.\S0[O(J[%NST6X M1$/!A==K:9=TDCIG-7#%W?PWLWZ8BYF/7V\'M;'( M"-Z5AW)VP&I6R 7W:8;6%;NFW.>A7BMO3"7QG0 _[U1OJR= 6 VL!?MA&RUWH^>^'MB;.; MHB:@E*#.U&W)"%C>4.6.A]3Z3L?!9$K]]# ,@V08MG/I,'5/88#M'?@#Z*]" MJZ/ (S8>1H -V7@Z"=)HRL;P0AQ%;#R.@NDD.JEM>EK;";09!N%HR-)P&*1A MB'&*M#%BR20-HBA\!#2ANG@$-(D<2#@*63).G?GI- DFZ1!C" M/@P[[H_@X M*))NDB9!F$88A$$Z 7@:!U-H"ATZF MTV (\A 5W_GD@W:GXB7Z+7>;K5"XN]8&1N%"7-^/].X8$;X5NVW+U< W/T\0\8SLKOO=B"[1-XG&=NJ:9<[@:3Y M@B^$/P;*O+MJ=5B\:5?>7ASV!9)IJ!/N(N+]T!7S_:XI_Z-I>]Z 20!4:()0 M++:=L[BO*3TQ5 ;M-F.V%N[C'L.2LDN%#Q4&AL?^%JJM13M[VL9JN] WD7P+ M?<0ZY[@=@OTV/9/_J9'H#M;GSJ,DWP4)^O''D]>M%YY3=9_I$M?(/=\I\3#PF-E_OZ>0X\#/S9IK6N2RY=TS.G:MQ>2KK&P]\KB@VEGQ5';X%]+?=]*.TH M7^X^[WCZ/[CQO&PO=V]R:W-H965T ME=Y,HD&TWYC+5>%X(YZ.:['"9W1_US-#J[A#R66)E96Z H/+ M270WN+T?L;P7^"IQ8P_>@9DLM'[AQ1_Y)$K8(528.480]%CC RK%0.3&:XL9 M=299\?!]C_[1E:)2;Z\TG;/E<,EZFE?6_L FR MP^L(LL8Z7;;*Y$$IJ_ 4V_8>#A1NDC,*::N0>K^#(>_EHW!B.C9Z X:E"8U? M/%6O3<[)BH/R[ R=2M)ST^="&"RTRM'8=_#AM9%N-XX=(?-YG+4H]P$E/8,R MA"==N<+"ARK'_%@_)H\ZM]*]6_?IFX!/PO1A..A!FJ2C-_"&'H^ET M]O(#3?BB'<(_=POK#"7'OZ=H!]31:50NF%M;BPPG$56$1;/&:/K[;X.KY/T; M/H\ZGT=OH?]T:'X=!1YT65))^#.8-28K*+'M+3PV1E8K< 72OT&$,H05.:Q M0@G#I#>XON(WW1C(@D'+!FT/UD(UK.- M$ H7#J_6:*@/!"&HCK TNH0,C:/. ]R=2 ++6ND=HF7% M^=,-M<$&TE>QOW[/I1YQXDR: =H"AL3GO>>^#FF=WAK[NULKY=E=4[?N M;++V?G,RG;IJK1KICLU&M9A9&MM(CZY=3=W&*KD(FYIZ*J(HGS92MY/STS!V M:<]/S=;7NE67EKEMTTA[_U;5YO9L$D^&@2N]6GL:F)Z?;N1*72O_G\VE16\Z M2EGH1K5.FY99M3R;7,0G;U-:'Q;\5ZM;M]-F9,GYF1421MWVX/T?P?;8GUMPR2ZLAC1K!U+ ;X'1+0;GV%K,:^_SYM5K!Q9Y=J8VQ7K>K MTZF'6)J<5KV(MYT(\141"?ML6K]V[$.[4(O'^Z> ,V(2 Z:WXD6!GZ4]9DG, MF8A$^H*\9+0Q"?*2U]K(?KV8.V^1$;\]9VXG+7U>&E7)B=O(2IU-4 9.V1LU M.?_^NSB/WKR -1VQIB])?UT\7A3Q/,!]'_RB&$K;2J^8;CF3[0)%1I-LJ5O9 M5EK6F.C*GNH'+<[\6J%1HY1)A+\US'6"W0G[K!:ZPJ8ORZ6N5!#XHUXJ=EUI MU6+@$K*Q5YLPY52KC65KLW4DJH-"KTHVNI=T133!595K3 MZ(I5:TD)HZQV7E?NF'V!MM>;W&L%/@WRT_4]@V '60%YT\LQG9P=(VH54'HS MKL'DC5XHZX(Z _!VG+.JAH<6;$Y.5\@JYXGMW4+!&2Q_9)ULP_!CT6M^0?RO3--M6!PA^ M+?U@&G-K2D/XN@D::T.Y1CT$&_.MI]SLA6 !IU [TU B.X_4);,K:=4N7I0! M7.LHC4+14!,3U:&]I#B5#2[>)%VE"ZS=5:ULLN06LWI!G[ M_KM2B.A-:]I_]>X((_&;(;O@&P[E&@[>]9.W>E,KUN(P[B/Q=8^1;118BC.K MH"(@)C>2Y0^!]&MM%[#/^OM>N\'"I35-#P#66U4I'(YXPRG\87QA6&OZ4"+E M0EX@/%M*4V211\: '5 3B ?F:)W7?@M_22"'3G+=7NEU9"/;^SXVNJTH>#!3 MW>&RX=2.':1>>OAEOO5R#M] #61O5*6!85_V,<-A':+U\]HJ]>AH8CA88-=P MLGQ#]8;$_@G1'&CT'2S%S")4VY6Z4>U6@0*O,!=H,QATP+*4Q^D,#0I_+-Z@ M5?(LBO'.!<^S"#N&5 S9US%CGZK#IB0J>2SRO?[/QH>:[[0/RH;93E%21+PH MXN1?%K MR//_ZP8$M*012W,^$X()GA8Q@^8X2=A'U4)/W>U9X JCZ>BEN]AHT/ N>):7 M_?.B^F.KG1[55<",.V:?,I#0.ME=[ ;2JPQ5T5.994Z_3\U&:AM"AS*38$8L MC04<)O9V],.==T?79#G\".\F$4^2DL51\% R UH8^:-Q@1.<1(I"PPZY'F:\ M+-*C/37#^$=8%?8J&(RP.%5M;2AQ'HC@Z;ZG[T]4^WHU[PT'9H4>$"+22MD5F M!5+3[0T4478?EKP0)%< 1!F1 B1,#B<G%!F&"EG)?N)6)8,.V"'!8_CY(A: [2# *[,\] L*/A,=1PC.4V %+HQDORY+HA2=IR2.$\[6DE_P3I%?P""2P M2WJS4"P@O9RG*)[7D)XH9CR;B;W^4]+KE VSG:($/!0ET>M)+XLS)L#(B9BA M"^)#O*,R^G/2BY*,I>"+C$B/TBQ/>1E%WT)Z1 -)__RK2&^6T.]9TH.148E\ MRN-B!\),9$\)+P6DK S'281J*7D))R5P4@%N_QA0/0[GX"SKG_L\%T!I%7:.@JA]XO#$+NE]T<::+B;2XZZ@[ MRAQ$:#TX=:'F^Z@/8QX5V='X[CGMD,CFZ!D:G2-9EMH_0Z.T0SVE,TC-,K( M?$#4F60\RQ(B4\&C5#SBT$'T4XA)3+\/?ZKL,$^+9XZN,$K\J1^9=A".Q:@, M/-K#.^@ TN%R$"#F63GPZ'M<.YLY OF7L],^E1+U!%8"E8)69P6A3-.4%TD> MJ#0%:<1H/_$5% M4*LEMD;'139AMOMTU'6\V83/-7/CO6E"-K&Z 8 +<3 9 >&PO=V]R:W-H965T"CRTIWV,N^K MXW[?)9DJI#LPE2KQ9F%L(3UN[;+O*JMDRD)%WH\'@Z-^(779.SOA9]?V[,34 M/M>ENK;"U44A[?I"Y69UVAOV-@]N]#+S]*!_=E+)I;I5_J?JVN*NWVI)=:%* MITTIK%J<]LZ'QQ=C6L\+?M9JY3K7@B*9&_.);B[3T]Z '%*Y2CQID/B[5Z]5 MGI,BN/&YT=EK39)@]WJC_0W'CECFTJG7)O^H4Y^=]J8]D:J%K'-_8U9O51// M(>E+3.[X5ZS"VO%13R2U\Z9HA.%!HUTNQ6M3%'6I_5I< MR1(U0?:].%]:Q5?NI.]AD@3[2:/^(JB/GU$_$E>F])D3/Y:I2A_+]^%JZV^\ M\?D;?C7:?G)!E*GXJ$V4]8.RU=XMT[JHV-7R42=]M H3ME[U3M[^]V_D_9%!]J"XC2FU2X()D'R:21I Q+JP2XQ4J/9?.U\)FVJ:BDY;=5 M;5TMH=>;1A=;D:V5 _$&[2QNO;3BD7N1P&7[+A*K3">9T%3DQAYYDF(M$XM9 MB/-<6>W>Z86*&EN._M?TSB"6V[:Y7DIB02=J-*)EI9W5SV3XLD1$9=D0Z$K[3)Q?7(L["UYZ^ MP6CRN48J_1?)%'B =H5[\8#[=81BP"R4@PO8A3WI:,QMM2%_*M>@0 !&4'62 M3)9+S@&<]!;4V; Q 4#=DPZ\VSRKK D51URW2HGW!FJ&0R[3HK;PQ@I=AETN M;#A+:5."2AORMWN"/6#4[^X30L-5TP\ >@N>+W&4PJ/9!G9[6L?1FKE!@D*" M-X3( *%,'XB/2N0*V]575/E,>F[%8H>#E',2]_*!87+SX^7=%ED0YUZ[N[EU M;$^726TM='3JN2 ( [XL#W5;W8C@Q7 0C0<3]IJN!\,QUX.@X3, 011A]PB( M>2;6"+5RE>+M/5\CJ7]!PXM9-)M-@R.S:#B:/%8:D;>LTWB9?Q'?2B&!Z@&# MDB-@&P(;VA0$N26# +%]/)%RZS5XFL-%S6OT'W?LMSF3.G\"R!@MX1112F)E>Z M6@@L<\4LHIS7!3^JG5K4.8%.N4W^K,KY7:,02'9LK(L>3FE MQR:VV=^&113XI'E$-4)>Y5SG<(.[F78ZG<#R%J%,&60!+?('NVB#='11'7+H MMEFD!8@RK]-0C'\!)1T>>-1\O,-37,W,\U7.:?=13W5U#<@I/5L5M:\0!77% MD]Q22588O$OE7)OH/\&8'YB=[WA N):V'3PL=4,C-X/($ %W_ MQQQFJI$[;\FWZ("%& VFT3 ^(B\GL^AP%HM=Q_%^YV,*DK'D3T;@ M24)=^*[2/FV_2IV'CS';Y>&3%M*^U#ASY6H!T<'!Y+ G;/A,%&Z\J?C3#+8; M9)XO,R5Q0*,%>+\P.*4T-V2@_59W]CM02P,$% @ M(.F6 I 'S(?!P MXA, !D !X;"]W;W)K&ULK5AM<^.V$?XK&/6F MOQ*W'3B\?.OT D2L1"0DP "B=^NOS[(*D7D[VN*V_ M2""(W7WV?<'+M?._AH(HJB]5:AZR@2H>1J\GBS<+Y2D<\^N4X MU)YT+D15.9Y.)N?C2AL[N+Z4O7M_?>F:6!I+]UZ%IJJTW]Q2Z=97@Y-!M_%@ MED7DC?'U9:V7]$CQG_6]Q].XYY*;BFPPSBI/BZO!S;._#BX'*::&;,CZX]5^IU>>,^66N#/*KUNGLV6R@LB9$5[7$0% 9 MF_[UE]8..P07DR<(IBW!5' G08+RHX[Z^M*[M?)\&MQX(:H*-< 9RTYYC!YO M#>CB]6T3L!."TC97]Q[.]G&C[K2%1V#[J&Z6GF05@"P6ZN'NX7(<(9GIQUDK MY39)F3XA9:;NG(U%4-_;G/)]^C$0]["G'>S;Z;,,[[0?J=G)4$TGT]-G^,UZ M,\R$W^P)?@]4ZDBP@&;U?_+:!BUA$]2_;N8A>CS]^YC>B>WI<;:<41]"K3.Z M&B!E OD5#:[_^(>3\\FWSX ^[4&?/L?]U7SW^E+4SZ0*O2)EG:*J+MV&*(S4 M3P4ID =G+97";Z6]<4U0;!J3$3@04OVWQGA2T2D6!K\HUR#W>AQX5WNW,@@E M/@3R^8:ECGJQ<>V4/@(+IUM*Y%"O0"]EIMO1D6S&?#_RRZ/6@H M#)6Q6=GDQB[E346YR31H%PMH*7A*LR 5,D,VHSU*?EGI7YP'#NM6(DK)4^V" MX2?F*J74,(72460$L@;'2FSC?>:JJK'I0"QP9,WVWHAG*<3.%B,_Y%Z)%)_=W#\R8E"XU&+QL,8'HJE-I0ZPE+[7DDQ&]NE,/5PU_>L4=S- MYRX8)%H\96YIS7\0218=\)C/%PA=-O*;T^'%NPOA]V8VG+Z;"#+V42P@356I MPA%7.*2'AR^[ B5$6,R&$!AJDDY4;E)"/"MWO0?QY0)3!)!Z7FYGXH"L-W#<#HRC60 GVTM;QQP(/MP^HC M _C(!CEERE+-Z85J_K=:#O<]\N<-:<\%SKB MZ'E)+.V3ADI^PX?.)#9S@Z!TD94$$$[U/75[V@Z#2$_1<"AUMA_LQ[6RQWS2 M%C)YJW,,((:;H1RA+Y@,0SJ6S K9ENV,57"ER<7/(>(OY2(ENZ$+XY3$B]7'*.QY0B1XNG3;*B;]*,%YJ::[E,C'W>G@S?3U(*\O+] M]!7R]H?_@0.$G\TN.ARGYP=,AXQ5>$I 'E.WK0B^-WW>-K1TLNT-"+K7]DQ; M],[/T^)L^OX0NZ#*=&V /3D/I:4QI>2 J;CIMI*>AS37I>2_#+3MQ)"R/NRS MA[@Y,?.<@#HS0@TAR2_;*M,$6C0E-Z84#?S6M\->RQ!8@PA#^#'?OG>+CD!G MNBS#IH#_VM*[/3>#-W ;VO4"$M@S/K#PZ$5+UE1&EJXDS:G0Y>((!"X AS"0 M^!(/4 ^P$H#EG8 MURQM$LAW-&99-D%"1XD^/F+5CA*[XXB,%E*F6]>M@1+[<]AG8=KN[F0TZ)WJ M0MQ!P?7,=T&#_H)(8A_U4^B!C)9(>(BIQ3[=D&%L)&\Y8N!IF*2Q4G:&8NV0 M@*Q-H-0A\I'ZQU:?@PEN-TOW/DB<#SF4R)..)9#6VCP4? M8L2[LMSS45*K=__.T.S)5//&3?M1YVSV:SS?M@)HU1\.T/]WW-0 MV"8ZVZ,=8*0//U?A(/H%+4KF%UW7)09A9-'PU0KCUBZI[:.*'+\9S2FNB9+4 M3PYN59^QW_C6D%_=7@(A*[CW_2*'5^EP5SYVKC6Q,#Z7%.+00=V+#<>D#$>H M>='YD&:H1]*(JJ@^?4XS,;9^?+S[B.>1.+TM!>&I6C!'>+=I& Y@A13I^WOB M1BY?K:%WS-O, Y(*5[^D??(.AT13\CV(MJ3STBR%AFN5_KH;8INQ-W"C3Y>= M(V/:S@6P"]5>,1.WBF]O%'SD0,-C]_7QSG>7BI"9_'6)RP?".'V"Z7?[#U@W MZ;O-]GCZ^H5$6<)]*!(+D$Y&[\X&RJ&ULK5EK;QLW%OTKA)ITM\! 3]>U4]N [-38 M!'9CV&GZ8;$?J!E*8C(S5$F.%>^OWW,OYT&][&11('!F..3EN><^29VMC?WB MEDIY\;7(2W?>6WJ_>C,8N'2I"NGZ9J5*?)D;6TB/5[L8N)55,N-%13X8#X?' M@T+JLG=QQF-W]N+,5#[7I;JSPE5%(>W3I9>>] M(0%2N4H]29#X[U%=J3PG08#Q5RVSUVY)"^/G1OHUZPY=9M*I*Y/_J3._/.^= M]$2FYK+*_;U9_TO5^OQ,\E*3._XKUF'N!)/3RGE3U(N!H-!E^%]^K7F(%IP, M#RP8UPO&C#MLQ"C?2B\OSJQ9"TNS(8T>6%5>#7"Z)*,\>(NO&NO\Q;W*I5>9 MN%/6@:2/5I9.,F'N;."Q 4T;I+6PRR!L?$#81-R:TB^=^*W,5+:Y?@!@+;IQ M@^YR_*S 6VG[8C)*Q'@X/GI&WJ35=L+R)B]I*ZU_VE!6_'LZ<][B[3_[] YB MC_:+I<]1(93]E'U+G[\870\_/49T$)/)9;R M42'6,(=&EGKEA"PSL=1P1*M3F?-K"BOKLM+E0OA8P%K[I;B_O4_HCWA7IOU$ M3'-EM;O1VI]8H/%+X D; YPW @-%(KH%/ ,;%RM9 M:N5HRGJI4]Y.&"NT=T@L,Z]L6=L;XT3TFSO3-YJUH".0U2%DD3R)K6Y#F)(*!2% SV@*C6(()83EVNJ56;1!ZQ83^UA+Z(2).-DM>@,\Q!:>6+J:^9CL0_5:EJIAAM,[C M$]Y@K?,<\4YM ZW<-E182@I9Y;$SQR_L\+X"1W4]Z(L/4*VF[CMT(T+"]VM= M$H'(:O'WCVAN7&7IK0GV!EX=ATU":.*WMBN M@7@'YM$QC\]$1.?]E,BZ $G$0I7*0I'45"5ZGI#BVOV_(T:2+4-V8; C,G*# M*+"V0^7%$ !GRGIRA(WA?[B.:#)$]Q*![FSP4.=S(OX=V@]TK>P-709M:2:6 M=33%MVE\7D?1JIKE.OV;RDU?W-HV+4>&/I!#./PVW*#&5T]SJL.%$&"\6QX9 M%\Y;5_MD2#0=TYPSZG5)1\SVKILE$.LB$3MHWB&8LXP3:K(-BO=O:V.[7PQC M)[K^SJK?%U.6&?RS:2J3+0>/317J]6G_Y'7+5^6=QS3B!Z@*9"0N?R0\\N<_ M]@;"6N$?''G#Q6&9A<+>Z*_2+Z&*)K0Q[2!74.>KQM%#(>M-1OW3U[LA<@A1 M*"RDW#2JQ=]"/QLHCSNC[X#9+]K!*FU MH,RS0AKS(5D\:K=3F>,5PFC3(AY,#(&2(00J#0=&%5D$Z2[G+.KN)6 MP>R634&0IS?W]5 W/PE\-\IMN/FF@5:5=96D1-:$1^339&3"(U%O:X)"=H.Q MEBK/-HP3Z;%A)R$A"911T8&05Z/^9"1@J?"9NB5/N90C65G. V@1R_KDS7H< M5M/L8Q2FDC0E' :"<%*!Q1Q"Z9? N59ME8]<&NO*X+!), T)BD&3BCMCK'%" M^30V[Y9;Z!#W90E:E,%WVFPLZNWB#?26)-9@HNI MKPPR4,[+5J+/(JG MH^3D=!@LNZY[]FW$FW7J8,8YX '(FSBOF357=N)/QMD_.NNLR]"9A-Y\MPP= M']=4Q4GQ =W)[\8K<"] 0?B$^14MFY'MM,0;D_0DEC+35D0,TZBIW*P0(DW[\X60\^N57UWQZBC$$H8ZWP=G*+$K] M7YB73L3(-' 1.A5QFJ+MYMQN(/@94;8)B?/0\)0-^NIX5$^F= @U$0!\L1L2 M_1Z/#+4!4;=2?,^>/U'&V<^HG"&[UH>'MI:%XK-[]=CRX\-M0+@A7(7KRSA1 MT!E&,8?3$B&? M+< %CDM$Z1Q+A_U??NZ%DM2\>+/BZW&PO=V]R:W-H965T M;YV_#S5SI(?&V+#(ZAC; MLSP/1N98N;ROE&11S].@^M9U4FI<;DT_'X)&^4MMERGGC7?CEW733: M\K6GT#6-\H\7;-QVD4VR'>-&K^LHC'PY;]6:;SG^UEY[G/*]E5(W;(-VECQ7 MB^Q\#E?E(AL+(#9<1+&@\+/A2S9&# '&E\%F MMGX4Q(W[3M M96>SC(HN1-<,RD#0:-O_JHMQIZ<7EE"]Z@W,Q?=/@)^6/:#89T70\/7[#WFP?WBS9FWTU//J@0V%< MZ#S3'^>K$#T:XL^70NXM'K]L41[)66A5P8L,KR"PWW"V_.Z;R@\-@B18^N M&Y'S=//QZFY$'4KK*=9,5S:RMU"ZX0W;CNG2E4RNHLF/IR>C9!06T B@;9D8 MH2MJ$,CYFBU[9\$6N\V&CYIRU1JE%6O.JB+K.BNS),IE[BA!IS:&7@-O5.9?07[B!&&L-?* MZK][GW+[Y-#SETY[EB2%(TEOZ494NRV2X4=D&+,A.6B4Q3@K*;#5R*+1&]$& MA*:S.FJ49D"R!0KDPVTMI.]N;G%1JR@9-_J>^V0@NPETMPJZU,I#?4251E0* M#EKE)5>%L\$972JI\RZ?A?.M\\]3B1ABY_O I"BOE.'?%6#$^RM0//-S8#75 M((UI,$U72H@UORSAV:BA'45F2"\,[T)-B1 4NY+\%XW4&F<(PU6K#\K=ETVZ M6YIW0-UY+XU] (].((@[.H]Y,SY0_$;"2I\ERX-9KZ M>=%V.0"*;R>G[Y/*D(O$$UL8<"VGO6D>CUX:;_G!YFG8K]-^#6B4SL9^">VY M^Q5^WF^N)_%^_R."M23*< 75\='[=QGY?J?VA^C:M,=6+F(K)K+&WQ#V(H#[ MRKFX.XB#_1^;Y3]02P,$% @ M(.F6%^9_!"< @ ,P8 !D !X;"]W M;W)K&ULI55-;]LP#/TKA ?L5,2)DW9%EP1(N@[; MH4#0HNMAV$&QF5BH/CQ*CMM_/TIVW'1(<]@NL4@]/O))(C-M+#VY$M'#LU;& MS9+2^^HJ35U>HA9N8"LTO+.QI(5GD[:IJPA%$8.T2K/A\"+50IID/HV^%S9#&Z6DX"/@)^2&S8^, C^[/ :E0I$7,;O MCC/I4X; P_6>_6O4SEK6PN&U58^R\.4LN4R@P(VHE;^SS3?L])P'OMPJ%W^A M:;%CSIC7SEO=!;.MI6F_XKD[AX. R^$[ 5D7D,6ZVT2QRB_"B_F4; ,4T,P6 M%E%JC.;BI F7!SY MQN_PW0@RTFP=K)!:E?!SL7:>^'W\.J:WI9L,LX:9P2#M,YA\_ MC"Z>\4.^F+G9QB_X?;^0\^V&+PE*J2J0](W5']S:$L=DKL4[.8H,5AJ_3Q_7$TOP/V1 M/_59'\P.7C1>"J5>7E,=:G)GX.T6([B1OHS)"(.* M J3F>_; V+V0,PAI]+'QQ['NE!(VND;1Q7CC/4QK<] MW7O[B;AH!\$KO!VGW#=;:1PHW'#H%O%L;"VGH=,7)8\U9$" M@/&ULK5?;;MM&$/V5@0($,>!*LJS$E]@& M?$G1/+@Q[*1Y*/JP(H?B-N0NL[NT[+_OF>7%E"T[+9H7B9>=,V?.7'9YM++N MF\^9 ]V5A?''HSR$ZG R\4G.I?)C6['!F\RZ4@7V#H4V?.7(UV6IW/T9%W9U/-H9=0^N]3(/\F!RI14EVR\MH8<9\>CTYW#L[FLCPO^T+SR@VN22!;6?I.;C^GQ:"J$ MN. D"(+"WRV?+0_HI0S M51?AVJY^XS:>MX*7V,+'7UHU:^?S$26U#[9LC<&@U*;Y5W>M#@.#_>DS!K/6 M8!9Y-XXBRPL5U,F1LRMRLAIH7-E")YK]UM$DP*&839(6_*P!GST#ODN7UH33Q'P4KDQ[>YLTVPZF[^ M]M'OQOQ=I_!&X;=ADE_GBY\<*B6 MOS8%W.#--^-)!QWZ2B5\/$*+>':W/#IY_6KGW?3]"VSG/=OY2^@_S-4FOB\C M?C+TN[WEG- MEVW@C*/Y+U/@W/!2&-$U5]9%PS>?;:43FNU/MP[I8UDY<1L++-AVF5H4W%M> M:)\4UM=0D3HGZSY6N4YRS(7OM99%5;U @FV.D@:@SVD-WJ+Q)-.F=(!H,W( MZZ71F4X4?/G6)]]AU'F\1XQDH8+K7^G I2>=B3;WI!S#\;(NE"ON.P^I1"+2 MG>>:,_I4L5,Q] M.=)QAE^H;NQA,7/;IXG([NM(F*6H!T(98Q:!$#SPH60GC M2+AE F^9#@*":/Q[Q#@(4A4%$$VMBK5XU0+CF%2+&W5NX5Z_VI_M[+WWCV C M+>4](S])[1Q6(M!6ZY06]TC'N21S0ZK;;+6O$9(V@9TN"8)HFX*R@(,V>+DYX,L@J6LK*S7,L"AE:<52X3"3[)5**/B;(<^.7JI0Z%:LBAWCY4:V2.-H2!G%@WV/H\.G>4#J'D<.X[I D7+K(X59<-97'$\ 2!AP M1?0*]>BZLJ0XL$UHVE!89=HHDVAHYT&ME2SVJR?.L@:-<"["2I]@V3TKY^%W MJ8V1>%4&[M+^S8#=>=L-V*;IU[HB%AP<_R>H^9@^Q!&D4EO%1@"U2O0*B&-, M7SF6P4,'\ZTJZB89$J$NL5>%)P*N-,3)%8*3UJH=)=9X;(\R\-/G95GK)^PL M#VSGS^XL:YX/MNFC26S)]%G=H33:/6-OOFG/>%CYH[WBX%_L%;A&U2=Q$&G7 MS5#=^ CP,>S%13<*H6.SR8A :%YIV@2:+*W3[:A!,ZC0#)NN,]J!I4USI(YI M:RH.?2(="K1$%UJU4Z^9EEL#-A*"TND0M)G*?]=.^U3' ^_CQCC8T!C56ELL ML$GTFL3\"ZFVLJ1GXK3#+O'S^NDIR2?-U>:B@_UA3VPWLYO7&^/_=L7!S^B* M36? R>#L7K);QB\4[+IRXFJ.\?W3_B/HM#G[/RQOOJ!P.H8VG@K.8#H=[[T= MD6N^2IJ;8*OX);"P =\5\3+'AQP[68#WF;6ANQ$'_:?AR3]02P,$% @ MM(.F6&S^-QB1!@ M0X !D !X;"]W;W)K&UL MC5?O;]LX$OU7!K[VD !:6Y9_II<$<)+FMH>D+>*TWU^]Z71R:.9&;,-WYYEYVU8@8D"YEZ]B#PLY27LBC8$6!\W_AL[99D MP_WGK??K$#MBF0DG+TWQ164^/VN-6Y3)N:@+?V=6O\M-/ %@:@H7_M.JF=OO MM2BMG3?EQA@(2J6;7_%CP\.>P3C^A4&R,4@"[F:A@/)*>'%^:LV*+,^&-WX( MH09K@%.:DS+U%E\5[/SYG10%O75>>$E"9_3!Y]+2.[V4SH-[[^CH7LP*Z8Y/ M.Q[KL54GW?B^:'PGO_#=HUNC?>[HK-JT0JSUJH#"?M4K;. M__F/[C#^UP&4_1W*_B'OYU,48E87DLR=/0_UB@F M]ZG *CP#KZ0 ML#0/V:*)57\:+>A69BI% !_F@M[$ M()4FGIT:J%0[S,"3,X7*P$J&DB^$!HRF1<)X;@IT,O?FA?SL:^QA.*+W\/:$ M"ZZ_&S67-$V5Y#5[3$X_2OH#FDJM /A&+9F"+G6C03*@/D\81*-13 >$-M@) M;?!BH?W'*.WI,SI #9D\I[/#O@YF1WZO%?A2>UT&2:CU(^*_!@3+#8)'S#\" M1U>_7]*'E9;6Y:H*;Y?"VC7S]%D4=0CGH:&1\$]@/9^W71E,O]<"JUQS^J=2 M5,9ZN--FV7R^N;FD;OP:B1@/HI,D06YN)TA/%XGKCT[H/D=)36^OZ+I&>N_> MOKL/)@E,^OVH-QK!FBXG$:P@BO]&=/]'1%_80SP<1Z,A:Z#;BZ/DY(2Z74JB M).Y!$4EPW##"D7INTJSXI>):$=M=EJ-"2Z<2L!?89;%CS;S;C#KYA.6GU%ZB MR2#&.Q;OK< 0I^VJD;+2J:H@WHM-@?S,*U?R[7;=]\9SGQ#K /3(R10+H+R M4,MMJ;(FX,4YD>:UD]Z[8SI*\-<[IEY[T'L-"CI#G#B2,6@9)G$4HW.\8 VM M'A;A[&*9.4X#%.J2%^GS OWA:THZ6 (<(Y'CDVC\,O=/0[@4A4)_T4HTKH\& MQS1L]\;L_H3A#R@9#J,QEW [25@]R/=H& TQPK1-2E-S6;#RM(%HLZ\X"\BF M:W&WPE' A&SL:LE+)-"W U]?=E*@%)AP-J,%5"QT"!X9];ER00KMP.T]O^XD M4AC!!RXXMH&JQC/,BC558MT4+."I(DB+O;(4&)Z5FPF4A3U%TZ1> #D-@R;P M'S)9Y0HR\3C;D2@*',Q26W-C1GW4NA(J>UA3% ;B7BF?AZ6JG>JV;1E"?K75 M 6*0/RH<]^#,&YK) $=E[>?B*T735P#QO5G*T $:D.. 1.CU%LW#JG-KRK^+ MV>?8FA<-WG);,^'+3 J[QR>8$+045@4YVS&8+'*]]TY&&0?5(.H_C3Y.< MSV4XRM*G]K1-;B6JQGB^F15&8 Z)H$6!OI#OIV"JHG8T:,?QZW:0*+<3%@0% M68>6$AK$?M$X:%'_9F4*!>(3.*ZQ$;.X#Q-\+6>VYF9T$@@>!()_%EB3LT Y MK;)KL(&-$@RGZ[CU;0J Q>E5<8WP/VJHLN'[=#3AYG+;#P$]48O*G"Q61F/*XYX3''O5): MGH#O:X8W*(' "%%0 &0 M 'AL+W=O\:)F]WL))U,G"8/G7V 2$A"0Q(L $I6?OV>#Z HR95EM[L/?=@'6R0(G.]V MO@MYL5'ZBUD)8=E=5=;FCDRC!2_< MH:HY7%E: M&%U=-'PI;H7]I7FO<3?J40I9B=I(53,M%I>#Z^C%RXSVNPV?I-B8@VM&ELR5 M^D(W;XK+04@*B5+DEA X?M;BE2A+ H(:OW>8@UXD'3R\WJ&_=K;#ECDWXI4J M/\O"KBX'TP$KQ(*WI?V@-O\4G3U.P5R5QOUGFVYO.&!Y:ZRJNL/0H)*U_^5W MG1^>O>92 MLT^\; 53"W9MC+"&\;I@;R6?RU):*0Q[]I'/2V&>7XPL1-+!4=[!O_3P\0/P M"7NG:KLR[*>Z$,7Q^1%4[?6-=_J^C,\"ON-ZR)(H8'$8IV?PDM[^Q.$EC]M_ M(TU>*M-J6/SK]=Q8#7 ^2)$7HM!E???Q.-PQ_/ M*)SV"J?GT*]ND99%6YX+UP>1MUK+>NF>_*QJW2^\$YP,+!BW;&_Z*1O/:_%Q M)=A"E4AI0K5$#^:,K:%/+K1%.2 -5:L9]UK:%61R+5AUH,."=%@[]^,.PU&MA+*V1KFV=J]JH4A9P2<%^ M4Q+K:SS$.?;LK7-*\IP]BYZS;]DT"V9Q["_&L]E?A(H)*DV#9#+Q%W$T(8K] M\'0;/@A>,HB&(' &[44[UJY$68!3:!B\[$5"W+.$1$:S8)*FN/C^FVDFWD7S5O!&:!V(PM!7H2GA]MGO.2U[E@KA('CKH0I@5)OD_U@&U6$@S"!FHH!0-!C%S6 M94-EQ6=8S>A:"[?SYTQC]VZI#4AZE6\W)K()[2D;,"A4^U@- 4 M$G!Y.@S#[\@()NZD1<(UTO)2?O4YL=LU[G:QE2H+"CPB*55!CZ*0;077OC2A MV7_!=*')S5YM9%-;N<0P>%J(QU3LO>1R7>5.CX#9;2.@XM?51 M(%82Q^D:;I*Y;%S .JTHG-)ILHL*"419P*P .FI5,=XTFDNX%MK?"@&VP_[$ M4771:DC4T-^/1WY267+M_&%7T/^(14.70.2"^%':OKU]=_-_SIXFQ!%C7?F= M"[L1H@8I,WB63.E(_!"#CTZEPTGF3TW\J6-*FS_):03R?TMKUX/^WKQ&E?Z, MWLK78M?P_P3Y'I\.:(!G-?K,?I:!^R14OVFU5TK@3\..RD^<@B;.>[TZH- M06F7354# :X#YBNNEYX3WT9Q$*4QLPH[BS87#CK?=>SU;E:V&P5E"Q"9)@\0 M^JB;]?;D)=P!OI-%]YL<1 ;-B*C9>7<0NL&0( +,-88<_ L5X8\I1A>:LK MZ^K;HA]D^!+F^\K0;?)J;+JX"%=H*+GP>"/MBB*I"]9PI_.36,#G>+,[Y3GB MX4'U)1_LY)YQP?#,1)SU$W'VY(GXWF!%2AV_X9"*KV4-ZDG$[4V-*;]U+CLU M Y^7^_$HM4V';K#8X\L]ODLW==>%TH?]F%2/9

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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 208 212 1 true 84 0 false 15 false false R1.htm 0000001 - Document - Cover Sheet http://dhcreit.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical) Statements 8 false false R9.htm 0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) Statements 9 false false R10.htm 0000010 - Disclosure - Basis of Presentation Sheet http://dhcreit.com/role/BasisofPresentation Basis of Presentation Notes 10 false false R11.htm 0000011 - Disclosure - Recent Accounting Pronouncements Sheet http://dhcreit.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 11 false false R12.htm 0000012 - Disclosure - Real Estate and Other Investments Sheet http://dhcreit.com/role/RealEstateandOtherInvestments Real Estate and Other Investments Notes 12 false false R13.htm 0000013 - Disclosure - Leases Sheet http://dhcreit.com/role/Leases Leases Notes 13 false false R14.htm 0000014 - Disclosure - Indebtedness Sheet http://dhcreit.com/role/Indebtedness Indebtedness Notes 14 false false R15.htm 0000015 - Disclosure - Fair Value of Assets and Liabilities Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilities Fair Value of Assets and Liabilities Notes 15 false false R16.htm 0000016 - Disclosure - Shareholders' Equity Sheet http://dhcreit.com/role/ShareholdersEquity Shareholders' Equity Notes 16 false false R17.htm 0000017 - Disclosure - Segment Reporting Sheet http://dhcreit.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 0000018 - Disclosure - Senior Living Community Management Agreements Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements Senior Living Community Management Agreements Notes 18 false false R19.htm 0000019 - Disclosure - Business and Property Management Agreements with RMR Sheet http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR Business and Property Management Agreements with RMR Notes 19 false false R20.htm 0000020 - Disclosure - Related Person Transactions Sheet http://dhcreit.com/role/RelatedPersonTransactions Related Person Transactions Notes 20 false false R21.htm 0000021 - Disclosure - Income Taxes Sheet http://dhcreit.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 0000022 - Disclosure - Weighted Average Common Shares Sheet http://dhcreit.com/role/WeightedAverageCommonShares Weighted Average Common Shares Notes 22 false false R23.htm 9954471 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://dhcreit.com/role/RecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://dhcreit.com/role/RecentAccountingPronouncements 23 false false R24.htm 9954472 - Disclosure - Real Estate and Other Investments (Tables) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsTables Real Estate and Other Investments (Tables) Tables http://dhcreit.com/role/RealEstateandOtherInvestments 24 false false R25.htm 9954473 - Disclosure - Fair Value of Assets and Liabilities (Tables) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables Fair Value of Assets and Liabilities (Tables) Tables http://dhcreit.com/role/FairValueofAssetsandLiabilities 25 false false R26.htm 9954474 - Disclosure - Shareholders' Equity (Tables) Sheet http://dhcreit.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://dhcreit.com/role/ShareholdersEquity 26 false false R27.htm 9954475 - Disclosure - Segment Reporting (Tables) Sheet http://dhcreit.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://dhcreit.com/role/SegmentReporting 27 false false R28.htm 9954476 - Disclosure - Senior Living Community Management Agreements (Tables) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables Senior Living Community Management Agreements (Tables) Tables http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements 28 false false R29.htm 9954477 - Disclosure - Real Estate and Other Investments - Additional Information (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails Real Estate and Other Investments - Additional Information (Details) Details 29 false false R30.htm 9954478 - Disclosure - Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details) Details 30 false false R31.htm 9954479 - Disclosure - Real Estate and Other Investments - Schedule of Disposal Groups (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails Real Estate and Other Investments - Schedule of Disposal Groups (Details) Details 31 false false R32.htm 9954480 - Disclosure - Real Estate and Other Investments - Impairment Narrative (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails Real Estate and Other Investments - Impairment Narrative (Details) Details 32 false false R33.htm 9954481 - Disclosure - Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details) Details 33 false false R34.htm 9954482 - Disclosure - Real Estate and Other Investments - Mortgage Debt Joint Venture (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails Real Estate and Other Investments - Mortgage Debt Joint Venture (Details) Details 34 false false R35.htm 9954483 - Disclosure - Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details) Details 35 false false R36.htm 9954484 - Disclosure - Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details) Sheet http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details) Details 36 false false R37.htm 9954485 - Disclosure - Leases (Details) Sheet http://dhcreit.com/role/LeasesDetails Leases (Details) Details http://dhcreit.com/role/Leases 37 false false R38.htm 9954486 - Disclosure - Indebtedness (Details) Sheet http://dhcreit.com/role/IndebtednessDetails Indebtedness (Details) Details http://dhcreit.com/role/Indebtedness 38 false false R39.htm 9954487 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails Fair Value of Assets and Liabilities - Assets and Liabilities (Details) Details 39 false false R40.htm 9954488 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails Fair Value of Assets and Liabilities - Liabilities (Details) Details 40 false false R41.htm 9954489 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails Fair Value of Assets and Liabilities - Narrative (Details) Details 41 false false R42.htm 9954490 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://dhcreit.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 42 false false R43.htm 9954491 - Disclosure - Shareholders' Equity (Details) Sheet http://dhcreit.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://dhcreit.com/role/ShareholdersEquityTables 43 false false R44.htm 9954492 - Disclosure - Segment Reporting - Narrative (Details) Sheet http://dhcreit.com/role/SegmentReportingNarrativeDetails Segment Reporting - Narrative (Details) Details 44 false false R45.htm 9954493 - Disclosure - Segment Reporting - Income Statements (Details) Sheet http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails Segment Reporting - Income Statements (Details) Details 45 false false R46.htm 9954494 - Disclosure - Segment Reporting - Assets (Details) Sheet http://dhcreit.com/role/SegmentReportingAssetsDetails Segment Reporting - Assets (Details) Details 46 false false R47.htm 9954495 - Disclosure - Senior Living Community Management Agreements - Narrative (Details) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails Senior Living Community Management Agreements - Narrative (Details) Details 47 false false R48.htm 9954496 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) Details 48 false false R49.htm 9954497 - Disclosure - Business and Property Management Agreements with RMR (Details) Sheet http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails Business and Property Management Agreements with RMR (Details) Details http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR 49 false false R50.htm 9954498 - Disclosure - Related Person Transactions (Details) Sheet http://dhcreit.com/role/RelatedPersonTransactionsDetails Related Person Transactions (Details) Details http://dhcreit.com/role/RelatedPersonTransactions 50 false false R51.htm 9954499 - Disclosure - Income Taxes (Details) Sheet http://dhcreit.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://dhcreit.com/role/IncomeTaxes 51 false false All Reports Book All Reports dhc-20240331.htm dhc-20240331.xsd dhc-20240331_cal.xml dhc-20240331_def.xml dhc-20240331_lab.xml dhc-20240331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "dhc-20240331.htm": { "nsprefix": "dhc", "nsuri": "http://dhcreit.com/20240331", "dts": { "inline": { "local": [ "dhc-20240331.htm" ] }, "schema": { "local": [ "dhc-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "dhc-20240331_cal.xml" ] }, "definitionLink": { "local": [ "dhc-20240331_def.xml" ] }, "labelLink": { "local": [ "dhc-20240331_lab.xml" ] }, "presentationLink": { "local": [ "dhc-20240331_pre.xml" ] } }, "keyStandard": 170, "keyCustom": 42, "axisStandard": 27, "axisCustom": 1, "memberStandard": 34, "memberCustom": 45, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 4 }, "contextCount": 208, "entityCount": 1, "segmentCount": 84, "elementCount": 400, "unitCount": 15, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 569, "http://xbrl.sec.gov/dei/2023": 36 }, "report": { "R1": { "role": "http://dhcreit.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Land", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:Land", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R3": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R4": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R5": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": null }, "R6": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-33", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-33", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R8": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical", "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical", "longName": "0000009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-48", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R10": { "role": "http://dhcreit.com/role/BasisofPresentation", "longName": "0000010 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://dhcreit.com/role/RecentAccountingPronouncements", "longName": "0000011 - Disclosure - Recent Accounting Pronouncements", "shortName": "Recent Accounting Pronouncements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestments", "longName": "0000012 - Disclosure - Real Estate and Other Investments", "shortName": "Real Estate and Other Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://dhcreit.com/role/Leases", "longName": "0000013 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://dhcreit.com/role/Indebtedness", "longName": "0000014 - Disclosure - Indebtedness", "shortName": "Indebtedness", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilities", "longName": "0000015 - Disclosure - Fair Value of Assets and Liabilities", "shortName": "Fair Value of Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://dhcreit.com/role/ShareholdersEquity", "longName": "0000016 - Disclosure - Shareholders' Equity", "shortName": "Shareholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://dhcreit.com/role/SegmentReporting", "longName": "0000017 - Disclosure - Segment Reporting", "shortName": "Segment Reporting", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements", "longName": "0000018 - Disclosure - Senior Living Community Management Agreements", "shortName": "Senior Living Community Management Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR", "longName": "0000019 - Disclosure - Business and Property Management Agreements with RMR", "shortName": "Business and Property Management Agreements with RMR", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "dhc:BusinessAndPropertyManagementAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dhc:BusinessAndPropertyManagementAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://dhcreit.com/role/RelatedPersonTransactions", "longName": "0000020 - Disclosure - Related Person Transactions", "shortName": "Related Person Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://dhcreit.com/role/IncomeTaxes", "longName": "0000021 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://dhcreit.com/role/WeightedAverageCommonShares", "longName": "0000022 - Disclosure - Weighted Average Common Shares", "shortName": "Weighted Average Common Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://dhcreit.com/role/RecentAccountingPronouncementsPolicies", "longName": "9954471 - Disclosure - Recent Accounting Pronouncements (Policies)", "shortName": "Recent Accounting Pronouncements (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsTables", "longName": "9954472 - Disclosure - Real Estate and Other Investments (Tables)", "shortName": "Real Estate and Other Investments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables", "longName": "9954473 - Disclosure - Fair Value of Assets and Liabilities (Tables)", "shortName": "Fair Value of Assets and Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://dhcreit.com/role/ShareholdersEquityTables", "longName": "9954474 - Disclosure - Shareholders' Equity (Tables)", "shortName": "Shareholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DividendsDeclaredTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DividendsDeclaredTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://dhcreit.com/role/SegmentReportingTables", "longName": "9954475 - Disclosure - Segment Reporting (Tables)", "shortName": "Segment Reporting (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables", "longName": "9954476 - Disclosure - Senior Living Community Management Agreements (Tables)", "shortName": "Senior Living Community Management Agreements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "longName": "9954477 - Disclosure - Real Estate and Other Investments - Additional Information (Details)", "shortName": "Real Estate and Other Investments - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dhc:NumberOfStates", "unitRef": "state", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R30": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "longName": "9954478 - Disclosure - Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details)", "shortName": "Real Estate and Other Investments - Acquisitions and Dispositions Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "dhc:NumberOfPropertiesAcquired", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dhc:NumberOfPropertiesAcquired", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails", "longName": "9954479 - Disclosure - Real Estate and Other Investments - Schedule of Disposal Groups (Details)", "shortName": "Real Estate and Other Investments - Schedule of Disposal Groups (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-54", "name": "us-gaap:GainsLossesOnSalesOfInvestmentRealEstate", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R32": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "longName": "9954480 - Disclosure - Real Estate and Other Investments - Impairment Narrative (Details)", "shortName": "Real Estate and Other Investments - Impairment Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AssetImpairmentCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": null }, "R33": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "longName": "9954481 - Disclosure - Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details)", "shortName": "Real Estate and Other Investments - Equity Method Investments in Unconsolidated Joint Ventures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R34": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "longName": "9954482 - Disclosure - Real Estate and Other Investments - Mortgage Debt Joint Venture (Details)", "shortName": "Real Estate and Other Investments - Mortgage Debt Joint Venture (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfStatesInWhichEntityOperates", "unitRef": "state", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R35": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "longName": "9954483 - Disclosure - Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details)", "shortName": "Real Estate and Other Investments - Unconsolidated Joint Venture Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R36": { "role": "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "longName": "9954484 - Disclosure - Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details)", "shortName": "Real Estate and Other Investments - Equity Method Investment in AlerisLife (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-76", "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R37": { "role": "http://dhcreit.com/role/LeasesDetails", "longName": "9954485 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StraightLineRent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "dhc:StraightLineRentExcludingPropertiesHeldforSale", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R38": { "role": "http://dhcreit.com/role/IndebtednessDetails", "longName": "9954486 - Disclosure - Indebtedness (Details)", "shortName": "Indebtedness (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:NumberOfRealEstateProperties", "unitRef": "property", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R39": { "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "longName": "9954487 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details)", "shortName": "Fair Value of Assets and Liabilities - Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AssetImpairmentCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-102", "name": "dhc:EquitySecuritiesFVNIHoldingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R40": { "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "longName": "9954488 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details)", "shortName": "Fair Value of Assets and Liabilities - Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-110", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-110", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails", "longName": "9954489 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details)", "shortName": "Fair Value of Assets and Liabilities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-148", "name": "dhc:FairValueMeasurementNumberOfDebtSecurities", "unitRef": "security", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-148", "name": "dhc:FairValueMeasurementNumberOfDebtSecurities", "unitRef": "security", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails", "longName": "9954490 - Disclosure - Shareholders' Equity - Narrative (Details)", "shortName": "Shareholders' Equity - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-153", "name": "us-gaap:PaymentsOfDividendsCommonStock", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-154", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R43": { "role": "http://dhcreit.com/role/ShareholdersEquityDetails", "longName": "9954491 - Disclosure - Shareholders' Equity (Details)", "shortName": "Shareholders' Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-153", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-153", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R44": { "role": "http://dhcreit.com/role/SegmentReportingNarrativeDetails", "longName": "9954492 - Disclosure - Segment Reporting - Narrative (Details)", "shortName": "Segment Reporting - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "longName": "9954493 - Disclosure - Segment Reporting - Income Statements (Details)", "shortName": "Segment Reporting - Income Statements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-161", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R46": { "role": "http://dhcreit.com/role/SegmentReportingAssetsDetails", "longName": "9954494 - Disclosure - Segment Reporting - Assets (Details)", "shortName": "Segment Reporting - Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-164", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R47": { "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "longName": "9954495 - Disclosure - Senior Living Community Management Agreements - Narrative (Details)", "shortName": "Senior Living Community Management Agreements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-181", "name": "dhc:RelatedPartyTransactionExpensesFromPropertyManagementAgreementTransactionsWithRelatedParty", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R48": { "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails", "longName": "9954496 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details)", "shortName": "Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-190", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R49": { "role": "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "longName": "9954497 - Disclosure - Business and Property Management Agreements with RMR (Details)", "shortName": "Business and Property Management Agreements with RMR (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-5", "name": "dei:EntityNumberOfEmployees", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "dei:EntityNumberOfEmployees", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "longName": "9954498 - Disclosure - Related Person Transactions (Details)", "shortName": "Related Person Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-202", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "unique": true } }, "R51": { "role": "http://dhcreit.com/role/IncomeTaxesDetails", "longName": "9954499 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "dhc-20240331.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "dhc_ABPTrustAndMr.PortnoyMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ABPTrustAndMr.PortnoyMember", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ABP Trust And Adam D. Portnoy", "label": "ABP Trust And Mr. Portnoy [Member]", "documentation": "ABP Trust And Mr. Portnoy" } } }, "auth_ref": [] }, "dhc_ABPTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ABPTrustMember", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ABP Trust", "label": "ABP Trust [Member]", "documentation": "ABP Trust" } } }, "auth_ref": [] }, "stpr_AZ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "AZ", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Arizona", "label": "ARIZONA" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r32", "r33", "r107", "r164", "r493", "r526", "r529" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Other Comprehensive\u00a0Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r15", "r33", "r404", "r407", "r451", "r522", "r523", "r695", "r696", "r697", "r704", "r705", "r706" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r102" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r380", "r381", "r382", "r540", "r704", "r705", "r706", "r724", "r751" ] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentForAmortization", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization", "label": "Amortization", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r10", "r53" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "srt_AffiliatedEntityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AffiliatedEntityMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliated Entity", "label": "Affiliated Entity [Member]" } } }, "auth_ref": [ "r575", "r634", "r675", "r723", "r728", "r729", "r730" ] }, "dhc_AlerisLifeIncMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "AlerisLifeIncMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AlerisLife Inc", "label": "AlerisLife Inc [Member]", "documentation": "AlerisLife Inc" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dhc_AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of acquired real estate leases and other intangible assets, net", "label": "Amortization of Acquired Real Estate Leases and Other Intangible Assets", "documentation": "Represents the amortization of acquired real estate leases and other intangible assets during the period." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt discount", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r10", "r76", "r112", "r321" ] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest expense (including net amortization of debt premiums, discounts and issuance costs)", "terseLabel": "Net amortization of debt discounts, premiums and issuance costs", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r321", "r441", "r652", "r653", "r700" ] }, "us-gaap_AreaOfRealEstateProperty": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AreaOfRealEstateProperty", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Area of real estate properties (in square feet)", "label": "Area of Real Estate Property", "documentation": "Area of a real estate property." } } }, "auth_ref": [] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of assets", "verboseLabel": "Impairment of assets", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r10", "r54" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/SegmentReportingAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "terseLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r135", "r163", "r183", "r226", "r241", "r247", "r263", "r286", "r287", "r289", "r290", "r291", "r293", "r295", "r297", "r298", "r399", "r401", "r429", "r490", "r568", "r669", "r682", "r718", "r719", "r731" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate properties held for sale", "label": "Long-Lived Asset, Held-for-Sale, Fair Value Disclosure", "documentation": "Fair value portion of assets classified as held for sale." } } }, "auth_ref": [ "r668" ] }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldForSaleNotPartOfDisposalGroup", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets of properties held for sale", "label": "Asset, Held-for-Sale, Not Part of Disposal Group", "documentation": "Amount of assets held-for-sale that are not part of a disposal group." } } }, "auth_ref": [ "r121" ] }, "dhc_BasicHousingAndSupportServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "BasicHousingAndSupportServicesMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic housing and support services", "label": "Basic Housing And Support Services [Member]", "documentation": "Basic Housing And Support Services [Member]" } } }, "auth_ref": [] }, "us-gaap_BuildingsAndImprovementsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingsAndImprovementsGross", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and improvements", "label": "Buildings and Improvements, Gross", "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [ "r122" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r398", "r665", "r666" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r62", "r63", "r398", "r665", "r666" ] }, "dhc_BusinessAndPropertyManagementAgreementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "BusinessAndPropertyManagementAgreementsTextBlock", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR" ], "lang": { "en-us": { "role": { "terseLabel": "Business and Property Management Agreements with RMR", "label": "Business And Property Management Agreements [Text Block]", "documentation": "Business And Property Management Agreements" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition\u00a0and certain other transaction related\u00a0costs", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r61" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r13" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Step acquisition, ownership percentage including subsequent acquisition", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage", "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date." } } }, "auth_ref": [] }, "dhc_BusinessManagementFees": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "BusinessManagementFees", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business management fees incurred", "label": "Business Management Fees", "documentation": "Represents the business management fees incurred pursuant to business management agreement with related parties." } } }, "auth_ref": [] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "California", "label": "CALIFORNIA" } } }, "auth_ref": [] }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CarryingReportedAmountFairValueDisclosureMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Value", "label": "Reported Value Measurement [Member]", "documentation": "Measured as reported on the statement of financial position (balance sheet)." } } }, "auth_ref": [ "r73", "r74" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r40", "r161", "r640" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period", "totalLabel": "Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r40", "r115", "r180" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Decrease in cash and cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r115" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r30", "r85", "r491", "r555" ] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareCashPaid", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Distribution per share (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Cash Paid", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r129" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Distributions to common shareholders declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r129" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Shares", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r672", "r673", "r674", "r676", "r677", "r678", "r679", "r704", "r705", "r724", "r746", "r751" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares of beneficial interest, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r101" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares of beneficial interest, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r101", "r556" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares of beneficial interest, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r101" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares of beneficial interest, shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r16", "r101", "r556", "r574", "r751", "r752" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 240,393,722 and 240,423,898 shares issued and outstanding, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r101", "r492", "r669" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r34", "r167", "r169", "r174", "r484", "r498" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss:", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Living Community Management Agreements", "label": "Concentration Risk Disclosure [Text Block]", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r118" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r45", "r46", "r47", "r48", "r75", "r133", "r624" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r189", "r228", "r239", "r240", "r241", "r242", "r243", "r245", "r249", "r286", "r287", "r288", "r289", "r291", "r292", "r294", "r296", "r297", "r718", "r719" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r189", "r228", "r239", "r240", "r241", "r242", "r243", "r245", "r249", "r286", "r287", "r288", "r289", "r291", "r292", "r294", "r296", "r297", "r718", "r719" ] }, "us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate improvements accrued, not paid", "label": "Construction in Progress Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for construction in progress expenditures that have occurred." } } }, "auth_ref": [ "r42", "r43", "r44" ] }, "dhc_ContractTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ContractTypeAxis", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Type [Axis]", "label": "Contract Type [Axis]", "documentation": "Contract Type" } } }, "auth_ref": [] }, "dhc_ContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ContractTypeDomain", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Type [Domain]", "label": "Contract Type [Domain]", "documentation": "Contract Type" } } }, "auth_ref": [] }, "us-gaap_CorporateJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateJointVentureMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Joint Venture", "label": "Corporate Joint Venture [Member]", "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project." } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Segment", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r21", "r240", "r241", "r242", "r243", "r249", "r709" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r110" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses:", "verboseLabel": "Expenses:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r187", "r188", "r303", "r328", "r459", "r641", "r643" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dhc_CumulativeCommonDistributionsMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "CumulativeCommonDistributionsMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Distributions", "label": "Cumulative Common Distributions [Member]", "documentation": "Represents cumulative distributions to common shareholders." } } }, "auth_ref": [] }, "dhc_CumulativeCommonStockDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "CumulativeCommonStockDividends", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Cumulative distributions", "label": "Cumulative Common Stock Dividends", "documentation": "The amount as of the balance sheet date representing cumulative distributions to common shareholders." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/Indebtedness" ], "lang": { "en-us": { "role": { "terseLabel": "Indebtedness", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r125", "r181", "r299", "r305", "r306", "r307", "r308", "r309", "r310", "r315", "r322", "r323", "r325" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://dhcreit.com/role/Cover", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r24", "r98", "r99", "r136", "r137", "r189", "r300", "r301", "r302", "r303", "r304", "r306", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r321", "r442", "r649", "r650", "r651", "r652", "r653", "r702" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis points per annum (as a percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "dhc_DebtInstrumentExtensionOptionTerm": { "xbrltype": "durationItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentExtensionOptionTerm", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension term", "label": "Debt Instrument, Extension Option Term", "documentation": "Debt Instrument, Extension Option Term" } } }, "auth_ref": [] }, "dhc_DebtInstrumentExtensionTerm": { "xbrltype": "durationItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentExtensionTerm", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt extension term", "label": "Debt Instrument, Extension Term", "documentation": "Debt Instrument, Extension Term" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal balance", "terseLabel": "Debt face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r77", "r79", "r300", "r442", "r650", "r651" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value disclosure", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r313", "r428", "r650", "r651" ] }, "dhc_DebtInstrumentIncreaseInInitialInterestRateDuringExtensionPeriod": { "xbrltype": "percentItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentIncreaseInInitialInterestRateDuringExtensionPeriod", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in interest rate", "label": "Debt Instrument, Increase In Initial Interest Rate During Extension Period", "documentation": "Debt Instrument, Increase In Initial Interest Rate During Extension Period" } } }, "auth_ref": [] }, "dhc_DebtInstrumentInitialInterestRateDuringExtensionPeriod": { "xbrltype": "percentItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentInitialInterestRateDuringExtensionPeriod", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial extension period interest rate", "label": "Debt Instrument, Initial Interest Rate During Extension Period", "documentation": "Debt Instrument, Initial Interest Rate During Extension Period" } } }, "auth_ref": [] }, "dhc_DebtInstrumentInterestRateAccretedValueIncreaseRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentInterestRateAccretedValueIncreaseRatePercentage", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accreted value increase rate", "label": "Debt Instrument, Interest Rate, Accreted Value, Increase Rate, Percentage", "documentation": "Debt Instrument, Interest Rate, Accreted Value, Increase Rate, Percentage" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate (as a percent)", "verboseLabel": "Interest rate (as a percent)", "netLabel": "Coupon rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r28", "r301" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indebtedness", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189", "r300", "r301", "r302", "r303", "r304", "r306", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r321", "r324", "r442", "r649", "r650", "r651", "r652", "r653", "r702" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://dhcreit.com/role/Cover", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r29", "r189", "r300", "r301", "r302", "r303", "r304", "r306", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r321", "r442", "r649", "r650", "r651", "r652", "r653", "r702" ] }, "dhc_DebtInstrumentPercentageOfEquityInterestAsCollateralGuarantee": { "xbrltype": "percentItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DebtInstrumentPercentageOfEquityInterestAsCollateralGuarantee", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity interest in each collateral guarantee", "label": "Debt Instrument, Percentage Of Equity Interest As Collateral Guarantee", "documentation": "Debt Instrument, Percentage Of Equity Interest As Collateral Guarantee" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r59", "r60", "r76", "r77", "r79", "r86", "r127", "r128", "r189", "r300", "r301", "r302", "r303", "r304", "r306", "r311", "r312", "r313", "r314", "r316", "r317", "r318", "r319", "r320", "r321", "r324", "r442", "r649", "r650", "r651", "r652", "r653", "r702" ] }, "us-gaap_DebtInstrumentUnamortizedPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedPremium", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial premium", "label": "Debt Instrument, Unamortized Premium", "documentation": "Amount, after accumulated amortization, of debt premium." } } }, "auth_ref": [ "r76", "r79", "r721" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r55" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r231" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r545", "r547", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r587", "r588", "r589", "r590", "r593", "r594", "r595", "r596", "r614", "r615", "r616", "r617", "r672", "r674" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r67", "r68", "r69", "r70", "r545", "r547", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r587", "r588", "r589", "r590", "r593", "r594", "r595", "r596", "r614", "r615", "r616", "r617", "r643", "r672", "r674" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r341", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r341", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r722" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r159" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposed of by sale", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r11", "r20" ] }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held for sale", "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r5", "r20", "r159" ] }, "dhc_DiversifiedHealthcareTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "DiversifiedHealthcareTrustMember", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diversified Healthcare Trust", "label": "Diversified Healthcare Trust [Member]", "documentation": "Diversified Healthcare Trust" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r129" ] }, "us-gaap_DividendsDeclaredTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsDeclaredTableTextBlock", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Dividends Declared and Paid", "label": "Dividends Declared [Table Text Block]", "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r686" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r687" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss - basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r175", "r199", "r200", "r201", "r202", "r203", "r210", "r212", "r214", "r215", "r216", "r220", "r413", "r414", "r485", "r499", "r644" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss - diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r175", "r199", "r200", "r201", "r202", "r203", "r212", "r214", "r215", "r216", "r220", "r413", "r414", "r485", "r499", "r644" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://dhcreit.com/role/WeightedAverageCommonShares" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Common Shares", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r209", "r217", "r218", "r219" ] }, "dhc_EncumberedProperties": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "EncumberedProperties", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encumbered properties (property)", "label": "Encumbered Properties", "documentation": "Encumbered Properties" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r684" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r684" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r684" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r688" ] }, "dei_EntityNumberOfEmployees": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityNumberOfEmployees", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees", "label": "Entity Number of Employees", "documentation": "Number of persons employed by the Entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r684" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r684" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Smaller Reporting Company", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r684" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r684" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r16", "r155", "r170", "r171", "r172", "r190", "r191", "r192", "r196", "r204", "r206", "r221", "r264", "r267", "r339", "r380", "r381", "r382", "r388", "r389", "r403", "r404", "r405", "r406", "r407", "r409", "r412", "r433", "r434", "r435", "r436", "r437", "r438", "r451", "r522", "r523", "r524", "r540", "r599" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r259", "r260", "r262" ] }, "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, difference between carrying amount and underlying equity", "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity", "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee." } } }, "auth_ref": [ "r261" ] }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentDividendsOrDistributions", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Unconsolidated joint venture distributions", "label": "Proceeds from Equity Method Investment, Distribution", "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities." } } }, "auth_ref": [ "r8", "r10", "r108", "r496" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment ownership percentage", "verboseLabel": "Equity method investment ownership percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r259" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r236", "r257", "r693", "r711" ] }, "us-gaap_EquityMethodInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Method Investments", "label": "Equity Method Investments [Member]", "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Joint Ventures", "label": "Equity Method Investments [Table Text Block]", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r258" ] }, "dhc_EquitySecuritiesFVNIHoldingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "EquitySecuritiesFVNIHoldingPeriod", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Holding period", "label": "Equity Securities, FV-NI, Holding Period", "documentation": "Equity Securities, FV-NI, Holding Period" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiGainLoss", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Gains and losses on equity securities, net", "label": "Equity Securities, FV-NI, Gain (Loss)", "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r501", "r710" ] }, "us-gaap_EquitySecuritiesFvNiMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiMeasurementInput", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement input", "label": "Equity Securities, FV-NI, Measurement Input", "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r423" ] }, "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiRealizedGainLoss", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gains and losses on equity securities, net", "verboseLabel": "Gains on equity securities, net", "label": "Equity Securities, FV-NI, Realized Gain (Loss)", "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r500", "r710" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated Fair Value", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r313", "r428", "r650", "r651" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r419", "r420", "r425" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r419", "r420", "r425" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r19", "r71", "r72", "r132" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r17" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r71", "r72" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r313", "r343", "r344", "r345", "r346", "r347", "r348", "r420", "r462", "r463", "r464", "r650", "r651", "r662", "r663", "r664" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r23", "r71", "r313", "r650", "r651" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r419", "r420", "r422", "r423", "r426" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r313", "r650", "r651" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Assets and Liabilities", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r418" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Quoted\u00a0Prices\u00a0in\u00a0Active Markets for Identical Assets (Level 1)", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r313", "r343", "r348", "r420", "r462", "r662", "r663", "r664" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "verboseLabel": "Significant Other Observable Inputs (Level 2)", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r313", "r343", "r348", "r420", "r463", "r650", "r651", "r662", "r663", "r664" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r313", "r343", "r344", "r345", "r346", "r347", "r348", "r420", "r464", "r650", "r651", "r662", "r663", "r664" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "dhc_FairValueMeasurementNumberOfDebtSecurities": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "FairValueMeasurementNumberOfDebtSecurities", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value measurement, number of debt securities", "label": "Fair Value Measurement, Number Of Debt Securities", "documentation": "Fair Value Measurement, Number Of Debt Securities" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r313", "r343", "r344", "r345", "r346", "r347", "r348", "r462", "r463", "r464", "r650", "r651", "r662", "r663", "r664" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Recurring Fair Value Measurements Assets", "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r419", "r420", "r422", "r423", "r424", "r426" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recurring Fair Value Measurements Assets", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r418", "r426" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease obligations", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r446", "r449" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leased asset, net", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r445" ] }, "dhc_FinanceLeasedPropertiesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "FinanceLeasedPropertiesMember", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Leased Properties", "label": "Finance Leased Properties [Member]", "documentation": "Finance Leased Properties" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired real estate leases and other intangible assets, net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r120", "r468" ] }, "dhc_FiveStarQualityCareIncMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "FiveStarQualityCareIncMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five Star", "label": "Five Star Quality Care Inc [Member]", "documentation": "Represents the information pertaining to Five Star Quality Care, Inc." } } }, "auth_ref": [] }, "dhc_GainLossOnEarlyExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "GainLossOnEarlyExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss on modification or early extinguishment of debt", "label": "Gain (Loss) On Early Extinguishment Of Debt", "documentation": "Gain (Loss) On Early Extinguishment Of Debt" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfProperties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfProperties", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "(Loss) gain on sale of properties", "negatedLabel": "Loss (gain) on sale of properties", "label": "Gain (Loss) on Sale of Properties", "documentation": "The difference between the carrying value and the sale price of real estate or properties that were intended to be sold or held for capital appreciation or rental income. This element refers to the gain (loss) included in earnings and not to the cash proceeds of the sale. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method." } } }, "auth_ref": [ "r700", "r713", "r714" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on modification or early extinguishment of debt", "negatedTerseLabel": "Loss on modification or early extinguishment of debt", "verboseLabel": "Loss on modification or early extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r10", "r57", "r58" ] }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on Sale", "label": "Gains (Losses) on Sales of Investment Real Estate", "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes." } } }, "auth_ref": [ "r148", "r149", "r150", "r698", "r699", "r700", "r740", "r750" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "verboseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r111", "r578" ] }, "us-gaap_IncentiveFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncentiveFeeExpense", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated incentive fees", "label": "Incentive Fee Expense", "documentation": "Amount of expense for incentive fee based on performance under arrangement to manage operations, including, but not limited to, investment." } } }, "auth_ref": [ "r80", "r749" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax (expense) benefit and equity in net earnings (losses) of investees", "terseLabel": "Income (loss) before income tax benefit and equity in net losses of investees", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r226", "r240", "r246", "r249", "r502", "r646" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in net earnings (losses) of investees", "negatedTerseLabel": "Equity in net (earnings) losses of investees", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r10", "r108", "r139", "r233", "r257", "r496" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r277", "r279", "r583" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r279", "r583" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r184", "r383", "r385", "r386", "r387", "r393", "r395", "r396", "r397", "r535" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/IncomeTaxesDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax (expense) benefit", "verboseLabel": "Income tax expense (benefit)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r147", "r153", "r205", "r206", "r234", "r384", "r394", "r503" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes paid", "label": "Income Taxes Paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r39", "r41" ] }, "us-gaap_IncreaseDecreaseInDeferredLeasingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredLeasingFees", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred leasing costs, net", "label": "Increase (Decrease) in Deferred Leasing Fees", "documentation": "The increase (decrease) during the reporting period in the book value of deferred leasing fees. Amortization of these fees over the terms of the leases reduces deferred leasing fees. Originating new leases increases the balance of deferred leasing fees." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Increase (Decrease) in Interest Payable, Net", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other income", "verboseLabel": "Interest and other income", "label": "Interest and Other Income", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense (including net amortization of debt discounts, premiums and issuance costs of $24,863 and $2,074, respectively)", "negatedTerseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r78", "r141", "r173", "r230", "r440", "r584", "r680", "r748" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r176", "r178", "r179" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r82", "r742" ] }, "us-gaap_InterestRateCapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCapMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Cap", "label": "Interest Rate Cap [Member]", "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount." } } }, "auth_ref": [ "r637" ] }, "dhc_InvestmentOwnedPercentageOfTotalSharesOutstanding": { "xbrltype": "percentItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "InvestmentOwnedPercentageOfTotalSharesOutstanding", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment owned, percentage of total shares outstanding", "label": "Investment Owned, Percentage of Total Shares Outstanding", "documentation": "Represents the number of shares held as a percentage of the total shares outstanding at the end of the period." } } }, "auth_ref": [] }, "dhc_InvestmentSaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "InvestmentSaleOfStockPricePerShare", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment owned balance per shares", "label": "Investment, Sale Of Stock, Price Per Share", "documentation": "Investment Owned Balance Per Shares" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in affiliates, fair value", "label": "Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure", "documentation": "Fair value portion of investments in an entity not consolidated. Includes, but is not limited to, investments in an entity that is affiliated with the reporting entity by means of direct or indirect ownership, an entity in which the reporting entity shares control of the entity with another party or group, an entity which the company has significant influence, but does not have control and subsidiaries that are not required to be consolidated and are accounted for using the equity or cost method." } } }, "auth_ref": [ "r725" ] }, "dhc_JointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "JointVentureMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Joint Venture", "label": "Joint Venture [Member]", "documentation": "Joint Venture [Member]" } } }, "auth_ref": [] }, "us-gaap_Land": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Land", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land", "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale." } } }, "auth_ref": [ "r694" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r27", "r183", "r263", "r286", "r287", "r289", "r290", "r291", "r293", "r295", "r297", "r298", "r400", "r401", "r402", "r429", "r554", "r645", "r682", "r718", "r731", "r732" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r106", "r138", "r495", "r669", "r703", "r712", "r727" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Shareholders' Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities of properties held for sale", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r3", "r88", "r94", "r123", "r159", "r160" ] }, "dhc_LifeScienceAndMedicalOfficeMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "LifeScienceAndMedicalOfficeMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Office and Life Science", "label": "Life Science and Medical Office [Member]", "documentation": "Life Science and Medical Office" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility, interest rate payable (as a percent)", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r26" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured revolving credit facility, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r26" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Revolving Credit Facility", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r29" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r56" ] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "MA", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Massachusetts", "label": "MASSACHUSETTS" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r350", "r466", "r521", "r546", "r547", "r607", "r609", "r611", "r612", "r618", "r635", "r636", "r647", "r654", "r667", "r671", "r720", "r733", "r734", "r735", "r736", "r737", "r738" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount Rate", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r726" ] }, "dhc_MeasurementInputMarketCapitalizationRateMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "MeasurementInputMarketCapitalizationRateMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Market Capitalization Rate", "label": "Measurement Input, Market Capitalization Rate [Member]", "documentation": "Measurement Input, Market Capitalization Rate" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r421" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "dhc_MedicalOfficeAndLifeSciencePortfolioSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "MedicalOfficeAndLifeSciencePortfolioSegmentMember", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Office and Life Science Portfolio", "label": "Medical Office and Life Science Portfolio Segment [Member]", "documentation": "Medical Office and Life Science Portfolio Segment" } } }, "auth_ref": [] }, "dhc_MedicalOfficeBuildingandLifeScienceBuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "MedicalOfficeBuildingandLifeScienceBuildingMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Office Building and Life Science Building", "label": "Medical Office Building and Life Science Building [Member]", "documentation": "Medical Office Building and Life Science Building [Member]" } } }, "auth_ref": [] }, "dhc_MedicalOfficeMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "MedicalOfficeMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Office", "label": "Medical Office [Member]", "documentation": "Medical Office" } } }, "auth_ref": [] }, "dhc_MedicareAndMedicaidProgramsMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "MedicareAndMedicaidProgramsMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medicare and Medicaid programs", "label": "Medicare And Medicaid Programs [Member]", "documentation": "Medicare And Medicaid Programs [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r350", "r466", "r521", "r546", "r547", "r607", "r609", "r611", "r612", "r618", "r635", "r636", "r647", "r654", "r667", "r671", "r720", "r733", "r734", "r735", "r736", "r737", "r738" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest, ownership percentage by parent", "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership interest by parent", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate, Type of Property [Axis]", "label": "Real Estate, Type of Property [Axis]" } } }, "auth_ref": [ "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633" ] }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate [Domain]", "label": "Real Estate [Domain]" } } }, "auth_ref": [ "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633" ] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgages", "label": "Mortgages [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r177" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r177" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r115", "r116", "r117" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net loss", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r109", "r117", "r140", "r160", "r165", "r168", "r172", "r183", "r195", "r199", "r200", "r201", "r202", "r205", "r206", "r213", "r226", "r240", "r246", "r249", "r263", "r286", "r287", "r289", "r290", "r291", "r293", "r295", "r297", "r298", "r414", "r429", "r497", "r576", "r597", "r598", "r646", "r680", "r718" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://dhcreit.com/role/RecentAccountingPronouncements" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r151", "r152", "r154", "r157", "r193", "r194", "r197", "r198", "r207", "r208", "r265", "r266", "r390", "r391", "r392", "r408", "r411", "r415", "r416", "r417", "r430", "r431", "r432", "r443", "r444", "r452", "r469", "r470", "r471", "r525", "r526", "r527", "r528", "r529" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://dhcreit.com/role/RecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dhc_NoncashInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NoncashInvestingActivitiesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing activities:", "label": "Noncash Investing Activities [Abstract]", "documentation": "Represents the information pertaining to the Non cash investing activities." } } }, "auth_ref": [] }, "dhc_NumberJointVentureArrangements": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberJointVentureArrangements", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number joint venture arrangements", "label": "Number Joint Venture Arrangements", "documentation": "Number Joint Venture Arrangements" } } }, "auth_ref": [] }, "dhc_NumberOfCommunitiesManagedByRelatedParty": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfCommunitiesManagedByRelatedParty", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of communities managed", "label": "Number of Communities Managed by Related Party", "documentation": "Represents the number of communities managed by a related party." } } }, "auth_ref": [] }, "dhc_NumberOfExtensionOptions": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfExtensionOptions", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of extension options", "label": "Number Of Extension Options", "documentation": "Number Of Extension Options" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r708" ] }, "dhc_NumberOfPropertiesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfPropertiesAcquired", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties acquired", "label": "Number Of Properties Acquired", "documentation": "Number Of Properties Acquired" } } }, "auth_ref": [] }, "dhc_NumberOfPropertiesIncludedInJointVentureAgreement": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfPropertiesIncludedInJointVentureAgreement", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties included in joint venture agreement", "label": "Number Of Properties Included In Joint Venture Agreement", "documentation": "Number Of Properties Included In Joint Venture Agreement" } } }, "auth_ref": [] }, "us-gaap_NumberOfRealEstateProperties": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfRealEstateProperties", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties owned (property)", "verboseLabel": "Number of Properties", "label": "Number of Real Estate Properties", "documentation": "The number of real estate properties owned as of the balance sheet date." } } }, "auth_ref": [] }, "dhc_NumberOfRealEstatePropertiesClosed": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfRealEstatePropertiesClosed", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties closed", "label": "Number Of Real Estate Properties Closed", "documentation": "Number Of Real Estate Properties Closed" } } }, "auth_ref": [] }, "dhc_NumberOfRealEstatePropertiesCollateralized": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfRealEstatePropertiesCollateralized", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of real estate properties collateralized", "label": "Number of Real Estate Properties Collateralized", "documentation": "Represents the number of real estate properties serving as a collateral for debt, as of the balance sheet date." } } }, "auth_ref": [] }, "dhc_NumberOfStates": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfStates", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of states", "label": "Number Of States", "documentation": "Number Of States" } } }, "auth_ref": [] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of states in which properties are located", "label": "Number of States in which Entity Operates", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "dhc_NumberOfUnconsolidatedJointVentures": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "NumberOfUnconsolidatedJointVentures", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of unconsolidated joint ventures", "label": "Number Of Unconsolidated Joint Ventures", "documentation": "Number Of Unconsolidated Joint Ventures" } } }, "auth_ref": [] }, "us-gaap_OciEquityMethodInvestmentAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OciEquityMethodInvestmentAfterTax", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in unrealized losses of an investee", "label": "OCI, Equity Method Investment, after Tax", "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI." } } }, "auth_ref": [ "r256" ] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property operating expenses", "verboseLabel": "Property operating expenses", "label": "Operating Costs and Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenseMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Expense", "label": "Operating Expense [Member]", "documentation": "Primary financial statement caption encompassing expenses associated with normal operations." } } }, "auth_ref": [ "r22" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r446" ] }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Statement of Financial Position", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease liability." } } }, "auth_ref": [ "r447" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, right-of-use asset", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r445" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r447" ] }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessor, Operating Leases [Text Block]", "documentation": "The entire disclosure for lessor's operating leases." } } }, "auth_ref": [ "r450" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r239", "r240", "r241", "r242", "r243", "r249" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/BasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r87", "r130", "r530", "r531" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets, net", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r134", "r162", "r489", "r682" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r7", "r14", "r131", "r166", "r169" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r83", "r486", "r550", "r551", "r682", "r747" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other non-cash adjustments, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r117" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Axis]", "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Domain]", "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForCapitalImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForCapitalImprovements", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Real estate improvements", "label": "Payments for Capital Improvements", "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use." } } }, "auth_ref": [ "r114" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchase of common shares", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r37" ] }, "dhc_PaymentsForTerminationAndOtherFees": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PaymentsForTerminationAndOtherFees", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Termination and other fees", "label": "Payments For Termination And Other Fees", "documentation": "Payments For Termination And Other Fees" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/ShareholdersEquityDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Distributions to shareholders", "verboseLabel": "Distributions to shareholders", "terseLabel": "Total Distributions", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r37" ] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of debt issuance costs", "label": "Payments of Financing Costs", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r36" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Investment in AlerisLife Inc.", "label": "Payments to Acquire Equity Method Investments", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r35" ] }, "dhc_PerCommonShareAmountsBasicAndDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PerCommonShareAmountsBasicAndDilutedAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Per common share amounts (basic and diluted):", "label": "Per Common Share Amounts, Basic and Diluted [Abstract]", "documentation": "Per Common Share Amounts, Basic and Diluted" } } }, "auth_ref": [] }, "dhc_PeriodOfActualAmountOfIncentiveFees": { "xbrltype": "durationItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PeriodOfActualAmountOfIncentiveFees", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period of actual amount of incentive fees", "label": "Period Of Actual Amount Of Incentive Fees", "documentation": "Period Of Actual Amount Of Incentive Fees" } } }, "auth_ref": [] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "verboseLabel": "Estimated Fair Value", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r427" ] }, "dhc_PrivatePayAndOtherThirdPartyPayerServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PrivatePayAndOtherThirdPartyPayerServicesMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private pay and other third party payer SNF services", "label": "Private Pay And Other Third Party Payer Services [Member]", "documentation": "Private Pay And Other Third Party Payer Services [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of properties, net", "label": "Proceeds from Sale, Real Estate, Held-for-Investment", "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period." } } }, "auth_ref": [ "r113" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r251", "r467", "r515", "r516", "r517", "r518", "r519", "r520", "r638", "r655", "r670", "r691", "r716", "r717", "r722", "r745" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r251", "r467", "r515", "r516", "r517", "r518", "r519", "r520", "r638", "r655", "r670", "r691", "r716", "r717", "r722", "r745" ] }, "dhc_PropertiesHeldForSaleSalesPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PropertiesHeldForSaleSalesPrice", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate sales price", "label": "Properties Held For Sale, Sales Price", "documentation": "Properties Held For Sale, Sales Price" } } }, "auth_ref": [] }, "dhc_PropertiesUnderAgreementToSellMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PropertiesUnderAgreementToSellMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Properties Under Agreement To Sell", "label": "Properties Under Agreement To Sell [Member]", "documentation": "Properties Under Agreement To Sell" } } }, "auth_ref": [] }, "dhc_PropertyManagementAndConstructionSupervisionFees": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PropertyManagementAndConstructionSupervisionFees", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property management and construction supervision fees", "label": "Property Management and Construction Supervision Fees", "documentation": "Represents the property management and construction supervision fees incurred pursuant to business and property management agreements with related parties." } } }, "auth_ref": [] }, "dhc_PropertyManagementAndConstructionSupervisionFeesCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PropertyManagementAndConstructionSupervisionFeesCapitalized", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Party transaction property management and construction supervision fees capitalized", "label": "Property Management And Construction Supervision Fees, Capitalized", "documentation": "Property Management And Construction Supervision Fees, Capitalized" } } }, "auth_ref": [] }, "dhc_PropertyManagementAndConstructionSupervisionFeesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "PropertyManagementAndConstructionSupervisionFeesPaid", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property management and construction supervision fees paid", "label": "Property Management And Construction Supervision Fees Paid", "documentation": "Represents the property management and construction supervision fees paid to related parties." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r342", "r350", "r376", "r377", "r378", "r465", "r466", "r521", "r546", "r547", "r607", "r609", "r611", "r612", "r618", "r635", "r636", "r647", "r654", "r667", "r671", "r674", "r715", "r720", "r734", "r735", "r736", "r737", "r738" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r342", "r350", "r376", "r377", "r378", "r465", "r466", "r521", "r546", "r547", "r607", "r609", "r611", "r612", "r618", "r635", "r636", "r647", "r654", "r667", "r671", "r674", "r715", "r720", "r734", "r735", "r736", "r737", "r738" ] }, "us-gaap_RealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAbstract", "lang": { "en-us": { "role": { "terseLabel": "Real Estate [Abstract]", "label": "Real Estate [Abstract]" } } }, "auth_ref": [] }, "dhc_RealEstateAggregateSalesPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RealEstateAggregateSalesPrice", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales price", "verboseLabel": "Sale Price", "label": "Real Estate Aggregate Sales Price", "documentation": "This element represents the aggregate sales price excluding closing costs, of real estate properties sold by the entity." } } }, "auth_ref": [] }, "us-gaap_RealEstateDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestments" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate and Other Investments", "label": "Real Estate Disclosure [Text Block]", "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures." } } }, "auth_ref": [ "r142", "r143", "r144", "r145", "r146" ] }, "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateHeldforsale", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate Properties, Net", "label": "Real Estate, Held-for-Sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r741" ] }, "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Real Estate Investment Property, Accumulated Depreciation", "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes." } } }, "auth_ref": [ "r487" ] }, "us-gaap_RealEstateInvestmentPropertyAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentPropertyAtCost", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total real estate properties, gross", "label": "Real Estate Investment Property, at Cost", "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments." } } }, "auth_ref": [ "r488" ] }, "us-gaap_RealEstateInvestmentPropertyNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentPropertyNet", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total real estate properties, net", "terseLabel": "Total real estate properties, net", "label": "Real Estate Investment Property, Net", "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments." } } }, "auth_ref": [ "r741" ] }, "us-gaap_RealEstateInvestmentPropertyNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentPropertyNetAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate properties:", "label": "Real Estate Investment Property, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in unconsolidated joint ventures", "verboseLabel": "DHC carrying value", "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments." } } }, "auth_ref": [ "r741" ] }, "us-gaap_RealEstateLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateLineItems", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate", "label": "Real Estate [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r635" ] }, "us-gaap_RealEstateTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateTable", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsImpairmentNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real Estate [Table]", "label": "Real Estate [Table]", "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions." } } }, "auth_ref": [ "r635" ] }, "dhc_ReceivableFromTenderOffer": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ReceivableFromTenderOffer", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Receivable from AlerisLife Inc. tender offer", "label": "Receivable From Tender Offer", "documentation": "Receivable From Tender Offer" } } }, "auth_ref": [] }, "dhc_RehabilitationServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RehabilitationServicesMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rehabilitation Services", "label": "Rehabilitation Services [Member]", "documentation": "Rehabilitation Services [Member]" } } }, "auth_ref": [] }, "dhc_ReimbursementRevenueLease": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ReimbursementRevenueLease", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reimbursement revenue lease", "label": "Reimbursement Revenue Lease", "documentation": "Reimbursement Revenue Lease" } } }, "auth_ref": [] }, "dhc_ReitManagementAndResearchLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ReitManagementAndResearchLLCMember", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reit Management And Research L L C", "label": "Reit Management And Research L L C [Member]", "documentation": "Represents details pertaining to Reit Management and Research LLC, or RMR." } } }, "auth_ref": [] }, "dhc_ReitManagementAndResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ReitManagementAndResearchMember", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RMR", "label": "Reit Management And Research [Member]", "documentation": "Represents details pertaining to Reit Management and Research LLC, or RMR." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r349", "r456", "r457", "r549", "r550", "r551", "r552", "r553", "r573", "r575", "r606" ] }, "dhc_RelatedPartyManagementAgreements": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RelatedPartyManagementAgreements", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of management agreements", "label": "Related Party, Management Agreements", "documentation": "Related Party, Management Agreements" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r185", "r186", "r456", "r457", "r458", "r459", "r549", "r550", "r551", "r552", "r553", "r573", "r575", "r606" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r456", "r457", "r730" ] }, "dhc_RelatedPartyTransactionCapitalizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RelatedPartyTransactionCapitalizedAmount", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related party transaction capitalized amount", "label": "Related Party Transaction Capitalized Amount", "documentation": "Related Party Transaction Capitalized Amount" } } }, "auth_ref": [] }, "dhc_RelatedPartyTransactionClosingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RelatedPartyTransactionClosingCost", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related party transaction, closing cost", "label": "Related Party Transaction, Closing Cost", "documentation": "Related Party Transaction, Closing Cost" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "dhc_RelatedPartyTransactionExpensesFromPropertyManagementAgreementTransactionsWithRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RelatedPartyTransactionExpensesFromPropertyManagementAgreementTransactionsWithRelatedParty", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property management agreement expense", "label": "Related Party Transaction, Expenses from Property Management Agreement Transactions with Related Party", "documentation": "Expenses recognized during the period resulting from property management transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related person transactions", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r579", "r580", "r583" ] }, "dhc_RelatedPartyTransactionPropertyManagementAgreementNumberOfConsecutiveRenewalTerms": { "xbrltype": "integerItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RelatedPartyTransactionPropertyManagementAgreementNumberOfConsecutiveRenewalTerms", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of consecutive renewal terms of agreement", "label": "Related Party Transaction, Property Management Agreement, Number of Consecutive Renewal Terms", "documentation": "Represents the number of consecutive renewal terms of agreement that the entity has the option to renew." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r349", "r456", "r457", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r549", "r550", "r551", "r552", "r553", "r573", "r575", "r606", "r730" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Person Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r453", "r454", "r455", "r457", "r460", "r536", "r537", "r538", "r581", "r582", "r583", "r603", "r605" ] }, "dhc_RentalIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "RentalIncomeMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rental income", "label": "Rental Income [Member]", "documentation": "Rental Income [Member]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments of borrowings on credit facility", "terseLabel": "Repayments of lines of credit", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r38", "r702" ] }, "us-gaap_RepaymentsOfOtherDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherDebt", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of other debt", "label": "Repayments of Other Debt", "documentation": "Amount of cash outflow for the payment of debt classified as other." } } }, "auth_ref": [ "r38" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r187", "r188", "r303", "r328", "r459", "r642", "r643" ] }, "dhc_ResidentFeesAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ResidentFeesAndServicesMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Residents fees and services", "label": "Resident Fees And Services [Member]", "documentation": "Resident Fees And Services [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCash", "crdr": "debit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "verboseLabel": "Restricted cash", "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r692", "r701", "r739", "r744" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative net income", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r103", "r129", "r494", "r525", "r529", "r534", "r557", "r669" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Net\u00a0Income", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r155", "r190", "r191", "r192", "r196", "r204", "r206", "r264", "r267", "r380", "r381", "r382", "r388", "r389", "r403", "r405", "r406", "r409", "r412", "r522", "r524", "r540", "r751" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "verboseLabel": "Total revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r227", "r228", "r239", "r244", "r245", "r251", "r253", "r255", "r340", "r341", "r467" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "verboseLabel": "Revenues:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Risks and Uncertainties [Abstract]", "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r351", "r707" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r207", "r351", "r689", "r707" ] }, "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Carrying Value and Fair Value of the Financial Instruments", "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disposal Groups", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r12", "r20", "r25", "r88", "r89", "r90", "r91", "r92", "r93", "r95", "r96", "r97", "r124" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentinAlerisLifeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r259", "r260", "r262" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r80", "r81", "r579", "r580", "r583" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r49", "r50", "r51", "r52" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://dhcreit.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r49", "r50", "r51", "r52" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379" ] }, "dhc_SeaportInnovationLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeaportInnovationLLCMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Seaport Innovation LLC", "label": "Seaport Innovation LLC [Member]", "documentation": "Seaport Innovation LLC" } } }, "auth_ref": [] }, "us-gaap_SecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebt", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount of mortgage debt", "label": "Secured Debt", "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r24", "r137", "r743" ] }, "dhc_SecuredDebtAndFinanceLeaseObligationsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SecuredDebtAndFinanceLeaseObligationsNet", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Secured debt and finance leases, net", "label": "Secured Debt And Finance Lease Obligations, Net", "documentation": "Secured Debt And Finance Lease Obligations, Net" } } }, "auth_ref": [] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Debts", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dhc_SecuredDebtsAndFinanceLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SecuredDebtsAndFinanceLeasesMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured debt and finance leases", "label": "Secured Debts and Finance Leases [Member]", "documentation": "Secured Debts and Finance Leases" } } }, "auth_ref": [] }, "dhc_SecuredOvernightFinancingRateSOFRMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SecuredOvernightFinancingRateSOFRMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "documentation": "Secured Overnight Financing Rate (SOFR)" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title Of Each Class", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r683" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Name Of Each Exchange On Which Registered", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r685" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r223", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r249", "r255", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r280", "r281", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r648", "r691", "r745" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r253", "r254", "r542", "r543", "r544", "r608", "r610", "r613", "r619", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r639", "r656", "r674", "r722", "r745" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r222", "r223", "r224", "r225", "r226", "r238", "r243", "r247", "r248", "r249", "r250", "r251", "r252", "r255" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment reporting", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dhc_SeniorHousingOperatingPortfolioSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorHousingOperatingPortfolioSegmentMember", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SHOP", "label": "Senior Housing Operating Portfolio Segment [Member]", "documentation": "Senior Housing Operating Portfolio [Member]" } } }, "auth_ref": [] }, "dhc_SeniorLivingCommunitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorLivingCommunitiesMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAdditionalInformationDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Living", "label": "Senior Living Communities [Member]", "documentation": "Senior Living Communities" } } }, "auth_ref": [] }, "dhc_SeniorLivingCommunityMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorLivingCommunityMember", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Living Communities", "label": "Senior Living Community [Member]", "documentation": "Represents the information pertaining to senior living properties. Senior apartments are marketed to residents who are generally capable of caring for themselves. Residence is usually restricted on the basis of age. Purpose built properties may have special function rooms, concierge services, high levels of security and assistance call systems for emergency use." } } }, "auth_ref": [] }, "us-gaap_SeniorNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotes", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Senior Notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders." } } }, "auth_ref": [ "r84", "r743" ] }, "dhc_SeniorNotesDue2042Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorNotesDue2042Member", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "5.625% Senior Notes due 2042", "label": "Senior Notes Due 2042 [Member]", "documentation": "Senior Notes Due 2042 [Member]" } } }, "auth_ref": [] }, "dhc_SeniorNotesDue2046Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorNotesDue2046Member", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "6.25% Senior Notes due 2046", "label": "Senior Notes Due 2046 [Member]", "documentation": "Senior Notes Due 2046 [Member]" } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "dhc_SeniorSecuredNoteDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorSecuredNoteDue2026Member", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured note due 2026", "label": "Senior Secured Note Due 2026 [Member]", "documentation": "Senior Secured Note Due 2026" } } }, "auth_ref": [] }, "dhc_SeniorSecuredNotesDueJanuary2026Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorSecuredNotesDueJanuary2026Member", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Notes Due January 2026", "label": "Senior Secured Notes Due January 2026 [Member]", "documentation": "Senior Secured Notes Due January 2026" } } }, "auth_ref": [] }, "dhc_SeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorSecuredNotesMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Secured Notes", "label": "Senior Secured Notes [Member]", "documentation": "Senior Secured Notes" } } }, "auth_ref": [] }, "dhc_SeniorSecuredNotesZeroCouponRateDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorSecuredNotesZeroCouponRateDue2026Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured notes, zero coupon rate, due 2026", "label": "Senior Secured Notes, Zero Coupon Rate, Due 2026 [Member]", "documentation": "Senior Secured Notes, Zero Coupon Rate, Due 2026" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes4.75PercentDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes4.75PercentDue2028Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 4.750% coupon rate, due 2028", "label": "Senior Unsecured Notes 4.75 Percent Due 2028 [Member]", "documentation": "Senior Unsecured Notes 4.75 Percent Due 2028 [Member]" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes4375PercentDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes4375PercentDue2031Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 4.375% coupon rate, due 2031", "label": "Senior Unsecured Notes 4.375 Percent Due 2031 [Member]", "documentation": "Senior Unsecured Notes 4.375 Percent Due 2031" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes5625PercentDue2042Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes5625PercentDue2042Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 5.625% coupon rate, due 2042", "label": "Senior Unsecured Notes 5.625 Percent Due 2042 [Member]", "documentation": "Senior Unsecured Notes 5.625 Percent Due 2042" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes625PercentDue2046Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes625PercentDue2046Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 6.250% coupon rate, due 2046", "label": "Senior Unsecured Notes 6.25 Percent Due 2046 [Member]", "documentation": "Senior Unsecured Notes 6.25 Percent Due 2046" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes9.750PercentDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes9.750PercentDue2024Member", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 9.750% coupon rate, due 2025", "label": "Senior Unsecured Notes 9.750 Percent Due 2024 [Member]", "documentation": "Senior Unsecured Notes 9.750 Percent Due 2024" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotes975PercentDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotes975PercentDue2025Member", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes, 9.75% due 2025", "label": "Senior Unsecured Notes 9.75 Percent Due 2025 [Member]", "documentation": "Senior Unsecured Notes 9.75 Percent Due 2025" } } }, "auth_ref": [] }, "dhc_SeniorUnsecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "SeniorUnsecuredNotesMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Unsecured Notes", "label": "Senior Unsecured Notes [Member]", "documentation": "Senior Unsecured Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share forfeitures (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r363" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r158", "r223", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r249", "r255", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r280", "r281", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r648", "r691", "r745" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r16", "r31", "r155", "r170", "r171", "r172", "r190", "r191", "r192", "r196", "r204", "r206", "r221", "r264", "r267", "r339", "r380", "r381", "r382", "r388", "r389", "r403", "r404", "r405", "r406", "r407", "r409", "r412", "r433", "r434", "r435", "r436", "r437", "r438", "r451", "r522", "r523", "r524", "r540", "r599" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsScheduleofDisposalGroupsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r253", "r254", "r542", "r543", "r544", "r608", "r610", "r613", "r619", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r639", "r656", "r674", "r722", "r745" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statement", "verboseLabel": "Summarized financial information of significant tenant", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r190", "r191", "r192", "r221", "r467", "r532", "r541", "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r573", "r575", "r577", "r578", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r599", "r675" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r207", "r351", "r689", "r690", "r707" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r190", "r191", "r192", "r221", "r467", "r532", "r541", "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r573", "r575", "r577", "r578", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r599", "r675" ] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Share grants", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share forfeitures", "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited", "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r18" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share repurchases (in shares)", "terseLabel": "Number of shares (in shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r16", "r100", "r101", "r129", "r533", "r599", "r620" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Share repurchases", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r16", "r100", "r101", "r129", "r540", "r599", "r620", "r681" ] }, "dhc_StockRepurchasedDuringPeriodWeightedAveragePrice": { "xbrltype": "perShareItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "StockRepurchasedDuringPeriodWeightedAveragePrice", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average share price (in dollars per share)", "label": "Stock Repurchased During Period, Weighted Average Price", "documentation": "Stock Repurchased During Period, Weighted Average Price" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r101", "r104", "r105", "r119", "r558", "r574", "r600", "r601", "r669", "r682", "r703", "r712", "r727", "r751" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders' equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r64", "r65", "r66", "r155", "r156", "r171", "r190", "r191", "r192", "r196", "r204", "r264", "r267", "r339", "r380", "r381", "r382", "r388", "r389", "r403", "r404", "r405", "r406", "r407", "r409", "r412", "r433", "r434", "r438", "r451", "r523", "r524", "r539", "r558", "r574", "r600", "r601", "r621", "r681", "r703", "r712", "r727", "r751" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' equity:", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://dhcreit.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r126", "r182", "r326", "r327", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r410", "r602", "r604", "r622" ] }, "us-gaap_StraightLineRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StraightLineRent", "crdr": "credit", "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Straight line rental income", "terseLabel": "Increase (decrease) in straight line rental income", "label": "Straight Line Rent", "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis." } } }, "auth_ref": [ "r9" ] }, "dhc_StraightLineRentExcludingPropertiesHeldforSale": { "xbrltype": "monetaryItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "StraightLineRentExcludingPropertiesHeldforSale", "crdr": "debit", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Straight line rental income, excluding properties held-for-sale", "label": "Straight Line Rent, Excluding Properties Held-for-Sale", "documentation": "Straight Line Rent, Excluding Properties Held-for-Sale" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r439", "r461" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r439", "r461" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsAcquisitionsandDispositionsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r439", "r461" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "dhc_TheLSMDFundREITLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "TheLSMDFundREITLLCMember", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsEquityMethodInvestmentsinUnconsolidatedJointVenturesDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateandOtherInvestmentsUnconsolidatedJointVentureNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The LSMD Fund REIT LLC", "label": "The LSMD Fund REIT LLC [Member]", "documentation": "The LSMD Fund REIT LLC" } } }, "auth_ref": [] }, "dhc_ThirdPartyManagersMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "ThirdPartyManagersMember", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third Party Managers", "label": "Third Party Managers [Member]", "documentation": "Third Party Managers" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://dhcreit.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol(s)", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dhc_USSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "USSwapRateMember", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "US Swap Rate", "label": "US Swap Rate [Member]", "documentation": "US Swap Rate" } } }, "auth_ref": [] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebtMember", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Debt", "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "dhc_UnsecuredDebtNotGuaranteedMember": { "xbrltype": "domainItemType", "nsuri": "http://dhcreit.com/20240331", "localname": "UnsecuredDebtNotGuaranteedMember", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Debt, Not Guaranteed", "label": "Unsecured Debt, Not Guaranteed [Member]", "documentation": "Unsecured Debt, Not Guaranteed" } } }, "auth_ref": [] }, "us-gaap_VariableLeasePayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeasePayment", "crdr": "credit", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease, payment", "label": "Variable Lease, Payment", "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability." } } }, "auth_ref": [ "r448" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://dhcreit.com/role/RealEstateandOtherInvestmentsMortgageDebtJointVentureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding (diluted) (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r211", "r216" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average common shares outstanding (basic) (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r210", "r216" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "c(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482309/360-10-15-4" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "970", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//970/tableOfContent" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "972", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//972/tableOfContent" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "974", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//974/tableOfContent" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "976", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//976/tableOfContent" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "978", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//978/tableOfContent" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-3" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-4" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479607/944-360-50-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481725/323-10-35-18" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-30/tableOfContent" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r638": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r639": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r642": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r643": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r644": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r645": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r646": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r647": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r648": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r649": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r650": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r651": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r652": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r683": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r684": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r685": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r687": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r689": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r690": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 74 0001075415-24-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001075415-24-000015-xbrl.zip M4$L#!!0 ( +2#IE@1[OUO8V ! (SI% 0 9&AC+3(P,C0P,S,Q+FAT M;>Q]:7?B2);H]_D5>O3,J\QS9*R-S9G%.Z272O/*@ 0GZ["')#WB+GEZ,;[#LR;63%VJ*4C^-?TPOM8;FY#KX M[%,[K)K>"!]G*+JNIM?!2G\LWP4\5#_%G_LDH.GE@1\N+A6^G%NF15^M,:!F M]=%[.H4?YBZ,0G_ENUNG\&MZH1UXAJ8VWEAH.O<#>DJWD(/T)+2 M/)F"!U]BO_5:-PB):T[@\S.8O_I93Z]53__GVTW/'-(1.7E]5Q"._>40PU_F M26 !8?.00XNT+=D^^]2OOSD!*K M_7E$0R+A$T[H7Y']]&OEW'-#X/*3AY]9+^[-E/TE!^.+07RN6'8P=\G+F>BZ%]]L_ MS_!"ZL#GZMF"> 5I>,\$G4/KMTX74OY[ X MGSC7KD5__C=]J4BV]6ME@!305@!I2J-FJ+7/IW-/S?"2#@@\"X7>E4,>*U), M:K]6@#S/!O9/:IT,B(/;W@#B[WK/E7 MU"KM?V3;03U]02)SS[ICZH-$]1 W<'W@':"@(:]$("'2^@.KFP7 MV-B&=7B!C1+D\B<0>V#W'7IC!^%D277 ZUOR_6]=T((^>WJ0:>6UG:]<+V;E M-S;IVP[PYWO6;&RRYO0--LVV\#7$LM7":]LN_'1>$/IT0$$:F#18(KY159P% M3"'!UB2F.LY"$-J_5@)[-'90.['OAC[N?%925W\&%HAQ]KKI.Y)7!E[DL[^8 M[CQ+H,?VB+RV!37V)+HDLU]_GU?\^+Y=#@9MUV!( M=D,?D0+C/RUXV<^Q8YMV^(V.^O *RQXA&8+Q/B'F"]H/K\$Z\9F0[?RT@PKJ MZ+,>=6W/O_5"&EQ$5%,,+7[&Y].ECYY 8;*"Z@>)%X,#L1$;[6&R ML]H,$-)?-MM9Y-KQMH(A 6DYV=D(U$?DTW8"6/9C^HCTM_1O?,9R2-6X@]0L M#;P34A&HF]=@2AR^L^^]B^Q0JO,%)?U$U=X-I?F=-7B58#>>^QA2?X22#%W# M6(:EO_:H"9BS\,?\!5A>]#@/Z:: ])YHNE5.2']W@_)1M:H(8.^0L&=5VAWU M>ZCE)P"W["< U.RES+$CH3\P]XG1^]6N5 MK[IS)S KB05^>';G>U9DAEV_1_TGVZ13&_L>'H(10M,;T8.TKE7NW%%N$*)O MCA ]1X1PYX>N0TC 'GY%:=!QK>3WX#"99>>^Z"'@IB"^X<'[Y0$.._=OWVO$ MW5,'4_]W (:7!TR^$A,#XL&7E]E?8NI%NNX,!K9CXP]QNNXP10JW3COGZ"J( MN[CU_"Z.QY\*?P;RO!-^//+<7>N8/?CVE5S#G-@:P(? : M>4"0<.OWGFW6A%M?*/QUX=87!'CAUO.#"^'6%XV!LKOU^U*]6GZA%+WT3GH! MJC=/^)?5URY$]>8)^-)[S06KWCQQ45:GN%C5FR<&=N[U%K>ULCN7>TX6%%-- M8935!2TZYEP0NDKON!82]0KPW+KE0,=C+R#.;[X7C<\=$@3P0).U!IP71',7?J6.-?!\^)/> M>B'\A-NUW0B$5-P9JD2)F!IWSCB>*OGF^>$C>:0W'G&#KGM/B7/)B.^"!J9O MCQ'$>"*\.[A+*/QU@YP;^PDT-4HKI$M[%\??=H00[MQM1$CWV:5^,+3'4SC_ MW;/=\'=X! @!?H$[D6I_XG*?XN4N%6Y_SNPGNXRK<>=X(]HFJOTWZCWZ9#P$ MX>8DA[?"L7_6^=^5.-NQ#(W_ (DY^/+2VT*0[EROJ)&[ M*(.@QC)0(P=%F37N@C6"=,M(NGH!I,MMG*LP/V?G5'5C#VC/M+$=;<>URJFL MN8O2%>."\4_-_) ,=\'$;4DF^0:HY+MK4;_SZ%.F;Q^\'G7693KXIYR-5]B+ M^@']*\)H+#JK2[HYSE^P:XJMG2A:+A3+W5F;DMDS19CBW,5M.M:U^T2#<)K=FOV6TELR MHK-F"X&EA=>NZSTQJ7YS<\XOD4PBFVZ$:UG157R\831SFOWY:Q N/"L*_3/\ M(7MZO[Q^X)IT7Y$(=Z'S?9,(/ZC@+FY\H-SZ M#E6SV^3?H.O0><3V'] MO==[)F/\3A!C@<3(0:BPSEUXESN*>IN5DB%-W2?JNSC#-9D@ZC[B9;WNU;TP M&0^)7;B+K'/++A< UB=V]& Z#?/>#G[,+^$:H.L#/2&WG)/Q(?#J_GEIUS*D MG+S:$.F7,K"+4&TYNB63;)#'TJE+Z^7CG[)GA!HB(R0(NDSR_^C34QO14VYE M&5\B&][F/A+7FBGN3+\]3!([^K1;2?%V])FJ;?%63!.6!G?IG7PT#LN,NQ"\PMR'FN(TV7]!^. WKSK-[ZE"4YE!. MD[M X;9^61RIHS>4!& Q3D[HE 8AW$::WJ+[&[ YNH-S'WSB=:=[-G[?C><^ MAM0?X7L7CQ1]=X,X1(L_[Q2Y;#"@E@]RN0W+'"MR\^1<;@,B1X7<+5QU-2?; MII2 M19.FD)_(60;[5J-V1WT3KHLYK;8?81\OA:V@+/AN<1?6RAO4.R$P0Y^G,%TM M#<*Y#9LM1S@[B3)K1 '\?P.I"ONGU"H-U+F-9QVQ!N4@>=/B-A3&+UWLS'CF M@1ZX#8C-I/ G'[_"$XEO#E]NZ!-UYBEDW.\H,PG"K>$V97/VLV9+RNP-W-I M<(\\Z*\OT]QX25GJV,K3E/X51W,;!14<+3CZ:#A:SV\.;8O;T+?@Z++Q#:]G M0;GGYSPU-+<)#,'/@I^/A)_SU,_<9JNV)]1;S_7SMMGRD#):::4,/VJ(V\R; M(-M#(]LRQ&/%_?04;E &DNT%_.&Y$K*IPF_Q< MC8#X"/W\K]^(_X.&R:!X^]^,&D2COH/L&JDJW*:.!964,\FH*MQEG44C7&Y" M!,=B"G";:>>*4E\S)?F9!U,*'N"#![C-3?-A#@NMQ&'3N%WQ K=973YX@4N* M/2CMQ!$O<)L1Y8KZRD$C7#B<(B67K1::VTG&1SFC555$;DY0QTKJ4+G-@*T^ M4K7L4%MNTBO+20608YE)4?N\DQ"0):/(O,L5E*YS?H( 7F,Y,AM F8=WGM[Q_KL&_^7^MZY M%XWCT';)NBFI*K>IAB*PSJ\J/AIZY#;B?:WH4PG$7Q*AQFVG(U#RO^JH]8Y-+;Y4?G:AQFVC@ ^W\:LE#)4AN\PPE M(\@2!_,XHD9NTPPEH\9C%H^YFFG<9AE*1I!'*QYSI<;2)AF*3RZ5M\^WJG&; M93@2?20(\A5!AFC@CR(#(-'!!DB74S1]1X$)D&#JCQ MF,5CKF;:060:."#(HQ6/N5*CR#2\FP=>LT!Y*G9UD6@XP-A%B>E1Y!D$,7)# MC"+-(.B1)Q--9!D$,?)"C :W289R"L?)3.Z@XUI7MDM,FFPN4JM[D-!>^723G"B C3RA!JX10/>1IF-6Y#'%FFK:!POJ?P-.*21V8K M@$-Y3P.*2,L?%SQ,-:GM/!#Q#D!H)]-'K0'$[*7; 8);#[P7]0,V"B.\?()_ M%N?XO;I@]X1JG*B;$NKLI=GP,V-+L96N,*78;^^PI&K<.O<]'#3"')4HL%T: M!+WX$<&*&2,@HV[L >V9-G5->@=>Y.E=[YG16;8]7O4?\)MSHAH-R3.M6MZHQWX9%Q(9>[B'(60 M00:.B)/*7SV\X'&RD%TPPU'3)7>AGDWH9251+L.Y7)+H_J."1=$$=T%; M?M6KT'0QR7 72!9*AV-J*67 ^7CD/W?A8"'_]W_DK<%=B%J(]/T20"G#P/O. M"N4*<>X"G.\YW8A8ZH#X=6S\X9)M) ]1^PT8Z9$\TAL/WM]U[REQ+@/DR@L: MF+X]Q@7AH;7N -Q'@/OL:P0SE M8(:"S.2/1HJ0H=XD GDBT9(&8AZ'MQV")F\_YARI7N4M> M"*(M#]$6)6E%_N>(B7:C]TU\R9Y)70*T-85Y^LV5YU.3!+LN3F%-%S<6[/43 M7%TW'%)_:M?"E]0_<,."NPR"H(]"Y<>D\(V.QH[W0NG2NK?TQ_0A& M6MPE!+CTO<78C37T21Y]RO:XE$ GO[Z'0@\B'U D,>Q=6/WIV6Z(,SL Q?\B M/H#F<35ML(M_7[SX/:3"710>A5GWV:5^,+3'4TJXL)_@*WRF]15D6SA$*_C! MC]9&T=:K3FJ?W=!'D)<, --7=K[@K>U7\92(ZZT3B^\@O!TUL&IQ%ZJ. M0Z!#:D4.J*'+OR*F9<*A9UV[3S0(\3&+WU(Z'[7M. "% ^-[3Z=O%0N+;MG MIU3!)(RFY$$5FL)=<'8U^^6)Z!52)@_]MJ.%G+]W& M786G\8:Z5)REIR8[)N IL.>K:?;')_$DMWH^?,)=-)$'8+_V>F;!O<;KF;UT M.S;@+JJWU@HLO0;*E;.XC+JM3O6O]"-O;LX/UX;D(#ZK*5Q&RP2E[,,'U13N M E'%(9^;EJ!%"0(N(TU'3@N[CW/:/\]\%%THW\#PD0""ON?,XQAOJ7K^XZFF M*/IIC_"[WSZ3U!^(*K&]GNR9#:C\/PS-"J MC=HX_/1L6^'P3%64_ZJP2]N?@S%QTQM,S_'\L[\!R2N#P:\:K8$V$F[5(0Y\.?JW\;3WP0>,\D+Y#)6\@84(4 M6"'X?$H (PC<%#&+Z"'^(V"H[X6A-SHS8+5L,<2Q']TSDZ*, ("$[,G)+7U& M/B< &X>, WJ6?OADV<'8(2^@.MD.V4V?YE^ Z'^B?HB-L)*7L/?%/T\IHZK$ MU!$"&896^N;DYRK\=+KX?:M9;2G+?U*J*OO^E#W/3W],< "+JK![8"<(K%\K M>N759I/E:^-08CU^)$83@,LQ(,!V'\\4286GI*\X97M? NYEP%U!_/#P]Q!< MXQ7!-9807*7]_?;ZX?)"ZCUT'BY[\R3"X6I[E^??[Z\?KB][4N?V0KK\G_.O MG=O?+J7S[K=OU[W>=?=VY18VH^]<-]7::$]_='I?KV]_>^C>RM+%^?_]FUI7 M/L7_@I-IM-(-[71ERX11I1VO8D.(MO8!T0W)Y*I[_RU9/&@QUW-OHQ$\R902 MI7R/HM1$!>@2M+8P]''AF1&:$%@B4&%Z;@ 7M%7EY!],%TZ?TI;V Y*.;Q-' M^N[:IF=1Z5MO%4S4C9"9'1+_B, 6 O4#/AE6XH(!XODC$H(!\#,\&]@_J742 M^M$$6!H23*MAU#^MA%>^M/!:HRZGA7]\[]P_7-[?_%.ZO[SKWC](=]_O>]\[ MMP_20U<">?( 0B.F%567NO>26OM@?92Z5]+#UTMI1MY,9$WG_ %_5ENZL9]] ME84Y-Q-W5YXOA4,J_952EQ0;SA+8T]22LI/I';O],K;&YXG4@F].1O"((=YV M8I&7DQ?P8$ZHFQ*M7FE_0Y=&TE590G_O->V6#\#=^R-1&47+1Q:X8IF+U0)R M0)Q@(B&-1$(:"Q)R-X+D]<:7TTNATOGAOG/;NT89G$4\QU\&]\:\H!-3"H3M2:KK;VP@$[D%DZ1V9N5GS< MTT<["$%JA1CH2W%2K[0OKG^_O.]=7UV#)_CULG/S\/6\ MD&Z]ZL=%ZEX9GB_"Z'N/3U& 5U1Y$6S]'W+.H>/7?_!>YXH M2U6IM.,5O7Z'_-Z7,.'3]>] ,=NN.0TOJZ"7.WGMY,X#[>_\KSV.38/D%1J( M>\VH-4_4NKX0W-HTD+T7^M_0ND]VBT+[S@=HVF/B2)<_J1F%]A.5XJ$ZP4?I M T!"0E!D,^T+V>JVC(9$W/$IF<.\7FG7U<8"RD\RT!1'T3H2(>>!%\'.9\_C2'>(A7ZKK2'T,; MOKF?R)TL3FDB-%"DJ"M+=#@#SW)O9G,MG0CK%U7K,[Z8:.E:',E'(WI(P&A" M,?V%NA0L),R<7>.6:1"^(R24+YAWX#'F#>.$&V-FG 80^=?SPN'7[G(-&7U M. ?Q.H))X=?YX*6*!8U@7-R2P")_@3_HF3^D;\3_04/IYN9MZ)<@;IP#F+6- MI$&STJY5ZUKMOZ2XVXETZX6P/BNBDJ886KZ!X=*";SFCMQBCWU[O TC<#^H";1QR$) MI('M4$LBC@-78[T8QE;^BFR,K(2>U*?)!?"2)+@RJ7L"YIZI>TJ"+3,QFHGW MU#%#-/*Q[@D$@8_^(UXZ]JE)F3>I:A*KAPRD#_!0P*T41.!L!4,/JR#24LQP M2,)7VY*>R?QZ<;'QSQZ['M.BPE>1A6 MT@5L)6RE) BEEB)9Y"6HSD(R:U#\//)]>')RGZAT04(2EP*^$EG39\P&A^\C)TG5&4HM*<**XB.0 M4N_D0?J /S8^:;I632X(AW8 RR9CK,7:M>B*%ST11C3XN)6HF0$4PBF1/!-1 M4Q.B1HB:(Q8UP-A$1MZ+2S!9U1U10,J<*ZTLKE43GO[^UJXKQ# M-B/;LAQ:3'W9S7*QD']A8*8P:5X:4%FB 46M(\?D^)[3./XYT.VCY[\LB>NP MBQA%F\E%,R&>>J7=623\79>2%\P(]4\[#3\723RWR\RK@T.@D&2E(,;>*COY MD @RJ[AF0$F[I*X]6JPUUIXMWD2&I98WW$X3LX[+JPY)%%\N=_^.F?93D/S& M('*>^L/K>*"Y&0^\#Z.+A" FW4:;!&]$<6;*7!Z'LP;)0-PMP M@YGC>BP^'05Q^ >(,.XZ$DY:.:1Q9(POX[N<%WSYLPVOAM=*+FS-0TWU9 ?, M;'*)RXKIP)C"@YEX,;8+M8AO!1*>Q+2M5973^@?R<6E 1WIMO/"*H>QQP&!( M'2=%HO0!4,-".>7I(T& MD+4_>]S$C&MT@Z1&-PJ9 $%)0EA4^AMY2;@B;E%TMA-2VU!W[*9;3":ZNO+C M;M$23G5B5!6#KO**THP*"!?3!CLZ^+5R?7NUI$B 09X5K,05TMTI\.<)T8U& M)Y;'>G/B T'/@UT%SU(FC:242ELS%%EOZ7)#FU13IFO-TD>JX*CY 3?=?-5^ M=NS%.C_IS_M$%QK23M?!%J!,;R%]6$D4+MZR^IC7Z\:KF_72;4QZZ0[]J77Y M2$_Z/B4_3L@ W)DSXCR3EP !(!KNEJ7A+B\'RM]N_K-":O&R^&FGS[A1)^?+ M7>-Y\;),UA(Q.6N?&!T%MGTZ+-A>WUY<_@^W&?-6M:%D/A+;K!IZ/FGN1K-: MSZFK5*M:5W9U('9_>8'-:KQWEQ8XT&Q'D>=>[\!XRRFO^"8=%F'>*1R9=V^O M97/S#OO!W'7N'Y(F$"E1+MAW.O8W=?3*@L P'=M\O M5?.50#LXY;D1N>2C,/:UH\-4@;S0H-"">8M1'5R7D(XDM2HT( ]KR8:ZJ09D MO>CB0W2%DB]Z6X(&A>+;HS2L M8P,LN-'%6AWXQ-PV5N_\A3B@#ZG4&U(*FA#/8ZG:)VE^%A [GG5!339J="X< MK@M]>3 4(O0E/SL2^E+H2Z$O"Y.&K97Z@=& MJ5?/'!%-*?4>A,]T0%:"]K;/]*K>5GVKQ'K<"GBIR*&7_2V! T*9VF/TK"V:0R?!$/IRO&> MI]GO\JKS&DX@ /^NU#N0#L2_JY7>OZN5V[^KE=J_JY7>OZN5VK^K'8)_5Q/^ MW2%9-(;P[[C9D?#OA'\G_+O"I&$3FS?CH+_0DU8X>LL.^PAE>##HKPMER,V. MA#(4IW@+7\OFXJ-E)*=X-7&*EXNU9$/=-^*21Z;/?PFD"SLPHR# 1ICHKG=< MXKP$-HOM3@T M!#BOL9XS3T-(B<._W;'-%Z,L P.AS[4AC -N-F1, V$:5#X M6C*4]:I:8AOHPC;@8BT9BB%(J?'0D30)@ A:\EBP"I)2: (4P +M:2$7?8?=X'Q##U M?^=[)K50XPO]?C@H%OJ=HQT)_2Y2X4+E%2?]P+]%$OP0$:^+FC!^=B04H5"$0A$6)@\UM=*>:+E957ACC["],_R7 M]&W'#E^$!CPV<: M"?7.-7)U4L^DWM-YI*X'=+^RJ][[KN+WU<*H*7KZC1+GKY.)T!V1 MQ>9B+1DQB"5ITA4Q0\\7$?L#PNLZ@R;=5WFZQ@I!7Q0YZ>(<4YEQ]]WUZ:,= M@'S%OE3$H>Q,4M*QMT?-R+=#F\9U3-\#BC^R0?V $M'%(VC9*X+[+T3&4I M"B3/E[S(AP>93F3AT6=@D, >V-22OE+BA$.3^%1Z\*,@9 $&L#J![6;ZIP51 M/[ MF_@8@HAC/,7!P L+0G8YO ^7 8] FH+W6L"-V*%M MP%K,O+F4\= M=N#[T[-MA<-$1F+Q)F=Y"^K#S*%R\9?5"9O_%9]O6KY4-N$6II#<-_:EP M>Z0G?9^2'R=D /@^(\XS>0G0Y9X%$\#HU9:7KW:/0D3C2*"]O9;-!5JCTGY M>14/>05Z7GYH8N?B(]EG8ZFPF"E;JL[+M3W;7VPUTGY>O@P4;Y'?M 747'G0 MON3_>Y31IF)$KQ1.@BS2I";4%_^[K.GFHMPO)<#KE24:*(-)N5-47%S_?GG? MN[ZZOKR0OEYV;AZ^GG?N+Z6'^^^]AY7JDY?%GW=O+RYO>[!T^-3KWEQ?=![@ MCR^=F\[M^:74^WIY^=#C?A(AB[>K!8SY+,A1,ATXL+A^D\HF),!H']"S]\"FM+K)= M]EIVTZ=Y2*"A\]HO1\#$/RU8T:FD%)."-Y<6(A56$;IXO?UUM5M=98 M^I-253-^7ZLU,]VQ:E&J7E54C<=%U=Y\U(ZR0Z6()[U_=.Y> X5KV9WMG@VN MD715/E8 7%"3COK47X"!(/$#P;"F:,81[UT_3*I^RQ?L! %%/SXOG"<6#=H[ M*AIX&#B3T@V^ 3(?5\L1S/*7! <-F8/A%8PW@Y].6?Q6&OO>&)=&@[.]B,52 MX/JH-[^&T/O$_/'H>R!@3Y)%FB:E@\%K!I?8?[6J5N.<&V[ 7]\ ^VOW/4L6 M66"E2&60&?_Y&D29ML@W$WRV?^(AIRN?F&Q80.3:X3WF#*+ JJ29+?:%>5*K M2&!FV"/B!+]63H \7#*B>.7)(R'C,R2FBA2'G'^MV#_#,S<:G5@>,T[P+J G MV#5EE(4!R,&)7J^TZX8J&TWU\^G\2E;(IO=PXL8H6*W=!0,(!C!/ZODS0 ,8 MH*;)K4:#$P;(K ('[/]*JP*_1+:#"X^/'-@C, J?TIYQ[U",KZ"QU%[2LD%S MJ8PH-R.MT203G'1"&X\/Y2/UZ6'A&K>;LT&S%;WMC'W0XK$9^AW3C$:1PPIW+3KV 9'SI7'" MS-\$C!_VI1"FZ+J8P596KM0J;4U6ZIJL:XM<^5$8_J4FKVUD?#[DI3/RTA2Y M:>C%DY=P!69= 9>&PA$HG2-P2S-;7D:E;<@-I2FWM+S2",(+. Q"W$)#O(,0 M:XP06PVYCH56_!/B\F8KS3=ZK;S/5#G&^W/2Q5SKWRG3L!, D3MWF/)/SW9# MZ0E^C0\^%Z>*#US(O4/;!M_G<#6]I.-:K+?TWQ%YOR>XRRH'ZY6VJBNRUFIQ MDM04]%:P4MTMO36 WK26W%+KG-!;3K$UKH5_7%N,YX6G3I_1!I M:HU8WQ%-M2KMEFP8O)#4,9CMYR08LFHG$S_0OR+["9#RWHHG83/E(+ 1)6 * MX7\NI_CHA.?$]U\ ++\3)Z(96:NFX+&GAJQJBZ%I88:7GZ36R.N=D)0*)&74 MY);.BV=W#);V/3A1OFUB3 4EMC"KBXNDI(A KLK*.QIXJ;)B\%(W*"AGKS&1 M;2A'9Y2C:9Q0SC'8R,E$@A$-AYXEV9- EC"1BQ*^,4:^,83,!!:S\I(!O%23 M&]N+86$36D$\-SPTW-57[Q G]'(,!W#$!;S@P M9K;4QZ$D2 ;%L':K(*1#XC[:V("+L%C5^TN A,V3@\"^LN%>>F,_4>"U%#5Q M%#%[;46M7FGKJMS8/I8AS&<.26F-W,Z7E!I 2KK&#UMG)9 M&$$YR&6&BIAYLG).L]+6P'I6FGF5MPGKF2?"62.%MR"<%A".UI0U;MRN8S"; MX_)XLFD/N$RVR[I[MBLZY@Z4FW= R;S_PQ$?&Q6E9)0<=:72KLFZT905/:\: M 2Z*^P5O"=[*NS@G*V^IR%N&49=5?>O*R7WP5A[G%3:Q!/=P_PR<=("$Y448 MMWH-J)*L[O"-J;>:[-[8I&\[T['5/1Q[,/0'R@?-G?&!#GR@J[*F M\M)I^?"=AHEFC-R<=*-()F_"1*V=,9'!VOTT=+E1X^7 DB"=/$E'579&.[68 M=C2YKHK"@WV*X%CR6K0?#_T>L'&M:?V8J$4H)"=D##:J+ M%A,<2>[)L),I@EYU +AV32="R,"W^$C;C:C5!?0E'387^(M5E?%B$PDBVF/: M.D!G2,PR,%+K%#0TQZ%\@[H"=M&:')S^RX_PH+.>.+"F6I882L7>N)B MQM;)RCXXQ$!OR+7MVUL+(YE#ZMGDV,46U(,S"NHMN:;RDK(X!O,X/GNQK?05 M'>#W&,;(RE<&>)RRTFK)NEZ*;N^"Z'B1Z%L070V)3E5:LF;4RD!T!S1B8",X ME6-QQZ"!S[W1R$Z&$[!FIRR*^$A=8/^%!VP.>,!XE2"CMJ MBQ,^ ER;G/#)/7IIV4_ILY-'G.#U9ZK*IKX6J-]!;03(C*Q&H$]=.K!-&_SN M-"DE2__YEIJYHS[CY3?-]^O;JV7JQG-[H6?^N"-^U^]A0S*+-52>/C(QW96) M FJ^K?-6+::VD\6T*NVJLAA.7/A"&A-?>L*'G4DK5Q_C8 LHLE4&G2@<>CZ0 M@+695S3935-Y [3+%YD#29O%'."OK,N^M&81"" ME0R\G75[VNYA?QT$47:X8]S34&2]I\# M="T&M*'ISDL!M]K:X@^,4++($OXTI7/I$G>G!:5!"(G55P&"**8F\ M9V! LXY5[X:R=8!4)*XXI)UU$RBVI)U&3#M;QSGY2EO%9* QTYEK-[<#RT9P M@ST])C96>DDF&=LA<42M5V$]M"8XN0.47+OG,4)F."TKDS5Q9G%=;*:J44931XH:B<(B:E$=WGT2AR"%K0>+P-)+?IC<19B0+G!H4$ MGF]=$M\%* 0=TXP1A(>5,&25M:"RI>!$F'I+DQ5UZTE.)%B"UQSX=4C? [QPO$!,ZLT'TPU9"/(#UPZ<% MBVG*:ZPT\WP62]=,U=X JFYIV!T\D)]+>$T#"VF!QSX*,YLW\LG3S,Y*-)M. M)&KI!SJ1J(QBV[)QS%\_8B?-A;V]1UD][0(P1<>,#WMA/]D6=:VL]98M YU9 MI0X.;7VQ1?+F(EO8V#Q2T1N])/*EHEI,19JLU1<3D7NGHN-HK5K\ L4V#JSP M+S[4$RPI_Q.G>[@,O#&IG: J;L0^Z2MQY_GX]$X8&VQXTOG!PQ/.\'S?35\V,>9HH,^ MO;]P?I252>6F>MYP$#8\:11#Y_5XD-6(/^BFU'F"YG"$W>9';SNNM2CZLHJQ MYLXFA6V%T(+\?,'&@HWW?9@Y%S9N[6PHV=[9F!DJI\Q62RN89\[2C(C_:+OL MO=-3-.W/?1_OG*UZ7KQGNI/9U9@4#<#<*4I;1U':XCFE'=$T>^(9UB?9Y@9K M>AA2B9B8127N"R R;K\O@0T%UA0[)/3HL^I&/\0#1.&0!A18@8#!'5)V8MBB M;A!_8F2!Z9ND@30>,PKPJ T[=5I=B;%D0896;6 B8^P%K-SJS*=Q>/'3LVV% MPY0M9VY,<*Q,;R%]6$04KKYE][2P5KHPN*NOJO9G_L75(J/;:HO6&@VBUYMU MS:"U5E.M]^&S"BRGT)K1_Y<*@B"Y:3@YJSLFC_2D[U/RXX0,8(-GQ'DF+P$R MVRR7 (N\@OMKD*T$S&"P,\"\-43N,^%F+=+01\'_M_4H L?Q 84;,@\>ND9. M^'Q*VLO07RB9-I:2Z<7U[Y?WO>NKZ\L+Z>MEY^;AZWGG_E)ZN/_>>UC)S[PL M_KQ[>W%YVX.EPZ=>]^;ZHO, ?_0>X#_?+F\?>E+W"G[Z=G=_^16N@ZU*U[?P M]Z7TX:;;ZWWD?H,?R A4>1A@W7DX]")XEA7($OUI4E#%8^K'WK $0IF48#<3 MM;)ZK?,&P5+-SFR)J89@A@MLP2'C@)ZE'SZEL7G;90MA-WV:-QWP!:_L%O:^ M^.=$7#::54VMH\1,HBW)BQ-A6H6-G2Y^7]>J6MU8^I-253-^W]"S/6G5HM1Z M56OJ/"ZJMNY194SW'DJ[*&X!$T$X>M#,3X;L#1%,S:)3.?14^N0@*;OC.L$ M!R\#^3U]HFY$@TWZ]^R8'O<8)2R7="LO8+CGU/*L":*^VZ)MM>'91@5WJLJ%O?51QI^Q20O7/ZUF< M3=5_@ 7Z82 -:%HR1?TGVQ333W8H#_3BY8&&/?::LJKE53+ 006/H+ )A1G% M4QAV$VRTY%J+ER&#!Z-RWO(X6WSKF[A*UT]B2.(02#'2H7CA@*-@&HK<:&RM M?L1YCX,BS;6-@79/FS@QQJC+BIY7:*$ VN1&J[VJZE-5,31B9_=S@_1RGFG= M3)I=_AQCB>M&^:\#'\B0<^Y'0.O ,V7E#I7=^=X85O,BX7\(SDN2:"(+1*BL M(%>EFZ+BW O8)*M4.FS"&A6 MV@U%5O6\6IF4+'IUX 2U1I/LA*):E7;=D)M+9F'Q1%$EU"GE]DA^HR[%X[A, MG5@CV\5FFNR,K'!("E(H"4J0X><0DMB363E?54"7R+4Z+PW&!2GM497D34LJ M]HEH-K8V2X1CJ&^[S+*<0>9]C"@6T%@F#;1*NYE7\EUX*#Q1S1JU MLAW9Z)5VBV_'MH0:I-QNR/5H3&P?N_I@6Q,2!/2=2D%8C=LK!2Q\":<8.1\2 M_S%[&%LU*FU5DU6#[]I-04([T1 YT5 -_8V6QLLTVH/1%J4O_]TJ;2YJ+'>L M0;9-@:J82F\UY%IN"1!1VWL8=+=&[6Q-> T@O+HF-QJE:,K.N3X2A;NB@ M"G<_X+C C](CBVO"RTG:&+9@<*R:%_@;(031UW1Z@ MISNXFR GLS)HQMD.,3:4?U+*-6F6'P6U<,"SQGD93PE5QW)_GF?5@405-T? MD=+P6"#2>):,%% S\EDO?UER:2CBG@5YK?'HA-X$&U=/M_8]A2W^FUJI3-A\ M1K"J*;D-"1814 Z):8T6R4Y-Z_6)IE;:_#?<**$^*9\KDLZ=8RHEKK'830,^ M83=NJ#Y2C'3<>-I\/& ^,XMK;)#E]M.TA.?!(06MT1DYD9".DZ_5UM99,^%U MY.IUS$R=2!YQ@M>?31)N-HX^"L].6I/)5$4IE22])GVPTU&HZ)G,'3C"P)=% M^Z$$8#79T!!9&OMT9$>CV,^Q@R BKDDE5N*'E_]GGD4*,TOI#J[B\5#3PW<7 MZ:(R,X\!\M>0F_5%GYWM*ML>UF7)=[6)&BH194GD2I8 OV-J8A&P\_)J+(KP M.'8A2.)<\TLV&EL)[":$ M^U[4L3L,T-^PV'S7O9S#37=P 9C)$OIMYA;Z%6Y\*;3S&\GH#$2U@>)F&46E ML>C;NU13^)>][BQHQ(?RYU XT9 M[.F (LN+^@Z=1U]YE\8-J1RRQJL<#3=*J#8.QV84#6,Y5QR(M_-9M$UC$+CD(#3]N#=$1_$QA*Q8"C;J171099W0LQ5(6U+?QNK M*T/-^Y"0*"_E<8'EODJ ER]+K'RU\P7/S#%?F[7.M MY7=B;B[1]*F6SYKQ,K0XF[RDT09!9GL[;,,^>< M(GKO_:N3N5NEFGE:'3<$<\CVZA_LCW0^+8&5D4>:#JL=C7#NPQ!\_4#RHC ( MBNQ9 MW2G>OB#6,FL=8T_+O8@I:6'5F1>,[0#UEJPN&;O*=:9$\,>[^6--F'.W#%+? MUWISXY &&.8.]4!^OJK3OXI3_Q$;'AM78/WF9>?Z^XM&<:ZK+8'EL43PJH'50 MQ:,EGAI=\*'%>.MO*98##(:_"P1<,_>; 7%0/LP/>=/WUU:&Q2^3)B+I8Q+7 M9N*L*%-GI?EVR4O."TER)9W8(;S,W6/C#$-Q!$PO"B?O"!AIY(;R/>8EX="BDCSYQ MI#'Q62_^<$@#"MQ%(LL&'D".LK W'/O$DL,$OQ[$,WO@QB"$+UC7G^I*Z"0+ M,K1JHP;;&'N!S5Q8GSH$)_)\>K:M<)A&?&=N3+A!F=Y"^K (X,Z5M^P1$V_" M77LU8VCF7UPM"A1;;=%:HT'T>K.N&;36:JKU/GQ6@=,56C/Z_\*I>,E-PTDL M;$P>Z4G?I^3'"<'3(F?$>28O ?+2#!Q&MGOR"NZO0;82,(/!S@#S5ACC,^%F M+=+01QWRM_4H:@"+H>Q"YL$&OL@)GT])>QGZ"R73A: 2(].+Z]\O[WO75]>7 M%]+7R\[-P]?SSOVE]'#_O?? @[1[<_'GW=N+R]L>+!T^];HWUQ>=!_BC]P#_ M^79Y^]"3NE=2[RMLZ&OWY@+V^8MT^8_OUP__Y'YG'RS/<8@?X+'/<.A%\"PK M^,C_LB>*8_5:1\1_!-F$ >?:O.$_63HS!J8Z@!E&)@)D'-"S],.GU)"P7;80 M=M.GY.F)XL 7O#*(V/OBGQ.!V&Q454U%F9@$A9(7)^*R"AL[7?Q>JU7K2G/I M3TI5S?B]H66[8]6BFE6C7A-K$FO*:4TJ.#N*P=FB> 14L]I0ZV\^:4W4><-< M0<;+ED178B'+3UZKTHZ+&F('RQM\[ONG[;BP88.@]2'"XYQE\@0<.K!6-,N) MPV!Q1VQ+NH[AJ!(\1GXN7K[&$ W MFV7"#AP\%W80'^#%^3)'"HX'#\2'Q,3KT'/ OPC -60-.>8 W5TO.$H&)T L]\\<[ M:T!G;;%=B,R1(=$6N(K$76-1T8 M3#:4Q=FE@K4$:QTR:[5VSEI&I6W(=;4I&TOF;PKV$NQUP.RE*3MGKQK.?&HT MFK+6$(:A8*_C8J\UAU?7L=>;3=!J];TU01-\)?BJT#+1!<;2-NR8DH,":Z!] MJ-0U6:MO,\=:\!A7Y':4/):%Q=8,",V!L9H8T]#UNMQLY347>'?<=5"'0W=P MT.MHNTLD)AA/G0T$=@1V!'8$=O9JD>O[&(U7:^4P=E+0C^!N@1V!'9ZQP]_$ MW[K"C^@]J)JJ0D:VY51@53[&>I_8>Z-]"\>S:@1V!'8$=@1V!':*QTXV9]K8 MX:S0NIK+4#=!,8*?CQ@[W(S^K6MR'GH2X0P1;!+8$=@1V!'8$=@1 MV!'8V0 M'F-'UJ5'G[!6B2(!)L)* CL".SS5SVN;%-#_A@*,6A>1#X"X@S5YUN_$B2@3 M;WT24 M;$%$W8,UE?_-9W<:BZJE5VK4E@WP%%7%)18+'!78$=@1V#@\[.;ID M>:K'.D_J\0@29;%SYM-QY)M#P))(EN44V5C>ZDUKK&GUQGCI?H*..7[J)8_, MUO"MWJBT=456&XLCK$2DK#STM,QM:6P@EU?0$I/-RP1PL])>/.$K"*7*,4D5<3V!'8$=@Y/.SDF59\CPIL** "^3]B5_S,1W$5 M[U<=5!IZ;>?[;P2X/&U[;XBV]\6TO=?VV?:^H<9M[_66+C>63/3EK8=5#F2X M0]+C+8HI.L2MBP#LO.U]0UM54R582[#6(;/6SMO>-_2T[7VK)MK>"_8Z*O;2 M=][VOF%@V_MZ2Y,5==&;%^PEV*MD[)4I+J9O>N!Y&:,M\E(MEQ/.@GWXH"3! M/FO99W_=[1OUN+L]F(+U;6HY!(]Q16Y'R6-96&S-8<(<&*N!H0O-:,H-1>?> M !39'G'5;K,]Q2]07,7[58*$Q%6"A,15@H3$5:6^2I"0N$J0D+A*D)"XJM17 M"1(25PD2$E<)$A)7E?HJ04+BJGQ(*/TY33UJX["RZA'O.U>WA_MG,HGZ.)0L M+^H[=#Z5*)8FEB:65HJE'==!NPMJTE&?^NE9.ZW0LW8'?Z).U_=YHJY9:6MZ M2ZZW#+EIY'6BK@2U9X=?87:8=63SW+&30K(6%I+IK89@!L$,G#/#PMC"O)FA MJ<2GUAJRHB]V%!,,P0O5"(:(&6+G9<9-;$$@*PU5;N9VC%,PA&"(73'$)DT# MWV"(@?V36B?_IKZWC!>T27,MP0F"$_:_M6R'O!8:K>[LD%>3G?57:II-_H1W"VP M(["SCQ;G"R'LG.C^R]Z"J:993P(4=A+[=CQ# 8GRR&$ HL".P([ CL".P M([ CL+-KD]I8TWWXPGZR+>I:P4QE;6:#NK&J:K",Z3Y!/&_X8SL@GB8WQ',$ MJ;%X6O(CCKH6Z3$19A+8$=CAK"K#V&3.X6\HP);,.&3BK8_C#T$CC:D;$'S? M;SZ+$BZJ'CSMT-BZDE50D>!Q@1V!'8$=@9W=Z\=U/EF.^K&E\*0?CR!5%GMG M_F2(LTB7Y13;6'[:W-#6G#9_:Z9V+WEDMC/G+;72KLFM1JWX:(<@)Q$%+S%V MLD7!-W$J5S Z4YS+M*-6:>)M7UX'4CJ^3]Q'.J)N^.5E>LD=><&O.L_$M[IC M5@=[-<7DM1LS6697T@#FDV&_Q5WPBVG M_<)V1K:\!:TR]QG+!3+E9.1EGN;.VWVW5IZ]$$PKF%8P[7N8=N=MR5NMM"VY MUC($XPK&%8R;"^/NNGVZIBBL?;K:DM567M-F!.,*QCUVQMUAFW=-4?-N\RXX M5G#L 7)LMASJWMK1:XH6MZ.OR4I]T5K.7*HDN%=P[P%R;R;FW77;?$W1T5"N M-76YJ;9*KG;%+'!QU997"1(25PD2$E<)$A)7E?HJ04+B*D%"XBI!0N*J4E\E M2$A<)4A(7"5(2%Q5ZJL$"8FK\B"ATY#T'0K_M>RG]F?X)[UZ1/Q'VV6)E<9\ M5M"D;DC]O--=JI+FN]@3S^P0WF:^G0'3, /V,*02,4UO!*MYL=U'R?5">!]V M78#EV;#61Y\XTICXH>0-I'!( RI%+HDL/)P$@'(MZ@;Q)Y8^(OCUP':):]IP M8Q#"%]@%(*A.4E>O@94LR-"JC1IL8^P%-F:\SGSJD-!^HI^>;2L$>>9O 1(L[,$"M3Y"NZO M0;82,(/!S@ 37/]^>=^[OKJ^O)"^7G9N'KZ>=^XOI8?[[[V' ME?S,R^+/N[<7E[<]6#I\ZG5OKB\Z#_!'[P'^\^WR]J$G=:^D\T[OJW1UT_VC MQ_U^/EB>XQ _ +$,@MB+X%E6\)'_94_4Q>JUSNC+V@I]R53M5/*SP@43 3(. MZ%GZX5.JIFV7+83=]"EY>J(N\ 6OZA;8^^*?$S'8TJNJUD1)F)B)R8L3(5F% MC9TN?E_7JPV]MO0GI:IF_+[6-#+=L6I1:JU:;S7X6U1#6?Y3^J@U1CJ7QXA7 MG?1?5KKSQIZ6G@QN;;+UF%UX.D/] +J22M_@NF$@78(*M:9GJ>= (O"]ZK*5 M95I+*K7X)@9-T8Q-CLYOLN%C IJ>A5/R:OPWLBW+H<6PT#D)AM+ \9X#:>![ M(\D;4[3"P4'%2%WJ7=4&15UW,Z5,F!/2@(9]/>JUM13J/2KAMR<\FP@6(H)U?;J;Y<%O-L M/F&L858>8UK=HOU0LNS A'V'@0R&$QW9T2A@PML.@HBU<#6](!330XH2WYT9 MG'4'5W%YD/MXCDCIN-9%BKW,#(J='(%!ZUN+=M%7FT.B6B/:=T95+=:QK+%U MFT&^.FV7Q #OA3[!/R7\"3QD-R2.9+/0AS"_]Q>4?=W=)$;*#;SE'E"RA&M4 M[//7VJ8QO3"O>22,M0TB7U-&-F&KJBAL#>/ (I/\R]G.*SN:F']%MD\M$+D@ M<"FKW)8(FHNYS#3'5P 7C(T[56-O)OV"DN<)SK:1(1GIJ@-#'2/R]FX'HV)[:<*)_8P3_%R/F0^(\T#PTU*NV:W-*VUBW"3WBOG_#A$4R&C^@N!"0^ISSVL=X,:\R$4[ W M";VBZG-JS_4 .]W!W00WF5FMB:S6W#ZI)7R#4L1W=D9'+70'M"7%5")>OU-Z M0!3&D7BL$Z8LPD/9H $IH&;DLZI@$8TOTK".YS[T)MBX>KJU4\[+$,C1E-P" M.<*T+J&PWIR,UHMK3:VTF[*JU440?K\4P7(D$@#\A!WG(-.#'^^7T<(6RD%( M,\3<>BZB)3Y1=?ESC$W,EG&/5FGKS47O5-2TE)M"U@C@3"2B5]KU)5Z5L(9W MBN_O[ES'P3\]VPVE)Q"OD4^Q&CST[7Z$B!!AYF*MX6\T''K6M?M$8_5W8>.Q M1M<*NO[%+)HR&S9&[(3F+<8I-# M/!/]@1+?A4T$'R=ACP'\ABBG(D!=G!4][45PY7NCY?R8G?$PI2@W6QS4 @MB MVF?I2D:J6B0<=E"SP4EJ0U2HE%#MG ^)^TA1[<35*7&DW29]VQ']-D2_C3U" M*T]S3]6J&N>,=T$'U,=S)WC6!'O^VF:+J)L71% MZ5)%W 1%7#^,GFN"6C;VQS *LT:-4.++9: I$]RZ(2P7BJLE&:]$2*'\(M00"O&.: M?@0F-0[P\FD@#.FB&KE7:+464ZAXBP60VI9=1 M3$9QK&./C9IQD&WL^)?&L3D]$TL4-G7AS>77V3TW4VQEYC:CTF[(:F.;"GEA M4_-(6WD9U=L05PT' LFU)4?F1$'O3DD%>X]NU)F]2&-[XUDZY6#/'"UQ0!\. ME;I+D/?EY7M +6#,B:,[P5]FEJQCVR2YOGTD)2L22V#,'S-!KK'T=TB16 XA M*]N?S-\'029:)%W$9'8LD%MAF>.=CC(KQ^*.8'+9ZR&#<5FAG<.8E4V$YW:P MY$XR;E'V(:"U0=E'\?5@^Z\:*T%LYWZF6:H]0M> LB)%$>(IJG3ECKPP#%QY M_CD9VR%QKF?PDMF4:E;:1EUN:"*:K/7F:'SUNOL M.%10\0L4VSC\4HDH8$7(2S,K7)9)E%# [Z0\;D5N^CK%X_MSTX91:=>:01U$E4::5'6%]Q""=L"SJ M(T1]A*B/$ [-P6_CT *U]W2>L;D>SA(P?6K9H30@)AY->!%A MVX(2HE,<=0;0J[9K.0 8'GEQ\;*R)"Z+BX^AGG.[>U^J+PQOSJ^8\I KC8R#*+8N,\Z!*ED;5\T>51%!IS76M\K.7& M:;=,$/O:!_A793\!1;C*6#[NA^[:)@[_Q=Q'-*UR?H]C$_[^<8NI^ M@B3\H>-:\U_,7'D'^\#SHZ^;)IM.A+"]_&FRV8SW)*27@P$U,ULH M1@XB'KBK NGZVW&EXM&?/#>$'>G&!YP?)YL[S!E5FC8_1%DY?- MA2\CSS.CZ#3$68SP7\M^:G^&?])%SSS'I#BY,:&6]N>^CS?.-*8^*P* M/AS2@ )QDLBRF=GDN19U@_@30P3!KY.D+=S(^K&RQ'QU)722!1E:G)T>>X&- MY'/F4X>$]A/]]&Q;X3!EE)D;$Q)1IK>0/BPB"E??LD=,O EW8QX:L_\.)^F9 M,7FD)WV?DA\G9 !K/2/.,WD)D$QGMC2RW9-7('R]^Y5[' QVML>8YT!P>#CP M"' #G$Y]O K61+A9BS3T4:K^S59;M-9H$+W>K&L&K;6::KT/GU60)PJM&?U_ M-8!;4"P@'YRC0&:#($A[&28+I;C&4HJ[N/[]\KYW?75]>2%]O>S8 _>@_PGV^7MP\]J7LEG7=Z M7Z6KF^X?/>D#7/9P??O]\N(C]WO[8'F.0_P ,V/AT(O@6590@F5/M,#JM8Z( M_PC2*9'3F&;^E'R%ROM5*=)D-TSY3F4\4_8FPF@TFM5VV=K839_F M7X@O>*7HV?OBGQ,IV3*J#;V.@C()A20O3F1H%?9ZNOA]W:CJNK;T)Z6J9OR^ MULAVQZI%J;6JH7*Y*./-1ZT)1&V8BW_SLM;"94N\I9@"BW$+%IA,B2?B.^.91T5<[2/RD/$,YXP!D,<+[AJRF:L4F4+X]2DT,"FOX> MXBM!?*(7C<<.\U? =S'3#GF@F6.G&$W'#05K2Q!CD%P M C];R_/(T[:L4*NT#5U6ZXLG:KF<\I+I+'6GP_HI:,=?@B*R#BH7EE!?!L'ESS&8GG88P1_@\T>^3ZTO47CKA?^DX6+8=+TYVE# '&W( M^O:'@40&07!,L1F$?;&,BA65LMJJ<<(RQV%0%+] L0V>%GA\VUAYR'7QU$Y! MAR3GJK%A#Z;C!2!WV<"/+(T]SK(<4&*"TL9CK;",9F%[QX.Y \]QV A?*3X2 M-8Y;E\(>88>@S'"6+RM*SPP1^'OL^?C7LQT.;7A Y*\ZS-LG#IMY%0PI#5GC M_! /#8] ]83PI?>,YX3?>L#T#/!DG6SN?":T+#LW-H^E/1\;JU751NT=Q\:, M5M:36"M/:-6;>9W0TO$$''^+:O!S;.P]=0#\'=WI,!841\C$$;+"@9;I"%E> MONXKSL!=<)SXOO8%.9WXD0TN_!F/=>129%5=G%[$(>/MN_[VK79(NTWY+1UK MD.M*:M5F;8/%+&FQA;@]T:OJ$M^W3P(:MVV2/JBO>KV(]MA[5M7S??LRBP8# MQQ4KQN*XXM)FYP3E;*ILMB0=-A&O5CNRYM5%(O_!FW0AV3BNNTT\5K2[YM)@ M%KUO.6UWW:B+=M>"Y07+<^!$[X_G&\?4[CIY^@GRU9FJ5U]G7D_B[PI*D8,W M*B$A#3POQ+;5,8Y<+(5,O[KW<$'#,!R?G9X^/S]7?_9]I^KYCZ>:HNBG/OQ\ MFEZ[X*(SJ\D.8C,ISG<'$@U,WWO&'M>>#];7M(R7-?*0P?0*(I_ERV.;;8RM MN"4Z4S6&8T9,P >Q6=X>#;61YX>/Y!&>.O:],>**8K_LF;UE[RTN6I)OT9)\ M90G,&JBNJB?)CI]C;(I>6]T4'5>+[+V^3;?6K.302;VAB3;J1;91Y[#A=:D; MJ-]V'RY[TD-76M%)_>KZMG-[?MVYF>VI_N'[;>?[Q?7#6UW4YR6>KKPA\?:] MYZ2Q^D1US_97ET$EFQ0,)M"V4C!$Y0)Z@DB@U GH>U J_K,=T%A9O.YP/@%" M,6+RE9V943[J:B6+PMLOTMZ2=K=HXJG5>/<)#&(+_#8:P&&=:9XI_=P55J+/0FML+%I/ST 5[QQ?','U.GH!G[ M++8;4:L3)M_A L!:)&,4 WX$._A"P)Q$N3?[MM2-2#;Q2@[";\F3XT+/R1M/ MU$J)*EGG[+D,%AH"ZP*L'3^P!S9<\Q4,[G!H(KL^^%$0,B/;ANN"J!_8EDU\ M&XUPX.)G*DM1_!$L;)F9CQ,C,2&B\\0*GVGOS!XX+34.P,0'9]'',M@7Z7NU M5Y4>J4O!_G1><%,@0> GW%WDLKXZ8]^&/8R=9!6_=3IW,G,5NLTA M>:)2GU)W!CBX\I$=3I?[!U[BV!0NQ0K/!]/&([LP*$$?;SD'5_!MP%PRW&-[WNQ%H"8=0!D%#TDBXU\]]P_(S=V M]K'DF#U__8,0&['YCUP N*)6&MSNN, 3CG3/"IDE>.P5[%%2E9/_9O#&Y[]0 MD/Z4= %R:[=MF.O;'M)O7@\$@P>A&, M0/R. Y3Q)S!,#-8/B6>;C#QVD3H@$0!@'Q M7QA\B30@MC_%%3X'2"MRX/$I_-%7\^U1,DUSALAM-EP;"%OJP,K890FE22$X MST$<4(G1GY2?!S'9>$R=X[+C_,9,5F-& LR\"A@&S'HRY:(NK(:PG<\N=WZI ML;>)#))N&C &UUBVR9ROQ.^CJLQ!""H5!!'M$4BPC7:'P M!I$!SO;DH$'L<"]EUYC14=C8X4N,,)2 J1 -0")/!!,V(@.91&,LDR"(1N,8 MZPR:A(U:GYY32(PXH!@SC!BQQJ WF:2Q;&R>$O>Q ALOF'E\@O8>F*.@0TP" MI#I]]=N)LA5[9+0KC2/?')( P6-CM,Z2) M3+.!V&U_HN)FXTCL9Y!U[J.-7E)\4QE)!]35A UC_/*AZ.4E\/D8."3T01_@GL]BE1P]T MEYL<&&*ZGD7D6-.[1S*5*6/?,RE%M8><;@#Y\C4(.",L/:!JAZT=P M$4@"60JP:R]\^SRTS2%C^F2Q$I*4C]0RI54G\&)5:M$!$EB:L\5XS!P[[7B3 MN,R$"1,>M/'LJA3,<@7&* -:E?Z@J4436RYL:>R1CIV^0@++(X@9"*_U+1;R MG&CVB0$-[#JQC<"8=BWB@W3]XL%_F/*]ZO2^R,LO.O?,.@>CT 2]L^.EO;D0!LY.[QR!5)6^L]Y]R9\RPU;BHN!27^*C M9$%,*SYEQ\E\*U%:\%N?16@8DS)9B7\E& ?9S!@"YSJD@I0%R..7>& [/@]! M\9)7EP"-H4+M4V:LRNES9A^!E /*VAY%(_:PJO3 F&-&5;#3?R$\W@(SU?'& M+&1NHZ;UI!]NCPM>2AHBO@E^%1YP@GLPO'828D,JR$2>X?M^,_(>DP, M*%11#$X#9H,26(IEL? J<>;LZS[%OK,!6XQ;992-$N41A=XSG=D [#.TF1\! M;@F^#7:0;&H!=K P!EQ8LT!+MF^G @I,[7&L:T>R(I@@N]/ MZ2-10@>K-R(OX":%,#PL&C-UR9X X/0]P A\ 9N?W.&])ICD[L1F F$$*C!Q M>L#[3_Y@= 0@02T9ZWLF;R30NRXF2V(%PI;[2D&>OO*;,P5(C,H>0SSOBH)H M6T1!8(53<7OG>RY\-&/;!DN1&6B#:W?VFM2E71+Y:"V)?+06(Q_8[P[0/2/G MY]_\=A!D@H9E.9.\-G\'9I_Y$O^[N-&FLKC1IK*XT94!&P:4):#2RA+&Z;K2 M+;8I B=:TAJI_\R4/>APD ,![&NY)O_.!$2BH+[+\)PJN_U$:D!V/YX)EW/]FH"@1U?QL1W>N21= M*5P-L&=H@/0=7U"?8XLTD6'(GC/[/[)7TO"ME)^PF*D\>Q#K2- M3\&KQZ9^+/IX$T]G+GZ(YAC0D;Q(91/CC?ULNZ_C$;&>AF7#NI-%T@E )NL! M+"966YK[93KYF>(.<7V(+8>X$VMGZ#U/GH).:Y!$->8A.8O;&0A5I;M7Y,/, M?R*A.^70)8"31BQD"Q;7"X/Z?!0S!=7$*UZ@WMF])+?3GTD8*WW%+ JCB1$, M8&7&)-@=U+4FP8I7;V TRFR1Q+M*B'-N8>PV]L0X5NRQ.%%LDC" DCFV O<0 M)3>&KP,6J?8F-)XL&7V]QT=@#6;AQM&+91=AZ N-U01+?T4$GQ_'H\(A['?H M.580FY% /&!Z4?;"13R@9_IJY].(;?P.]#U#WPO0P((7 ,+@N0CTV-I.PV33 M:'+JQ:^*XH*=2%E(!Y>+7L; QN(J%A@+X+V@]5P6>L3T_"1<*ZFU5-,D<9&Y M*%W2O"+3HXRJ=,E$$+&\<:RB WQ@$FIGWN]LK (,4.)$,3)84',T)F:X ,!G M&X##XAV>NQB<7 F667XJ88P'C((I?(V51L$<@B-H JVT_5GST9234G1ONI%L-"0V8?).D#E+?@.M-'CP7= MD9Y!CF$4#.]/A5JB:V9]RT18^.@)SG>RD5-%]W%F-,4"ELBBCNFJ.PP1U&XN,@%N9C@(GWL.K_V MM>.TI(3L:.K'ZJOKQT0IF"@%$Z5@HA1L-Z5@*X(^+$#T5DAH;?"G($&ZUH:6 M8U^/SAO2VUK1K?RMZ.4*\]VAX<9FM7.SW>KXK:73MX@B8P/S2X:%MPKCFDMB MGDUU67@8<'HYS7]W6:SAFN4T-X@/KV(_=5G,%;XM3I4J.DKR\>83R^O9J(48>(:MW!U,4WTT.I4Q.1"E3' ,T]8:ZU6 N%/#R['K"3( MO 5 J!L XKL[J];^CH_[/7Y<9FS75T BFGN%Q)8L)6M.*JRP4<"(8DF;@T/^ M[.3(FH,# /3IA@>R(.'-X%(S+]9-P_:> "N["I&?L?QKN*C41T3*#)VO&-) M!/HU]<2S=IA\3/DK < M=88!K,A/K5<,MU-I!.L=!DF!\1(E7<: [D7633)+! 3->Y2&MD>UV*JT/7>) MJ$@7EQ0UHPH,DI).T '_F:DWA?[6P+]T"YTT@MG#5]WAF[(>0F\I8+_(=66Q MC1/S91,S!95AK/\"EF-:$J*,LT)]ZGC/<7J,60"L:,H.IJ"Q/( )9KE\FCR" M9?FFR6!K*J-2#9ODQ:8'%N"![.F39V ;\R!$&^T1_ TPMP9A6H^;5EM6I4[< M[!QK?^2YDFNLRXR39"@HXUKKV34GJ;Q)CCAQ UC%^_0^H'$O>HQK%JVDTBJ% M01"!'3!Y7J:6.MX(]CB$ZS"HF\2Q/V".^&-UB^*5GCFD5N30[B#6"<3Y#58_ MQC$D,YDDW'28G*2Z4M<3]_#;NX=U^I,RMAF,AJ+GEQKL=)E=>1G M1>!GOPW:FUJU832S-FA7C:IAO-UV?//OZTT]KU[H]:;!V:(TK:H8O"U*5:J- M-5WC"YG)L>&F]-;R;64&@U:M*?G@1JUJ:DZXT:JZKNT--QNVLR]%N_2+1#6A MR;!!E[:,K?I+ 8*;Y'3-D6[_X65,XY/#L3URI&"(/8(90,P_M;9REM?$A >:YE66N)\^"-BVF#%P_BV72"3)9&C'N$+B_ [/CVO\&/%9#?(?]VN>"0O"-'O\_2M59MR]*U#'.L\>9XO/8[BFI6!A<*F41=:U3K MBI8UT6DTJWIK;39FH^^UJI(Q.[DRIZA6C6:V^=%OO*+>RF=1>E6K[R^G>$AY M*Y&UV"9K<8B@F*WTGP)#AJ>'!Q-UYLJIF8_EL>JL&ZSP[<45OB*X5T!P+^<3 M&*UZI;TX@:K\4\5%(( +,EX6"%@[I30EW*]@H(-]CN9Y9J\?1RT9LF;4CL_M MW^,\Y )(K1>?S[EAYW/>):/!%RMQ@Y$-='. MU4\@4FT\TB,UYY/N8;WUUPHBLZV&B*K#<6C;25!SY9"QYLK\ZZ MDZ;#I\)A"@+[!I; K3=*K%<_QX!N9X)L;LHX*Y MA^$\EZ3S4CS9(FP+$O:!%:RA&P5O10)G/9*)Y2R#*J']DM.&6%&\^>9$X M=9K. \0$;Z52=N9@B3)-:_:I%Z_DCD8+V/2(1C*8/\30 7$];^IL#BT;&X.( MB4(1-L,M8CY!XMDT+'J"L63J!6W]M;#&%EZ*&QJ'G:RQ,2_5[7+.X_"M2L/$ M, =LLSRAIKWQ7(=HEM"$\?8E-GNT?%[:(,.>O1^,=@> 6/@!#J[A+?PYI?'1 M#]B8RW3"AM3C!6_\R>DHN1B ["07[$2UHG:;R#\ZMS1QA@R%3W&*9Q\-7X@7 MF=1DP K"!LOQS"P^! CX.98R+YQH%#>'+A\.Q"?PT>7QO"WB&(R0-ZYN.+%4RU_+]@CRB3-T6) '>T(O'/6SA$\TMHTN M;$E'R#E>UZ BFF^30&>@$^^1BY%R@K^W7A,?(-QC#G7)7U-:YNL@\U59T=6T MYD.53;QW?GG5;7\)/5H[KT_32MNAA GIO7,/+:^1U5>HE.A,3 "8]]<>]QN MTQZW!FMIVN/6>_$W37ORD M25UPP<5W+./3-Q:""P$<=]XD;;UZ^7M2P6."[ MYOIK'6))J][:SE)??;68>1B)R^_,0PB8CRQRSH+%'9F,78PJIYRSO]2F<.#- M5@V<8LG ,B:ORU]*^#F6_2J))A[.F$;$Y(].*!)AZ9U=] RYKZ8C+!77%QR\ MB4?#:#<'QCIY(TQ>FU[:KRQ;OCG9I8K&P7IEUQVU-KI;@9P'JTM MJ_V*3>.:%&@V%?7[51:K[3*O*1U SWKY/'=Z?W%W8?6RYG@X:Z:FINY'4^N> M7:BRVM9D-:..YK@X9NEVT#7)\*6"/$K&I;HM2J<%AO1D8WWVNINE$VI]=06WVEJDQ5 MH^2@SC7YESV]TRRJP*(ZK:ZQOO]PDZEZ6JEDE^YB#G+O#N35&X7 -Q..'XLU M/N\+!D>6J_O=LYR1-3=M24SASDG./:$)BGM-I-R$#H?)5PA5FALWP!&9Y@NI M'^]\-@)F.<:>".4M-RW'F'7T@[,"7?G87)H"WX&0^#:\0-O M@?ZU:]PN\P.4LO=4<;HAXMT_N]!:1MI-7WF:ZX$RL0Z6_*DHOW9^!6'5._)\ MX6-TT+\=%WPY[O#%'+$!U;"7]:RK[;.+CMJ6V[N?ZE?'I+.WHSCEY4=4I#BI MRMF%8ZW1G+#)#>A.^=Y2/B#OE5D=)!+]:^?/J36:7CD!&&.WJ[^G;Z'IO,8%EJ^S%RM4Y%4>OMO3.'E,8=W&@!U/:U%]!;5/; MFMID(>TGXW.7*@NF(?7ZV'&66C\=X]-=L:)(V%FL&/-R4];LF/>V<7>BNCIT M+-0J[]]T M3Y-FOU/(G(Y\*$>06\@'&G77[G;D3F7C[NJ9#2J>_@$IA9(>E[(@/^PB&[17 M*!DTD2.R][=_7()*K]4A* Q$RV/L H:CZ+!4.9HY"WX;"=XZMRTQO$[3=MU'J5G*YB* M83MAGMQ0Y,F5'=+1V3"A^IZ[ZE"TE!4CVII0,4YOB6:[\&DU""IKC(-I4K"? MF;Q=->SEQGUBU).2 [#'1]0X+R&D8HA$$XG6G$,L+NG)]"QR8'ITECP1_]%C\!?UR"RK8&\:.[R=@JTIZ/#(RNC!EO1\+@QS M)$:3AW#8S^^M^Y;D/YMSOK^)N(J^$:-[ BQ-<)T,>,WMA5\: )NFXRT#X)/I M6_[]'. ]OG7^$&>!T% RMZ^>71BM#-3[Y1@YY([\M=MP2%YZ(I$O7TP:6AYF M!V0,X287 MDA:V;046+#QQM*4TCNZ&!I?+J_\=?@1$!WH9?^*GJ N^$%/QUIZ72Q/Q2D4LPX2DJY\!G7CA1>M+EQ3ER*I'UY E5J=! S*GWBHQ(&V*A@R M)@=S]GOQSZ'W:_YHI_K6=X()!YH]&M&1:K5N. M=5#HZWLWS$25Q+8Z-7_,I MH.-K)]EN81#.!\Y"M%YFGZ/5274T?].:@/8XLIBS/+H.;%=N\3P#N3V#W"G- M '?8^4WK9W=^6_5JR*$230W__OT''SE:Z%#-3,B\ *<9T1T GT^N'[B.O%PY M4@'@=M@E6V]G=\G.!5S8.AUAM_##697BZAD?'X4C5SG-X.]\>C5>%<_F%.RC M)96>=TD'!A\T&0?>SKD19+]$8S ?'10Z .1RTDU;+]V XMP9^^KZ_A>P3W/& M5I45<;J"(JZCI&T]VN3?WY7:@;ZZ ]]Z=.#3*[>27BU89AT]W57OO9C(RZ>J M+1_RA%R,*[.M\*NU\ZU(P./,VX3O4@P^)C*+4).FPX*80D'I2^_X,.SW--:7 M7LE8]$)X'4@25 &77DS)OGQE_WT-N#ER&CF( E^TO!A>TU>7#9G[RZY\5)<9SO.CKG$>BN+MX=FXB( _'<( M80'5@?/R 8BTZ_CDX$A'+>+_\7.5@=\_4>( M1$/7_1%"CHO+T'PU1W %3W&,5\1-]FP,E4.MTO1CSX72"8]R^$+.H<='%$K! M*PZJ\YJ#^FQ-)K!64) _L>"9,2<-"L+(Q=$,>"?8JQ]^2<6OAB4G@.'A&3CD;#B\U'&@G>Q D@ 8;26-)=CR4# M"C=37H/K#1(KR#I9'-C3U=/*\"0*?!0Q$*)="TM J'&E=]:KQ")([Q(M\8PN MCF\Q MA[#I19!_R_[G7F=+^MX*TXX> G'3U(NC/H_LPQ#8V8\/Y@0V M>&[:S^:+CZD[21T(%""QH"XJ0*OPRH7*84;77_S3K,U:)*!NX$-_VWP^P#4? M*+P-1'>)+ P(\)^_FOF^UKI,9?]\_[ MW^\?:K_XF]N'JWOIX5:ZO+WY?'5S#WN 3_>W7Z\_#Q[@CR_7-X.;R^O!5^G^ M ;[X=G7S<"^]^_UF\/OG:_C]?4&[06OGS.T^Q)[?C;%WH!?)$G)BN MXY!BT M(523YX$T!S;.U6*0"B9:C:BC('=_MGS&A<1XM2:G@/$DOJ)>X";/]E@ M5,2Z1)]K+2#MV'@0B._PT0STCCF2B[> M?$GIH(S2V>P(CCC5\#CCL2P_5-H M^9)-D$.&6#R^(4L^0H<(ZH<8^L#;"(6E*2CPP72$KPGUM?@1+>D6 M-!6;@!WE_:'R CS91(*)$L!";9X"]Q21IRP+OD! +\>=X;)M,!B9PR96P-.B M,,U,:.X4QL7WC.G?<<++SA?P$3^##'$]1O;/% P4N)AG!'$UDW$/)5^C6#80 M*WT"2'KHU25]KHQ;LB[(D'$4J&EB92 <':B140H@P%Q&7H8I&XCZLC0S7T(E M."Z]O27?H=[)#G99.Q@V)5[Q3%O?C-YCF%KT,#@F433+X$$8_D4$"$'\P M\D:03@X82P_PDU:,BW$C'Y"&L 6W&WHOGI+'SA,^GC%#+.O,IV8@\,^VV2@P MAY:-VC_@E+\8HB\0_0V =0E$XX^-UF\1.(<($5#CA6&5P!]ZI8@-$XYAP'A, MP2.1B\82CV4_F3>R?(*O6!J_-WRJH)S0UX%TAS8'G"::^+3/<'^ANRZ&PS&B M[9]D*WF,<,%;0C2 )C?FX9\GYG 74C92 ':5,G8W3'&Z%Z_X"F^X2P:88[/6 M:*-;)L.LI4A6J;5L2FU-+::< \G (6&RGI$K4]*TSHE$P"PUV8>$XW5-S^9[B,$J3%MZGP-J5QK3AON$["'8DR.7#6>VC";'-_RMAQ M2G5@CV.7"EE"[!<[G@''!!V9'$1)B;0$_[ &(R73D^*:1[/],)R]5DI+Y/P0 MUZ'YD_"MTNOEZ)U'.8EDH'QG;^I-$EAGQ=%!@FR M!^%1R8(-6G"_E\$#*I$@,J*0J"[)Q)HJCQ)YYEWR\7=\8I8KR>W+)FK<4?2"=#K=V"- PHEX;D0Z*2OEC (SG>2 M.%^0Q4M?W,B:>$83-HS><:8*:V;I9"\OW!<9T=&^3"$$['!GY"(8^^'#(R\.9SV^)Z7&R Q*\,HWD9:Q3WAZG2L3%' M9EQ2D/"H-2TT"OFE'^B+H@&N5X9+L$C7%)L- RJ3!64VND/;>C0%+88>A!CO M,YP!Q..BA,;E@X%OO&H4TFRO&*'O[020EW"W-+'W0/579<-(ET>79T^E%AZ1 M5NDE]VG)?2V=>)?2$//S.JI2L'=R*ATT'359ZV3(T]TN_-6GTE%HR=T,(S+[ M5%+J/:?GC12\Q$K(%9DT 9 G8;/5))O&M/X/UL\/4VL,XN<<%ZNNB)^,2\"L M21D3D<"C?VA=FQZC;WZ3$;XIL:OE-Z42>_DNB]LUTG72F?<<.9O^6EAS,A! MD0[5<##N/HH9O4P[=A'C1Q:@R?4R67S%U4N!J;=',2&XXK M33!]Q N-%]C@PB9K+2[@PKI:V!H%Y7^";1$E)HW,.=3CI^<^U@ MS28;.X 5KXKB\(=FO$H]EMC.+3G(PB)Q*F&-51<_Z6%#=_OJ[R$I+6=;RWD. M&=1BSJ5WROMRLJ=?ID+N]7U>.C3U3VGGE.@GLWICB/&8+?FH.(M;.&%9J(-= M/C]*."ND7(;4GK8+2EM?;\N&EF%4%MSLRE91E+W3RFYWP_%NT7*A TI>3^YT MTE-O,S>U-$10VJ8K:W=33>KZ":FE:AV[[0T=6@6C?4B,21S'958\^QA]G,D< MVK))?1O.,&OD<3B<\Z:\9MO% A]-UC,UVTS6(V" D6PL7,9-ES[47GN/AZKF M%+ F@AF)$EQ>=QYI4>32!+W'(J66.JMPA8DK;$D&3BXOI/)2Y]W;4+3\A:]G M.V.@BX46LJ%F!)2R#_FCJ/VI]\GJFT^6:#*99+XE>98YKBV-SJY!=C78(X5) MLYX.P+5:T^\43; H&AEVT %"FRPPON_$5JD:!9V>PSJ/<@>WJ2D\1N-N)Y<@ MIRQ4!8C.OID_T='VR?4\&IY[:<[AEU?07^?L0C=RM*$1O5*:B'=REH,E$P@# M4!0]\]FANH&DD1Z#@SQEL!KX8;&\T"+X#FKKC*V>< M59/5!;VUV\J8;;$Q:I+PFH!I_V_3";MTP G-%YZ_P!B)\+ZN0ESXBNFDRN'T MAI+@NY"B,%4/(..'H"F-OU01H,D=->WCX^'-6,L6 M(^ZO+@>15(GQ'HD<5&2CUY%!VF;4_5P[2\U;.!^CV"K%@1%2/BC0'*6RL(0G MUR!84B"C_*ZC@1.(T%PXE3]PXX!L'61*/EN/)Z[C"R,%X5)6)&#NL#,'6.V@2@/\[ 4 M".0C0 K6L;#\:0A>[EK9&LPYS0G^95J._Y5JCVZ=JZ67WTY>8UKW--X4-T/- M*RYUCE#S6U/DB\F=Y4YO3YX>X)MK/#W<@Y?ET)'&8&N0\8@N<*[8\2ZY 3/Q&O8LK;RO/IW1**J9="1A@OJPUMDS/"NU8;.U2 MWJ++:Y>6;/R39.?5K1$] 4KKMOQ]URR3;-U**"+A23:XF3&[%\LFNC? M/P=VQ[#<(.PD0BUS7O+-))$!%2TI7C(OGXW[YY33-/J](RI[!<"29Y1GNQ^C(^)VL]&^6>_+,1L1E^/L!U.:6)X?8,H$GVAC M6\P11OV(]XI.=M)B)E!2FM(2X4W*>"QI-*QKY+N,@K%Y<#OA[8-"$V*0L.[_ M%0(ERX;H8WY!UJR$<%\K35S]U7UGPK4EW;C2R/2G,;B>K6C B>A;YH=\AJ"- MC"-LR,W- ;R8(4M)6.?*IW2$_>O+FLGK'"CY%MI +.\/7-VU6 C^ ML-YHZZ,75VEEC-?ZA00H!NYFU/H(9VE1/NG,XM$\8+5N'+M2N$'][X5-GV'? M="S86$SF/#ZJU5Z!)(%.5#$LC9(1^4%P5WP2I;OKKE96C"V?]WCDJQ#E;>4X M\X8X6K(K&/?Q?A8O?67G>'CAA=J6.T9&.E78JG(]1[(24P(2:;G5]+[Z4]3E MFSBFX0.-#Q(U[W&Y?'I0RPH!QV:FH?36?#J+&\(5;PO=U2MV2LEK"DR(3 MHS6A45=.)OWX<+3^1& *0D>TB1".Z20:S4\8:TG7$T1,T2Z \>Y] M'&IR?%2)6AV@D2&C UVBP'%,#_$+YA2T%M,T4CT7]\&7Z)5)]L3I-CHH'E;/ M9$A&/D.B3*J0R?J[W@-_S;53?C=ZO!MRHZ:IEC/&7 MB(*KCLE06I59[?U3RFKO;)'5_L6T/)*;<6J[G\YM[W?3">?];CJW'9\F_1$J M"8.X!N9KLC[D%3GO_&492U"C^9UE-\Q7-W#&B;5]XX7GXUOG#H4)8CI<<.,Z M7O@G37(A5T\&E'JK\$@Y30ZOPJ,^%P?< UYSSJL)_=6XF"AB(NT%]7-1ET_L M-=$9OD GA*6?-%G"*0N/H-C_-S8+;. %-F]1.5\$9#B-P:9R>'>$E6;T4POT M7'CERU)GV(4?7[S4L)WT,=I-4:NKOTS\1K8-QL$7N9MI@"J9'W.?G8 M-;?-EW/+H>.@FSXNOPZ?OSIE'E_'?Q8^V[[>,OKDMA5CNL6+A4>W!3_]FO[> M,%H=5WO;X(;A M[05':I>\K&83UU.RL[V2.Q'F@.@%IIN?+BA2U:M+T"B(2+6:=)Z]V\\@BCV+ MS(KJSCMW2'8[/2>[WL@0]G+GZEH!"+V:\S;0WANT-U#O:^%Y -(NW@J%X!NI MZU+"!/D6MY'RA3%R_K9903;PA-W8L(!CAO(FTC='/QX]=&1_$/L=C1B;3%Y- M]GE3@\F!5;UU6PS&R_.JUDX!?/>5[$WMO;23_DA&JV<46')&-A.B^@>MI628 MA-BNCOM]WBFKT?M\?-IX]$D2+(,N;:D>LF(M2OQ]E>)*[3"Y,^KO4J>ME0K< M;"AC2;!JWI#[JIKR M&&5BPZAHSN1QZM 7/G7HJ^L\ M?L4Q<%5H#MC@I"]W]73/C./7'!JB:X@NC^@VM'+=@N@FUD\V_O!?YKE9]*9C M7+:G*NK'$R2X#3I.E53\%J]JP+M[\/Y*R=+YV=IA;O:23JUU5K*U/QPPWSX1 MJ=__ZY?ATFEI.L(!2P!*5@]UEOKGJ*O\F9>\?F/!U!W'WI?;9X=Y_M2:KZW# MU-M8]I15][I2\(I%8]B72R3XWS-SCC,[_OT'SK%-3E*T8O_/II"&7V;((J_* MIU&^^.;5.HAPKBV.;*6Y@@!6[(Q'G?C@E0O''<(ITOC"L,@AC*B(O]_S>MM- M=R7K'))U&(YIOV!Q%1^<'95[OK+J#<1X\M#U[$._Y^788#=^>;JQ$OZ0:UQK MYGEWSBYZK:Q*9YD7"UK!ZIB45^] V"EBO.R<"J7V M4GEG:DU_W%S_QI\8UMIE%'EB,6>\O%Z2H,(Z*RKXY-588OJEQR=@4X6W[R]F M8M#SS.23.-=A5X3@5+GC\DZ3LA2\S'FK5CY )YYOSAOF<0*BB9:.F.GF@!ID MS8G6Q*KB2M+DH.APU#8?G3Z?>Z8%5 &KOV=,HBHXC5P6DX4G)G!R*!'VL$?3 M&_-:45C_$@/(KP>JL4A13T*D*#L4*3AHK;Q(^7K_[7,C3[(I?DF:4"')D 7/ MC*WIDYG'E+6=,&6EC4PYH^+XE]?T_E#:^FY6J>0+OSS)MQVTC=WL V->![:E U M L4(!Q0G?ANY/@U2EWQFVW)I+%#:.>YGY/,Q;!+N9_Q__SNNI30N=',C/**5 M033&(MJ1F',C:)0*FTA?@Y^I+0QP2@];[GA\MFD!+FL.W46014!A^[;$@87O M77->&9U9D@T^CJ*U76+,;-C-47##,142#V,5F7=] !@^,3%4B$99\4Y#81,= MOWQ;C-CHH(9M)'_Q QHMP!#XP Y;*&?VRI*C/VD> M!+YW9;9;LJ<[?T_\X.1@-[PNT5BRM4&C2DU='$V!%]HXA40P0@KM8([654CL M4<#'Y_W%XK9%.6U9=*67ZAP#WZ6;USPL*5%^W*4KYWA!L7%_"@[$N=4R^]XD M1^/')AJ.\7:1U#0.KXI;NN*4*VK;@@E&ZSKH-(VTDV2-^O42=)I.VH=82]-) MN]Z+OVDZ:>^IDW;P8VQ=MV2YB;9IT_Y@[557;M.NH0=$T M[3I #YFB"?T[5V@VPDY=ZC'%9R'LQ,>\D7?12O96*9#9+GDT2%WI\W&< M6:DH(W_LF4V2B*4F[XLPBUE URJNVS"[W? ME7O]JKIYE6%C%=7<-+36T-I6M*;NA]84/BQ9RQ W#:TMK?\M$]K)4MF&@615 M49G*)9IN;%V97>JD&A)K2.S@)+:A=6Q5)*8AB;7E++NI;B1V@.XQAS2XMS6W MC0K-[0VU_0DS7-7/+O"W=*)EEA'>V4V;F.A^M1QV9/+.(^H%%7D?N]NJ#1 >;-''7,2=UMS$GM\WKB4;["2-HV$N^;:=#H%-%H/[Y@33N[T'JZK&3TA3L,&KTQC^_V MZFZ5/M^TNJOIJ.YJF?UG,M1=36F\N[OF#/OQ[FH&%S#M3N/=/4DTVH]W5^N M@.GJ563--&A41S3:CW=7ZR(WTN2>OK7QW:!1'=%H/]Y=K8?!LZ@:W);WSKNT_A3ZHA& M^_'NZ@KV0V[+>J\N_I0&C2I%H_UX=W45N9$J]QOO[FFBT7Z\N[H&W$A1:A1K M:KR[)=7=W7IW=1U;N:M%DQGT)G=WYYQA/]Y=W0#. .INI]\D79XD&NW'NZMW MSBX4 ]"H-OZ4!HTJ1:/]>'?UKN!&:KT'N3=H]$HTVH]W5\=Q7(;>>'%&X:7, MQ$WWB-X:X5P'.)JQN\"Q!-1?XTWVAZD2,B?$>?834S(PIB3WM*[J=V< M^&L^H-@'K#5G+IS ?S&'C,'96OZ(IBC*TMQC,VLQX\. *?)F^?Z"PFXTIWME M6/3ZX= U/AVU=J?S)XVL!E:0&-8;HKX7% MHY)X9_B0>!AX2X)W>#C@=/9XJ++D\@G:.-H8 MWY!\(:++,Z/1\ *W[P?P] =+7(BYB.'DYIS= M94Q(SYW17-\9Z7\FH1"DQV4C#N7*-\) *WA)"[E>3C+I>#HZCV3:-V;Z@,%X M]#>4E,K'?]_SIP)N+@D]V.$(!=\S8*K/G$CFM6.9UUTCB_/7VC_(6GMG%\%S MNI%MNK-MR&KY%/',;-^H1HPH#K-G)T.;)='REO[EDC(EB(DB\++^'+V*?H=Z% M(M_TI]+$=I]1\S+M%TQPPH7#?1X2(\QS4*ZJOB*;!IU#S(ZH*G!-&':=58 GPLM$J:UFU-HG[3UT;GNA?@6H3O. C/P,*@L@ MM'F >S_9<$W,)A3.KP#N;#P(Q'?X9 8L90[/!M,5EG:/$];%D_\A\6>'C$0L M[F+Y1'/FI]/#-QS4[@Z&GGAN!6"3C@JH4Y?N; 9+I\U+WQ= .9B5>%[&/JJ) M8O@9I(A0UDDJ@';M!%-?8@[:"1DL5495?RZV/"9V_?CHL4>A.>>+0825GQ:" MZH9Z)$+=.Q:]D2_X.^S6'=^+9Q;QF20D(-9"MF6EFRZ%#'GVB)\O7[/,.=,8 M32-3XM#$OX24HHM"P321_K[.303+IC5O (.:U 36 >!/L9@!7\MW7$36CC'$ MVC+2:6826(=+FY4Y:P[M1P0L7,%F<]M]85RFW7V[0PGB _7Z$[%'%$+F3S)' MD1=P.3Z6YN8+"21W:%N/1.V9!BPBWQ.*#[@-G@2@1)G^;((*DWD@I#S2NYC- M58,8'[G-O'0YGAM\#1*&Q(P0H$(^<06:"M.(!CQS'*G0V6\7CR-MF^LHXIXE MK82$VWP.[ 0E9+1 DLW%'2GM&O$\D!:!9PT7=(SG*9Y>7!A]MIXL8'MC'Q0S M&R Z?D 098@@?578I(;_'BO_'(N="RH!!?>OA>F!>F2CMI2 ,[HPDM@G)"UJ MU=AJ MSGNY!OX99%)U4]^/"@QWY!%_RQ#X+G2T-PR"I&8C@6+-[;HW"HP'%Q1":4G9 M.^@X^T-"*#L/X-^F \K:BZ0(C>Y5"=Q%BA_>)%15M8%J=5#]PH8>1U9C-V"M M#)0GEA7U=L:GY_NTM VN/>Y%)?]6Y!,(GW9I^M/O8!AG>;.,LXMVJUU56\63 M'9K>4-B)4-@&RDHG%PJ=WK^=1'25H+6R.88=RC'4VSN?GUY9$F&^>AKZK6 7 M+)\^FZORKFK VX#W>*_*R#!>#54?1=#VUI$&<\^R(Q-T):B0$TW("R:X$Y$9 MBH$K_N#0"MLBHJEOH?V%D:$L[:^;H_U1+%,$,3%^.)][[D_*2 $PK-W#AK7O M7+[V\N0KSY+[B5FP>'9S\T4*II:_?*C+*5!@Z77$T?$\(THN@FNFIC.N,K?& M.*7@02T0_,,FWX@9,;;AP^R3RWC8*CB/]K\C()QBGB MW\"VPB3,6UH7O$&<5=D\S&X[.S-8$NORSZ5O;(PZKG0[F6!R">[^JS5ATOW( M8IA1^1T 1NU7/I))%=.74[W;K@^:1Y>1GSQ_K?;[\17XK0=!%A\N&/ #D"CP, ML-@'N\-O2;< FN+G(]Z*:25 ;$ G"" ?GD5@GHGGN/PY"8A3M[LQ\O[P&O@1 M)8[',T1=6+P7_4;MZ.#R(6( \WU,73)]4 UL&_^U<6V^6%OB)?&BXM<-+6"+ MHZED@UP!>+B>Q9)O#*$5,*#"0( #,2O:Z=+^3,=\A.>6J*007$#')()TNST1 ML>6&<^(NP<':\2WF$,S+19!_2U8*Q"$XG;(ZYS#QWZD71Y(>V8>AQ\P?'\P) M+/;$"'Z)W [HX)^_FA>YZ3C[Q[0L5>CLXO/U'U=W]]=?KJ\^2[]=#;X^ M_'8YN+N2'NY^OW^H_>)O;A^N[J6'6^GR]N;SU( _OES? M#&XNKP=?I?L'^.+;U\ >0[4$Y58P-8-0< *04'W$\@F29[:+V7OX%^@]:,H% MJ%.*A\ %,N6ZNC-40 &(6 PC@TWEL:0T9-X3I8N"LA(]!N0N_,8H6QJLL@GC MI8I<%GKT.51M*9LTL5ZTZ$">#MG4M">EBF[KH[:#JN>&NOK__*VGJNV/H)%] M$.H!?:-\#+4MT!5D )<%"D=2;P ;=PX,%JN4A6:2?\:\!M6V4>^1.+F*@\>S MBA4;L)\]3+GT@A?Q=A!398S0G2#;8HRUL0^ M\/5FP&U_$CY8_"IAF:P%:T@_NTJ#OW=V\9ILW_O1E(T7-KN=K!K*U['A]NE% M_)@VF;L97*BKIDWF-7Q,R^1C>C$C^*#IL7VMI7;ULNFQNMKJ]KH5Y5<:O7*9 MFFN2/KO]UB4TC+ZZY,^FT6%B^JTU[^\8'ILP62Y[':PRG$FU7UQ>4N# M!RH1^,9+!*[B$H&P-%4ODVIWBIU.BV9NO3)!:].L@S+"8.?*5C'4*NR$*CY[ MH AP=W1 ]2-=]&H529IK@)8 V@VH^D*C:V!7$G:78#;@ZM%@/U%Q<,>>&"CC MB=JU@TF$VB6"U454-H!I '-Z@*EH?A;/I%5;JE%W1NL$%")'E]*^4_]//_?X M5-.+-W0.%^+[B^?.,/*%S_S3"J:7"Q_VQ[RKG]AJ$N RP!"TC_7]/\OF1'6U MLPM#EY7M>Q+79ZA-0R^G2B\;6G5O32\3ZR<;?_@O\]PL4M%1TO541?W8T$I# M*W6GE0U]L?,NHP7K&@P MW/&8<&$^":60\$Q?GF]2]>2X.,SVY@>,&QOFU.]8I>M6IM(UX^OKB%T;QM?O M@ZWWL EF3U;4=!?,!L6.'\4Z&P:A[YB!]1L&=LK8M:'_P![X5Z]=-_Y5:6BA M7V^EE#<)\T08=V>MF@I,_]ZN^\EQ4V'G\-9A3ZG83U_W;CP-;A;$3?7PN*E6 M)B(:Y#PMY*R!_J)5ZX1N4/,T4//PB*D#U^RVY6[&>(P:HJ;0NL-%1&5HE(Y= MI='7W/_V[J_(I*NS)7F.QX>^\B<]+ MHFM16#/>Q(8/YG:+NEA=XM#T@3,.96QI5=PXNU UN=?OUL3%W>#1/EUDU>$1 M-G#N:;*NU"56TB#2/MU9:Q IC2M=P)7^UEZI!D]JB"?[8C>46M*5.]MWC*]C M:+;^:N%G-O?@='@;'&HN-,..._^E+PX9K#UQ^MJD&";/!3[;##\ H0T2QU.: MV/K K]MR5Z]+>FZ#4OO4$7>!4OWVV87>D?NJVJ#4*:+4!FUQ)RBE4(O[[@F5 MW#0855"OW D^J6<7W;:L:%I-$.J-.1[_Q1PP%FRN7(YGEH,#*:@W=^-W/)AZ M*0X%26OI2(0=5R)]NZ\UZ=LGC4D;M,H*,:FZXO0&D^J(21N4R5*85$#N&R#W M9:/3:Y#I!)%IOZC4J1P&]-R1*MTP #'%Y@5#K\9H?>Z>*_3QN3;B2[Z28P@NG1G0\LA M&R]QE'?\K"C04$:9J*XLNO$CU!&I-JBENT&J7H-4)XU4&S34,DB51I[^V46O MJCSY!F_JA#>[PQJCW:X1UAS P1J B8GC4![$6)ZS838VVMHLU7QS*Z+WT^=QC:IBENF)1MMX^S" MZ,C=[LY;U1R;)?]V46Z#8KDURG7.+C2M+6O:UE&F!N=.!>#]W6UI&/FP /J52I$S+P2.Z=>[A@&XGWZ/C*&ZD++*_%E;P(OELM/ L/#=9,3OM% MID[=D.D-.!VOX;P]Y@=4 ,8+ORQGY,Y>UVO@S1IGE:J0X9D,G/$MGL@U'4@9 M2FIJN4X;@38HC=LC4%.W==H(M$%-+() !5Q"V#Y/5K6M.RPW.%1#'-H'!JGM M>F'0&_ L1@JAR-=M7(G[C#UG$U'4A2--(-C[+Z.79'&?>V-WUQ(S"FIX:S!# M/;O(Z+_2(,:1(T9!S>UUC7L,53N[,+JRFE%!W6#.<6/.;O%&)[PQ,N8:[AUO M-BAI8\N?V^8+KI'EHUES5=Y5E5:NM3.4X=7F6'7J<$ YFD,&Q,&$GU0*S)^A MKDQ.5!&1MQP,Q$O,]!S8M8\)G9;S!!3&FA*XNFC;.4DQW%;%HPYGP5K. B C MAGBXCO^),(!?]V#^9/XWRW$]./:$V;O\%!XK^<:"J0N_(!Y@-6OI+!O5P,G& MW8RAVZ6S;)K2D^/'Z)25<(08C?.S5- XTS,V&I1^@RB=LF^.$*6[5 S=[U20 M"]F@]-&C] D@= ^TCJ[<[]::1[\)Y_RJR=&XYP^8IB$(4?A,/C&'3:R@1)A= M[==CL[\]!H32J8!_'7CJ2WOCUCQM#*L,/ MM2;X\0:R;J_J[2,^/I+9@6)7L0VE:4!>IRU"]!J7VK^F50JGU>E]U=5P- M/M41GPJI?1OQ*8TWQMF%VC,:G#E!G#F$4.N@4.OUJ^K V*1^U/JJ!KSURJQ9 M8W =76;-#1A"-G"GJAW:F^X1\0C.0\XU -_870QMQF,26T2MZF9S_KVL'5\) M9&HM7G>4/P2H'$O;TB*UBZ,SE0P[L;0CIHH#/)"#KZ':AFKWG".U'=7V*LAB M:LBV(=N&;$OF@6U'MGW*U.IU*BA;:,BV(=LW3[;[(%J=)GS*JI&>-7,T1$NF M_J^!":^*!JG#7D8\ZX_2_2["W=TL9G!R(SY5'F%@*7UF=+NFUNEU5)T9_9[2 M&<)G!1;59H8^_+^.?A8^=N6IX7#=KHJ')7YAXT$0?JN>Y=[3Z7_0T_? M\;R MR/N9Z3U:3@A4' "0A,R(8;8BC@3 W4%C$B_FO2@MP_=?T]YK24I5>YD_M MEE+R^X[>*75'WJ(4O=7OZLVBCGE1ZQ^UP1-X1)D.V7& -7O*#NXH1?;..#;(Y M !9]8V/^^.YZP03@XT;0YPK%&@]Z$>#NZ(#J M1Z7WO]U^EXK$'1JH)0,VKO/AGCUBW+B!74G87;H.K=X,V+B,/#B%W$<^#=;$ ML;Z5)SENNF>MN;?6XCMQ=T;U\*FU4Z.<*U(O,*&ZO!=#H=0939<[[8J'YE9P M? ?*YFKHMZ'?ZNG7V G]JF<7FJRT-=G0TT&_AGX;^FWHMR+Z[>R$?K6S"[W= MEWN]BL>'-]3;4&]#O2'U[D;V8K=!6=-[VVXUO,(>QL$>3?DA7*JQ0)*75Y+1:JN"9% M77%W)OY;(E+:C2*ETVAT^=Q\9!^&'C-_?# GL,-STWXV7WP\J*0'V7+"%771 M?;P*L%RP3"8[ PM'.: ,.0=$9QY>!6LR:[,6:>HA>_C;YO.!XWF@.+$[ MD; G#E:I_/-7\V+Y[ ^*GBD7'Z'GY^L_KN[NK[]<7WV6?KL:?'WX[7)P=R4] MW/U^_U#[Q=_>KFWO8 WRZO_UZ_7GP ']\N;X9W%Q>#[Y* M]P_PQ;>KFX=[Z=WO-X/?/U_#[^]S-[@<==':68[: ^WYW1A3#CS)G(%T"'PL MS@ZF[@(>.?9EB?T<,>#K1F==B*M;-,*UW[R,?J>EZ4;9O Q=;QE=HZ+ OF&4R_#( M#>QK+4VIW:*4EM(O^_*WNZ@F+^,MY&5\ <8-3%MZ #V$2=_@^JDO70$7'"\G M:VA-LD:3K-$D:]2)=#%9H\DW:'(U:I^K49+M';+V^HX],; D_//#2X3:.3OK M(BH;P#2 .3W 5#E,IMOJ&G7GLP[FONUFP'89D)UF_.TT(VA*I[L^AB:D=]@U M'I_YIQ5,+Q<^[(]Y5S]']@+A@K$V^-_XP?Q9.N!FT'BO=L:DR:/M'-;0RZG2 M2V_']+*V,Z/>.<'.C VMG"JM] \O6[IG%WU95](M&!IRJ0M.->3"R65#E]]] M4$OO[*+3D77M2%INEFI:> P6G&]A@,&7)@P>BMY]>-"3-7IEP_8W.^.@%-EU MVP?5Z)HI/:>-71LZ)^^!JQOMLPNUVY>-_M8&=H-B=42Q72L.:QF8H30,[)2Q M:T-]ZC[XEUHW_E7IE'JUI=9<+^5%]9Z(X]9ROOQJM.H$";&[86K'/BA1J]A3 M7_>BM08W"^)F#:2$7IF4:)#SM)!S0YG@/I#3J-8-W:#F::!F#3"S@LEX[Z.XV\'K]JQ M\\+YE@VT&F@UT*IY@N]1AX>_>^X<5O,BX3]F !N0F&#G37CX8&ZWV_ P+ET_ M\ ?..!2QI37Q[MF%JLF&LO4 W2:.4D<\VN BJPZ/<%I81Y4U=>O.GPTBU1&1 M-C@-UB!2&E?ZR'.V]DHU>%)#/'D]FI3C-QU,+^EUY';&>,+C#\_67RW\S.8> M' YOXH,Y@^;,A<7]E[XX9+#VQ.EKDV*8/!?X;#/\ '0V2!Q/:5I3@-;:L3SY[@U*%=<2=H)1Z=J&KLF*<4/5=@U*%M<6=H)0&7$KN9$P9;S#J^#'J M$ BEGUUT=+G7KBI&V=2EE$&/?S$'; 6;*Y?CF>58?N!1Z]_&[W@P]5(<"E+6 MTI$(,ZY$!G?':#*X3QJ3-FB5%6)2=>7I#2;5$9,VR/Y2F%1 ['>Q$W^ON[4> MV2!3#9%IS[C4JQGYBUN/&?J>-U;<3=?33PH<7^/ZE M.QM:#EEYB:.\XV=%H88R^D1UQ=&-*Z&.2+5!,]T)4G7;#5*=-%)M4"S*(%4: M>92SBW[CUSQ%O-DIVJ@U0INWY;R\GLU-R\/FY#CE:8O)X(U55X6>2#/YXC.Y MG)K>8_F!#[AI,Z G/^[:+WQKG^V45/ M[FU?.]A@W(E@W(X1KM<&)M=1Y6Y7J3W*-4UCFON;IC%;Y/]2 @:\%7@ .M'G MO!&!=5B3Z<3Y]\;\7SB4KZ[OWSKW<"RWD^_1H91P8O6J:][A8^B5/M1$^\H@.YC\[CR].-=<=@D_]EXY#D MRC#I)NQYVNBT06.L&IV:BK'31J<-0K\\.A40_UWTA2MJT];J%#'J$ C5JQ=" MO0&7XS6.V7Y8SLZ#C3V616:9'@F V=\BR=R30=21M@WY5RG MC4 ;=,>M$:C?E&Z=-@)M$.Y%$&BS..\K9Q>ZK/2;'GJGB$/[02&U7BCT!CR, MD48HTG4;EV(9Z+W;B288]>)($XAV=J&TTPW(WS?&]W%C1D$5;PUFT)S&=-)8 M@QE'CAD%!>\K^_?T#9"X75G/: '98,YQ8\Z.$:=#B-/-Z$Z_=\39H*:-+7]N MFR^X1I:/9\U5>5=56KW6SE"'EYID(2G42#]&QS8&X&?NV)K FHCN7$]BIF>_ M@-*,HQX6EC\-.R&,V?!U8?G&#*TJ?=/',V/^K7.U=#JWD\]P-F7<8MW&+7;2 MN%0@B[,R7.HUN'1DN+2MGN[#!N#3EEA50!/K8UI>NYMVFA57Q!JRDP?\(W#IM8/)HO,D0M!Q-# M)9NP 152RWD"*X\==ICIFRT7W>SRQ<-$VOWBN;-+N-ER%@ /,4;.=?Q/=.K\ MN@?S)_._68[KP5$G0B[+3^&Y.M]8,'7A%SQ]Y 1ETW,Z;068 ' !HZHN*HJ^@IEPU=W]YSU:#T\:-T42VKSBBMG5UHAFP8Z=*&*K?U]/C$&F'TF\@87K4V&N_V@:T%($01M/O$3Z2X'[+3KJ[. MK/$9U1&#-B:2;(U!U966-1A41PPJISUDH%(:9;J@GE;5SZK!ECIARPZ0I5*9M\K=*G M5%YX(L+M<4M29RK$7>-Q7 MO>G4[ANP=ZQDADW5GNU-]XC !&PNAC;CP8DMXE=9-N8A9O89B&XK=J& 86)S(X9IASA="C<0 9E# M"P!LFW.?G8#LLA_**;/LY,[]%R0L@;:9<$O8___/'9&@?3\UZWU>L8 M:+0)5XEX,?]5:0&^_IK^7E-;G6XW\Z=V2\G\/N]1BM[JMCNE'I7_?4 M%J6TE/HMJEI(*>K:1VUPQ-4BGX 3B35B5.?XU9HPZ7YD,0>^^.YZP03@XT;'P$7:&@=N$>#N MZ(#JA]3WO]U^EXJXO1NH)0,'KO/AGCUB;+*!74G87;H.K=X,V+@,[SR%6HH' M-P!>9OH^"U)9=5L9#&MMAL8B+@F?6MO%Y;Q9G?5QHP&A8FD[N(O=(7J=CJQG M.+!V$#,J=7S'Z,MJZ+>AWTSZ[>Z$?C'#7E8T7>YW]Q+S;>BWH=^W2;^]G=!O M_^Q"UW6YJVT].:FAWH9Z&^K-IMZ=Z,YJ^^S"D'6] _+W-*AW]Q&E3A116N_$ M%%_1-M7J/98I]W?*P:&V?^& @_-W>0>-I&^F8SXR:F8\>/08??)#/!4+ MOEAVMF8'\L1;,]:B%O-&[]#WO#F0H2*SN%UXTHS@ 33(X65S>(T$O"QXF>DQ MR:6&*7#9\$4*II8WEN8FC=B6Y@O/7Y@ S< 5SR+8FA%L6](7ZXE)]X'I24N' M(F.7Z>@W67J>6J.I9,$+'?$^7 D TO*I)?5$&MBP3Q_]X[)XEX__ON!O+NR% MG+V)I2=?'5X?3)G/EO8'_$U:+&_$A,O]@'F9.VHEUB$]+DP/;F+\R0"5%WZQ M Q!B'K%.=./# ID)N\.RTP!V.)_;P&LHQ+L8^M;8,KV7?_B2.P3>PQO32$17 M]-#$U=D07D;7HT"]:PY' -/HKP4I 'T 4 ".,2 I FW- 8K7Q4^#$V>V-;,<0'$)\6DT-9U' M.C4D;\^U05!.S(4=4&/TIZ@3.O]N[KD<1P'A[AF3B TJ"B'69.&)(91BB2XBW_8\UF:WJ\],1S*P!Q.2K(:[)Y,M+@-\&%@+U$)!OM^Q#XF>(< M8RE7M0J9R4O:/.HG5:SKFR^AZ!M/1^<@;(;,NYTDX"# \.GECMG(;K\#DWV) ME*QV+ 35-9I>_G)Z[1TM!Q/LE?30IM07(:->(VPH" T8/>4$SA5&$8O6B:\B MN;>D/YED,Q-8^?KG!5,S( DVR\ P)'R\/3!_$G>]N[I^B!DRW$XBZN'N_BA9 M[)_427?A>;#K!!N8I4LTL@2=_A_ K=>1L"2%HDNRC_2Q92$3R7WK![%G@W:$))*.?4 ]4, MRF"X]>5^/^UC?@UBY70\J-F6N[AE14O3TC*2R,A-"$)$#MP5?B']&"NK\WF'IO"=B_8!'.W(63U0%([9U=Z!E##O?#C@JML']VT>MN/F0ZQU'\P UG M-31M,H?\*6-H&3Z@=4-K\)>>@@)[R,C\8W"<(XON=I^$0<3\ #:,7RU\-EG8 M*/AY3Q_\U>/;#A\HTA%6)'BVOT9(:"%&=65(A &Q(/[Z(VM+KWW!U.)CO;X3JGU3_-VJQ% GD*9/VW B[#LXL'4N MY[&M+7=BF1>Y:NK^,2W+>7AV\?GZCZN[^^LOUU>?I=^N!E\??KLW-Y^O;NYA#_#I_O;K]>?! _SQY?IF<'-Y/?@JW3_ M%]^N;A[NI7>_WPQ^_WP-O[\O:$1H*WT&#KKG=V,L-O B-@T,/IBZ"WCD&,PC M]G/$Y@&ZNH"G(]<&/F^BT81V'#H^GBV?<1$]?I_%8_)]JT?C14W:6:3C M-C0GN@UUHDO7#_R!,PX5OPS)K>%DF_3(RM>H%AOB0Z56I: ^D:'Q;&N,R-R9 M)[Y"31*T/W-HV2#Z:8MPJ$_6"$XEMG/)7X=O,(.BWH/07AZ^@,I!>HL?:RXF MGUEC+\9< =J#+GND_@CNL5ER.L!*,.\]D$8 ,M-R-KJ(HD!!@-J?+XP'/-#X M$8M@#G!':V,%&Q")GIEM.\SW(]2H*3!WY6"])8?T T5QR#80/WK^83VN]PST M>]#726XDHDPOPGKT_&UGNLC5UQ?)H7.99"]_L ML7I?K^,(E:I3= IT.!YB&M/&\B-3KL/"T\F$#.=_84!SA6\F(6Z[(WH=_/JG MY:.DL3@+O+9AP:[ET]E-3>#% ?H'R&KE\;.5&"G&1)UA;/ F"SGY9/ M@H];S?#FJ36GW7&C'V$1&>R9D!"*PF8-\PGXAV0GOB0 7K#XY6D9F MW%1 &X"6SW((0G/3&D?'%XH1?L\K%;Y^OM?F.P\A^U]<[R%^):A7Q+>_,%8Z M)4=#![BLM-/I.-)XX2%X$%8^0Z5$^FL!^V<4#."82Z/W?H;:%6FZ$F;4X . M6X]0^0N?P^\('3!P.9U(A%KB6);/]!B)NV!H90UW*X\R.9G2]7(/:P9F?W75 M]$2]UQ@@.=8RM70L6 M'J^]K'^2-Y\X_+F:EG>%*CGWNEQU*JX(!M\=TE>'7)882V,%CZL"S2X M\P* ?'.U[ZC+- T#R@--VQE5UJ&7]D[:O1R@MN:3Z8/2B\$OU-%(O5O,YZX7 M1&K>@?IKO_&BKK=4LZ7TV^NC-P+QD)C-N\QYO+\<_P,.=NZYCYXY:^8?[I!+Y*3G[I%+Z&W@$IKC4P"!L,BS%L M0_+R/C!,HVDC7;VJ9F^- -HLD!6UI1KU%D:\'>V:L'S5EL^F>YHN77N#S^DP MV!HH^#KPUW9/5M2M.WI5?M 'LD ;2F\HO7)*KX&N;N"XQ;YL]+=6UFM,Z351 MQ-(]!9=:T&W34;!_2AT%E7;AEH*8&OP)X_- -GO"8%V$]GH.J==#L_O9-N M+1B^@%3)\!79C05YTM#=M[M7=1CD+\]8TC'5QE))2"X;9+.Y[;XPMLH+C;SR M*&:=7P$\@I>P2.I*/&&E+&)B_63C#_]EGIM1):5WSRX<-YVP':Y&M*: @_6Q M29U-)_UD>I:[B,L&L=[%8W\M+(^2_46+1,KJ'488@K6C8;DI7 2W#U\0'^+* MFUS01(4J:9.[LZ9X+"S9M+$!9ABL@P@CER#-P M;9\Y6;#MG5T$SQG 72V\ 2@DBS<3=101A EBY]([Y;UDQD#-*N8)JT)Y[4E4 M/1;=$Q4-?:2S?*?B$Z/\^8)/I Z/X3TV2&,[S+S'AHWN9*D9I;B0*E9YTCYF M#5'.MYCYY,8SGVQL0^B+F4_)._''F?D?UX-U..X39P_T5]AEA'*1L&! 5$@5 MJFE^1GB_$/HR/PB/@H.!YST&P 9HS_!OV;:&N(!DX9>.NI-+UPIEA55.Q5A0&@07%/?9-@ 0%-4/F6! M#7LO9$1_J2EMU$G)"I_%=SLTL6;(=:*:4FRE0!T^ N%4"Q:>(V.1\)A-+"=N M_;2636/O7&P?\CA=@6?N0K!B=02JX9@:1Q&O^-=@\%WFG7%'P0([/%%]%.[' M=!S\8N49>%B\--'"2ZAIA&U+0U9PFV5W*4?HL5YKQ?--%'[")>[X=C*@3?'6 M7+>3Y!EGB.+QPHM$<7C>H!T26GYX8::WJGBB4@.O05Q%5AV.>US&5RYW0B"% M%8VP]7^; %_O!2\R2(49@['FN$%8%PKB;PGVT;TA0'!)@DY2DR;I@1%.9(/8 MR4(0(=SI5W,\LQS+IV[B3ZQIO)$24E$Q&;&[3!7(X= !:XZW,QIAEI=Q.:&NO>R#BKC[&7Z9HVCH MN4Z9V3GHL!FJ;&15Z%:KYNQ\(QW VU+1^M[%7)V@UPX5EDQ[0=,=:T)F>?+2T#+?W49X0@D. !XQ#]\ M$53A?A'A\L97Y=KI8CE%0@,1B84F4/PN4MG"TX^>OK(HR@?S?6 C_(7/KO<# M'VDO?%*:)-J/%\ GX5=/^N;)STYT+9#M&1NRR0 NATTLX>KF"= 1&E*WK&@5 M?.R90//1"'$?SRB*.ZV\0]Q$SR!0$WQ"C[N%?!!;DVW@_*^&,I-Z_?.*HRWMSUQ.N.A$4\8C<1[#.1PY(ZEW''!.^SD(^P!$/ M&.?2&?%M1<>?")-YS)H-%QXR$$3*0WD>OIO6N+3%UD>7=5>MQ/2LT/OPFKUT MR/UN:&GK,]&L+T8;9YS U$-UP8)7%W .DAL[GK(F5V;KQG#A7M>Z"AYZ8O%6 ML]FI#D,6/#/&(?=O%WB#] =\O_ $,B0C? ?I+[LQX/X?7/037_/_"5&8&7]? M=DAD-F\E (C]#^)'E0VF=Y2<8+K/0"ZA$Y<6+8E52XE5^V%/S+CTQ@)^8 4+ MT;G1V92+XM__\%#M/#5U_MOG^'O%K%=(8S]/&E,C6*C!H]+ MR_*YK%G^CN@8%0A!:0GZ2DS@PK5P\D2>L+ #/N@OO)7/2Q3:@IGV<,'7N'8^ M2S&OZVHB'R'D5='&K"#>>!S@QDM6=EC$@5(L>:NGGE3REE)Z'FQ.!HN_;BQL M1TTG2G74=.Z6>+;TG50L*?GX5Z5H\7=DO/GH4K22"1N<8T\M9 ^4JB)"0KA) MPO^L_ V9*.C:&;7DY'#-=['Z%W5]?Q^KQOY*N]C94K8,*<\H84U'M"'F23ED MG'@T2W6)6ZRS&*CP X4S,"G^%-'Y>.'C_%99&EM@72)#Q$=S2X6Z+;O$;X#7 MBX[4XH;D5:UH[SC EC8C6/!B;,^ES2_H.K-MQ7^3P]F>;KBJV$WT8+FX?U.ASI MIA:;@*(F\M*B;2R]^-J9L;V M5L87T][0TG'0N(Q.+/OREO1OYCCPP9.^M"10 IR1)>Q/3B&KB,%_0TT#?OR^ M!-!+ NA5!-#;!.#,\)8-RR>:X@&$!.@%M#F@4\'].*/ 8S.3^I"G#HK?RNWE M -[,_0B.].\%P$@8"5R5$* KL3<$"/_]B^4@ (&K)7]_\)B)HL6+B3WA(\ ' MA PAI-_H3#ZUI$O;]'YPJ-^S$:P>"1WO$@!-'Q"]@>#H<_4FGR)B[$=&%A.( M'-DVZ#GP19JJ'[V_!(W(*P<9DT'JD0DT2!#6*JEL) & 6=RX/OX:AV"'@.9> MC_"/Q*+C,[@7_!P!?PVB=,Y(GB8X: 1FA+*5N"2(V/A$4-%\ >KDJ")QTY*^ M>1%;3AQT#@\A\EM" [&^I9[I?%TM,<)C!2.3@O.;+W"2,YKE$0'A?7(,F-6W M+HM M'+C1Z16<^U$#>'EU46%IA^7C='[DLM(45>54K\E#>B9RYX&>07!DT?% MY76ND>B0>9<.]R[U*D]EZGVS'-(&KM%'!U;7+;S$0TT+]%!T L*R/[W?4^(<1MC3";&80&HTDKG&/R2YMYYN,=U'J2[04(!^_KU MDAS4*]^C %E6F1-*:> ^,F(19'DD?N"DNQ4HU79[CX1LG%UT6NEA/26@VDJ, MTK*X.A9Y08&\><[>BN!='6WOKW#W-<4#@-< Y!(.H05G[QDD6R\6M'ZTEB-] M84./9[Z&))[0@R@"'<9#8'F14Y17B-FD6TG?&)"_1]B.0!Y\O1-?Q=>+:7;A M<2P)N64:F"\\?V$Z02P<$Q)M1$5)XW#. %E5I-L /4R9/5Y"I\0^EC +(UY8 M(D/QN@WYGH#\Q$?2U+04?U&S&=,]T,7MY!ZYXG=\7?RTM#\4,^!:6IID$D%V M')' N,-O NKY,2(<:%0C# !R2$>SC;)1QLW"SN+4]!EMSL4 --A1+&U4RFNQ-V\YD>^)HJ%)2C*3LME/3*-"=K9*Y^(% M%K= ,/7=7P =AFL'+=V)5[RD&H2"D),KH!R/AE'9%,(F"8+\'28-KU"Q;:9< MK\OC,YH\OAJLI7Q'5.8**D#*YW0C?),WDEO9%$!P10LD$AN M<4E&?BVACZY:;BCOXJP+G/0I;VN\J9GJ9FB\A66HE^YL*.8JW@=LGK [K^!3 M;-Q=.P.^='8=>M;N027"HFDG2-P5VWZ95AX6%>BM=-7J+U&9!BE7171R*LU. M:/KY2@YE!(8%(.&9%-/FTV#=T((J ZZ8>P3&(6?^%&6%M0$.**6SCGJ8@"_W M^FGXB2I%$>U8Q:1E#U^NM9:C\6%-5#3F#?':3#HG$E&B9\<7*7 8U=C:E:.V M]>W]#]]-C])6,G"Q?W;1Z>3AXG%;Z?>,<9<?RS0K\ MT*-H6W:PJ^ MDG[6VU0BUV$3N#*L8CP\HF>$?V27BKREE8)EE<05S?*=N5[PB*TNF#_RW.QMKB36F42_G_Q5R* MS!R%.69K\]7B=B7M NU*0-/SLZ=0U[XYR2LHFB=O>O(1)&3F=D!2VT4[(&5U M_BJ9@]G-R\%\;4.CLOBY.6_Q-+#S*S,Q9SNUJ4,AIXWK"4M68!$C%N:3 F-; MB:G'=2%TH'#1__RMIRK=CWYF^35_J+_<\6),=12\?0GF-9"R'V>E@A)**QHO M+ZF\-I]3F;Q5F\FT7 '+5FEG=)TI7?>@MG/F@%>\8 T$849@H62GGYP:AGH2 MZ%H2^)+#F,PAF*HB"R2N<"+?=SJ'-"*3I3(H7N"TI%AC,@IOGC?@/7SN&(KW M*O.JC9/*JU9;'/-$6]92&=;7Q&" #M:E5'?U=&)S5T^G5/.'2? T]KH<:GKH MD1!%J+,P&TB;1]>&P!M@[^.P2@%PEY$O4%18S*)L,XK]WEU=/\BB(@'YRG58 MMA>.';YTQ\35E7ZOPTL?9L1NY*@6 FE-SBC%3,39)FP<53W-7$HZX2NBLX+U MBDZ"SDK)J+@@ZEGYC#FI?N!9PX7H;8GW\FY0_%%N7*,8>5'PI:#4Q]3O/9H@ MX03_0)X1O5!TT"1]1F TMI5R96GJ/@-$0%$5L(C21K3B\)3YTW]()7S:W$ MP?,#1#Q'-%[.Q4TL1Q362>\H=DO5L.^EB;W SF9!Z,84C#.VN0>" MWK/P])PPPDI:\$14N>);DKF.C[ )/[P8&RV[<7)W0BU#?'%]T_3QS&65H-]C[*F ])BQ='\XK6 ME*O+PQ)J^+3%.CN88;:AATV5RD#OI)0!K721U97IH:?*#Y-M,N1_-T/^=]/R M_T]:*.#] +@U.M4N>>E$V-]=J61;6)/1Q9,W3'9O_&# MQA;FD8R7'[7ZC!EF M&5O!XH\\%ADEW JSI>>)0G>NOOI)BA(D$/-Y]-;YQL MUS!W,=? (L4J>M5*-NMR+#/9:\2:@6%.A2OA1KBR-A(Q,52K,.(7;ISG:N9M MO4GI69?2T\E/Z2DN#/KZ605Y0+K:ZAI-*M A4X$*"/0#)9AUZO!QGF9#:^JH7IXNN0VTO*/T=&$H;-)%&T? MQY#PI^["1C45K6H*,@'G^X_H:Q,' '/B2Y,(;HF&'0@X,)6Y!04FF[L4PR(G MZ_]R80X M)%I3<;LT]#=@3S#RLX#U]F+3G 7SF4=O$U8F9G"4&KOP&4A:AZ,[ M7\V?IC^%50:8M/*Y==E*VLV3E;@%Z4_6Q.*>+*H30-^W;]H<(%S'-DT8.%8?IN^"(F!*2C;>\3 MV1O%*C)9";>N/4K8*ODAT"W $ \;"GA["EN*62M0L,?3D@7!PW!G8 M='SZC/<#7;FA[D&N-BPE,S!QJL^(NYB"0]N7BS MS3$[4?X4HCMN:\R&@7BJCX7T[AP4!QHB)WF6_P.S?D,H(%M WR[Y$$TP#GW> M[1 X#HM5-E@'K@O?F.1G"UP(]WR3M8L>0>X6QD\>IY'(X;&R=-H[ A1L6,J5 MX2T%W+A;'F\Y\-OM=^#)CY2X>(1(>NV$720IGH#.1)!#(U,4T,6X 9CE\20! MRTGB"$G1UGU+^B)<[: ;4ZDYB # ,,I.7L8X:0:ZLS6W>0&/#^]$\%(]/@,H M.<+CC&ECB9DE:]\#<+0X?R-F9 4T8@FT6N:MOAQ6'_%BV"92R!!#!CAW1-Q+ MK3+& Q7%E,OEI=/TYMX(XU@B7B)?JB;(^%KB%H25W4)?&%'O0B"F"&';25\ M:LPE:&9)+:&XTS,CLI<>;7<(FU\B&NPM9@XYYI*LP(9X1(T4+WL$?N\@9=%" M0(7G(CUX2>2YE"2XR$F3)/YP\;'R+V@<3M&)WQ ]24["B-Q&"&A'Z$%%'BQC M]PT;>PN"E"$F:TXF2.+4@B6Z>K1DNW'I.4D$M; = P_6A%UDHOZ9J\\7_B7J M92,@[GJ$, !%FIB2_V0Y?"P?(A9.QA;MT\(\2,#9<=AAE;^=ZTH\T5J\$UD8 M[92W2@45S,;V"6B0B6:[+E?M<)@+#R!YCRP0@3(_C#W&05)X&4=KC#<* )HC M/"B2&V1TT6(PAL=[D7I1:'#$0WIR^/)P=!H("'/A<](FI=//2-GA'2C$X#0@ MI"B6"'82LJMC9*I"\H-\@6V9HJDO]_!1URM&I2VQ.;#$6[W(@G!'HP6L?O0B M9TH;:2 Z?Z"O5-2#< &'&#XQG\#,)%V-"VLN>6?TSXL#VQY%A+5L4P#\%H & M+YP/ LJ2[R>!TW@Z//J-'F@6!+QK$&&6&3857)IZYX2KXT)W'+Z8=+N$ P*_ MN[S]X_KS!Z4/5 $'"MCB8-53)PW+!VU6![OKLA!+_$N MWCP\ST'*$Q>/D QRLYBP]3 J>B)I"0_>#9O8AF(BEE,K8QQ#96\EVIY"&SFT MFX!WQF&!Y1&ASCA+3/!\*,QAE:YEB=R'8,&=A:4V9[RUP-+/ _C]#K8D?3&I M%]E92+&;/%0%O>3=8B'3VKFUOM_>/7RY_7I]*VUT<-4$:9<]HF3M^J2@\9X2 MU/S^R8)WA:(,SA6NMUQ)%#+F5# F$I(HOB0,:!=;J7H4\J?2QO?G90@]$2$W M"&+".@^#2S3>>X3+FOOL//SP,1R);3FT?[KIX_+C,9JR,MJ;#HC_+ (M_7Y+ M[?0QUH(SM>.)Y"(,TP)X_IKQO=[J&UKF3^V64O)[0^N4NB-O49V6KI1]]Z[7 MU&VI?;UF:]):>L>HV9JZK5ZO;OA4SS5U2SYI'VM2]&[-UF2T^LC5:K:FGEHW M_@1PZO;6/NE7D@M<-H#T0<%&F6=1G'^,*MVY.O\I*5DM"59%$)<^56L&P&-,NV[A' :WC!P;OM?_/H??K!0#E>V30OUF W)-&QR,^ M7S N FH=!Q)B#7KTW@)L4DIU.^[7N)?MVVR2TERCS>\SC:HHWOR+(K.?,#+[ M1QB9O<,HQA6/8@PH*KN3@CR]U>D56&-&/AM:'!_4EJ&DS01,)>?&WSMEM2/+ MZ>)]]ME2:P?J]2F5.^:&1))@O%ZVG9)8VH;YU&_E?A)1VB!NLM M",E\9D'ZU$$@VU=)24K^V3\H_N>$ET)LYX)T=<5']=G=&-)[7! MMDU7R8Q&C$TF'X57EJJ:YH%$2;-2N(G$BS3WQM=2K5H@Q;2D#;Z@98+W,0:6M9EN$5=(.P:)=%!*Y M/+4YU:*GVI/U7D?N=_HG?K8E[B_+Q@]R;OY?+6F2B$U7Q.%VB__U ^/?=X;P MA1']0#M79;6CR5JO=^*$_Q:9NJ:T]+H=ZX% \4O#(1L.^4H.V>G6C8BJX8T- M"K\5%#9T6=%/7;5_BQ)>T5N=NAUK(^$;]GA<[%%KRZK1>+5.CSWJW5;MI%XM MV&/I^(?H$G94OC$LN'J54%C9;&ERR@#6L5",JI7E@]F8L3-6]Y;/QI!5M7W\ MQW-J?&91,#VT0>:D:)8-O2UWVLKQX_.)GE!':QWB<&JA'U6 'ENC1/T877$+ M,6N/-4< I=>6V_H)B-<394=:NR\L@:<1%@QYKC!==[BH-=ZWK M\6C]MTN]KTT&/BHC]<&CKFT."\(NC[G-2*L.I)1Q01\C[:BOS \XLNC 41Z- MW.Z\,K!3I],Y-6;T>H_96\;EMBKWVPVOJ>WYM%Z90WO\&M0>LBU.VEV6M<>: M(T"_)^MMK6%&^SZ>8OE^LM9M!$5=24=I&8V@:+ CGW:U0^!'0[N%O-ROK:@Y M?MI]$SEC?S+;IO;"O(%"D]91NCJ\RB5\:N2+=^ M8'YM,XTJ(%1SIM:5U;8B:\IV#3=.@+4U(B\S@-1NE8U1'!XS:J&1'JG8;.1( M(T=>IQRWY6YWN_9GC11II$A],.-4I$C#Q1LN7KS+B*QT&U.@8>(-$Z_:.?TK MS8;/&$8O;M355A>]SNGQ.F)T,#TX>:. 9SN^Q1P"Z!9!_BT[GTFEM#?!1R5D MZJ[, DK\=^J%JYF;C^S#T&/FCP_F!!9[;MK/YHN/Y)K8T\QR/JS <'7[N9N< M3':V28ZA8S9R/9,.!^B">7P6TC_-VJQ%FGIL\O^<_"/CC__-7\R+K))/'8WJ/<$("615U MF=%%6$C4$6,V\0, CFW.?78>?O@XMORY;;Z<6PYMD6[ZN/P&//\57D#OXS\+ MU.BJK7:W@]@A8D;BQ>NG='?T5ENI:G1X3]$K&1VN&"U-R_[IP(M:__+7#S3? MGT;9K]:)OU;IZ)^M8'](,64FV^US&.+T=&!QXT:K9Y18)UYXT:UEI*AZ27& MC1K-N-&J,::GGGP#_V* .&@9]:DAE5&ZU]U;0*JCKN\MMN%F(D19B'5[I1EP M#3-\=\ECWRYJ=-XJ:AQUP]!B&V[:A>X(L%L$M8Z=;!K<:'#C#2N?36N9?=/& MB:@;#6XTN/%*OAE&KQW78?FN]<-?M3Y?)2.@+\[M S+YH#ZATDT>:>\WXGWNEC:Q1)<.BU-1SCD( (0 (-7?>']&3:"TJM M\)AI2\P/S(!)IN\SN,P,X-3\0)K;"Y177F!:CF2._EI8W#5.O_JR-&03UV/2 M&%\PLBC3@]SZ\X4WFH+9(,T]\O3;MCNB7WWZV48Q:,WFIN7-8%G2LV?!N\?N MLP//M##>^-):]J4?+3:H)X - 'P+X[S#%\E9S(;,X])?A"9(YG]O .^'24SE3K79G^B>30#J-%C:>FKOPI)O;:PEI$0C5(3$-XPVWV6* .,4@BFS,0M2/_SMYZJ MMC_>N,Z'?PT&WZ4OEF/"\P'_OC'37P"6TA7*QU-!'+UVB(,'/A-A63<.R]H8 MEO5%6';NN7,0 2_<$^2'YRKY>.S!BJ/(EYZGS&/ Q@'[X(6$*8 4<_,%CWQB M_02$0-X!S %Q(6!PYBAQ?'^!CX.OW"$H669X([Z;>!$L:P9BB$017B:693$2 M5_"-Y4GLYYPY/KP=KZ;UX<+H5G=L32QX-^=YR;5*SXSP%?!M#M1B(45,1+8+ M?WLHUNC]N. 1L\8W6S0,?,>F*)PY FGCNCET7G 6]Q7/C1F@T7GL]( M3N->\*++VTB:(DN8N$-/P604 M^B"HVI?>6>_AD .\*40@H0<0!W]T\;@]-F9/P-;GB!I-9KB M>X7?> B/@K\<-^!K0QH$-(*OA@R?!#L"M!QS.L$'SV?WS6Q M A1HN$Y"RG#7I3 PB6\'1+?/"P^W1-R0DNMF/+F.Q K:'%P"_&F"3M M\2-*:H%TO;L F(R!R[.?(P:6-:!G=)$+R&#.P!P/_/?G!4\,SB?,N\;X^TJ[ M')'EE7&B^TWS[G=:;4,MG>:MM=2>5E%&M=$I=T=N1G6[PMSSTU^46D7N^3;I MQXI1)+>V?NF0ZQ**I52":9-57#I!]KBR8_$I7TE\;9-8O'56\7$![8[+_09D M)=A.JIW=&TCKN$]H:4(_'\?:)_X(I]2DFE8&;_65DWQ.L'#]5([T_V?OW9_< M-H[$\7\%Y8]S6=47"Q, 08*K7*H4VX9O/A:@,L'0$Y5(G-)8*:GW]/3T_W*BC.2I-TCJ3[H7#[XRUN&RTB)P3_ M"#D E// ^*%2H%# UYT[(7QU0T<5ZV=-;V2.1!M4FY;6MEOGA:1(2-9XR:)= M:_*,Y(R7#&/[5J47PAI7L!=<,[[\Z 4V@ OEYIDY<;*?B;W:].U1:PLK^[:> M:!N^[RUB29ECNZ6M&X@BYE<+$EX+N=BX:<+ MR@CL9>$%_36%%W8X=Z]VZ+IF\GO9@:^AJZH.]7/T$3M,GRC):?WAM-&DOSUG M)9_UA\\,5=?/U+7R6@I2M72.5E/8KL]9>D71]PM6+9M6V&G58HVT87]WQ)+3 M^L-I$ZVU5RX933+:'M[20)OLF6PC0TDG\9;P;SQ6N$*W2>[(+F)'9FN3L=SZ M=X4:%\QHH(UDC*DSU+A@1@.K>::@>1\JOMA]*_AB:R-"PWU^E[?JCRTU+9LB=5-V Y6T^JB[A]OG+KG*IQX$BB?L732N%#)<6- M)$ZJ&Q-U-!C4+H_#VYC^#4_-X>,3EJP8:]:?E#G 3/5C $7+&$O14A61HE)' MXBR8*!$ [SG*TX[T-@!LA@4P*,M-4WYCBN=[5*+ #UV V F?5_:Y,$E%.];T MJ@ @83D>8,0650C.0O9=8DF7+Y6?OBU]4?GDBSMG7A94+F2NKJHCK/QN6Z4+ M51"?%8MZ16T$8DDG$>40DK(,0K7L0>.R!J->E#6P;9PPTW1X?Y+*^ MKHUTZR"7]<>PB6\WTO89B.T.44# T/3!H:H:C(Q#(6HT/ RB#@>3K>G#0W4> M/!1,IR;>AOWY^0MX'OBI7C/HJ/==*,>-;M#_+WA/ARM?T9'B @(_H^-.?J-WI8CXE<4(%''$6F&)ZT'#^VR1\7B-K(( M4#-TO0O##*#X-_/X?D7Y3/>?^1_W5%?U**'%H6:M'I9N G#;8:FA#8>'.BQM M2/-.>"5'?JI7DB[$F[.JU'HK6F\'6GI]LW05']MR<9IU!=[K&ER#]_=M%7S" MX[EFB+3&LA;3P9 YM(>J:>QY15=6[^DL7=NW(>Q;-]=F>) M@B5/=9ZGCLM' M77.$6N=;-U]^I]E&-U1S=.EU\KJ_H7S]4]>G^:U]"U)(S2^]"R=I\K;8H^EBUK?[>1[ELZMC:.?+J.Z#5)6>\M#>RM',( MK62-'K#&6!V.C/YK]*[N9D^U,^XM ]J74 E:JJ9CJ*;VA3HOA#6NX[Q^O\W7 M@<[K^[1-/>^1?/\4Q]BC4=C+Y?)'7TH0Q-2];8?*]CT'JC*EGC.EC# M&*JCP3DZ6,H#57F@*AJH2MTD==.6AMP7T%M7GJANVZC:\D2UX8GJ\>Z*7V2$ M2U?UD:Z:XS,U3I7T>8D^(WFF*EECLZH;R7,+R1I;W$%U,CY3 R-YIBK/5-%L MM>TV*G73=>@F2]^W'$;?6>,ZSE0G\DRUH2"8,L;5"E\3O-$D[ZAVDSKVM08@ M)6>\E#MBR6,+R1K;[JB:MCQ2[<53%\F X]9[$:F:KD,U69-K+;IQ%2>JYD"> MJ#;$U7Y%IZXVOF4.!JH]/L?)C#Q/;9#?>:T7.B1GO+1-GV&@@PJ]JSM+>9KZDDLA-9/43)N-EGFM_LQ5'*::NCQ,;8@K0X:W6EU0U<&I MN830^T521S?E!57)&IO/V0UYT"Y98TN1+74\;ELI^VV_KO X53]><>2+C' 9(UL=3=JF8G0P^GZ1U#%;)\E< M2/A1RXF\OGKI(!K3DY52IFC9;K8&\G'K)YZFF MXH2>DLY9S)Q9RF)YO-HP;7*_LDI7&^Z:C$9[%%7J8"S^(JFCF[)KIF2-S:PQ M&,BC=\D;FXV@KHX->;[:BZL<;UVZT 'K+3NL3:VNKV) M_1JE3G#.P]9I%'LLODVCY1UB+8D"WU/R9?=J3SL^WAW@!L&QQGCLAP(:JP-S MI%K#/<-G;;BJZ\>X%T;9?4S+T:G: ;MSIB270[Y_7$[NFNG\_FCLVVVV-?2) M:DSV/(WOC6+NZD[TQ*>QTOA(XW,"XR$V7?F+.:0&_'JV@[1]WZ\PB@FLX$79 M-&!KG"*AZQ]TYWZ_$]CIE@D[SE/=ID#S]S?&LB87=5G@-_J#>8H#0#D/3(G9 MPO%#@%X)F),P)67Q0KGQ0^69.7'RI@,Q&HZN70S4'X?*>J4[U0P7W=D,7.?[ MU\K;>];)Z2EO=]4:']>R=U7^R';_D#K -_!?SW_\ZU_@GWRX10M]I]NY!EIYA#Q\"X, M,Y"J?X/C$ -ZG$#Q0S=:,,5/E"FX#9X2A?1+HBRS.,F<,%722&'?_"0M?(M$ M<1(EFBD?G-B=-C"BF# M41=.2M"X61SC:^S;DH4)ON OI@ #XX_/HEAQ03& DZ.$+*77%Y'GSWQX&U@K M20K@<.!O.13<&WIT@HPISB("S?)O)_5AE4Y:C =KB;)863 /U0[\.?-=1N,$ M_HPIB>NS$+Y8QM$251-+M$(U-F#0*CN>D1O?;:<9QQ$@WH\)-PDB!S&2QOX2 M]#?BFYX!&\!"'R@1^(^(7&"=11;ZB)+\ >"6=.['GK)TXO1908PY:11SLCRQ M( @9D,H%9##X\HG%#+EI%@5!])0H-QY\ '\5V B&B3)8L)>\N6N([A$@0GR# M6Y65,V@^)P964+D4FHD;+1?G72;L+O_P-E>L?DBXI)?>UN?#"5:,% -C]L^-[6AB-KXT\#3=_\RI:A#&TP,@XR MDC[0)E8[H+9/8=IMW]@"U%";#,8' 6J@C6W[,$#9@/1)QX"::.9XV#&8=) . MP]PYU N9*9W8M$]65/!XHV?]O[ 5;[ 1;^A3[5@X5W5=6OK';#%E,5J@7PLK M>O6H^">83K#*L?+E7YD#AO!GQM*3(&6G8%3,ZR;K>0:,E5XK]UR4S^2[\C_N MR8$]BJ-M:;;5 ,"WRRCQT6^ZBUD #M0C>XONQZVIZ1L\!'2S<83:_H [-E)\M,LX[RLMHV3=7<^M9;C6 ME]8,G?_Q_VQ#-]YV+3E YAM*NEY^QETS4EY>QIUD8:F:.D?7L^#BK)5%)%]= M"5_UNBQ)XVW!?BWV+O"RXS'%I8,WL25U)'4D=21U.D"=#MAZR1V2.RZTCGIC M3U!6!S_=QJEGL11)'4D=21U)G6-3IP.V7G*'Y(YKCPF.Y=ZH#<;:5G3O8$2C M-S6CFU'$,DT%4^R;9$M*1BX961WIY^BB)\-S+]-&UUOW.[J0Z(MD#I(]MX]4'JU3*W/E'UX3ENLLDHVLO$&=K7>LE0LL9+R&\ M<: 8&JU[K(VM;KMO37O-'&T[\V*SW&;-6OHA5F;;M._#(NG<@8\SO7].%NR: MO._;0^/5R.FV7(*;:N^9578ALGE45=U/;;V/$W1P5/71A3JWSG]=[W13UPJG M379/KV+F5-W3-67[#-16'5XN6Z8O>9] YX&).3%JTZ3I^C@/6AL*H3^KHJ/Z+X/K>?W[GZQ-FC<>..;)'QI!9$UL?3>&S M#M08,&LX_3]8WW?Y6_.XI-8#NYW&S/GCEL+H=T[PY#PGJ-"JK =\MX+Y5:1M MIUX#1CXZ8M?Z?J*:(?IZS(UBDKP[4/(LYMUA/__TY9^_?/VB?/I9^?3K3Y_? M?;W_]/&+\WIF"_:-!XL$25EAVS)2@K9>:'3NCZI"-G4;P@#"KP2<4S&?@0 M!-$3JMWT*5(2]D :\$[YP#QT'I1/LYGO,AKP%W_&E"^NST+XXE<8&][U(_KI MRW]]^E53 CGX2%F#P@&#LY!PL%CEF1!2AH]RF)E672WYA1A@'N.">* M<1--^02S-5^+F!7@ ^L1 M YG TP@3&(L@7XAQ(CY.91%D(SRT8ODS\..C#US*69 XK/B-5" \/LT2(&0" MQDY%:_?$@@#_&R!LB8"M,DD)5#G=U >.=>=*X$Q1.*(8'RQGS+&5,F""5* # MB56LM+8^)P0E P+#0C^* 8Y'Q"\8U@6>=^#(Z=Q)\Z4IR1SY"W"]H!F#")D( M_P)B^R@0R'1B$'A 15(GW$HG*? D+MM%R:S R^)'0&V"_%D, YC!PT/ C[)T MGE&.$\(T01O3YYSWD>FJ\ +;(+M-V=P)9H0:R=(Q&"!A2\LYW&2 UD1>1,A9M307BD5<\%EPDW *89GLVY*%":NL M Z=W4L#+-*.= $X#8R^9ZP,,ZV-O9YX7G*8S,L_7NGZG92;9 I7(OPD7K*:7 M"P["OY@#E!+:NM#%*)7X5CJ/&5,6 , <7&U8I[?)3R=JP ?SKHW@B:]PZ[L2 M'"]<.[&2W%VDK;*+!G^9L+O\PUO/3Y:!\WSGAX09>NEM?<(-?>=I/OZS\)Q& MNC;01^@\B;"_F%CX51I@^H?U[RU3LXS)QI\&FM[R^XDU;O7&-J",@38TV@UU M&J#,S3]5AMJPX\\)#-J0G>>I%PZ#&D8N=CXV67ML0VR,2\9Y(CYK#CL_."(- M\8%KB)]*#:& G>7<-DZU/ MEOMS/&P-57UXCJ(CI\E_D*S6G:598W5@G..VQ"69I!V9B#TP21B]E=FJK=)W M!K:J&VUO!LHT\Q-=IQA/5&O2J294/=1I_7:S/T;A[1<>9)9W)UO=%%>MP3GN MU9XH(['>WJNQ\LA/HQ;*UGX*EAX.%('YIZ7!<_ PITQDBMYM#I/O#UW M[GS+]RL$W'#+X2*@ZPS#O-:KZK+V_$BINY3-=1-$2?*FR1G@T:M5=/S]'G)F MO\,8\K10'N&\N+2;L:KKYIMNA 0DEUTHE^D#=3CH5&7/'EHC>5!X74=1-X:A M&O:@N6Z69X2G(LQ8M8;#CA"FAYJLWWZU/![<5VZLD6J/1GUT-B^<,*:E6H;1 M$<+T4*'U^& 08UD8PSK3D>"QZO-T#Z&!:ZRH9 SJZ*C^*VLCO5 ;:=LE[)4R#>^CQ=*)>5&/ M1J^83>LKL6\N U7F@-+"^FM4,")X5K!ZQYM612$ZHA/^N5HO"D "90Q2JX+X MSUB,QWRBI)&?%$H#*YC,G? !"]+$6&L%T.TG0CL(M:%NJE9"8_("*+5WJNJF M94T.*MS2\&F3UPORV,P/26_@W%A#IBR^Q(%6$>J/G^YY 1;4J M[]6.\!$4>(?7;(%)$C?VE_G33_-GK!,S98'/'AD]YR.W*%1(*6/6<.&MF\C@X&EO[^[MVORL]%D:P/ M?)A$$X5U7N+2K75*-O'L:0N7V+9FC/G38B[G*HV MZ-I.G_/ P/76MNG[5%=V)B]S76468H/*"ZIA=:I_;/DJPF M6:U5\@YH-:LCN3LRJ:JDRT0;GY8J'6BF))/:9>[T[OI*0W6LGZ-9JTQL;W!- M9ZP:(U,2IY/$&:O#85N/4M+F-+09FEK;NE>'($T?#7Z_XTSR[L?>I>&,UF9? M[E1.0QOL)RQITTW:W$S&+6Z 2JJG+IHT^&,I]_\7N^V]^H<*7 M#[37A\F=@*'UQXJ6".3AVX1?N&^,P>6N= 62=*G$E0UYGMQ1VF#[R4&_]_FO MLPF=HTBXN+:][]_!_O'2X5@(&JMBAPK[5^:G6 ;/S6(?3:&*%:/ECK@-7K%D MM6Z\E:Y])ZECJ[K1]DA"TN9$5I&((Z]]=HXN\!_MQ-=QY5;X)/%O+#/,DI1W MC*!S;]X=0FZ!6Z6)P%9+UJCI)FV&JMXZO4K2YE2&19WLT>)-TN78=!F.VA1Q ME.?=>]G[2ALC,<0M/G]7=,X5;8MN)X=OM=72/1"]L)25;FPR'M H/CY6K;'< MUG2/,,.Q.K9EF:'N$6:BCB=28#I'%V.@G2.;I/NNP?G[^_;[J2N(M&#. 9ZP M+"+/GV&W4FJQ&2O,B8-G\*^PCV?F)_,\%]%CT_W.7:YVT[+?N8O<4IYLJS\8 MGSB'6M*E298(D$7*3"=IT_;<1<9A>N4-3-DLXFVRL1UWZGQ3;D2@M^^,B2E.V9NGB@# MJ88U:;V5/01FSK0%EN(@Q6'78=UHCTM!4ARD.%RB.)BF.AKHUR0.EQVV'IE: MV\C6=>1UG7^#T^^G)'HE>OO[E$2O1&]_GY+H/3YZ?T@=\%_SN^>5R_,+)W[P MP]S5U0UP36KWZ8<#S5J]4J_;9[A3;_!K2NC[K?\;+I1;)8Q29<$>94'] MMCW]/.9&,5U:NP/'E,7XU'=__< \]#253[.9[S)*5O_%GS'E MB^NS$+[X-8K3&>PMHGPEIP?_N[_>K:%Q!^.(KW!C9-4W$B[#8@C83QO9L'#6 M^48*UA(XRX3=Y1_>YBSLAP01O?2V/B%.L.*LTWS\Y[=/OI?.[T:V-C%&?_JN M4"]B8OZKKL$*?UC_WC"UX63S3P--;_F];0Q;O;$-*'VDC8VQ!*K'0)GFSJ%> M,(,].@C:O$/?L::- 8S)=RMZ(EE,) M^;U4;.?(/,@9ZCS2N9G-W@7!-OYJ$FF2>NCEP&_'&2#!Y,H/3NS.%5-7)7Y: MX$<*Q]93BFW$[QW]C8$Q;)+#TF3!UX0T4S*39*;C,-,5W(?X&J5.\-H^2L>^ M\MPH,:)S)ZFMN_6V1<.Y$[\E225)>T]2?;!G)U1)TP[3=,]K-4>EZ17DXG-O M(OE7YL1,F;$]VU!=;9[96!U9\NIZ=VDC^X5TDS:V.K0E;;I*&WO0MB_S@6AS M!=OW3ZZ;P:SNLZQ5T(HI)ZT3NB^DNI5DC9>V^,:UMI&7K/&2UI"L(5EC"VM8 M6MN-VX6P1IL\7[N+V9J3D3886FVS-?619@T/E>YGF=9!TOU&VFC2+G'P.F&R MM(EE2YAZ23L)4W]AZB*/ TRCW2,U3+YZ(4UBYV/6N%'&9XTU.#;T5Z>L=":SNQGVR\SNXZ13#S7K->G4AC8<'BJ= M>O]$I@9YI+T3NX]1>%L2_ZAY8&VEJACDM!+?*_*MYLDKGUF2!6F3W*R&K-XK M=!P>$7UEC/=12%+EI&!(7T#+">3K#'FDES1&+UANK;R3Q-@+&&L2.>T:*YY@ MC)Z!VZLQ>B$74I.\3I/TX0[8ZKI.

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�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�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end XML 76 dhc-20240331_htm.xml IDEA: XBRL DOCUMENT 0001075415 2024-01-01 2024-03-31 0001075415 dhc:SeniorNotesDue2042Member 2024-01-01 2024-03-31 0001075415 dhc:SeniorNotesDue2046Member 2024-01-01 2024-03-31 0001075415 2024-05-01 0001075415 2024-03-31 0001075415 2023-12-31 0001075415 us-gaap:SecuredDebtMember 2024-03-31 0001075415 us-gaap:SecuredDebtMember 2023-12-31 0001075415 us-gaap:UnsecuredDebtMember 2024-03-31 0001075415 us-gaap:UnsecuredDebtMember 2023-12-31 0001075415 dhc:RentalIncomeMember 2024-01-01 2024-03-31 0001075415 dhc:RentalIncomeMember 2023-01-01 2023-03-31 0001075415 dhc:ResidentFeesAndServicesMember 2024-01-01 2024-03-31 0001075415 dhc:ResidentFeesAndServicesMember 2023-01-01 2023-03-31 0001075415 2023-01-01 2023-03-31 0001075415 srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 us-gaap:CommonStockMember 2023-12-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001075415 us-gaap:RetainedEarningsMember 2023-12-31 0001075415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001075415 dhc:CumulativeCommonDistributionsMember 2023-12-31 0001075415 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001075415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2024-01-01 2024-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001075415 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001075415 us-gaap:CommonStockMember 2024-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001075415 us-gaap:RetainedEarningsMember 2024-03-31 0001075415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2024-03-31 0001075415 us-gaap:CommonStockMember 2022-12-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001075415 us-gaap:RetainedEarningsMember 2022-12-31 0001075415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001075415 dhc:CumulativeCommonDistributionsMember 2022-12-31 0001075415 2022-12-31 0001075415 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2023-01-01 2023-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001075415 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001075415 us-gaap:CommonStockMember 2023-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001075415 us-gaap:RetainedEarningsMember 2023-03-31 0001075415 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2023-03-31 0001075415 2023-03-31 0001075415 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2024-03-31 0001075415 dhc:SeniorLivingCommunitiesMember 2024-03-31 0001075415 dhc:JointVentureMember 2024-03-31 0001075415 dhc:MedicalOfficeMember stpr:AZ us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2024-03-31 0001075415 dhc:MedicalOfficeMember stpr:AZ us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2024-01-01 2024-03-31 0001075415 dhc:MedicalOfficeMember stpr:AZ us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2024-03-01 2024-03-31 0001075415 dhc:LifeScienceAndMedicalOfficeMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2024-03-31 0001075415 dhc:SeniorLivingCommunitiesMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2024-03-31 0001075415 dhc:PropertiesUnderAgreementToSellMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember us-gaap:SubsequentEventMember 2024-05-02 0001075415 dhc:MedicalOfficeMember 2024-01-01 2024-03-31 0001075415 dhc:MedicalOfficeMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember stpr:MA us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 us-gaap:CorporateJointVentureMember dhc:SeaportInnovationLLCMember 2024-03-31 0001075415 srt:MinimumMember dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember dhc:USSwapRateMember 2024-01-01 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember dhc:SecuredOvernightFinancingRateSOFRMember 2024-01-01 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:InterestRateCapMember us-gaap:CorporateJointVentureMember dhc:SecuredOvernightFinancingRateSOFRMember 2024-01-01 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember dhc:SecuredOvernightFinancingRateSOFRMember 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember 2024-01-01 2024-03-31 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember us-gaap:CorporateJointVentureMember 2024-01-01 2024-03-31 0001075415 us-gaap:CorporateJointVentureMember 2024-01-01 2024-03-31 0001075415 us-gaap:CorporateJointVentureMember 2023-01-01 2023-03-31 0001075415 dhc:AlerisLifeIncMember 2024-03-31 0001075415 dhc:AlerisLifeIncMember 2024-03-31 0001075415 dhc:AlerisLifeIncMember us-gaap:EquityMethodInvestmentsMember 2024-01-01 2024-03-31 0001075415 dhc:AlerisLifeIncMember 2024-01-01 2024-03-31 0001075415 us-gaap:MortgagesMember 2024-03-31 0001075415 dhc:FinanceLeasedPropertiesMember 2024-03-31 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2023-12-21 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2024-03-31 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2023-01-01 2023-01-31 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2023-01-31 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2023-02-28 0001075415 us-gaap:LineOfCreditMember us-gaap:UnsecuredDebtMember 2023-02-01 2023-02-28 0001075415 dhc:SeniorSecuredNoteDue2026Member us-gaap:SecuredDebtMember 2024-03-31 0001075415 dhc:SeniorSecuredNotesDueJanuary2026Member us-gaap:SecuredDebtMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes975PercentDue2025Member us-gaap:SeniorNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:SeniorNotesMember 2024-03-31 0001075415 dhc:UnsecuredDebtNotGuaranteedMember 2024-03-31 0001075415 dhc:SeniorSecuredNotesDueJanuary2026Member us-gaap:SecuredDebtMember 2024-01-01 2024-03-31 0001075415 dhc:SeniorSecuredNoteDue2026Member us-gaap:SecuredDebtMember 2024-01-01 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2023-12-31 0001075415 dhc:TheLSMDFundREITLLCMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2023-12-31 0001075415 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2024-03-31 0001075415 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-12-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2024-01-01 2024-03-31 0001075415 srt:MinimumMember dhc:TheLSMDFundREITLLCMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 srt:MaximumMember dhc:TheLSMDFundREITLLCMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 srt:MinimumMember dhc:TheLSMDFundREITLLCMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 srt:MaximumMember dhc:TheLSMDFundREITLLCMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2024-03-31 0001075415 dhc:TheLSMDFundREITLLCMember us-gaap:CorporateJointVentureMember 2024-01-01 2024-03-31 0001075415 dhc:MedicalOfficeMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember us-gaap:FairValueMeasurementsNonrecurringMember 2024-03-31 0001075415 dhc:MedicalOfficeMember us-gaap:FairValueMeasurementsNonrecurringMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes9.750PercentDue2024Member dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes9.750PercentDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes9.750PercentDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes9.750PercentDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes9.750PercentDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorSecuredNotesZeroCouponRateDue2026Member dhc:SeniorSecuredNotesMember 2024-03-31 0001075415 dhc:SeniorSecuredNotesZeroCouponRateDue2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorSecuredNotesMember 2024-03-31 0001075415 dhc:SeniorSecuredNotesZeroCouponRateDue2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorSecuredNotesMember 2024-03-31 0001075415 dhc:SeniorSecuredNotesZeroCouponRateDue2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorSecuredNotesMember 2023-12-31 0001075415 dhc:SeniorSecuredNotesZeroCouponRateDue2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorSecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2024-03-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2023-12-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SecuredDebtsAndFinanceLeasesMember 2024-03-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SecuredDebtsAndFinanceLeasesMember 2024-03-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SecuredDebtsAndFinanceLeasesMember 2023-12-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SecuredDebtsAndFinanceLeasesMember 2023-12-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2024-03-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2024-03-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-12-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-12-31 0001075415 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001075415 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001075415 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001075415 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001075415 dhc:ReitManagementAndResearchMember 2024-01-01 2024-03-31 0001075415 2024-02-15 2024-02-15 0001075415 us-gaap:SubsequentEventMember 2024-04-11 2024-04-11 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2024-03-31 0001075415 us-gaap:CorporateNonSegmentMember 2024-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0001075415 us-gaap:OperatingSegmentsMember dhc:MedicalOfficeAndLifeSciencePortfolioSegmentMember 2023-12-31 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2023-12-31 0001075415 us-gaap:CorporateNonSegmentMember 2023-12-31 0001075415 dhc:FiveStarQualityCareIncMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 dhc:FiveStarQualityCareIncMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 dhc:FiveStarQualityCareIncMember srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 dhc:FiveStarQualityCareIncMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 dhc:FiveStarQualityCareIncMember us-gaap:OperatingExpenseMember srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 dhc:FiveStarQualityCareIncMember us-gaap:OperatingExpenseMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 dhc:FiveStarQualityCareIncMember dhc:RehabilitationServicesMember srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 dhc:FiveStarQualityCareIncMember dhc:RehabilitationServicesMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 dhc:ThirdPartyManagersMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2024-01-01 2024-03-31 0001075415 dhc:ThirdPartyManagersMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2023-01-01 2023-03-31 0001075415 dhc:ThirdPartyManagersMember dhc:SeniorLivingCommunityMember srt:ScenarioForecastMember srt:AffiliatedEntityMember 2024-04-01 2024-06-30 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2024-01-01 2024-03-31 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2023-01-01 2023-03-31 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2024-01-01 2024-03-31 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2023-01-01 2023-03-31 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2024-01-01 2024-03-31 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2023-01-01 2023-03-31 0001075415 dhc:SeniorLivingCommunityMember dhc:ReitManagementAndResearchMember 2024-01-01 2024-03-31 0001075415 dhc:ReitManagementAndResearchMember 2023-01-01 2023-03-31 0001075415 dhc:DiversifiedHealthcareTrustMember dhc:ABPTrustAndMr.PortnoyMember 2024-03-31 0001075415 dhc:AlerisLifeIncMember us-gaap:RelatedPartyMember 2023-03-20 0001075415 dhc:AlerisLifeIncMember dhc:AlerisLifeIncMember 2023-03-20 0001075415 dhc:AlerisLifeIncMember 2023-02-02 2023-02-02 0001075415 dhc:AlerisLifeIncMember 2024-02-16 0001075415 dhc:AlerisLifeIncMember 2024-02-16 2024-02-16 0001075415 dhc:AlerisLifeIncMember dhc:ABPTrustMember 2024-02-16 0001075415 dhc:ReitManagementAndResearchLLCMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001075415 dhc:ReitManagementAndResearchLLCMember us-gaap:RelatedPartyMember 2024-03-31 0001075415 dhc:ReitManagementAndResearchLLCMember dhc:RentalIncomeMember 2024-01-01 2024-03-31 0001075415 dhc:ReitManagementAndResearchLLCMember dhc:RentalIncomeMember 2023-01-01 2023-03-31 shares iso4217:USD iso4217:USD shares dhc:property dhc:state dhc:jointVenture pure utr:sqft dhc:option dhc:security dhc:segment dhc:community dhc:employee dhc:agreement dhc:jointVenture_arrangement 0001075415 false --12-31 2024 Q1 http://fasb.org/us-gaap/2023#OtherAssets http://fasb.org/us-gaap/2023#OtherAssets http://fasb.org/us-gaap/2023#OtherLiabilities http://fasb.org/us-gaap/2023#OtherLiabilities 10-Q true 2024-03-31 false 1-15319 DIVERSIFIED HEALTHCARE TRUST MD 04-3445278 Two Newton Place, 255 Washington Street, Suite 300, Newton MA 02458-1634 617 796 - 8350 Common Shares of Beneficial Interest DHC NASDAQ 5.625% Senior Notes due 2042 DHCNI NASDAQ 6.25% Senior Notes due 2046 DHCNL NASDAQ Yes Yes Accelerated Filer false false false 240393722 641481000 652977000 6129767000 6165490000 6771248000 6818467000 2062327000 2020843000 4708921000 4797624000 130299000 129916000 38107000 9447000 207123000 245939000 1040000 1022000 15740000 0 31723000 33948000 215084000 228240000 5348037000 5446136000 751890000 731211000 2073757000 2072618000 12197000 13020000 218000 32000 23751000 22847000 237521000 269517000 3099334000 3109245000 0.01 0.01 300000000 300000000 240393722 240393722 240423898 240423898 2404000 2405000 4618950000 4618470000 1692019000 1778278000 -4000 0 4064666000 4062262000 2248703000 2336891000 5348037000 5446136000 62650000 66438000 308126000 279592000 370776000 346030000 307604000 286080000 70133000 64800000 7568000 5873000 86000 93000 12142000 5925000 397533000 362771000 -5874000 1233000 0 8126000 2237000 4195000 24863000 2074000 57576000 47780000 0 -1075000 -87970000 -52042000 187000 -31000 1898000 -647000 -86259000 -52658000 -4000 0 -4000 0 -86263000 -52658000 239193000 239193000 238589000 238589000 -0.36 -0.36 -0.22 -0.22 240423898 2405000 4618470000 1778278000 0 -4062262000 2336891000 -86259000 -86259000 -4000 -4000 2404000 2404000 558000 558000 30176 1000 78000 79000 240393722 2404000 4618950000 1692019000 -4000 -4064666000 2248703000 239694842 2397000 4617031000 2071850000 0 -4052667000 2638611000 -52658000 -52658000 2397000 2397000 270000 270000 5975 6000 6000 6400 1000 1000 239682467 2397000 4617294000 2019192000 0 -4055064000 2583819000 -86259000 -52658000 70133000 64800000 24863000 2074000 291000 2448000 28000 -311000 0 -1075000 12142000 5925000 -5874000 1233000 0 8126000 385000 674000 1231000 1411000 1898000 -647000 669000 1954000 -10102000 -15499000 904000 2540000 -7173000 -20525000 28602000 6042000 46723000 60292000 3343000 3548000 15459000 0 -58839000 -56744000 0 250000000 822000 538000 5257000 1990000 78000 6000 2404000 2397000 -8561000 -254931000 -38798000 -305633000 246961000 688302000 208163000 382669000 31809000 43166000 0 0 0 14006000 17369000 20195000 207123000 380117000 1040000 2552000 208163000 382669000 Basis of Presentation<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2023, or our Annual Report.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.</span></div> Recent Accounting Pronouncements<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2023, the FASB issued Accounting Standards Update, or ASU, No. 2023-07,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASU No. 2023-07, which requires public entities to: (i) provide disclosures of significant segment expenses and other segment items if they are regularly provided to the Chief Operating Decision Maker, or the CODM, and included in each reported measure of segment profit or loss; (ii) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by ASC 280, Segment Reporting, or ASC 280, in interim periods; and (iii) disclose the CODM’s title and position, as well as an explanation of how the CODM uses the reported measures and other disclosures. Public entities with a single reportable segment must apply all the disclosure requirements of ASU No. 2023-07, as well as all the existing segment disclosures under ASC 280. The amendments in ASU No. 2023-07 are incremental to the requirements in ASC 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU No. 2023-07 should be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact ASU No. 2023-07 will have on our consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASU No. 2023-09, which requires public entities to enhance their annual income tax disclosures by requiring: (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 should be applied prospectively but entities have the option to apply it retrospectively to all prior periods presented in the financial statements. ASU No. 2023-09 is effective for annual periods </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact ASU No. 2023-09 will have on our consolidated financial statements and disclosures.</span></div> <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2023, the FASB issued Accounting Standards Update, or ASU, No. 2023-07,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASU No. 2023-07, which requires public entities to: (i) provide disclosures of significant segment expenses and other segment items if they are regularly provided to the Chief Operating Decision Maker, or the CODM, and included in each reported measure of segment profit or loss; (ii) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by ASC 280, Segment Reporting, or ASC 280, in interim periods; and (iii) disclose the CODM’s title and position, as well as an explanation of how the CODM uses the reported measures and other disclosures. Public entities with a single reportable segment must apply all the disclosure requirements of ASU No. 2023-07, as well as all the existing segment disclosures under ASC 280. The amendments in ASU No. 2023-07 are incremental to the requirements in ASC 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU No. 2023-07 should be applied retrospectively to all prior periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact ASU No. 2023-07 will have on our consolidated financial statements and disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASU No. 2023-09, which requires public entities to enhance their annual income tax disclosures by requiring: (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 should be applied prospectively but entities have the option to apply it retrospectively to all prior periods presented in the financial statements. ASU No. 2023-09 is effective for annual periods </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact ASU No. 2023-09 will have on our consolidated financial statements and disclosures.</span></div> Real Estate and Other Investments<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we owned 371 properties located in 36 states and Washington, D.C., including four properties classified as held for sale and two closed senior living communities, and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Dispositions:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not acquire any properties during the three months ended March 31, 2024.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we sold one property for a sales price of $3,600, excluding closing costs, as presented in the table below. The sale of this property does not represent a significant disposition and we do not believe this sale represents a strategic shift in our business. As a result, the results of operations for this property are included in continuing operations through the date of sale of such property in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"></td><td style="width:14.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.332%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss on Sale</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Sales price excludes closing costs.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had four properties classified as held for sale in our condensed consolidated balance sheet as follows:</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"><tr><td style="width:1.0%"></td><td style="width:48.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.267%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real Estate Properties, Net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Office and Life Science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Living</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May 2, 2024, we had two properties under agreements to sell for an aggregate sales price of approximately $10,375, excluding closing costs. We may not complete the sales of any or all of the properties we currently plan to sell. Also, we may sell some or all of these properties at amounts that are less than currently expected and/or less than the carrying values of such properties and we may incur losses on any such sales as a result.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future undiscounted cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we recorded impairment charges of $12,142 related to two medical office properties that were classified as held for sale as of March 31, 2024.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments in Unconsolidated Joint Ventures:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had equity investments in unconsolidated joint ventures as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Carrying Value of Investment at March 31, 2024</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Square Feet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seaport Innovation LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,922 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134,479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The LSMD Fund REIT LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CA, MA, NY, TX, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,299 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,203,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the mortgage debts of these joint ventures:</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:52.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Balance at March 31, 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in Massachusetts) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11/6/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by nine properties in five states) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/11/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in California) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/9/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.22%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,625 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts are not adjusted for our minority equity interest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We provide certain guaranties on this debt.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This mortgage loan requires interest only payments until the anticipated repayment date on August 6, 2026, at which time all accrued and unpaid interest along with the principal balance of $620,000 is expected to be repaid. This mortgage loan matures on November 6, 2028 and any unpaid principal from the anticipated repayment date through the maturity date bears interest at a variable rate of the greater of 6.53% or the then effective U.S. swap rate for the swap terminating on the maturity date plus 5.00%.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The debt securing these properties is non-recourse to us.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This mortgage loan matures on February 9, 2025 and requires interest to be paid at an annual rate of the one month term secured overnight financing rate, or SOFR, plus a premium of 1.90%. This joint venture has also purchased an interest rate cap through February 2025 with a SOFR strike rate equal to 4.48% and an initial premium of $1,200. The maturity date of this mortgage loan is subject to two remaining one-year extension options.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the unconsolidated joint venture for 10 medical office and life science properties in which we own a 20% equity interest, or the LSMD JV, and the unconsolidated joint venture for a life science property located in Boston, Massachusetts in which we own a 10% equity interest, or the Seaport JV, using the equity method of accounting under the fair value option. During the three months ended March 31, 2024 and 2023, respectively, we recognized a $1,613 and $(647) change in the fair value of our investments in our unconsolidated joint ventures. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 6 for further information regarding the valuation of our investment in these joint ventures.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment in AlerisLife:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we owned approximately 34.0% of the outstanding common shares of AlerisLife Inc., or AlerisLife. We account for our 34.0% non-controlling interest in AlerisLife using the equity method of accounting. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, our investment in AlerisLife had a carrying value of $15,740. The cost basis of our investment in AlerisLife exceeded our proportionate share of AlerisLife's total stockholders' equity book value on the date of acquisition of our initial interest in AlerisLife, which was February 16, 2024, by an aggregate of $29,500. As required under GAAP, we are amortizing this difference to equity in earnings of an investee over 21 years, the weighted average remaining useful life of the real estate assets owned by AlerisLife and the intangible contract asset with us as of the date of acquisition. We recorded amortization of the basis difference of $174 for the three months ended March 31, 2024. We recognized income of $111 related to our investment in AlerisLife for the three months ended March 31, 2024. These amounts are included in equity in net earnings (losses) of investees in our condensed consolidated statements of comprehensive income (loss). See Note 11 for further information regarding our investment in AlerisLife.</span></div> 371 36 4 2 2 5 0 1 3600000 <div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"></td><td style="width:14.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.332%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss on Sale</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,874 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Sales price excludes closing costs.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had four properties classified as held for sale in our condensed consolidated balance sheet as follows:</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.602%"><tr><td style="width:1.0%"></td><td style="width:48.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.267%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type of Property</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real Estate Properties, Net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Office and Life Science</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Living</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1 3600000 5874000 4 3 34245000 1 1525000 4 35770000 2 10375000 12142000 2 <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had equity investments in unconsolidated joint ventures as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Carrying Value of Investment at March 31, 2024</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Square Feet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seaport Innovation LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,922 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134,479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The LSMD Fund REIT LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CA, MA, NY, TX, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,299 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,203,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the mortgage debts of these joint ventures:</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:52.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.759%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Balance at March 31, 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in Massachusetts) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11/6/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by nine properties in five states) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/11/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in California) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/9/2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.22%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,625 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts are not adjusted for our minority equity interest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We provide certain guaranties on this debt.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This mortgage loan requires interest only payments until the anticipated repayment date on August 6, 2026, at which time all accrued and unpaid interest along with the principal balance of $620,000 is expected to be repaid. This mortgage loan matures on November 6, 2028 and any unpaid principal from the anticipated repayment date through the maturity date bears interest at a variable rate of the greater of 6.53% or the then effective U.S. swap rate for the swap terminating on the maturity date plus 5.00%.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The debt securing these properties is non-recourse to us.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">This mortgage loan matures on February 9, 2025 and requires interest to be paid at an annual rate of the one month term secured overnight financing rate, or SOFR, plus a premium of 1.90%. This joint venture has also purchased an interest rate cap through February 2025 with a SOFR strike rate equal to 4.48% and an initial premium of $1,200. The maturity date of this mortgage loan is subject to two remaining one-year extension options.</span></div> 0.10 85922000 1 1134479 0.20 44377000 10 1068763 130299000 11 2203242 1 0.0353 620000000 9 5 0.0346 189800000 1 0.0638 266825000 0.0422 1076625000 620000000 0.0653 0.0500 0.0190 0.0448 1200000 2 P1Y 10 0.20 0.10 1613000 -647000 0.340 0.340 15740000 29500000 174000 111000 Leases<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases provide for base rent payments and, in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We increased rental income to record revenue on a straight line basis by $291 and $2,448 for the three months ended March 31, 2024 and 2023, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $74,704 and $75,306 of straight line rent receivables at March 31, 2024 and December 31, 2023, respectively, and are included in other assets, net in our condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $11,350 and $11,986 for the three months ended March 31, 2024 and 2023, respectively, of which tenant reimbursements totaled $11,284 and $11,924, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Right of Use Asset and Lease Liability:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $22,555 and $22,937, respectively, as of March 31, 2024, and $23,366 and $23,748, respectively, as of December 31, 2023. The right of use assets and related lease liabilities are included within <span style="-sec-ix-hidden:f-362"><span style="-sec-ix-hidden:f-363">other assets, net</span></span> and <span style="-sec-ix-hidden:f-364"><span style="-sec-ix-hidden:f-365">other liabilities</span></span>, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.</span></div> 291000 2448000 74704000 75306000 11350000 11986000 11284000 11924000 22555000 22937000 23366000 23748000 Indebtedness<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal debt obligations, excluding any debt obligations of our joint ventures, at March 31, 2024 were: (1) $2,100,000 outstanding principal amount of senior unsecured notes; (2) $940,534 outstanding principal amount of senior secured notes; and (3) $8,669 principal amount of mortgage debt secured by one property. The mortgaged property had a net book value of $13,466 at March 31, 2024. We also had two properties subject to finance leases that expire in 2026 with lease obligations totaling $3,528 at March 31, 2024; these two properties had an aggregate net book value of $22,365 at March 31, 2024.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until its repayment in full on December 21, 2023, we had a $450,000 credit facility that was fully drawn. As of December 21, 2023, our former credit facility was paid off in full and the related credit agreement was terminated. The weighted average annual interest rate for borrowings under our former credit facility was 7.6% for the three months ended March 31, 2023. In January 2023, pursuant to the credit agreement, we repaid $113,627 in outstanding borrowings under our former credit facility and the commitments were reduced to $586,373. In February 2023, we and our lenders amended the credit agreement to reduce the commitments from $586,373 to $450,000 following our repayment of $136,373 in outstanding borrowings under our former credit facility, and as a result of that reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $1,075 for the three months ended March 31, 2023.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, all $940,534 of our senior secured notes due 2026 are fully and unconditionally guaranteed, on a joint, several and senior secured basis, by certain of our subsidiaries that own 95 properties, or the Collateral Guarantors, and on a joint, several and unsecured basis, by all our subsidiaries other than the Collateral Guarantors and certain excluded subsidiaries, and all $500,000 of our 9.75% senior notes due 2025 and all $500,000 of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint, several and unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries. The notes and related guarantees (other than our senior secured notes and the guarantees provided by the </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collateral Guarantors) are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and the notes and related guarantees are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1,100,000 of senior unsecured notes do not have the benefit of any guarantees as of March 31, 2024.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior secured notes due 2026 and the guarantees provided by the Collateral Guarantors are secured by a first priority lien and security interest in each of the collateral properties and 100% of the equity interests in each of the Collateral Guarantors. No cash interest will accrue on these notes prior to maturity. The accreted value of these notes will increase at a rate of 11.25% per annum compounded semiannually on January 15 and July 15 of each year, such that the accreted value will equal the principal amount at maturity. During the three months ended March 31, 2024, we recognized discount accretion of $20,659 for our senior secured notes due 2026 in interest expense in our condensed consolidated statements of comprehensive income (loss). We have a one-time option to extend the maturity date of these notes by one year, to January 15, 2027, subject to satisfaction of certain conditions and payment of an extension fee. If we exercise this option, interest payments will be due semiannually during the extension period at an initial interest rate of 11.25% with increases of 50 basis points every 90 days these notes remain outstanding.</span></div> 2100000000 940534000 8669000 1 13466000 2 3528000 2 22365000 450000000 0.076 113627000 586373000 586373000 450000000 136373000 -1075000 940534000 95 500000000 0.0975 500000000 0.04375 1100000000 1 0.1125 20659000 P1Y 0.1125 0.0050 Fair Value of Assets and Liabilities<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain of our assets that are measured at fair value at March 31, 2024 and December 31, 2023, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:55.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.768%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Non-Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Real estate properties held for sale (Level 2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 10% equity interest we own in the Seaport JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 8.00%, an exit capitalization rate of 6.00%, a holding period of 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 20% equity interest we own in the LSMD JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 6.50% and 8.00%, exit capitalization rates of between 4.75% and 7.00%, holding periods of 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We have assets in our condensed consolidated balance sheets that are measured at fair value on a non-recurring basis. During the three months ended March 31, 2024, we recorded impairment charges of $12,142 to reduce the carrying value of two medical office properties that are classified as held for sale to their estimated sales price, less estimated costs to sell, of $19,744 under agreements to sell that we have entered into with third parties. See Note 3 for further information about impairment charges and the properties we have classified as held for sale.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the assets described in the table above, our financial instruments at March 31, 2024 and December 31, 2023 included cash and cash equivalents, restricted cash, certain other assets, senior unsecured notes, senior secured notes, secured debt and finance leases and certain other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:42.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 9.750% coupon rate, due 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,892 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,350 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured notes, zero coupon rate, due 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771,981 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.375% coupon rate, due 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 5.625% coupon rate, due 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 6.250% coupon rate, due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,699 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured debt and finance leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,020 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,837,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,444,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,816,849 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,399,525 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes unamortized net discounts, premiums and debt issuance costs.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the fair values of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs as defined in the fair value hierarchy under GAAP) as of March 31, 2024 and December 31, 2023. We estimated the fair values of our three issuances of senior unsecured notes due 2025, 2028 and 2031 and our issuance of senior secured notes due 2026 using an average of the bid and ask price on Nasdaq on or about March 31, 2024 and December 31, 2023 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.</span></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain of our assets that are measured at fair value at March 31, 2024 and December 31, 2023, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:55.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.768%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Non-Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Real estate properties held for sale (Level 2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 10% equity interest we own in the Seaport JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 8.00%, an exit capitalization rate of 6.00%, a holding period of 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 20% equity interest we own in the LSMD JV is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 6.50% and 8.00%, exit capitalization rates of between 4.75% and 7.00%, holding periods of 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers. See Note 3 for further information regarding this joint venture.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We have assets in our condensed consolidated balance sheets that are measured at fair value on a non-recurring basis. During the three months ended March 31, 2024, we recorded impairment charges of $12,142 to reduce the carrying value of two medical office properties that are classified as held for sale to their estimated sales price, less estimated costs to sell, of $19,744 under agreements to sell that we have entered into with third parties. See Note 3 for further information about impairment charges and the properties we have classified as held for sale.</span></div> 85922000 85699000 44377000 44217000 19744000 0 0.10 0.0800 0.0600 P10Y 0.20 0.0650 0.0800 0.0475 0.0700 P10Y 12142000 2 19744000 The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:<div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:42.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 9.750% coupon rate, due 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,892 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,350 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured notes, zero coupon rate, due 2026</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">751,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771,981 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384,110 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.375% coupon rate, due 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 5.625% coupon rate, due 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">211,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 6.250% coupon rate, due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,699 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,627 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured debt and finance leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,020 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,837,844 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,444,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,816,849 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,399,525 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes unamortized net discounts, premiums and debt issuance costs.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.</span></div> 0.09750 497892000 500350000 497454000 490750000 0 751890000 798419000 731211000 771981000 0.04750 495065000 405400000 494746000 384110000 0.04375 494060000 374350000 493845000 375000000 0.05625 343041000 200480000 342946000 211400000 0.06250 243699000 153600000 243627000 154000000 12197000 11638000 13020000 12284000 2837844000 2444237000 2816849000 2399525000 2 2 3 3 Shareholders' Equity<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Share Purchases:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we purchased an aggregate of 30,176 of our common shares, valued at a weighted average share price of $2.58 per common share, from certain former employees of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares. We withheld and purchased these common shares at their fair market values based upon the trading prices of our common shares at the close of trading on Nasdaq on the applicable purchase dates.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributions:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we declared and paid quarterly distributions to common shareholders as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.368%"><tr><td style="width:1.0%"></td><td style="width:20.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.255%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Distributions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 11, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 22, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 15, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2024, we declared a quarterly distribution to common shareholders of record on April 22, 2024 of $0.01 per share, or approximately $2,404. We expect to pay this distribution on or about May 16, 2024 using cash on hand.</span></div> 30176 2.58 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we declared and paid quarterly distributions to common shareholders as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.368%"><tr><td style="width:1.0%"></td><td style="width:20.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.255%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Distributions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 11, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 22, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 15, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 0.01 2404000 0.01 2404000 Segment Reporting<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in, and report financial information for, the following two segments: Medical Office and Life Science Portfolio and senior housing operating portfolio, or SHOP. We aggregate the operating results of our properties in these two reporting segments based on their similar operating and economic characteristics. Our Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities on our behalf.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also report “non-segment” operations, which consists of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:42.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283,416 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,338 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income tax expense and equity in net earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,726)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,964)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87,970)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86,259)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.403%"><tr><td style="width:1.0%"></td><td style="width:31.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,103,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,888 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,348,037 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:44.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346,030 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,858 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,098 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income tax benefit and equity in net losses of investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,055 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,544)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net losses of investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,408 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,544)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,658)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:32.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,866,422 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,134,978 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,736 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,136 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2 2 <div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:42.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">283,416 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,922 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,779 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,338 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397,533 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income tax expense and equity in net earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,726)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,964)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87,970)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,866)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86,259)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.403%"><tr><td style="width:1.0%"></td><td style="width:31.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834,609 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,103,540 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,888 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,348,037 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:44.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346,030 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,858 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,098 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,771 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,195 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,075)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) before income tax benefit and equity in net losses of investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,055 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,544)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,553)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net losses of investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,408 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,544)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,658)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:32.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medical Office and Life Science Portfolio</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,866,422 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,134,978 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444,736 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,136 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 54149000 0 8501000 62650000 0 308126000 0 308126000 54149000 308126000 8501000 370776000 23897000 283416000 291000 307604000 20740000 46922000 2471000 70133000 0 0 7568000 7568000 0 0 86000 86000 12142000 0 0 12142000 56779000 330338000 10416000 397533000 -5874000 0 0 -5874000 0 0 0 0 0 0 2237000 2237000 222000 68000 57286000 57576000 -8726000 -22280000 -56964000 -87970000 0 0 187000 187000 1613000 0 285000 1898000 -7113000 -22280000 -56866000 -86259000 1834609000 3103540000 409888000 5348037000 57022000 0 9416000 66438000 0 279592000 0 279592000 57022000 279592000 9416000 346030000 23515000 262329000 236000 286080000 20035000 42152000 2613000 64800000 0 0 5873000 5873000 0 0 93000 93000 2308000 3617000 0 5925000 45858000 308098000 8815000 362771000 0 1233000 0 1233000 0 0 8126000 8126000 0 0 4195000 4195000 109000 271000 47400000 47780000 0 0 -1075000 -1075000 11055000 -27544000 -35553000 -52042000 0 0 -31000 -31000 -647000 0 0 -647000 10408000 -27544000 -35522000 -52658000 1866422000 3134978000 444736000 5446136000 Senior Living Community Management Agreements<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages many of our SHOP communities. Five Star manages these communities for us pursuant to a master management agreement. AlerisLife guarantees the payment and performance of each of its applicable subsidiary's obligations under the applicable management agreements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with ABP Trust’s acquisition of AlerisLife on March 20, 2023, we amended the master management agreement with AlerisLife to eliminate any change of control default or event of default provisions. See Note 11 for further information regarding ABP Trust's acquisition of AlerisLife.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Senior Living Communities Managed by Five Star.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Five Star managed 119 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by Five Star to our taxable REIT subsidiaries, or TRSs.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred management fees payable to Five Star of $10,407 and $10,014 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $9,998 and $9,137, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $409 and $877, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred fees of $10 and $879 for the three months ended March 31, 2024 and 2023, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Senior Living Communities Managed by Other Third Party Managers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Several other third party managers managed 111 of our senior living communities as of both March 31, 2024 and 2023. We lease our senior living communities that are managed by these third party managers to our TRSs.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, we terminated our management agreement with one of our third party managers which manages certain of our communities located in Wisconsin and Illinois. We have transitioned these communities to another third party manager which we have an existing relationship with. The terms of the management agreement for these communities are generally consistent with the terms of the existing management agreements with our other third party managers. We paid termination and other fees of $1,106 during the second quarter of 2024, and expect to incur additional costs during 2024, related to the transition of these communities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred management fees payable to these third party managers of $5,725 and $5,238 for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:55.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.552%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue from contracts with customers:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic housing and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicaid programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,657 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private pay and other third party payer SNF services </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 119 119 10407000 10014000 9998000 9137000 409000 877000 10000 879000 111 111 1106000 5725000 5238000 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:55.421%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.552%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.555%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue from contracts with customers:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic housing and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,655 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,187 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicaid programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,657 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private pay and other third party payer SNF services </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308,126 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 243655000 222187000 23849000 21657000 40622000 35748000 308126000 279592000 Business and Property Management Agreements with RMR<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of many of our properties, including our medical office and life science properties, and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized net business management fees of $4,878 and $3,270 for the three months ended March 31, 2024 and 2023, respectively. The net business management fees we recognized for the three months ended March 31, 2024 include $849 of estimated incentive fees based on our common share total return, as defined in our business management agreement. Although we recognized estimated incentive fees in accordance with GAAP, the actual amount of annual incentive fees for 2024, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2024, and will be payable in January 2025. We did not incur any incentive fee payable for the year ended December 31, 2023. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized aggregate net property management and construction supervision fees of $1,904 and $1,992 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, $1,538 and $1,463, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $366 and $529, respectively, were capitalized as building </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,728 and $3,533 for these expenses and costs for the three months ended March 31, 2024 and 2023, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Agreements between our Joint Ventures and RMR.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have two separate joint venture arrangements with third party institutional investors, the Seaport JV and the LSMD JV. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures.</span></div> 0 2 4878000 3270000 849000 P3Y 1904000 1992000 1538000 1463000 366000 529000 3728000 3533000 2 Related Person Transactions<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the majority owned subsidiary of RMR. The Chair of our Board of Trustees and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and, until the acquisition of AlerisLife by ABP Trust on March 20, 2023, the chair of the board of directors and a managing director of AlerisLife, and currently the sole director of AlerisLife. Jennifer F. Francis, our other Managing Trustee, our former President and Chief Executive Officer and a former managing director of AlerisLife served as an officer of RMR until December 31, 2023 and will remain an employee of RMR until her retirement on July 1, 2024. Our current President and Chief Executive Officer and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and secretary of AlerisLife and, until March 20, 2023, a managing director of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees of other public companies to which RMR or its subsidiaries provide management services. Mr. Portnoy serves as the chair of the board and as a managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services. As of March 31, 2024, ABP Trust and Mr. Portnoy owned 9.8% of our outstanding common shares.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AlerisLife.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Until March 20, 2023, we were AlerisLife's largest stockholder, owning approximately 31.9% of AlerisLife's outstanding common shares, and ABP Acquisition LLC, or ABP Acquisition, a subsidiary of ABP Trust, together with ABP Trust, owned approximately 6.1% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own. RMR provides management services to both us and AlerisLife.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 2, 2023, AlerisLife entered into an Agreement and Plan of Merger, or the ALR Merger Agreement, with certain subsidiaries of ABP Trust, pursuant to which ABP Trust acquired all of the publicly held outstanding AlerisLife common shares at a price of $1.31 per share by tender offer.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the ALR Merger Agreement, on February 2, 2023, we agreed to tender all the AlerisLife common shares that we and our subsidiary then owned, into the tender offer at the tender offer price, subject to the right, but not the obligation, to purchase, on or before December 31, 2023, AlerisLife common shares at the tender offer price, and otherwise pursuant to a stockholders agreement to be entered into at the time of any such purchase. On December 20, 2023, we and ABP Trust extended our right to purchase AlerisLife common shares until March 31, 2024.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2024, we exercised this purchase right and acquired, together with our applicable TRS, approximately 34.0% of the then outstanding AlerisLife common shares from ABP Trust at the tender offer price, for a total purchase price of $14,890, and we, our applicable TRS, ABP Trust and AlerisLife entered into a stockholders agreement. Following this acquisition, ABP Trust owns the remaining approximately 66.0% of AlerisLife.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Joint Ventures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In connection with our entering into the LSMD JV in January 2022, we paid mortgage escrow amounts and closing costs that were payable by that joint venture. The remaining costs totaled $6,080 as of March 31, 2024 and are included in other assets, net, in our condensed consolidated balance sheet. RMR provides management services to each of the Seaport JV and the LSMD JV. See Note 10 for further information regarding those management agreements with RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Manager, RMR.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases with RMR.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We lease office space to RMR in certain of our properties for RMR’s property management offices. We recognized rental income from RMR for this leased office space of $109 and $61 for the three months ended March 31, 2024 and 2023, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information about these and other such relationships and certain other related person transactions, see our Annual Report.</span></div> 0.098 0.319 0.061 1.31 0.340 14890000 0.660 6080000 2 109000 61000 Income Taxes<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended March 31, 2024 and 2023, we recognized income tax expense of $187 and benefit of $31, respectively.</span></div> 187000 -31000 Weighted Average Common Share<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">s</span><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share.</span></div> Restricted cash consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties.